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Abstract 
Multimetallic Emitters for Bioimaging and Display Applications 
Ruth Daniels 
 
The luminescent properties of transition metal complexes of heavy metals such as platinum(II) 
and irdium(III) are often highly luminescent and therefore are interesting for use as 
phosphorescent dopants in organic light-emitting diodes (OLEDs) and as luminescent probes in 
bioimaging. The majority of complexes investigated to date contain only one metal centre with 
multimetallic complexes becoming more widely studied in recent decades.  
 
This work explores the synthesis of novel dinuclear emitters based on cyclometallated Pt(II) and 
Ir(III) centres. In particular, complexes in which the metal centres are rigidly-linked via 
cyclometallating bridging ligands. The complexes described in this work are highly luminescent 
with high quantum yields in degassed solution and relatively short luminescence lifetimes.  
 
Dinuclear platinum(II) complexes linked via pyrimidine-based bis-bidentate ligands 
incorporating mono- and bis-thiophene cyclometallating units have been prepared and their 
photophysical properties investigated. These complexes were observed to emit in the orange (610 
nm) and near-infrared (730 nm) regions of the spectrum for the mono- and bis-thiophene 
respectively, with relatively high quantum yields (ϕ = 0.15–0.85).  
 
 
 
A further dinuclear platinum(II) complex, rigidly-linked via a bis-tetradentate bridging ligand 
offering O^N^C^N coordination, was successfully prepared. To the best of our knowledge, this 
is the first example of di-platinum(II) complex in which the two metal centres are linked via this 
type of bridging ligand.  
 
 ii 
 
 
 
 
Dinuclear iridium(III) complexes linked via bis-bidentate bridging ligands based on the central 
heterocycle pyrimidine have been prepared. These pyrimidine-linked complexes exhibited high 
quantum yields in degassed dichloromethane solution at room temperature, in the range 0.88-1.0. 
A representative structure is shown below. Variation of the monodentate chloride ligands to 
alternative ligands such as cyanide and acetonitrile was also investigated. Incorporation of a 
cyanide ligand was observed to blue-shift the emission relative to the analogous chloro complex.  
 
 
 
The effect of varying the central heterocycle of the bis-bidentate bridging ligand was investigated. 
The identity of the central heterocycle of the bridging ligand has been shown to have significant 
effects on the properties of the resulting dinuclear Ir(III) complexes, as is discussed below. 
 
Di-iridium(III) complexes linked via 2,5-pyrazine based bridging ligands have been successfully 
prepared. However, photodegradation of the complexes was observed in chlorinated solvents. To 
resolve this problem, a bis-bidentate bridging ligand incorporating a thiazolo[5,4]thiazole core 
was employed and the resulting di-iridium complex showed improved photostability. 
 
 iii 
 
 
 
A 2,3-pyrazine-linked dinuclear iridium complex was synthesised and was observed to have a 
twisted geometry at room temperature and therefore, is chiral. Through a high-temperature NMR 
experiment, it was shown that this complex racemises at 80 °C.  
 
 
 
Finally, incorporating pyridazine as the central heterocycle leads to the sharing of a monodentate 
chloride ligand between the two iridium centres. This leads to the formation of a cationic dinuclear 
iridium(III) complex. This complex was investigated as a luminescent probe in bioimaging. 
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Chapter 1 
Introduction  
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1.0 Introduction 
Interest in luminescent complexes of second and third row transition metals has increased greatly 
in recent decades.1 A large number of research groups have reported on the synthesis, 
characterisation and photophysical properties of a wide range of complexes, particularly of 
ruthenium(II), platinum(II) and iridium(III). 
 
 
Figure 1: A figure to show the structure of [Ru(bpy)3]2+ and fac-Ir(ppy)3. These luminescent metal complexes and their 
derivatives have been extensively studied and have been utilised in a number of applications.  
 
The increase in studies of such complexes can be attributed to their potential to be utilised for a 
wide range of applications such as organic electronic devices, chemical sensors, bio-imaging and 
photocatalysis.2 The most popular contemporary application is in organic light-emitting diode 
(OLED) devices. These devices have become widely studied for use in display and lighting 
technology and have most recently been used in products such as mobile phones and flat-screen 
televisions.3 
 
The suitability of these types of luminescent metal complexes for such applications originates 
from their favourable photophysical properties in addition to good chemical and photochemical 
stability and, in some cases, colour tunability of emission across the entire visible spectrum.2  
 
This research is concerned with the synthesis and characterisation of multimetallic triplet emitters 
for use in applications such as bio-imaging and OLEDs. Relative to the study of monometallic 
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luminescent transition metal complexes, there have been fewer investigations of multimetallic 
complexes, in particular those in which the metal centres are rigidly linked.  
 
In this chapter, a review of the literature will discuss the development of luminescent transition 
metal complexes; briefly discussing the synthesis and photophysical properties of monometallic 
compounds before explaining in more detail the research carried out relating to multimetallic 
complexes. The advantages of multimetallic complexes over their monometallic counterparts will 
also be reviewed. 
 
1.1 Luminescence Principles 
Luminescence is the emission of light by a substance where the original energy source is not heat 
(incandescence). Luminescence can be caused by the energy generated by exothermic chemical 
reactions (chemiluminescence) or electrical energy (electroluminescence). The metal complexes 
discussed here are photoluminescent in that the source of energy is the absorption of photons, 
although electroluminescence is also possible in some cases.  
 
In the case of a transition metal complex, features of luminescence are dependent on the metal 
and ligand components of the complex. The molecular orbitals formed on the combination of 
specific metal and ligand orbitals often have either dominant metal or ligand character. The 
mixing of ligand and metal character coupled with the order of the molecular orbitals influences 
the nature of the lowest energy transition (Figure 2) and therefore, the properties of luminescence. 
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Figure 2: Molecular orbital diagram for an octahedral metal complex, depicting the transitions possible upon excitation.  
 
1.1.1 Absorption 
As a photon of a particular energy is absorbed, the molecule is promoted to an excited state 
through a transition corresponding to the energy of the photon absorbed. As shown in Figure 2, 
octahedral complexes like those formed by Ir(III) and Ru(II) can have four possible transitions to 
form excited states. These transitions are metal-to-ligand charge transfer (MLCT), ligand-to-
metal charge transfer (LMCT), ligand-centred (LC) and metal-centred (MC). The identity of the 
lowest excited state is determined by the ordering of the molecular orbitals which in turn is 
directly related to the molecular structure of the metal complex. Methods of synthetically 
modifying the structure of a transition metal complex in order to adjust the energies of the 
molecular orbitals will be discussed in later sections of this review. 
The energy stored in the excited state of the molecule following absorption can be lost radiatively 
through luminescence or non-radiatively through processes such as vibrations and rotations. 
These processes have rate constants kr and knr respectively. 
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1.1.2 Emission 
There are two types of photoluminescence; fluorescence (singlet-singlet) and phosphorescence 
(triplet-singlet). 
 
 
Figure 3: A Jablonski diagram to illustrate the electronic and vibrational transitions that occur in emission of both 
fluorescence and phosphorescence, following absorption of a photon. Solid downward arrows represent radiative 
processes, whereas dashed arrows correspond to non-radiative processes.  
 
Considering the Jablonski diagram shown in Figure 3, in the case of fluorescence, a photon is 
absorbed and the metal complex is promoted to a singlet excited state (S2). Non-radiative 
relaxation of this excited state, through thermal vibrations and rotations, to a lower vibrational 
state of the same electronic state or internal conversion (IC) to a lower electronic level (S1) can 
then occur. This is followed by emission of light due to radiative relaxation from the lowest 
excited state. Fluorescence is a spin-allowed process.  
 
For phosphorescence, the molecule is similarly promoted to a singlet state (S2) on absorption of 
a photon before relaxing to a lower electronic excited state (S1). Unlike in fluorescence, 
intersystem crossing (ISC) then occurs. This is a transition to a state with a different spin 
multiplicity (T1) and is of more importance in molecules that exhibit large spin-orbit coupling 
(SOC) constants. The large SOC constant resulting from the presence of a heavy metal ion leads 
to more efficient intersystem crossing and relaxation of the spin selection rule. Therefore, the 
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radiative rate constant (kr) for the formally spin-forbidden process phosphorescence, relaxation 
from the T1 state to the ground state S0, is increased and phosphorescence becomes observable at 
room temperature.  
 
Emission via phosphorescence is advantageous for applications. In the case of OLEDs, the ability 
to harvest triplet excited states increases the theoretical efficiency of devices to 100% (statistically 
shown to be limited at 25% in fluorescence-based devices).4 In addition, the longer lifetime of 
triplet excited states results in the ability to distinguish triplet emission from short-lived 
autofluorescence in bio-imaging applications.5 
 
1.1.3 Non-Radiative Processes 
A high rate of non-radiative decay of excited state energy via processes such as vibrations and 
rotations is promoted by a large difference in geometry of the metal complex between the ground 
state and the excited state. One of the main ways in which distortion can occur is through 
population of antibonding metal-centred (MC) eg orbitals. In an octahedral metal complex, a small 
value of Δo results in d-d excited states (eg) that are close in energy to lower-lying excited states 
such as metal-to-ligand charge transfer (MLCT) states (π*).  
 
 
Figure 4: An energy diagram to illustrate how a MC d-d state close in energy can lead to deactivation of a lower-lying 
MLCT state.  
 
ΔE 
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Upon excitation to a MLCT state, these close MC states can be thermally populated at room 
temperature, leading to a large degree of distortion of the metal complex and deactivation of the 
lower-lying state through vibrations. This results in a loss of luminescence. 
 
1.1.4 Measurable Luminescence Quantities 
Experimentally measurable parameters, lifetime of emission (τ) and quantum yield (ϕ), are related 
to the radiative and non-radiative rate constants and are therefore used to quantify observed 
luminescence. The equations relating τ and ϕ to the rate constants are shown below. 
 
𝜏𝑜𝑏𝑠 =  
1
𝑘𝑟+ 𝑘𝑛𝑟
      and      𝜙 =  𝑘𝑟  ×  𝜏𝑜𝑏𝑠 
 
1.2 Monometallic Transition Metal Complexes 
Luminescent metal complexes containing a single metal centre in which the metal centre is 
chelated by ligands such as those shown in Figure 5 have been studied by a large number of 
research groups.  
 
 
Figure 5: A figure to show the most common chelating ligands used in the synthesis of transition metal complexes. 
Many derivatives of these ligands have now been synthesised and utilised in the preparation of such complexes. 
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Initially the majority of work was focussed on complexes of ruthenium(II) and osmium(II) with 
polypyridyl ligands.6-9 In recent decades, many research groups have begun working on 
complexes of Pt(II) and Ir(III). The interest in complexes of heavy transition metals was initially 
sparked by the study of [Ru(bpy)3]2+ and today is sustained by their potential application in many 
areas of applied chemistry.9, 10  
 
The growing number of applications for which complexes of heavy transition metals can be 
utilised has resulted in complexes of platinum(II) and iridium(III) being intensively studied. 
Initially, the focus was on the synthesis of complexes incorporating polypyridyl ligands such as 
2,2′-bipyridine (bpy), 1,10-phenanthroline (phen) and 2,2′:6′,2″-terpyridine (tpy). More recently 
the focus has shifted to Pt(II) and Ir(III) complexes of cyclometallating ligands such as 2-
phenylpyridine (ppy) and 1,3-dipyridylbenzene (dpyb).5, 11-30  
Cyclometallating ligands have significant advantages over their polypyridyl analogues. During 
the cyclometallation reaction, proligands such as 2-phenylpyridine form five-membered 
metallacycles through the activation of the C-H bond of the phenyl ring ortho to the 2-pyridyl 
fragment. This reaction involves abstraction of a proton and consequently, cyclometallating 
ligands are anionic and form very strong, covalent metal-carbon bonds. In 2-phenylpyridine, for 
example, the C- atom is a very strong σ-donor whilst the pyridyl moiety is a good π-acceptor, 
meaning that such ligands offer a very strong ligand-field. Incorporation of cyclometallating 
ligands means that the higher-lying metal-centred d-d excited states of a complex, which act as a 
major pathway for the non-radiative deactivation, are raised in energy and much less likely to be 
thermally populated at room temperature. As result, excited state energy is more likely to be lost 
radiatively, leading to the high quantum yields observed for metal complexes of cyclometallating 
ligands.19, 31, 32  
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Figure 6: A figure to illustrate the effect of cyclometallating ligands on the photophysical properties of a square planar 
Pt(II) complex. The luminescence from the terpyridyl platinum(II) complex is lost via population of low-energy 
deactivating MC d-d states. The cyclometallating ligand in the cyclometallated analogue raises the energy of the d-d 
states as discussed above. Therefore, emission is observed in solution at room temperature.17, 20, 33   
 
Additionally, the ability to tune the emission energy and hence the colour of emission is greatly 
improved with the incorporation of cyclometallating ligands. The shift of the 3MC excited states 
to higher energy increases the scope for variation in the size of the energy gap between the highest 
occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO) of a 
complex. As a result the colour tunability of the metal complex is increased.11, 32, 34 Generally, the 
ease of tuning the emission energy of a metal complex containing cyclometallating ligands is also 
facilitated by the distinct localisation of the HOMO and LUMO on separate moieties of the 
molecule as shown in Figure 7. This means that the selective functionalisation of the aryl or 
pyridyl rings will exclusively alter the energies of either the HOMO or LUMO and therefore, the 
energy of the emission of the transition metal complex.31, 35  
 
 
Figure 7: An illustration of the localisation of the HOMO and LUMO on the general structure of a cyclometallated 
metal complex in which 2-phenylpyridine is the ligand. The same localisation of the HOMO and LUMO occurs with 
complexes of other cyclometallating ligands. Generally, the HOMO is localised on the metal centre and the 
cyclometallated aryl ring of the ligand. The LUMO is localised on the heterocycle, the pyridyl moiety in this case.  
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As previously stated, transition metal complexes of cyclometallating ligands such as 2-
phenylpyridine and 1,3-dipyridylbenzene are now widely investigated with studies of both their 
structural and phototphysical properties carried out. In the following sections, the synthetic 
methods and photophysical properties of monometallic Pt(II) and Ir(III) complexes incorporating 
bidentate and terdentate ligands, including the strategies employed in refining them for use as 
emitters in an array of applications, will be discussed.  
 
1.2.1 Platinum(II) and Iridium(III) Complexes of Cyclometallating Bidentate Ligands 
Homoleptic and heteroleptic cyclometallated complexes of both Pt(II) and Ir(III) bearing 
bidentate ligands such as 2-phenylpyridine and its derivatives have been observed to be highly 
luminescent in fluid solution and tunable across the visible spectrum.31  
 
In the 1980s, it was first observed that mononuclear square planar d8 complexes, such as those of 
platinum(II), could be obtained as luminescent species, even in solution at room temperature. Key 
to this is ensuring that there is a large enough energy gap between the lowest excited state and the 
deactivating MC d-d states, as discussed previously. Cyclometallated Pt(II) complexes are 
characterised by high quantum yields and long-lived excited states with emission thought to 
originate from excited states that are predominantly of 3LC character mixed with 1MLCT 
character through the strong spin-orbit coupling of the heavy transition metal.13, 36 
Homoleptic bis-cyclometallated platinum(II) complexes, for example cis-[Pt(ppy)2], were first 
prepared in low yield by the treatment of trans-[PtCl2(SEt2)2] with the lithiated ligand, for 
example 2-(o-phenyl-pyridine)lithium. The range of bis-cyclometallated platinum(II) complexes 
reported by Von Zelewsky et. al. are shown in Figure 8.37-39  
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Figure 8: Bis-cyclometallated platinum(II) complexes prepared by Von Zelewsky and co-workers.37-40  
 
Attempts to prepare homoleptic platinum(II) complexes of the type shown above by the treatment 
of the 2-arylpyridines with K2PtCl4 did not lead to formation of the homoleptic complexes, but 
the isolation of cyclometallated complexes with the general formula [Pt(C^N)(HC^N)Cl] in high 
yield. The molecular structure of these complexes include one cyclometallated C^N ligand, a 
monodentate chloride ligand and one HC^N ligand acting as a N-donor with a pendant, non-
coordinating aryl ring as is illustrated in Figure 9, using 2-phenylpyridine as an example.41, 42   
 
 
Figure 9: Reaction scheme to show the platinum(II) complex isolated on the reaction of 2-phenylpyridine with 
potassium tetrachloroplatinate.  
 
Luminescence of the bis-cyclometallated Pt(II) complexes of the type shown in Figure 8 is only 
observed at 77 K in a rigid acetonitrile matrix, with lifetimes in the μs range. The exception to 
this is [Pt(thpy)2] for which a quantum yield of 0.30 was recorded in acetonitrile solution at room 
temperature.  
Given that homoleptic, bis-cyclometallated platinum(II) complexes exhibit poor luminescence 
efficiency, the focus shifted to heteroleptic complexes of Pt(II) in order to acquire more emissive 
platinum(II) complexes. Heteroleptic complexes with the general formula [Pt(C^N)(LX)] have 
several advantages over their homoleptic counterparts. Physical properties of the complexes such 
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as the charge and solubility can be varied through appropriate selection of the ancillary ligand. 
Additionally, the ancillary ligand gives further control over the identity of the lowest energy 
excited state. Through substitution of electron-donating or -withdrawing groups on the LX ligand, 
the amount of electron density on the metal centre can be altered. This leads to variation in the 
amount of MLCT character mixed into the lowest energy transition and therefore, modification 
of both the emission colour and luminescence lifetime.43  
In 1995, Pt(II) complexes of cyclometallating ligands 2-phenylpyridine and 2-thienylpyridine 
were reported where the ancillary LX ligands incorporated were based on the N^N ligands 2,2-
bipyridine and ethylene diamine. It was found that the identity of the ancillary ligand altered the 
nature of the emitting state of the final complex.44  
β-Diketonate ligands such as acetyl acetonate (acac) and dipivolylmethane (dpm) are also widely 
utilised as ancillary ligands in heteroleptic platinum(II) complexes. The synthetic procedure used 
in the preparation of such complexes is shown in Figure 10. 
 
 
Figure 10: A reaction scheme to show the synthetic route used in the preparation of heteroleptic [Pt(C^N)(LX)] 
complexes in which the LX ligand is a β-diketonate ligand. In this example, 2-phenylpyridine is shown as the 
cyclometallating ligand.43  
 
In 2002, Thompson et.al. reported the synthesis of a series of complexes with the general structure 
[Pt(C^N)(O^O)], as shown in Figure 11. All of the complexes were highly luminescent in frozen 
glass solution at 77 K with several also being emissive in degassed solutions at room temperature 
(ϕ = 0.02–0.25). The highly structured emission spectra observed and luminescence lifetimes 
measured, in the microsecond range, are consistent with emission originating from an excited 
state with mixed 3LC-MLCT character.13, 43 
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Figure 11: A figure to show the cyclometallating and β-diketonate ligands used to prepare [Pt(C^N)(O^O)] 
complexes.43 
 
It was reported by Thompson and co-workers that the photophysical properties of the heteroleptic 
platinum(II) complexes, bearing combinations of the C^N and β-diketonate ligands shown above, 
are strongly governed by the nature of the cyclometallating ligand and the substituents present on 
the C^N system. It was observed that variation of the β-diketonate ligands, acac and dpm, had no 
significant effect on the emission characteristics of the final complexes.43  
In 2011, Huang and co-workers reported the study of heteroleptic platinum(II) complexes of four 
different β-diketonate ligands; NDBM, NPTPD, DBM, and CPNPD, as shown in Figure 12. These 
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particular O^O-coordinating ligands were chosen as they have triplet-state energy levels lower in 
energy than those of acac and dpm. In order to investigate the effect of this on the excited state 
properties of the final heteroleptic Pt(II) complexes, the photophysical properties of the four Pt(II) 
complexes were investigated and compared with those of [Pt(ppy)(acac)]. The four heteroleptic 
Pt(II) complexes exhibited intense luminescence in solution at room temperature with quantum 
yields in the range ϕ = 0.02–0.11. The photophysical properties showed that the excited state from 
which these complexes emit can be attributed to mixtures of 3MLCT, 3LLCT and 3LC/ILCT. It 
was observed that the excited state properties of the Pt(II) complexes could be significantly tuned 
through variation of the β-diketonate ligand with emission wavelengths ranging from blue-green 
(485 nm) to yellow (550 nm).45 
 
 
Figure 12: Series of heteroleptic Pt(II) complexes reported by Gao and co-workers bearing 2-phenylpyridine as the 
cyclometallating ligand and incorporating four different β-diketonate ligands. 
 
The homoleptic and heteroleptic platinum(II) complexes described in this section are facile to 
synthesise, charge neutral and air stable. Additionally, the ability to tune the absorption and 
emission wavelength through independent variation of the cyclometallating and ancillary ligands 
offers further benefits. Consequently, these cyclometallated complexes are good candidates for 
utilisation in applications, for example, optoelectronic devices.  
  
Similarly to the Pt(II) complexes already discussed in this section, homoleptic and heteroleptic 
complexes of iridium(III) incorporating bidentate cyclometallating ligands have also been 
intensively studied.  
 15 
 
The earliest and now most widely studied example of a homoleptic Ir(III) complex was reported 
in 1985 by Watts et. al. The tris-cyclometallated complex, fac-[Ir(ppy)3], is a bright green emitter 
with phosphorescence originating from an excited state with predominantly 3MLCT character. 
The quantum yield for fac-[Ir(ppy)3] was originally reported as ϕ = 0.40 in degassed toluene 
solution at room temperature, however, this value has now been revised upwards to ϕ = 0.97. This 
homoleptic Ir(III) complex was first synthesised via the reaction of Ir(acac)3 with an excess of 
ppyH in glycerol at reflux. A further two synthetic methods that have been reported for the 
preparation of homoleptic iridium(III) complexes as shown in Figure 13. Methods B and C offer 
advantages over method A. For example, the (C^N)2Ir(O^O) and dichloro-bridged dimers can be 
prepared in high yield from IrCl3.H2O, a relatively cheaper starting material than Ir(acac)3. 
Secondly, methods B and C give higher yields of the desired Ir(C^N)3 product (80-85% vs. 45-
60%).23, 24, 31, 34, 46  
 
 
Figure 13: Reaction schemes to show the three synthetic routes that can be used in the preparation of homoleptic tris-
cyclometallated iridium(III) complexes such as fac-Ir(ppy)3.24 
  
The synthetic routes shown above have been extended to homoleptic iridium(III) complexes of a 
wide range of cyclometallating ligands. A selection of the bidentate C^N-coordinating ligands 
reported in the literature are shown in Figure 14, incorporating different aryl and heterocyclic 
rings in conjunction with a variety of electron-donating and -withdrawing substituents.  
 
μ 
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Figure 14: A figure to show a selection of homoleptic Ir(C^N)3 complexes reported in the literature and their emission 
maxima recorded at 298 K.24, 47, 48  
 
The structural and electronic properties of the cyclometallating ligands have a significant effect 
on the photophysical properties of the Ir(C^N)3 complex. The introduction of electron-
withdrawing fluoro- groups as with 4,6-dfppy results in a blue-shift of the emission of Ir(4,6-
dfppy)3 (468 nm) relative to the emission of the unsubstituted Ir(ppy)3 (510 nm). Conversely, 
incorporating electron-donating substituents results in a red-shift of the emission. For example, 
variation of the phenyl ring of ppy to an electron-rich thiophene ring in thpy results in a red-shift 
of 40 nm. Increasing the size of the conjugated aromatic system of a cyclometallating ligand also 
results in a red-shift of the emission. As shown in Figure 14, the homoleptic complex Ir(piq)3 
bearing an isoquinoline group rather than a pyridyl ring displays emission of 620 nm, a red-shift 
of 110 nm compared with Ir(ppy)3.24, 47  
Homoleptic Ir(III) complexes are formed as a mixture of facial (fac) and meridional (mer) isomers 
in which the configuration of the C^N ligands around the iridium centre is as shown below.  
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Figure 15: A figure to show the general structures of the facial and meridional isomers formed in the preparation of 
homoleptic iridium(III) complexes.  
 
Thompson et. al. reported the selective synthesis of facial or meridional isomers of Ir(C^N)3 
complexes bearing cyclometallating ligands derivatised from 2-phenylpyridine and 2-
phenylpyrazole. Their corresponding photophysical properties were also investigated. It was 
found that the reaction conditions imparted significant control over the configuration of the 
homoleptic iridium(III) complex. In general, at higher temperatures (> 200 °C) it is predominantly 
the facial isomer that is formed with the meridional isomer being the main product formed at 
lower temperatures (< 150 °C). This, coupled with the fact that the meridional isomer can be 
efficiently converted to the facial isomer at higher temperatures, suggests that the meridional 
isomer is the kinetic product with the facial isomer being the thermodynamic product. The two 
different isomers were also observed to have significantly different photophysical properties. The 
meridional isomers display emission spectra that are broader and red-shifted compared with those 
of the facial isomers. In addition, for the meridional isomers, the phosphorescence quantum yields 
are lower and much shorter luminescent lifetimes are observed.24 
Homoleptic iridium(III) complexes, as discussed above, are easily synthesised with control over 
the configuration of the product possible through careful selection of the reaction conditions. They 
exhibit good photophysical properties and the ability to tune the emission of such complexes over 
much of the visible spectrum means that this class of iridium(III) complexes are good candidates 
for applications such as OLEDs. For example, Thompson et. al. reported OLEDs based on 
Ir(ppy)3 to have internal quantum efficiencies of greater that 80%.49  
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A second class of highly phosphorescent, tris-chelated iridium(III) complexes reported in the 
literature are heteroleptic complexes in which the Ir(III) centre is bound to two cyclometallating 
ligands and one ancillary ligand, anionic or neutral. The selection of an anionic LX ancillary 
ligand such as a β-diketonate leads to formation of a neutral complex, whereas incorporation of a 
neutral ancillary ligand such as a diimine ligand gives a cationic Ir(III) complex.31  
In the synthesis of homoleptic iridium(III) complexes, it was found that many of the 
cyclometallating ligands that could be incorporated into Ir(III) phosphors do not lead to the 
formation of tris-cyclometallated complexes such as those discussed previously. It is thought that 
this is due to both steric and electronic effects. Heteroleptic complexes of the general formulae 
[Ir(C^N)2(L^X)] and [Ir(C^N)2(N^N)]+ are easily prepared, with many examples showing 
efficient room temperature phosphorescence from mixed LC-MLCT excited states, similar to 
their tris-cyclometallated analogues.31, 50-52  
In 2001, Thompson et. al. reported the synthesis and characterisation of a series of neutral 
[Ir(C^N)2(L^X)] complexes (Figure 16) incorporating a range of C^N and monoanionic L^X 
ancillary ligands. These heteroleptic complexes are prepared using a two-step synthetic procedure 
as shown in Figure 17. Firstly, iridium chloride reacts with the cyclometallating ligand in 
refluxing 2-ethoxyethanol, resulting in the formation of the corresponding dichloro-bridged dimer 
in good yields, greater than 75%. It has been shown, through crystallographic studies, that each 
of the Ir(III) centres within the dimer are octahedrally coordinated by two bridging chlorides and 
two C^N-coordinating ligands. The two cyclometallating aryl rings are positioned cis to each 
other around the iridium centre as a result of the strong trans influence of the formally C- atoms. 
In the second step, the dichloro-bridged dimers are easily converted to monometallic complexes 
through treatment of the dimer with a bidentate, anionic ancillary L^X ligand, for example, a β-
diketonate, 2-picolinic acid or an N-alkylsalicylimine. The final heteroleptic iridium(III) 
complexes are air stable, can be sublimed and formed in high yields, often greater than 80%.50  
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Figure 16: A figure to show the [Ir(C^N)2(LX)] complexes prepared by Thompson and co-workers.50  
 
 
Figure 17: Reaction scheme to show the two-step synthetic procedure utilised in the preparation of neutral, heteroleptic 
complexes of the general formula [Ir(C^N)2(LX)]. In this reaction scheme, the cyclometallating ligand 2-ppy is shown 
as an example.50 
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The photophysical properties of the [Ir(C^N)2(L^X)] complexes were also investigated by 
Thompson and co-workers and the data obtained is shown in Table 1.50  
 
Table 1: Photophysical data reported by Thompson and co-workers for [Ir(C^N)2(L^X)] complexes.50 
C^N LX Absorbance λ (log ε) Emission 
λmax (nm) 
Lifetime (μs)a Quantum 
Efficiency* 
298 K 77 K 
ppy acac 260 (4.5), 345 (3.8), 412 (3.4), 460 
(3.3), 497 (3.0) 
516 1.6 3.2 0.34 
tpy acac 270 (4.5), 370 (3.7), 410 (3.5), 460 
(3.4), 495 (3.0) 
512 3.1 4.5 0.31 
bzq acac 260 (4.6), 360 (3.9), 470 (3.3), 500 
(3.2) 
548 4.5 23.3 0.27 
bt acac 269 (4.6), 313 (4.4), 327 (4.5), 408 
(3.8), 447 (3.8), 493 (3.4), 540 (3.0) 
557 1.8 4.4 0.26 
bt pic 206 (4.6), 326 (4.6), 355 (4.1), 388 
(3.9), 437 (3.8), 475 (3.7) 
541 2.3 3.6 0.37 
bt sal 276 (4.6), 325 (4.3), 450 (3.7), 540 
(2.9) 
562 1.4 3.1 0.22 
bsn acac 274 (4.7), 300 (4.6), 345 (4.5), 427 
(4.0), 476 (4.0), 506 (3.9) 
606 1.8 2.5 0.22 
pq acac 268 (5.0), 349 (4.4), 433 (3.9), 467 
(3.9), 553 (3.6) 
597 2.0  0.1 
 
(a) Lifetime and quantum efficiency measurements were made in 2-MeTHF, except for the 77 K lifetime of [Ir(ppy)2(acac)], which 
was carried out in a CH2Cl2 frozen glass. The lifetimes have error bars of ± 10%, and the quantum efficiencies are ± 20%.  
 
The absorption spectra observed for the heteroleptic Ir(III) complexes were similar to those of the 
dichloro-bridged dimers and the [Ir(C^N)2(bpy)]+ complexes of the same cyclometallating 
ligands. This indicates that the dominant transitions in these [Ir(C^N)2(L^X)] complexes are due 
to the ‘Ir(C^N)2’ fragment. All of the reported heteroleptic complexes are emissive at room 
temperature with luminescence lifetimes in the range of 1-5 μs and quantum yields between 0.1 
and 0.4 for degassed 2-MeTHF solutions. Thompson et. al. reported that, like the Ir(C^N)3 
complexes, these [Ir(C^N)2(L^X)] complexes emit from an MLCT excited state. The emission 
wavelengths observed range from 512 nm (green) for [Ir(tpy)2(acac)] to 606 nm (red) for 
[Ir(bsn)2(acac)], as can be seen in Table 1. The emission spectra recorded show that variation of 
the cyclometallating ligand has a noticeable effect on the emission wavelength. Across the series 
of complexes in which the cyclometallating ligand is varied, via the introduction of electron-
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donating groups or an increase in the ligand conjugation length, a red-shift of 94 nm is observed. 
Conversely, altering the ancillary LX ligand seems to have a relatively small effect, with only a 
21 nm red-shift observed on going from [Ir(bt)2(pic)] through [Ir(bt)2(acac)] to [Ir(bt)2(sal)]. This 
observation suggests that there is a significant 3(π-π*) contribution from the C^N ligand to the 
emitting state. Despite this, the L^X ligands can assist in modulation of the photophysical 
properties through electronic effects on the iridium(III) centre. For example, for the [Ir(bt)2(LX)] 
series, the emission maxima obtained increased according to the donor strength of the LX 
ancillary ligands, pic < sal ≈ acac.31, 50, 53 Following this study by Thompson et. al., a large number 
of research groups have reported the synthesis of heteroleptic [Ir(C^N)2(L^X)] complexes with 
emission spanning the visible spectrum.50, 54-57  
Heteroleptic bis-cyclometallated iridium(III) complexes incorporating neutral N^N ancillary 
ligands have also been investigated. Introduction of neutral N^N ancillary ligands gives cationic 
iridium(III) complexes. The preparation of such complexes is carried out using a synthetic 
procedure similar to that employed in the synthesis of [Ir(C^N)2(L^X)] complexes, as shown in 
Figure 18. Compared with the preparation of neutral heteroleptic iridium(III) complexes, cationic 
complexes can often be synthesised in good yields under milder conditions with the final 
complexes commonly isolated as PF6 salts following a counter ion exchange reaction using 
saturated KPF6(aq) solution.29, 58  
 
 
Figure 18: A reaction scheme to show the synthesis of heteroleptic [Ir(C^N)2(N^N)]+ complexes. Firstly, synthesis of 
the iridium(III) dichloro-bridged dimer is carried out via the reaction of IrCl3 with the cyclometallating ligand, in this 
case 2-phenylpyridine. Secondly, this dimer is cleaved using a neutral diimine ancillary ligand to give the cationic 
[Ir(C^N)2(N^N)]+ complex.29  
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Bernhard and co-workers reported a series of six cationic Ir(III) complexes showing emission 
across the visible spectrum from blue to red (Figure 19). The observation of both high-energy, 
vibrationally-resolved 3LC bands and low-energy, broad 3MLCT bands in the emission spectra 
suggests that the luminescence of these complexes originated from a mixed excited state.29  
 
 
Figure 19: A figure to show a series of six cationic [Ir(C^N)2(N^N)]+ complexes. The complexes exhibit emission 
across the visible spectrum from blue to red, as can be seen from the emission spectra shown.29  
 
As shown above, the photophysical characteristics of these heteroleptic complexes can be tuned 
in order for their application in optoelectronic devices. In 2014, Iha and co-workers reported a 
series of four cationic iridium(III) complexes displaying emission ranging blue-green (522 nm) 
to orange (602 nm). The structure of these cationic complexes are shown in Figure 20. These 
complexes have quantum yields ranging from ϕ = 0.23–0.96 and luminescence lifetimes in the 
microsecond range. It was reported that the excited state from which these complexes emit was 
mainly 3MLCTIr(ppy)→N^N in character.59   
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Figure 20: A figure to show the structures of cationic iridium(III) complexes prepared by Iha and co-workers. The 
structures of both the cyclometallating and diimine ancillary ligand are altered, resulting in complexes exhibiting 
emission varying from blue-green to orange.59  
 
A further series of cationic iridium(III) complexes were prepared by Zysman-Colman et. al. as 
shown below in Figure 21. Through the substitution of one, two or three methoxy- groups on the 
cyclometallating ligand, the emission of these complexes was shifted significantly to the red. This 
series of complexes display red to near-infrared emission with wavelengths ranging from 595 nm 
to 730 nm. Unfortunately, the quantum yields obtained for this series of red emitters are relatively 
low, between ϕ = 0.15–0.001, and the luminescence lifetimes are very short (ns). The observation 
of low quantum yields, relative to the blue-green emitter discussed above, is consistent with the 
energy gap law.60  
 
 
Figure 21: A figure to show the series of eight complexes prepared by Zysman-Colman and co-workers in 2015.60 
 
The photophysical characteristics and colour tunability of the heteroleptic iridium(III) complexes 
discussed in this section have led to this class of cyclometallated iridium(III) complexes being 
widely investigated for use in an array of applications.  
 
In this section, monometallic homo- and heteroleptic complexes of Pt(II) and Ir(III), incorporating 
a variety of cyclometallating and ancillary ligands, have been discussed. As has been previously 
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stated, many of these complexes are ideal candidates for utilisation as emitters in optoelectronic 
devices such as OLEDs, amongst many other applications. The strategies that can be used to tune 
the photophysical properties of such complexes will be discussed further in section 1.2.3.  
 
1.2.2 Platinum(II) and Iridium(III) Complexes of Cyclometallating Terdentate Ligands 
There are three classes of cyclometallating terdentate ligands that have been utilised in the 
preparation of cyclometallated transition metal complexes of Pt(II) and Ir(III); N^N^C, C^N^C 
and N^C^N. In this section, the focus will be on N^C^N-coordinating ligands.  
Terdentate ligands have a number of advantages over their bidentate counterparts. It is known 
that non-radiative decay is favoured if there is large distortion of a complex on going from the 
ground state to the excited state. The amount of distortion can be decreased by increasing the 
rigidity of a system. Therefore, to reduce non-radiative decay and improve the photophysical 
properties of a transition metal complex, it is beneficial to increase the rigidity. Terdentate ligands 
are inherently more rigid than bidentate ligands and consequently, can give complexes with higher 
luminescence efficiencies. Cyclometallating ligands with tridentate coordination also give 
complexes with higher chemical and thermal stability and for metals such as iridium(III), such 
ligands also offer a route achiral complexes.61  
 
Many research groups have focused on the synthesis of platinum(II) complexes of 
cyclometallating terdentate ligands in recent decades.  
Che et. al. investigated Pt(II) complexes of the general formula, [Pt(N^N^C)Cl] and reported a 
series of complexes in which the N^N^C-coordinating ligand was derived from 6-phenyl-2,2′-
bipyridine bearing different substituents at the 5-position of the central pyridyl ring. This class of 
N^N^C ligands combines the cyclometallating ability of 2-ppy with the π-acceptor properties of 
2-bpy. The series of complexes prepared by Che and co-workers is shown in Figure 22. Figure 
22 also shows the absorption and emission spectra of complex 1.2.61. These neutral Pt(II) 
complexes are air and moisture stable showing photoluminescence at room temperature, both in 
solution and solid state. Only a very small variation in emission maxima (562 -568 nm) was 
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observed on variation of the substituent on the central pyridyl ring. The lack of a trend in emission 
maxima suggests that there may be very limited electronic communication between the 
substituent and the Pt-N^N^C core. The emission spectra recorded show broad, structureless 
peaks, indicative of emission from an MLCT state. The luminescence lifetimes are in the 
microsecond range (0.52-1.47 μs) and the quantum yields were measured in the range ϕ = 0.025-
0.068. Despite the low quantum yields, these complexes show improved photophysical properties 
relative to Pt(II) complexes of 2,2′:6′,2″-terpyridine. A further study of this class of 
[Pt(N^N^C)X] complexes by Che et. al., showed that replacement of the monodentate chloride 
ligand with a monoanionic isocyanide ligand results in higher quantum yields (ϕ = 0.060–0.11). 
This is likely due to the strong ligand field of the R-N≡C ligand.62-64  
 
 
Figure 22: A figure to show the series of [Pt(N^N^C)Cl] complexes studied by Che and co-workers. The absorption 
and emission spectra of complex 1.2.61 recorded in CH2Cl2 at 298 K.62  
 
Studies carried out by a large number of research groups have shown that Pt(II) complexes of 
N^N^C ligands exhibited emission from triplet charge transfer excited states whereas the 
luminescence displayed by complexes of C^N^C ligands was assigned as originating from a 
perturbed 3π-π* (LC) state. Despite all the research into Pt(II) complexes of N^N^C and C^N^C-
coordinating terdentate ligands, the luminescence of Pt(II) complexes of N^C^N terdentate 
ligands were not investigated prior to 2003.18  
In 2003, Williams et. al. reported the photophysical properties of a platinum(II) complex of 
N^C^N-coordinating ligand 1,3-dipyridylbenzene (dpyb). Cárdenas first prepared this complex 
 26 
 
in 1999.65 The synthetic method used by Williams and co-workers for the preparation of 
[Pt(dpyb)Cl] and derivatives bearing substituents at the 5-position of the central phenyl ring is 
shown in Figure 23.18  
 
 
Figure 23: The synthetic route used in the preparation of luminescent platinum(II) complexes. The terdentate proligand 
was reacted with K2PtCl4 in acetic acid at reflux for 3 days. The desired complexes were isolated as yellow solids in 
yields ranging from 40-59%.18  
 
This new class of luminescent platinum(II) complexes were found to be highly emissive in 
solution with quantum yields significantly higher than previously reported Pt(II) complexes of 
terdentate ligands (ϕ = 0.58–0.68 in degassed CH2Cl2). The complexes display highly-structured 
emission spectra with maxima increasingly red-shifted as the electron-donating character of the 
substituent increases (C(O)OMe < H < Me). This, along with the small Stokes shift observed and 
the relatively long luminescence lifetimes (7.0-8.0 μs), suggests that the emission originates from 
an excited state with primarily 3π-π* (LC) character.  
Platinum(II) complexes of N^C^N-coordinating terdentate ligands exhibit superior photophysical 
properties compared with complexes of N^N^C and C^N^C ligands. It was proposed by Williams 
et. al. that the N^C^N ligand has a stronger ligand field which helps to raise the MC d-d states, 
removing this pathway of non-radiative decay within the resulting Pt(II) complexes. Additionally, 
for the [Pt(N^C^N)Cl] complexes, there is an improved ability to tune the absorption and emission 
properties over a wide range (~ 5000 cm-1) via the variation in the substituents on the terdentate 
ligand. These photophysical properties result in these complexes being ideal candidates for 
applications such as OLEDs and bioimaging. Continued research into Pt(II) complexes of 
terdentate N^C^N ligands has focused on the optimisation of their photophysical properties for 
such applications. This has been done by further variation of ligand substituents or through the 
replacement of the monodentate chloride ligand with alternative monodentate ligands, both 
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neutral and anionic (eg. pyridine and PhO-), shifting the emission further to the blue or to the 
red.18, 21, 61, 66-68  
 
The reports highlighting the favourable effects of terdentate N^C^N ligands on complexes of 
Pt(II) have led to the widespread study of iridium(III) complexes incorporating N^C^N-
coordinating terdentate ligands. In 2004, Williams et. al. reported the first example of a charge-
neutral, cyclometallated Ir(III) complex in which the metal centre is bound to a terdentate N^C^N 
ligand. The structure of the iridium(III) complex and the synthetic route utilised in its preparation 
is shown in Figure 24.25  
 
Figure 24: A reaction scheme to show the synthetic method used in the preparation of the first example of a 
cyclometallated Ir(III) complex incorporating a terdentate N^C^N-coordinating ligand. The first step is the synthesis 
of the dichloro-bridged iridium(III) dimer and is analogous with the preparation of dichloro-bridged dimers of 
cyclometallating, bidentate ligands. The second step involves the reaction of the dimer with molten 2,6-
diphenylpyridine at 110 °C, in the presence of silver triflate.25  
 
In the synthesis of this bis-terdentate Ir(III) complex, in order to ensure terdentate binding of the 
N^C^N ligand, it is necessary to incorporate substituents at the 4- and 6-positions of the central 
phenyl ring. The presence of substituents at these positions ensures that the competitive bidentate 
binding observed for terdentate N^C^N ligands with iridium(III) is blocked. Using this method, 
the desired complex shown in Figure 24 was isolated as an orange solid.17, 25, 27  
Investigation of the photophysical properties of this complex showed that the complex is strongly 
luminescent in degassed acetonitrile solutions with a broad, structureless emission maximum 
observed at 585 nm at 295 K. The complex has a luminescence quantum yield of ϕ = 0.21 with 
an emission lifetime of 3.9 μs in degassed solution. The properties obtained indicate that the 
 28 
 
emission originates from a primarily CT state. This bis-terdentate Ir(III) complex, being both 
charge neutral and an intense orange emitter, has desirable characteristics for use in OLEDs.25  
Since this first report, iridium(III) complexes of terdentate N^C^N ligands have been investigated 
by a number of research groups. A selection of the complexes reported are shown below in Figure 
25.  
 
 
Figure 25: A figure to illustrate the structures of monometallic iridium(III) complexes, both cationic and neutral, 
incorporating terdentate ligands as reported by research groups in recent decades.28, 30, 69, 70  
 
Following on from the work by Williams and co-workers, further bis-terdentate complexes have 
been reported. In 2005, Haga et. al. synthesised a highly luminescent bis-terdentate iridium(III) 
complex of the N^C^N-coordinating ligand 1,3-bis(1-methyl-benzimidazol-2-yl)benzene 
(Mebib). The second terdentate ligand incorporated into this complex was the N^N^N ligand 2,6-
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bis(1-methyl-benzimidazol-2-yl)pyridine (Mebip). The coordination of both the monoanionic 
Mebib ligand and the charge-neutral Mebip to an iridium(III) centre leads to the formation of a 
cationic Ir(III) complex. This complex is an orange emitter with the emission maxima recorded 
at 593 and 623 nm. The quantum yield for this complex is comparable with the previously 
discussed bis-terdentate complex (ϕ = 0.10) and the luminescence lifetime was measured to be 
1.6 μs. The photophysical data obtained indicates that emitting state has mixed 3LC and 3MLCT 
character.69 Further research into bis-terdentate iridium(III) complexes was carried out by Chou 
and co-workers in 2015. A series of charge-neutral complexes was prepared in which the 3+ 
charge on the metal centre was balanced by coordination to one monoanionic N^C^N ligand, 
derived from 1,3-dipyridylbenzene, and a dianionic N^N^N ligand based on 2-pyrazol-3-yl-6-
phenylpyridine. The series of complexes prepared by Chou et. al. exhibit intense phosphorescence 
across the visible spectrum, from green (490 nm) to red (600 nm). The emission maxima were 
tuned via substitution on the terdentate ligands N^C^N and N^N^N ligands. The luminescence 
quantum yields ranged from 0.22 to 0.72 and the emission lifetimes were measured in the range 
ϕ = 0.81–3.37 μs. This class of highly luminescent, chemically robust bis-terdentate iridium(III) 
complexes shows good potential for use in OLEDs. A device reported in this work, using 1.2.72 
(a) showed an EQE of 12.1%.70   
A second class of highly luminescent iridium(III) complexes incorporating terdentate N^C^N 
ligands were also reported alongside the bis-terdentate complexes previously discussed. In 2005, 
whilst investigating the bis-terdentate Ir(III) complexes, Haga and co-workers reported the 
synthesis of complexes in which the iridium centre was coordinated to one terdentate terpyridine-
based ligand, a bidentate ligand derived from 2,2′-bipyridine and a monodentate chloride ligand 
(3+2+1 mode). It was observed that these mixed ligand environments led to cationic complexes 
with higher quantum yields than the bis-terdentate systems also investigated in this study (ϕ = 
0.19 vs ϕ = 0.10).69 Further investigation of such systems by Haga et. al. and Williams and co-
workers was carried out. The complexes synthesised, in which the polypyridyl ligands were 
replaced with cyclometallating N^C^N- and N^C-coordinating ligands, are shown in Figure 25. 
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Such complexes are generally readily accessible from the dichloro-bridged iridium dimers as 
shown in Figure 26.28, 30  
 
 
Figure 26: Synthetic route utilised in the preparation of the mixed ligand iridium(III) complexes reported by Williams 
and co-workers in 2012. The first step is formation of the dichloro-bridged iridium(III) dimer via the reaction of the 
terdentate N^C^N ligand with IrCl3.3H2O. Secondly, this dimer reacts with the selected bidentate ligand in the presence 
of AgOTf as a chloride scavenger. The desired 3+2+1 Ir(III) complexes were isolated in moderate to high yields (35-
94%).30  
 
The range of complexes prepared by Haga and co-workers (Figure 25) showed strong orange 
emission with quantum yields in the range ϕ = 0.77–0.95 for the neutral complexes and ϕ = 0.16–
0.24 for the cationic complexes in which X = MeCN. [Ir(Phbib)(ppy)Cl] showed the highest 
quantum yield of ϕ = 0.95. Replacement of the monodentate chloride ligand with neutral MeCN 
was observed to drastically decrease the luminescence quantum yield. The luminescence lifetimes 
for all complexes were in the microsecond range. The series of mixed-ligand 3+2+1 complexes 
prepared by Williams et. al., with terdentate ligands derived from 1,3-dipyridylbenzene, also 
showed significantly higher emission quantum yields than previously studied bis-terdentate 
complexes (ϕ = 0.20–0.70). These complexes were shown to be highly luminescent in degassed 
CH2Cl2 solution at room temperature with the emission maxima tunable from blue to red (476-
593 nm) through modulation of the ligand substitution pattern. As a result of their excellent 
photophysical properties, the complexes reported by Williams and co-workers were successfully 
employed in the fabrication of highly efficient OLEDs showing EQEs between 1.3–10.9%. The 
performance of these OLED devices is comparable and, in some cases, is superior to that observed 
for tris-bidentate iridium(III) complexes such as fac-Ir(ppy)3. The presence of both a terdentate 
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N^C^N ligand and a bidentate N^C-coordinating ligand in the mixed ligand systems discussed 
here offers additional opportunities for fine-tuning the emission energy, resulting in additional 
control over the photophysical properties.28, 30  
 
The complexes of platinum(II) and iridium(III) discussed in this section, incorporating terdentate 
N^C^N ligands, have been shown to be highly luminescent with high quantum yields and 
relatively short emission lifetimes. The emission wavelengths can be successfully tuned across 
the entire visible spectrum through the systematic functionalisation of the cyclometallating 
ligands on the metal centre. Overall, in this section it has been shown that complexes of 
cyclometallating terdentate ligands are comparable or superior to the best emitters reported with 
bidentate ligands.  
 
1.2.3 Colour Tuning Strategies for Cyclometallated Complexes  
As mentioned previously, colour tuning of the absorption and emission of cyclometallated 
transition metal complexes is possible as the HOMO and LUMO of the cyclometallating ligands 
are localised on separate moieties; with the HOMO being primarily associated with the metal 
centre and the metallated aryl ring and the LUMO localised on the heterocyclic ring. Therefore, 
substituents introduced onto the aryl ring predominantly influence the energy of the HOMO 
whereas substituents introduced onto the heterocyclic ring primarily affect the LUMO. The 
addition of electron-withdrawing substituents (eg. -F, -CF3, -CN) generally stabilise molecular 
orbitals while electron-donating groups (eg. -alkyl, -NH2, -NR2) normally destabilise molecular 
orbitals. Consequently, this simplified concept of colour tuning, within cyclometallated 
complexes of transition metals such as platinum(II) or iridium(III), leads to strategies that can be 
applied to tune the emission from blue to red.   
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Figure 27: A figure to illustrate the colour tuning strategies that can be utilised through independent modulation of the 
HOMO and LUMO energies. 
 
As is shown in Figure 27, a blue-shift in the emission can be achieved either by the addition of 
electron-withdrawing groups to the aryl ring to stabilise the HOMO or electron-donating groups 
to the heterocyclic ring to destabilise the LUMO. This results in an increase in the HOMO-LUMO 
gap and a blue-shift. In addition, a blue-shift can also be achieved by replacing the heterocyclic 
ring (eg. pyridine) with more electron-rich azeheterocycles such as pyrazole. Figure 28 shows 
that substitution of fluoro- groups on the phenyl ring of the cyclometallating ring results in a blue-
shift of 42 nm. A larger blue-shift of 60 nm is observed on the substitution of the pyridine ring 
for pyrazole. The effects of these colour tuning methods are additive and therefore, when both the 
aryl ring and the heterocyclic ring are altered, the blue-shift observed is larger still (102 nm, 
comparing the emission of Ir(dfppz)3 (390 nm) and Ir(ppy)3 (492 nm) at 77 K).24, 48 
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Figure 28: Strategies for blue-shifting the emission of cyclometallated metal complexes by raising the LUMO and 
lowering the HOMO.24, 48  
 
As discussed in previous sections of this review, factors such as ligand field strength and the 
rigidity of the final complex can have a significant effect on the photophysical properties 
observed. The preparation of efficient blue emitters has proved to be a challenge. This is likely 
due to the fact that the increased HOMO-LUMO gap required for high-energy blue emission leads 
to the emitting state being closer to the deactivating MC d-d states. This often leads to a reduction 
in quantum yields as the emission is shifted to the blue. Therefore, in order to obtain efficient blue 
emitters, it is particularly important to incorporate cyclometallating ligands with high ligand field 
strengths capable of providing rigidity to the final complex. The bidentate Pt(II) complex shown 
in Figure 29 has the required combination of electron-withdrawing and electron-donating groups, 
on the aryl and pyridyl rings respectively, to lead to emission in the deep blue region of the 
spectrum. The blue-shift observed, relative to Pt(ppy)(acac), is accompanied by a substantial 
decrease in quantum yield. The Pt(II) complex incorporating the related terdentate N^C^N ligand 
shows efficient blue emission at room temperature with a quantum yield of ϕ = 0.60. This is as a 
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result of the stronger ligand field provided by the cyclometallating N^C^N ligand and the inherent 
rigidity of such terdentate ligands.  
 
 
Figure 29: A figure to illustrate the importance of high ligand field strength and rigidity in the preparation of efficient 
blue emitters.68  
 
In order to achieve a red shift in the emission, it is necessary to incorporate electron-donating 
groups onto the aryl ring, destabilising the HOMO, or to add electron-withdrawing groups to the 
heterocyclic ring to stabilise the LUMO. This gives a decrease in the HOMO-LUMO gap and a 
red-shift. In addition a red-shift can be achieved by incorporating cyclometallating ligands with 
increasingly extended conjugation. As the conjugation length of a molecule increases, the 
HOMO-LUMO gap decreases resulting in a shift of the absorption and emission to the red. 
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Figure 30: Examples to illustrate some of the strategies that can be used to red-shift the emission of cyclometallated 
complexes.47 
 
As is shown in Figure 30, the replacement of the phenyl ring in Ir(ppy)3 for a more electron-rich 
thiophenyl ring in Ir(thpy)3 results in a red-shift of 40 nm. Increasing the conjugation of Ir(thpy)3 
to give Ir(btpy)3 gives a further red shift of 46 nm, giving orange emission at λmax = 596 nm. A 
larger red-shift of 110 nm, relative to Ir(ppy)3, can be achieved by replacing the pyridyl moiety 
with an isoquinoline unit leading to emission in the red region of the spectrum (λmax = 620 nm). 
Again, the effects of strategies to red-shift the emission are additive and therefore, through 
combining increased conjugation on both the heterocyclic and aryl moieties with a more electron-
rich aryl ring, a substantial bathochromic shift is observed resulting in emission in the red region 
(λmax = 644 nm).47  
As the emission wavelength of a complex shifts to the red, the luminescence quantum yield tends 
to decrease in agreement with the energy gap law. As the HOMO-LUMO energy gap becomes 
smaller, non-radiative decay of the excited state energy via vibrations is more allowed. The 
complexes shown in Figure 30 show a decrease in quantum yield as the conjugation length of the 
molecule is extended. Increasing the conjugation raises the energy of the HOMO and this can lead 
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to a decrease in the orbital contribution to the lowest excited state from the metal centre. As a 
result, the triplet state becomes increasingly like an organic triplet. Therefore, it can be concluded 
that adding an increasing number of conjugating groups will not lead to efficient red emitters.  
 
These colour-tuning strategies are widely used in the preparation of complexes of transition 
metals, such as platinum(II) and iridium(III), that exhibit absorption and emission wavelengths 
across the entire visible spectrum.  
 
1.3 Multimetallic Transition Metal Complexes 
The design of luminescent multinuclear complexes of transition metals, particularly of ditopic 
polypyridyl bridging ligands, is widely studied in coordination chemistry. Such complexes are 
important in areas of catalysis, supramolecular chemistry, as functional materials, in molecular 
recognition and in optoelectronic devices.71-78 Multimetallic complexes have a number of 
advantages over their mononuclear counterparts. Improved light-harvesting can be achieved as 
multinuclear complexes have increased molar extinction coefficients relative to monometallic 
complexes and frequently have lower energy absorption maxima. This property is especially 
important in applications such as solar energy conversion and photocatalysis.79-82 Additionally, 
the presence of a second metal facilitates spin-orbit coupling and increases the radiative rate 
constant leading to more efficient phosphorescence from triplet states for multimetallic 
complexes.83  
There is a wide variety of bridging ligands utilised in the preparation of polymetallic emitters. 
The specific bridging ligand selected can have significant effects on the chemical and 
photophysical properties of the final complex. In systems with bridging ligands that incorporate 
large, flexible spacer groups, holding the metal centres far apart, the metal-containing units retain 
their individual properties. Complexes of this type are used to investigate electron- or energy-
transfer between the metal-containing units. In contrast to this, in multinuclear systems in which 
the two metal ions are held in close proximity and both bound to a common heterocyclic ring, the 
 37 
 
properties of the final complex are substantially different from the analogous mononuclear 
complexes.72, 83-85 
Many of the multimetallic complexes reported in the literature were initially based on Ru(II) 
polypyridyl units with metals such as Os(II) and Re(I) often also incorporated. Increasingly, due 
to the excellent excited-state properties of cyclometallated complexes of Pt(II) and Ir(III), metal-
containing units of Pt(II) and Ir(III) have been increasingly utilised in the preparation of 
multinuclear complexes.  
There are a variety of bridging ligands available, varying from those offering bis-monodentate 
bridges between metal centres to those acting as bis-tetradentate bridging ligands. In this section, 
multimetallic complexes incorporating cyclometallated platinum(II) and iridium(III) units linked 
by such bridging ligands will be discussed. 
  
1.3.1  Monodentate Bridged 
Multinuclear complexes in which the metal centres are bridged by ligands offering bis-
monodentate coordination have been studied by a number of research groups. The bridging 
ligands of this kind reported in the literature vary from cyanide to poly-N-heterocyclic carbenes 
and are utilised to link two or more metal centres in the preparation of both homo- and 
heterometallic complexes.62, 72, 86-89 
Dinuclear complexes of platinum(II) have been studied in order to investigate the intramolecular 
excimer/aggregate formation possible via metal-metal and/or ligand-ligand (π-π) interactions. 
The formation of excimers or aggregates, possible with square planar Pt(II) d8 complexes, has 
been widely studied for white-light generation in optoelectronic devices.72, 90 In 1999, Che and 
co-workers reported the preparation of diplatinum complexes in which the cyclometallated 
Pt(N^N^C) units were linked by a diphosphine or pyrazole, as shown in Figure 31. These 
complexes all display photoluminescence with photophysical properties differing as a function of 
bridging ligand. For the complex [(Pt(N^N^C))2(dppm)]2+, it was concluded that Pt-Pt 
interactions were occurring between the two Pt(II) centres. In the absorption spectra, a moderately 
intense band above 400 nm was observed and assigned to 1[dσ* → π*]. Broad, structureless 
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emission was observed with a peak maximum at 652 nm, attributed to a 3[dσ*, π*] excited state. 
In addition, the emission was red-shifted at 77 K, thought to be due to the shortening of Pt-Pt 
contacts with lattice contraction. For the diplatinum(II) complex, [(Pt(N^N^C))2(dppCn)]2+, there 
is a larger separation between the two platinum(II) centres as a result of the longer carbon chain 
of the diphosphine bridging ligand. In contrast to the previous complex, the absorption spectrum 
for [(Pt(N^N^C))2(dppCn)]2+ showed no moderately intense band above 400 nm and on cooling 
to 77 K, the emission observed was blue-shifted, showing different behaviour than was observed 
for the 3[dσ*, π*] excited state in [(Pt(N^N^C))2(dppm)]2+. Therefore, it was concluded that there 
were no Pt-Pt interactions in this bimetallic Pt(II) complex and the emission for this complex was 
assigned to a 3MLCT excited state. In the case of the pyrazole-linked complex, there are negligible 
Pt-Pt interactions observed at room temperature. At 77 K it is thought that the intramolecular 
separation between [Pt(N^N^C)] units may decrease sufficiently to give weak π-π interactions. 
This is confirmed by the observation of low-energy shoulders in the solution and solid-state 
emission spectra at 77 K. This work by Che et. al. shows that the bridging ligand incorporated 
into a multinuclear complex can have a significant effect on photophysical properties of the 
resulting complex.62  
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Figure 31: A figure to illustrate the structures of binuclear platinum(II) complexes reported by Che et. al. in 1999. The 
complexes were isolated in high yields (53-79%) by reaction of the monometallic precursor with the appropriate 
diphosphine or pyrazole bridging ligand.62  
 
Similar results were obtained by Thompson and co-workers in the study of pyrazole-linked di-
platinum(II) complexes as shown in Figure 32. It was observed that simple synthetic control of 
the extent of Pt-Pt interactions could be achieved through variation of the substituents present on 
the bridging ligands.86  
 
 
Figure 32: The structures of pyrazole-linked dinuclear platinum(II) complexes reported by Thompson and co-workers 
with a side view of 1.3.1.4 (a) to illustrate the potential for Pt-Pt interactions, dependent on the R groups present on the 
bridging ligands.86 
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The incorporation of more sterically demanding R groups at the 3- and 5-positions of the 
pyrazolate bridges was found to force the two Pt(C^N) units closer together, therefore enhancing 
the Pt-Pt interactions. For example, the Pt-Pt distance in complex 1.3.4 (a) where R/R′ = H is 
3.376 Å whereas for complexes 1.3.4 (c) and 1.3.4 (d), the Pt-Pt distances are decreased to 3.046 
Å and 2.834 Å respectively. This decrease in Pt-Pt manifests itself in the observation of an 
additional lower energy band between 400 and 500 nm in the absorption spectra for 1.3.4 (c) and 
1.3.4 (d), assigned to singlet metal-metal-to-ligand charge transfer (MMLCT) transitions. These 
broad absorption bands are red-shifted as the Pt-Pt distance is decreased, demonstrating that the 
energy of the 1MMLCT state is highly dependent on the intramolecular separation between the 
two platinum(II) centres. The control over the photophysical properties that these bis-
monodentate pyrazolate ligands afford to the final complexes make this type of dinuclear 
complexes ideal candidates for a range of applications.86  
Homometallic dinuclear iridium(III) complexes incorporating bis-monodentate bridging ligands 
have also been reported. The linear, ambidentate ligand cyanide was used as a ditopic bridging 
ligand to link bis-cyclometallated iridium(III) units in the preparation of a tetranuclear Ir(III) 
complex, reported by Nazeeruddin et. al. in 2011. The two-dimensional tetranuclear complex was 
isolated in high yield (74%) using the synthetic procedure shown in Figure 33. The complex is 
highly luminescent (λem = 496, 521 nm, ϕ = 0.66) with the photophysical characteristics observed 
being largely similar to the analogous monometallic complex.87  
 
 
Figure 33: The synthetic route used in the preparation of the two-dimensional tetranuclear iridium(III) reported by 
Nazeeruddin and co-workers. The complex was isolated as a yellow solid in high yield (74%).87  
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Alkynyl ligands form strong σ M-C and η---(M) bonds and therefore, have a relatively strong 
ligand field.  Consequently, such ligands have been successfully employed as auxiliary ligands in 
the synthesis of luminescent metal complexes of transition metals such as Pt(II) and Au(III).91-98 
Combining the benefits of alkynyl ancillary ligands and cyclometallated Ir(III) complexes, 
Lalinde and co-workers reported the first examples of dinuclear Ir(III) complexes in which the 
two metal centres are linked by η2 alkynyl bridging ligands, as shown in Figure 34. All of the 
bimetallic complexes are emissive in fluid solution at room temperature and at 77 K. The emission 
spectra are broad and featureless with maxima ranging between 505 and 515 nm at 298 K. 
Theoretical calculations carried out by Lalinde et. al. suggest that the emission originates from an 
excited state with mixed 3MLCT/3LLCT character. The quantum yields for these complexes are 
in the range ϕ = 0.007–0.024. These values are relatively low and it has been suggested that the 
flexibility of these systems in solution leads to efficient non-radiative decay.88  
 
 
Figure 34: The alkynyl-bridged dinuclear iridium(III) complexes (left), in which the R-group on the ancillary alkynyl 
ligand are varied, all show emission in solution at room temperature and at 77 K. The emission spectra of these 
complexes measured at 298 K in CH2Cl2 for R = Tol, C6H4OMe-4 and 1-Np and in THF for R = SIMe3 and tBu are 
shown (right).88  
 
It was shown by Lalinde and co-workers that the alkynyl ligands utilised to bridge Ir(III) centres 
in the dinuclear complexes shown above did facilitate electronic communication between the two 
metal centres. Alkynyl groups were also incorporated into the bridging ligand used by Williams 
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et. al. in the preparation of a heterotrimetallic complex of Ir(III), Pt(II) and Au(III) in 2015. This 
complex was studied in relation to white-light generation from a single multinuclear complex 
with the electronic communication between the three metal centres investigated. As shown in 
Figure 35, the three cyclometallated metal centres in this trinuclear complex were linked via a 
1,3,5-triethynylbenzene core. Electronic communication was also facilitated by this bridging 
ligand, as can be concluded from the emission spectra obtained, although the trimetallic complex 
still retains the properties of the monometallic units it is comprised from. Dual emission was 
observed, containing bands assigned to the iridium and platinum components. These bands appear 
as a broad peak at 577 nm, originating from the Pt(II) moiety, with a shoulder at higher energy, 
assigned to emission from the Ir(III) unit. There was no higher energy emission detectable from 
the Au(III) component at room temperature. These observations are indicative of energy transfer 
from the Au moiety to the Ir and Pt units. Williams and co-workers suggested that this occurs via 
Förster resonance energy transfer (FRET) with a significant contribution from through-bond 
Dexter energy transfer.72  
 
 
Figure 35: The structure of the heterotrimetallic reported by Williams et. al. in 2015 in which the metal centres are 
linked through a 1,3,5-triethynylbenzene core. 72 
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The bridging ligand linking the three metal-containing units in this complex showed minimal 
conjugation and as a result, the metal complexes retained much of their individual character. In 
order for efficient white light generation to be obtained, with emission observed from all three 
moieties, further improvements must be made.72 
A further class of strong-field ligands popular in the synthesis of transition metal complexes are 
N-heterocyclic carbenes (NHCs). Such ligands have previously been used in the preparation of 
bimetallic complexes of Pt(II) and Au(III). In 2016, Peris and co-workers reported the synthesis 
of a dinuclear Pt(II) complex in which the cyclometalled platinum(II) fragments are linked via 
pyrene-bis-N-heterocyclic carbene bridging ligands, as shown in Figure 36. This complex 
displayed strong luminescence with vibronically-resolved emission bands observed between 372 
and 437 nm. The quantum yield of this complex (ϕ = 0.031) is relatively low in comparison to 
other cyclometallated Pt(II) complexes, but higher than those complexes with similar pyrene-
based bis-NHC ligands. The photophysical properties observed, including a luminescence 
lifetime in the nanosecond range, suggest that the luminescence exhibited has fluorescent 
character with the excited state localised on the pyrene-based bridging ligand. It was found that 
there was very little participation from the cyclometallated platinum(II) fragments. Consequently, 
Peris et. al. were unsuccessful in preparing efficient phosphorescent emitters utilising NHC-based 
bridging ligands.89  
 
 
Figure 36: The structure of the dinuclear platinum(II) complex prepared by Peris et. al., in which the two metal centres 
are linked via the bis-monodentate pyrene-bis-N-heterocyclic carbene ligand.89  
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From the multinuclear complexes discussed in this section, with metal centres linked via bis-
monodentate bridging ligands, it is possible to conclude that the class of bridging ligand 
incorporated has a substantial effect on the properties of the final complex and whether efficient 
phosphorescence is observed.  
 
1.3.2 Bidentate Bridged 
A more widely studied class of bridging ligands utilised in the preparation of multimetallic 
complexes is those offering bidentate coordination to multiple metal centres. There are a variety 
of common bidentate binding modes that have been previously employed within such bridging 
ligands, including N^N, N^C, N^O and O^O.  
 
By far the most intensively investigated of these binding modes is the N^N mode, for which a 
wide range of polypyridyl ligands have been utilised. A selection of the bridging ligands utilised 
in the preparation of multinuclear complexes are shown in Figure 37.  
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Figure 37: A figure to show a selection of the bis-bidentate polypyridyl ligands used in the preparation of multinuclear 
complexes. The range of ditopic ligands includes both flexible and rigid ligands that are both non-conjugated and 
conjugated.78, 99-109 
 
Bis-bidentate ligands bearing 2,2′-bipyridine binding sites separated by phenylene or 
phenyleneethynylene spacer units have been used to prepare both homo- and hetero- multimetallic 
complexes of Ru(II) and Ir(III), in which the length of the insulating spacer groups was varied. 
These types of complexes were synthesised by De Cola and co-workers and Williams et. al. using 
a ‘complex as ligand’ approach and in situ Suzuki cross-coupling reactions of complexes 
respectively. The separation between the metal-containing units in these multinuclear assemblies, 
imposed by such polypyridyl bridging ligands, leads to the observation of fast and efficient 
electronic energy transfer within the heterometallic complexes, from the cyclometallated Ir(III) 
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centres to the Ru(II) moiety. The rapid energy transfer to the Ru(II) centre was found to be 
unaffected by the length of the spacer unit of the bridging ligand. This energy transfer process 
can be rationalised by considering the energies of the excited states for the corresponding 
mononuclear complexes for each metal-containing unit within an assembly. Although the 
bridging ligands bearing phenylene-based spacer groups provide sufficient electronic 
communication for efficient energy transfer, they also provide insulation meaning that each 
component within the heterometallic assemblies retains the photophysical properties of the 
corresponding monometallic complex.78, 99-101, 110  
Utilising more flexible and, in some cases non-conjugated, bridging ligands, such as the abp, bpfd 
and bppb linkers shown in Figure 37, enabled further investigation of the effect of increased 
spacer length and extent of conjugation on the properties of dinuclear iridium(III) complexes. 
Comparing complexes of 1.3.10 and 1.3.11, the shorter and more conjugated bridging ligand 
(1.3.10) gives an Ir-Ir separation of 5.124 Å relative to 6.996 Å with 1.3.11. The closer proximity 
of the metal centres and conjugation in the abp-linked di-iridium complex allows electronic 
communication between the cyclometallated Ir(III) centres, resulting in red-shifted charge-
transfer absorption bands and the appearance of an additional band above 450 nm.102 The 
dinuclear Ir(III) complex prepared using the non-conjugated bppb bridging ligand shows 
photophysical properties consistent with the findings discussed above. The lack of electronic 
communication between the metal centres in such multinuclear complexes leads to absorption 
and emission properties similar to that observed for the related mononuclear complexes.103  
When the metal centres of multinuclear complexes are linked via more rigid, conjugated 
polypyridyl bridging ligands it is observed that the chemical and photophysical properties of the 
resulting complexes are significantly different from the corresponding monometallic complexes. 
For example, the bimetallic complex in which Ir(tfmpyb) [tfmpyb = 1,3-di(2-pyridyl-4,6-
bis(trifluoromethyl))benzene] units were linked by bridging ligand BiBzIm (Figure 37) was found 
to have substantial electronic coupling between the iridium centres, accounting for the difference 
in absorption and emission observed for the mono- and dinuclear complexes. A cationic dinuclear 
iridium(III) complex prepared by Zysman-Colman et. al., incorporating 2,5-dpp [2,5-dpp = 2,5-
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dipyridylpyrazine] as the bridging ligand, also showed significantly different photophysical 
properties with respect to the analogous mononuclear complex. A large red-shift in the emission 
(~ 125 nm) was observed at 77 K on going from the mono- to the dinuclear complex, with the 
emission maxima for the bimetallic complex observed at 715 nm. No emission was detected at 
room temperature for the dinuclear Ir(III) complex. It is thought that emission from excited state 
of the di-iridium complex at room temperature is quenched as a result of non-radiative decay, 
consistent with the large red-shift observed and the energy gap law.104-106 Further multinuclear 
complexes of cyclometallated Ir(III) subunits have been synthesised using rigid, conjugated 
polypyridyl bridging ligands with the final complexes displaying properties beneficial for use in 
both molecular devices and bioimaging.107, 108, 111  
 
In comparison to polypyridyl linked multimetallic complexes, there are relatively few examples 
of multimetallic complexes in which the metal centres are linked via a cyclometallating bridging 
ligand. In 2004, Tsuboyama et. al. reported the synthesis of dinuclear iridium(III) complexes in 
which Ir(ppy)2 fragments were linked via the cyclometallating bridging ligand, 1,4-bis(pyridin-2-
yl)benzene (BPB) as shown in Figure 38. This complex could only be isolated in very small yield 
following separation of the mixture of diastereoisomers formed. Comparing the photophysical 
properties of the dinuclear complex to the related mononuclear complex, Ir(ppy)3, it was observed 
that the emission of the di-iridium complex is significantly red-shifted (~ 150 nm) and shows a 
much smaller quantum yield (ϕp = 0.040 compared with ϕp = 0.97 for Ir(ppy)3). From the emission 
spectra and the short luminescence lifetime recorded for this complex, emission is assigned to a 
3MLCT excited state. 
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Figure 38: The structure of the dinuclear iridium(III) complex reported by Tsuboyama and co-workers in 2004, 
utilising the cyclometallating bis-bidentate bridging ligand BPB to link the two cyclometallated Ir(III) centres.112 
 
Following on from this, Kozhevnikov and co-workers reported di-platinum(II) complexes and 
mixed-metal Pt(II)/Ir(III) complexes wherein the metals are rigidly-linked through pyrimidine- 
and pyrazine-based cyclometallating bridging ligands, as shown in Figure 39. Using these 
bridging ligands, two metal centres are coordinated to a common heterocyclic ring, facilitating 
electronic communication and allowing conjugation of the LUMO across the entire aromatic 
system of the C^N^N^C bridging ligand. Consequently, this leads to luminophores that have 
intrinsically different properties from the related mononuclear complexes in which the separate 
metallic units do not retain their individual identities. It was observed in the study of these 
complexes that the introduction of additional metal centres allows further control over the 
photophysical properties of the resulting multinuclear complexes. With respect to their 
monometallic analogues, red-shifted absorption and emission maxima were observed for all of 
the bi- and trimetallic complexes. This is due to the delocalisation of the LUMO which results in 
its stabilisation and a decrease in the HOMO-LUMO gap. Additionally, the incorporation of 
additional metal centres was seen to increase the radiative rate constants despite the red-shift. 
Ordinarily, a decrease in the value of kr would be expected with decreasing energy of emission in 
agreement with the energy gap law. It is thought that this effect could be due to the increase in 
spin-orbit coupling resulting from the presence of a second heavy metal ion. In conjunction with 
this, non-radiative decay is kept to a minimum by the rigidity of the systems and therefore, the 
quantum yields of these multinuclear complexes are high, even in the red region of the spectrum 
(ϕ = 0.36–0.41). The excellent photophysical properties obtained for this class of cyclometallated 
complexes mean that they are ideal candidates for use in an array of applications.84, 85  
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Figure 39: A figure to illustrate the structures of the multimetallic complexes prepared by Kozhevnikov et. al. in which 
the metal centres are linked via cyclometallating bis-bidentate bridging ligands, through a common heterocyclic ring.84, 
85  
 
The pyrimidine ring has been further employed in the preparation of cyclometallated multinuclear 
complexes as shown by Zhou and co-workers in 2016. Zhou et. al. reported the synthesis of a 
dinuclear complexes in which the metal centres are linked via the cyclometallating bridging ligand 
2-(4-(tert-butyl)-phenyl)pyrimidine (Figure 40). The complexes showed highly efficient orange 
(580 nm) and red (603 nm) luminescence for R = H and R = F respectively, with quantum yields 
ranging from ϕ = 0.43–0.68 in solution. Again, the emission for the dinuclear complexes is 
significantly red-shifted relative to the corresponding mononuclear complexes (~ 80 nm). The 
bimetallic complexes reported by Zhou and co-workers were applied to OLEDs resulting in 
devices exhibiting the highest EQEs recorded for di-iridium(III) complexes (17.9% for 1.3.24).113, 
114  
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Figure 40: The structure of the dinuclear iridium(III) complexes reported by Zhou and co-workers, using the 
cyclometallating bridging ligand 2-(4-(tert-butyl)-phenyl)pyrimidine to rigidly link the two metal centres.113  
 
In 2017, Kozhevnikov and co-workers further demonstrated the potential of pyrimidine-based 
ligands in the preparation of highly luminescent multinuclear complexes and reported the 
synthesis of a tetrametallic mixed Pt(II)/Ir(III) complex exhibiting emission in the red region of 
the spectrum (λem = 611 nm) with a high quantum yield of ϕ = 0.76.115  
 
In addition to polypyridyl and cyclometallating bridging ligands offering bis-bidentate binding 
sites, ditopic ligands with N^O and O^O binding sites (Figure 41) have also been used in the 
preparation of multinuclear complexes.  
 
 
Figure 41: A selection of the bis-bidentate bridging ligands bearing N^O and O^O binding sites utilised in the 
preparation of homometallic di-Ir(III) and heterometallic Ir(III)/Pt(II) complexes.116-121  
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Dinuclear iridium(III) complexes in which cyclometallated Ir(III) units are linked via rigid bis-
N^O bridging ligand have been prepared by a number of research groups. Mazzanti and co-
workers reported a di-iridium(III) complex bridged by a ligand based on terpyridine-carboxylate 
whilst Bryce et. al. prepared a bimetallic complex of iridium(III) linked through a non-innocent 
diarylhydrazide bridging ligand. The resulting multinuclear complexes synthesised using these 
rigid bis-N^O ligands were isolated in moderate to high yields (30-86%) with facile separation of 
diastereoisomers for the diarylhydrazide-linked complex achieved. The photophysical properties 
observed for these bis-N^O-bridged complexes are distinct from the analogous monometallic 
complexes, displaying red-shifted, tunable emission with high quantum yields. This shows that 
such complexes have potential for application in optical devices. Bryce and co-workers employed 
the diarylhydrazide-linked dinuclear complex (ppy)2Ir(µ-L)Ir(ppy)2 in an OLED device, from 
which high efficiency green emission was obtained (EQE = 11%).117, 118  
Ditopic bridging ligands incorporating O^O bidentate coordination sites have also been utilised 
in the preparation of multinuclear complexes, including those of cyclometallated Pt(II) and Ir(III) 
subunits (Figure 41). Bridging ligands incorporating diketonate binding sites have been 
particularly important. In 2008, Thompson and co-workers reported the synthesis of platinum 
dyads, linking cyclometallated Pt(II) centres via a bridging ligand composed of two 2,4-
pentadione (acac) units covalently linked at the 3-position. The homodyads displayed 
photophysical properties that closely resembled those of the equivalent mononuclear complexes, 
although presence of the bridging ligand does increase the radiative rate constant of the dyads 
relative to the monometallic analogues. Contrastingly, the heterodyads undergo efficient energy 
transfer, governed by the electronic coupling allowed between the two metal-containing units via 
the bridging ligand. The bridging ligand was also found to play a key role in the photophysical 
properties observed for multinuclear complexes reported by Do et. al in 2010. The 
cyclometallated Pt(II) and Ir(III) centres were linked via a 1,3-bis(3-phenyl-3-
oxopropanoyl)benzene bridging ligand offering two diketonate binding sites separated by a 
phenylene spacer. The resulting bimetallic complexes showed weak red emission in solution (λem 
= 615 nm) with quantum yields in the range ϕ = 0.0023–0.0030. In solution, the lowest excited 
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state has a major contribution from the 3LX state localised on the bridging ligand. The emission 
observed in the solid state was much more intense (λem = 570 nm), likely as a result of 3MLLCT 
transitions resulting from the interaction of pyridine rings in the peripheral cyclometallated Ir(III) 
units present.120, 121 
 
1.3.3 Terdentate Bridged 
Terdentate ligands, as discussed previously, have structural advantages over ligands offering 
coordination with lower denticities. The use of bridging ligands offering terdentate binding sites 
have been investigated by several research groups for the preparation of multinuclear complexes. 
Bis-terdentate bridging ligands offering two terdentate coordination sites are commonly 
employed, with those based on N^N^N, N^N^C and N^C^N coordination being the most widely 
investigated.  
Ditopic bridging ligands based on the polypyridyl ligand terpyridine have been utilised in the 
preparation of dinuclear iridium(III) and platinum(II) complexes as shown in Figure 42.  
 
 
Figure 42: A figure to show the structures of  dinuclear complexes of Ir(III) and Pt(II) in which the cyclometallated 
metal-containing units are linked via terpyridine-based bridging ligands.12, 122  
 
 53 
 
For the Pt(II) complex shown in Figure 42, the optical properties were not investigated although 
self-assembly through intramolecular interactions of the metal-containing subunits was observed, 
dependent on bridge length and temperature. On the other hand, for the dinuclear Ir(III) complex, 
the photophysical properties were studied with emission observed from charge transfer states 
between 600-620 nm. Only the complex of the short tpy-tpy bridging ligand showed appreciable 
phosphorescence at room temperature. This emission is observed to be slightly red-shifted relative 
to the mononuclear analogue, likely due to the strong electronic delocalisation across the bridging 
ligand. This effect is reduced in the bimetallic complexes of longer bridging ligands and therefore, 
only very weak luminescence is observed that is similar to that observed for the corresponding 
monometallic complexes.12, 122  
Although a large number of structures have been reported incorporating terpyridine-based 
terdentate ligands, these complexes are rarely luminescent at room temperature. Therefore, as 
previously discussed, the use of terdentate cyclometallating ligands is advantageous. 
Cyclometallating bis-terdentate bridging ligands bearing two N^N^C- or N^C^N-coordinating 
binding sites have also been utilised in the synthesis of multimetallic complexes of Ir(III) and 
Pt(II) as shown in Figure 43.83  
 
 
Figure 43: Structures of multimetallic complexes in which the cyclometallated Pt(II) and Ir(III) centres are linked via 
cyclometallating bis-terdentate bridging ligands bearing N^N^C or N^C^N binding sites.83, 123-125  
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In 2011, Abruña and co-workers reported the synthesis of the heterobimetallic Pt(II)/Ru(II) 
complex bridged by the cyclometallating bis-N^N^C ligand 2,3-di(2-pyridyl)-5,6-
diphenylpyrazine (dpdpz). This complex was observed to emit in the near-infrared (NIR) region 
of the spectrum (780 nm) with a quantum yield higher than that of the related mononuclear 
ruthenium(II) complex (ϕ = 0.0015 vs. 0.00057). It was suggested that this may be due to efficient 
energy transfer from the Ru(II) centre to the Pt(II) unit.124 Earlier, in 2008, Williams et. al. 
reported the synthesis of dinuclear iridium(III) complexes linked via a bridging ligand bearing 
two-N^N^C separated by a tri- or tetraphenylene spacer group. The emission spectra recorded for 
these di-iridium(III) complexes showed emission in the red region of the spectrum (λem = 632-
633 nm, ϕ = 0.027), thought to originate from a 3π-π* state at 298 K. As observed for the similar 
bis-bidentate bridged complexes discussed in section 1.3.2, the large phenylene spacer groups of 
the bridging ligands result in these dinuclear complexes displaying photophysical properties 
similar to those of the mononuclear complexes.123 Williams and co-workers also reported the 
synthesis of a di-platinum(II) complex in which the metal centres were each cyclometallated by 
an N^C^N-coordinating binding site and rigidly-linked via a xanthene core (Figure 43). Within 
this complex, the two platinum centres are held in a face-to-face arrangement enabling 
intramolecular Pt-Pt interaction to occur. The di-platinum(II) complex displayed deep red 
emission in solution at room temperature (λem = 690 nm, ϕ = 0.20, τ = 1.7 μs) resulting from the 
formation of an intramolecular excimer between the two metal-containing subunits. The relatively 
high luminescence efficiency, despite the low energy of the emission, demonstrated that 
exploiting intramolecular excimer formation may be a useful strategy by which to obtain efficient 
red emitters.126 Ditopic terdentate N^C^N bridging ligands were also used in the preparation of 
dinuclear iridium(III) complexes reported by Kozhevnikov et. al., with an example shown in 
Figure 43.  These rigidly-linked complexes in which the Ir(III) centres are linked via a common 
heterocyclic ring showed red luminescence equal to some of the best red emitters in the literature 
(λem = 625 nm, ϕ = 0.65, τ < 1 μs). Based on the photophysical properties observed, these di-
iridium(III) complexes are extremely strong candidates for use as dopants in OLEDs or as 
sensitisers in applications such as dye-sensitised solar cells (DSSCs) or photocatalysis.83  
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1.3.4 Tetradentate Bridged 
Compared to all classes of bridging ligand previously discussed in this literature review, there are 
very few examples of bis-tetradentate bridging ligands. There are currently no reports of 
cyclometallating bis-tetradentate bridging ligands in the literature. 
Figure 44 shows the structure of a dinuclear platinum(II) complex reported by Houjou and co-
workers in 2017. The di-Pt(II) complex is an example of a fused salen complex in which a bis-
salen ligand, offering bis-tetradentate coordination, is utilised to rigidly-link two platinum centres 
leading to a highly stable bimetallic complex. Houjou et. al. investigated both the optical 
properties and the potential for Pt-Pt interactions within this complex to result in excimer 
formation and emission from MMLCT states.127  
 
 
Figure 44: The structure of the dinuclear Pt(II) complex in which the two metal centres are linked via a salen-type 
bridging ligand offering bis-tetradentate coordination via two equivalent O^N^N^O binding sites (left). The emission 
spectra recorded for the di-platinum(II) complex, in o-dichlorobenzene solution, is shown as the solid red line, labelled 
1.3.36, in the spectra shown (right).127  
 
The photophysical properties of the complex shown above were recorded in o-dichlorobenzene 
solution at room temperature. The bis-salen linked di-platinum(II) exhibited red phosphorescence 
centred at 636 nm with the low-energy tail extending to the NIR region of the spectrum. As can 
be seen in the emission spectra shown in Figure 44, the emission observed from this bimetallic 
Pt(II) complex is red-shifted by 62 nm relative to the corresponding monometallic complex PtLb. 
The emission was assigned to a mixed 3LC-3MLCT excited state and with no emission bands 
attributable to 3MMLCT transitions despite the close proximity of the Pt(II) centres (3.43 Å).  
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The rigid, conjugated bis-salen ligand utilised in the formation of this dinuclear platinum(II) 
complex results in a complex with advantageous structural and photophysical properties. This 
suggests further potential for investigation of bis-tetradentate ligands in the preparation of highly 
luminescent transition metal complexes.127  
 
1.4 Applications of Luminescent Metal Complexes  
Luminescent metal complexes of transition metals such as Pt(II) and Ir(III) have attractive 
chemical and photophysical properties that are extremely desirable for use in an array of 
applications, ranging from electroluminescent devices such as OLEDs to bioimaging and 
catalysis. 
As mentioned in section 1.1.2, the heavy metal atoms within these systems have large SOC 
constants and therefore, are able to facilitate efficient intersystem crossing. Consequently, the 
spin selection rule becomes relaxed and the formally spin-forbidden T1→S0 transition can occur, 
leading to phosphorescence. The ability of a molecule to exhibit phosphorescence, harvesting 
both singlet and triplet excitons, means that 100% theoretical internal quantum efficiency is 
achievable.96, 128  
In particular, complexes of cyclometallating ligands have been widely investigated for utilisation 
in the aforementioned applications. One of the attractions of such complexes is the ease with 
which the excited state properties can be tuned via simple ligand modifications. In addition to 
facile colour tunability, high quantum yields and luminescence lifetimes in the microsecond range 
are also advantages of cyclometallated transition metal complexes.  
The utilisation of luminescent complexes of cyclometallating ligands in electroluminescent 
devices, such as OLEDs and LECs, as well as in bioimaging and as chemical sensors will be 
discussed in the following sections.  
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1.4.1 Organic Light-Emitting Diodes (OLEDs) and Light-Emitting Electrochemical Cells 
(LECs) 
Electroluminescent devices such as organic light-emitting diodes (OLEDs), and light-emitting 
electrochemical cells (LECs), based on phosphorescent metal complexes, have attracted much 
attention due to their potential for application in large area displays and solid-state lighting. 
Electroluminescence in such devices arises from the radiative decay of excited states that are 
formed via the recombination of charge carriers, holes and electrons, injected from the anode and 
cathode respectively. As stated previously, the presence of a heavy metal atom enables both 
singlet and triplet excitons to be radiatively active. This phenomenon was first observed in the 
1950s by Bernanose and co-workers.3, 129, 130  
The first commercialised OLED was fabricated in 1987 by Tang and VanSlyke at Eastman, 
showing efficient low-voltage electroluminescence from a thin-film device.3, 11 Since this first 
report, there has been a large number of successes in the fabrication of phosphorescent OLEDs 
(PhOLEDs), making use of heavy-metal triplet emitters. Baldo et. al. investigated the utilisation 
of the platinum(II) porphyrin complex, octaethyl-porphine Pt(II) (PtOEP), whereas, Thompson 
and Forrest fabricated highly-efficient devices incorporating cyclometallated iridium(III) 
complexes such as fac-Ir(ppy)3 and Ir(ppy)2(acac).3, 49, 130-132  
OLEDs have a number of advantages over more traditional technologies, such as liquid crystal 
diplays (LCDs). For example, OLED devices can be produced from low-cost materials using 
fabrication methods suitable for scaling to large areas. This class of display does not require 
backlighting and light is only emitted from required pixels, therefore resulting in devices that are 
more efficient and capable of being much thinner and lighter. Additionally, due to the robustness 
of OLEDs, they may be deposited on a wide range of substrates, both rigid and flexible. These 
benefits have led to rapid development of this technology with OLEDs already widely utilised in 
displays for mobile phones and televisions.11  
The general structure of a multilayer OLED is shown in Figure 45. The anode in these devices is 
generally indium tin oxide (ITO), whereas the cathode is usually a metal such as aluminium. The 
thin organic layers between the two electrodes promote more efficient injection of electrons and 
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holes towards the emissive layer. The structures of the organic compounds utilised in the 
conducting layers of the device are shown in Figure 46. The most important layer is the emissive 
layer, containing the organometallic transition metal complex as the emitter. The emitter can 
either be deposited directly between the charge transport layers or, as is more common, the emitter 
can be doped into a host material such as CBP, as is shown in Figure 46.3, 11  
 
 
Figure 45: A schematic to show the structure of a typical multilayer OLED (left) and the idealised working principle 
of a multilayer device (right). Following the injection of charge carriers under the influence of an external electrical 
field from the cathode and anode (1) electron and hole transport occurs via a hopping mechanism along the LUMO and 
HOMO levels of the molecule, respectively. (2) Accumulation of the electrons and holes takes place in the emissive 
layer (3) Formation of excitons occurs (4) Excitons collapse resulting in the emission of light.3, 11, 133 
 
 
Figure 46: A figure to show the structures of the conjugated organic compounds utilised in the conducting layers of 
the OLED device as described above. Organic molecules other than those shown above can be utilised as hosts in the 
emissive layer and in the conducting layers of multilayer OLED devices.3 
  
Using this type of device structure, various OLED devices have been fabricated including both 
those for full-colour displays and those emitting white light for use in solid-state lighting 
applications.  
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For multi-coloured displays, it is a requirement to incorporate OLEDs based on emitters 
displaying efficient blue (~450-470 nm), green (~500-550 nm) and red (~650-700 nm) emission.11 
Examples of cyclometallated iridium(III) complexes utilised as emitters in the fabrication of 
highly-efficient monochromatic OLEDs are shown in Figure 47. Adachi et. al. reported a green-
emitting device incorporating Ir(ppy)2(acac) as the dopant and showing a maximum external 
quantum efficiency (ηext) of 19.0% and a power efficiency (ηp) of 60 ± 5 lm W-1. The highest 
efficiencies were obtained by doping the Ir(ppy)2(acac) in concentrations between 5-12%.131 
Green emitters generally have higher efficiencies relative to red and blue triplet emitters and as a 
result the fabrication of highly efficient red and, in particular, blue OLEDs has presented more of 
a challenge. The comparatively poor performance of red emitters can be explained using the 
energy gap law. A deep red PhOLED was obtained through the use of the tris-cyclometallated 
complex Ir(piq)3 using a hybrid of triphenylamine/oxadiazole as the host material within the 
emitting layer. This device displayed an ηext of up to 21.6% with a ηp of 16.1 lm W-1.134 The 
development of a true blue emitter with a high quantum yield is challenging as a result of the large 
energy gap required. This leads to the energy of the lowest excited state being in closer proximity 
to the deactivating 3MC states giving a potentially thermally accessible pathway for non-radiative 
decay. A typical iridium(III) complex employed in blue OLEDs is FIrpic as shown below. This 
complex displays sky-blue emission. Utilising the complex Ir(dfppy)(fppz)2, the fabrication of an 
device displayed deep blue phosphorescence was possible. This OLED showed a high external 
quantum efficiency of 8.5% and a power efficiency of 8.5 lm W-1.133, 135  
 
 
Figure 47: Examples of cyclometallated iridium(III) complexes that have been utilised in the fabrication of highly-
efficient monochromatic OLED devices, exhibiting phosphorescence across the visible spectrum from blue (450 nm) 
to red (620 nm).50, 54-57, 135, 136  
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In addition to monochromatic OLEDs, there has been increased interest in white-emitting OLEDs 
(WOLEDs) due to their potential in applications such as solid-state lighting and backlighting. 
White light has three characteristics defined by (i) CIE coordinates (Commission Internationale 
d’Eclairage) of (0.33, 0.33) (ii) the colour temperature (CT), shown by the black body curve on 
the CIE chart in Figure 48 (iii) the colour rendering index (CRI), for which a black body radiator 
has a value of 100. Considering all these characteristics it has been shown that, for lighting 
applications, that white light with a warmer colour temperature (< ~5000 K) is preferred over the 
theoretical ideal white light with the CIE coordinates (0.33, 0.33).133, 137  
 
 
Figure 48: CIE (x,y) chromaticity chart. Within the boundary of this diagram, all of the colours of the visible spectrum 
are described by specific CIE coordinates. The curve shown within the diagram shows the colour temperatures relating 
to a black body radiator.137  
 
In the fabrication of WOLEDs, it is important to select both the right combination of emitters and 
the appropriate thickness for the layers of each emitter. Two main strategies have been utilised in 
the construction of WOLEDs offering balanced white light; the (R-G-B) strategy using individual 
layers of red, green and blue emitters and the (O-B) strategy incorporating only orange and blue 
emitters. The (R-G-B) type devices are popular as a more balanced white light can be achieved 
using this strategy. Thompson and co-workers reported a device comprised of Ir(III) bis-(2-
 61 
 
phenylquinolyl-N,C2′) acetylacetonate (PQIr), tris-(phenylpyridine)iridium (Ir(ppy)3) and bis-(4′, 
6′-difluorophenylpyridinato)tetrakis(1-pyrazolyl)borate (FIr6), showing red, green and blue 
emission respectively. Following the investigation of a range of host materials, the optimised 
device showed a high EQE of 26% with a power efficiency of 64 lm W-1.138 Utilising the (O-B) 
strategy for the construction of a WOLED is advantageous when compared with the (R-G-B) 
method as, due to the requirement for less dopant materials, this class of device has both lower 
production costs and a simpler fabrication process. Using phosphorescent dopants FIrpic and the 
tris-cyclometallated iridium(III) complex of the ligand (9,9-diethyl-7-pyridinylfluoren-2-
yl)diphenylamine), Kwok and co-workers prepared an (O-B) white-light-emitting device with 
CIE coordinates (0.31, 0.41) and a power efficiency of 7.6 lm W-1.139 Blue phosphors such as 
FIrpic tend to have short operational lifetimes due to low stability and therefore can impact the 
colour-stability and the device lifetime of a WOLED. Thompson et. al. reported an improvement 
in operational characteristics of WOLEDs through the replacement of the blue phosphor with a 
blue fluorophore. In these improved devices, the blue fluorophore harnesses all the singlet 
excitons while the remaining triplet excitons are harvested by the phosphorescent green and red 
emitters. Unwanted direct energy transfer between the fluorophore and the phosphors is 
minimised by the presence of a layer of undoped host material acting as a spacer.137, 140  
In addition to the multi-dopant devices described above, it is possible to achieve white-light 
emission using a single dopant. Williams and co-workers found that through variation of the 
dopant concentration of the planar platinum(II) N^C^N complex shown in Figure 49, the colour 
of emission observed from the fabricated OLED devices could be varied from sky-blue to white 
light. The electroluminescence spectra recorded for each of the OLED devices fabricated are 
shown in Figure 49, with the dopant concentrations varied from 3-100%. At low concentrations, 
only the sky-blue phosphorescence of the monomer 1.2.80 is observable. As the dopant 
concentration is increased, there is the appearance of a broad band in the red region of the 
spectrum. This is due to the formation of triplet excimers or aggregates formed by Pt-Pt 
interactions. At 100%, in the neat film, there is almost no observation of the blue monomer 
emission.68  
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Figure 49: A figure to show the electroluminescence spectra and CIE chart for 1.2.80 at different doping 
concentrations.68 
 
The CIE coordinates obtained for the WOLED devices fabricated become more red-shifted with 
increasing dopant concentration. For dopant concentrations 20 and 25%, the CIE coordinates 
observed were very close to white light; (0.36, 0.37) and (0.37, 0.39) respectively. In addition, for 
these devices, high CRI values of 87 and 88 were obtained. For the WOLED device with doping 
of 1.2.80 at 20%, the EQE was measured at 3.7% with a luminous efficiency of 7.4 cd A-1. The 
CRI values observed for the WOLED devices fabricated in this work are among the highest values 
reported for devices based on triplet excimers.  
 
An alternative class of electroluminescent devices that can be utilised in applications such as 
displays and lighting is light-emitting electrochemical cells (LECs). For incorporation into OLED 
devices, organometallic complexes must be charge-neutral, however, cationic transition metal 
complexes can be utilised as emitters in LECs.133 Ionic transition metal complexes (iTMCs) of 
metals such as iridium(III) are particularly suitable for incorporation in such devices as a result 
of their excellent photophysical properties, high stability, reversible redox properties and colour 
tunability.141, 142  
LECs offer several advantages over multi-layered OLEDs. Generally, LECs have simpler device 
architectures, consisting of a single layer of an ionic luminescent material sandwiched directly 
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between two air-stable electrodes, resulting in lower fabrication costs. Additionally, LECs 
generally have low turn-on voltages and are amenable to large-area solution processing.141, 143 
In these single-layer devices, incorporating iTMCs, electrons and holes are directly injected into 
the emitting layer from the cathode and anode respectively. On the recombination of these 
electrons and holes there is emission of light. The ionic organometallic complexes incorporated 
into the emitting layer are capable of supporting the processes of charge injection, charge transport 
and emissive recombination. Charge transport occurs via a charge hopping mechanism.29, 143  
Cationic iridium(III) complexes have been employed by a number of research groups in the 
fabrication of LECs.60, 142, 144 Bernhard and co-workers reported the preparation of a single-layer 
LEC device in which the emitting layer was composed of the cationic, bis-cyclometallated 
iridium(III) complex [Ir(df(CF3)ppy)2(dtbbpy)][PF6], as shown in Figure 50. This device showed 
an EQE of 0.16% with a luminance of 33 cd m-2.142  
 
 
Figure 50: Structure of the cationic, bis-cyclometallated iridium(III) complex, [Ir(df(CF3)ppy)2(dtbbpy)][PF6], 
incorporated into a single-layer LEC by Bernhard and co-workers.142  
 
Thompson et. al., also using cationic, bis-cyclometallated Ir(III) complexes, fabricated 
electroluminescent LECs showing emission across the visible spectrum, from blue to red. The 
structures of the iridium(III) complexes utilised are shown in Figure 51. The structure of the 
green-emitting complex [Ir(ppz)2(dtbbpy)][PF6] was varied through ligand modification in order 
to give the blue and red-emitting complexes. Substitution of fluoro groups at the 4- and 6-
positions of the phenyl ring on the ppz ligand gave the blue emitter [Ir(dfppz)2(dtbbpy)][PF6]. 
Whereas, substitution of a tert-butyl group at the 5-position of the phenyl ring of the ppz ligand 
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in conjunction with replacement of the bpy ligand with the more conjugated biq ligand gave the 
red emitting complex [Ir(5-tBuppz)2(biq)][PF6].   
 
 
Figure 51: A figure to show the series of complexes reported by Thompson et. al. and incorporated into LECs showing 
electroluminescence across the visible spectrum, from blue to red.29  
 
The devices fabricated using these complexes showed electroluminescence across a wide colour 
range with blue (492 nm), green (542 nm) and red (635 nm) emission observed. The EQEs were 
in the range 4.6-7.4% with the luminance values between 1700-11500 cd m-2.144  
 
The complexes discussed in this section illustrate that the chemical and photophysical properties 
of cyclometallated complexes of Ir(III) and Pt(II) are ideal candidates for use in 
electroluminescent devices such as OLEDs and LECs. Extensive investigation in this area 
continues in order to isolate complexes with improved properties and to maximise the 
performance of such luminescent complexes in devices. This includes achieving higher external 
quantum efficiencies, improved device stability and lifetime and finally better colour purity.60  
 
1.4.2 Bioimaging 
The utilisation of transition metal complexes as luminescent probes in the imaging of cells and 
biological tissues is a rapidly emerging area of research. In bioimaging, the design of luminescent 
molecules capable of both entering cells and targeting specific structures, whilst having low 
cytotoxicity, is essential for the understanding of processes occurring within biological systems.67, 
145  
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Fluorescence microscopy is a tool widely used in the cell biology and biomedical science for the 
visualisation of biological tissues and the study of biological systems, from the interactions 
between single molecules to the investigation of the function of whole organisms. Fluorescence 
microscopy is a highly sensitive tool as a result of the efficiency with which light can now be 
detected. Excellent spatial resolution can be achieved using confocal microscopy with exceptional 
temporal resolution also attainable. Use of this technique for the imaging of biological samples 
relies on luminescence from fluorophores intrinsic to the cells or from external fluorescent probes. 
A wide range of fluorescent dyes are available commercially with many being based on fluorone 
cores and derivatives, for example, the rhodamine dyes and fluorescein. Alternatively, fluorescent 
proteins such as green fluorescent protein (GFP) have also been previously employed as 
fluorescent probes.67, 145, 146  
Dyes based on luminescent complexes of metals such as Ir(III) and Pt(II) are interesting 
alternatives to organic fluorophores and have many superior chemical and photophysical 
properties that prove beneficial for bioimaging. Firstly, through the synthetic methods utilised in 
the preparation of these complexes a large variety of functionality can be integrated into the final 
structures. This is useful for the modulation of properties such as charge, lipophilicity, 
cytotoxicity and compartmentalisation within the cells. Additionally, metal-based dyes have high 
quantum yields, absorption and emission wavelengths tunable across the visible spectrum, large 
Stokes shifts, long luminescence lifetimes and enhanced photostabilities.146, 147 Due to the long 
luminescence lifetimes of luminescent metal complexes, the short-lived autofluorescence of 
biological molecules can be eliminated using time-gated emission experiments such as time-
resolved emission imaging microscopy (TREM). Figure 52 illustrates the concept utilised in 
TREM experiments.67, 145  
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Figure 52: A figure to illustrate the concept of time-resolved emission imaging microscopy (TREM). (Left) A diagram 
to explain time-gating for the elimination of short-lived autofluorescence. Using a time-gated CCD camera, a series of 
images can be recorded at different time delays following the excitation pulse. (Right) Images of live CHO cells 
incubated with a [Pt(N^C^N)Cl] complex and imaged in the presence of a fluorescein solution in 1M NaOH, taken at 
0 ns and 10 ns after the 355 nm excitation pulse.67  
 
Ideally, in order for a luminescent probe to be useful as a bioimaging agent, it should satisfy a 
range of criteria. It is necessary for a luminescent probe to have a high extinction coefficient in 
the visible region of the spectrum. For work involving cells, excitation in the blue/green region 
of the spectrum is acceptable. However, for tissue samples, the optimal excitation wavelength lies 
in the deep red or NIR region (650-950 nm) resulting from good tissue penetration and low 
autofluorescence. A high emission quantum yield is desirable due to the fact that with increased 
brightness of the emission from the luminophore, a lower excitation intensity is required. 
Solubility in water is also essential, in conjunction with high cell permeability and low 
cytotoxicity. The cell permeability and cytotoxicity of a luminescent probe are strongly linked to 
its structure. A careful balance of these two factors, through synthetic design, is essential for an 
imaging agent to be successful. With respect to luminescent metal complexes as probes, a higher 
lipophilicity is generally linked to an increased cytotoxicity although sufficient lipophilicity is 
required for cell permeability. Additionally, cellular uptake and compartmentalisation are 
controlled by the charge, size and the substituents incorporated. A positively charged complex is 
likely to have higher cellular uptake due to facile interaction with the negative surface charge on 
cells. Finally, a high chemical and photostability are also required in order to avoid degradation 
and photobleaching of the luminescent probe. Using the criteria discussed, luminescent 
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cyclometallated complexes have been prepared that are capable of staining a range of cellular 
structures, from the cytoplasm and nucleus to the mitochondria and lysosomes (Figure 53).145, 148  
 
 
Figure 53: Phosphorescent cell stains based on cyclometallated complexes of Pt(II) and Ir(III). These luminescent 
probes localise in specific areas of cells; the cytoplasm, nucleus and nucleoli, mitochondria and lysosomes.146-155 
 
Williams et. al. reported a series of highly emissive platinum(II) complexes for utilisation as 
TREM agents in bioimaging. The Pt(N^C^N)Cl complexes were shown to have low cytotoxicity, 
to be photochemically robust and exhibited efficient phosphorescence, making them ideal 
candidates for live-cell imaging.  
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Figure 54: General structure of the cyclometallated platinum(II) complexes reported by Williams and co-workers for 
as bioimaging agents in TREM experiments (left). The emission spectrum of 1.0.2 is shown in water (dashed line), in 
aerated CH2Cl2 solution (dotted line) and HDF cell nuclei (solid line) (right).67  
 
This research group have previously shown that such cyclometallated Pt(II) complexes absorb 
strongly in the UV (ε ~ 104 mol-1 dm3 cm-1) and visible (ε ~ 200 mol-1 dm3 cm-1) regions of the 
spectrum and also display intense phosphorescence in solution at room temperature, with 
quantum yields in the range ϕ = 0.60-0.70 for degassed dichloromethane solutions. 
Three cell lines were selected for incubation with 1.0.2, (i) normal human dermal fibroplast (HDF) 
cells, (ii) neoplastic human cells taken from an invasive melanoma (C8161) and (iii) common 
animal-derived cells (CHO). The cytotoxicity of the platinum(II) complex was investigated using 
an MTT assay [MTT = 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]. The Pt(II) 
complex was found to have low cytotoxicity, only significantly reducing cell viability at high 
concentrations (100 μM) after incubation for 24 h (Figure 55).67  
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Figure 55: Cell viability of CHO (left) and HDF (right) cells as determined by MTT assay by Williams and co-workers. 
Cells were incubated for 5 min with the [Pt(N^C^N)Cl] at different concentrations, washed with PBS (three times) and 
incubated with fresh culture medium for 24 h (mean ± SEM, n = 3 for all experiments, **, P < 0.01).67 
 
Cell imaging of all cell lines was carried out using 1.0.2 as a luminescent label. Maximum 
emission intensity was obtained after a short incubation of 5 min, suggesting high cell 
permeability. Upon excitation, the Pt(II) complex was observed to emit a green-yellow light with 
an emission profile almost identical to that recorded in aqueous solution (Figure 54).67  
 
 
Figure 56: A figure to show the confocal micrographs of human dermal fibroplast, C8161 human melanoma and CHO 
cells. These cells were incubated for 5 min with 100 μM solution of 1.0.2 and then washed with phosphate buffer 
solution for 5 min. The images were captured following excitation at 488 nm. Areas in which 1.0.2 accumulates are 
shown as both grayscale and rainbow intensities. Scale bar: 10 μm.67 
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The compartmentalisation of the cyclometallated platinum(II) complex was first investigated 
using co-staining experiments with a common nuclear stain, DAPI. The preferred localisation of 
1.0.2 in the nuclei of the cells was confirmed both by confocal microscopy (Figure 56) and high-
resolution two photon images. 
In this study, Williams and co-workers showed the huge potential for the utilisation of transition 
metal complexes in bioimaging as these charge-neutral, cyclometallated Pt(II) complexes have 
been effectively used as labels in a range of eukaryotic cells.67 
Li and co-workers also demonstrated the successful application of transition metal complexes in 
bioimaging. Cationic, cyclometallated iridium(III) complexes displaying bright green and red 
emission were utilised as dyes in the imaging of living cells. The structures of the complexes used 
are shown in Figure 57. Both of the iridium(III) dyes showed exclusive staining of the cytoplasm, 
as can be observed in the confocal luminescence images shown below.156   
 
 
Figure 57: Chemical structures of the cationic iridium(III) complexes utilised for bioimaging of living HeLa cells 
(left). Confocal luminescence (a and d) and brightfield images (b and e) of HeLa cells incubated in 20 μM solutions of 
[Ir(dfppy)2(bpy)]+ (top) and [Ir(dfppy)2(quqo)]+ (bottom) in DMSO/PBS for 10 min are shown (right). Overlays of 
these two images (c and f) are also shown. (λex = 405 nm)156 
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These promising results, in addition to the high cell permeability, low cytotoxicity, low 
photobleaching observed, show that such complexes are excellent candidates for specific 
phosphorescence bioimaging agents.156  
The use of phosphorescent transition metal complexes in bioimaging has offered many 
advantages and opened up new opportunities, including new microscopy techniques. Further 
investigation in this field of research continues as the demand for imaging dyes with the 
advantageous properties of these complexes increases. Their synthetic versatility, facile 
modulation of photophysical properties and relatively long luminescence lifetimes mean that such 
compounds are extremely attractive for use as luminescent probes in biological systems.  
 
1.4.3 Chemical Sensors 
In addition to the application of luminescent transition metal complexes as bioimaging agents, 
similarly they have also been utilised as chemical sensors. A chemical sensor is a compound 
capable of detecting an analyte through enacting a change in the properties of the system, such as 
variation in the absorption, emission or redox potentials. Chemical sensors are particularly 
important as a result of their application in the detection of species of biological and 
environmental importance.157, 158  
The use of photoluminescence techniques is an extremely effective tool in the detection of 
analytes due to their high sensitivity and selectivity, facile visualisation, excellent temporal and 
spatial resolution and short detection response time. Commonly, luminescent chemosensors are 
based on organic dyes with examples of lanthanide complexes also reported. More recently, 
phosphorescent transition metal complexes have been attracting increasing interest as 
chemosensors due to their advantageous photophysical properties and the sensitivity of those 
properties to changes in the local environment.157, 158  
In general, a chemical sensor is comprised of two components; a receptor unit and a signalling 
unit. The receptor unit is involved in the selective binding of analytes whilst the signalling unit 
reports on the interaction between the receptor and the analytes. Incorporating a phosphorescent 
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transition metal complex as the signalling unit means that the chemical information obtained 
through analyte binding is converted into an optical signal.157  
In the design of chemosensors, several approaches have been devised for linking a receptor unit 
to the phosphorescent signalling unit as is shown in Figure 58. These approaches include the 
“receptor-σ-signalling unit approach”, the “receptor-conjugated-signalling unit approach” and the 
chemodosimeter approach” as described schematically in Figure 58.157, 158 
 
 
Figure 58: Schematic to show three approaches used in the design of chemosensors, linking the receptor unit to the 
phosphorescent signalling unit. (1) The “receptor-σ-signalling unit approach” in which the receptor unit is linked to the 
ligand of a phosphorescent complex via a spacer (2) The “receptor-conjugated-signalling unit approach” in which the 
receptor unit is conjugated to the ligand of metal complex without a spacer (3) The “chemodosimeter approach” in 
which the receptor unit is conjugated to the signalling unit but on binding of an analyte there is an irreversible chemical 
reaction between the phosphorescent metal complex and the analyte.157, 158  
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Each design approach described above endows the resulting chemical sensor with a different 
functionality leading to a variety of possible mechanisms of action. The first potential mechanism 
is the photoinduced electron transfer (PET) mechanism and is most common for chemosensors 
prepared using the “receptor-σ-signalling unit approach”. Generally, this results in turn-on/turn-
off phosphorescent chemosensors. In many cases, PET quenches the emission from heavy metal 
complexes and therefore, on binding to an analyte, the PET process can be inhibited and emission 
is observed (turn-on). In the second possible mechanism, binding of the receptor unit to an analyte 
perturbs the energy levels of the adjoined metal complex resulting in a change in the lowest 
excited state and in the emission properties observed. This mechanism is most often observed for 
“receptor-conjugated-signalling unit” type chemical sensors. The third mechanism is based on 
fluorescence resonance energy transfer (FRET) in which binding of the analyte results in a 
variation of the amount of energy transfer that occurs between an energy donor and acceptor. A 
further three mechanisms of action have been suggested for chemical sensors. Firstly, the 
detection of the variation in photophysical properties based on the extent of metal-metal 
interactions on binding of a d8 metal complexes to analytes. Secondly, detection of variations in 
the emission intensity resulting from ligand distortion following binding of an analyte. Finally, 
the phosphorescence signal from a heavy metal complex can vary based on changes in the local 
environment resulting from interaction with an analyte.157  
Chemical sensors acting by the different mechanisms of action described, possible due to the 
prudent design of such systems, are utilised in the detection of a range of analytes from metal 
cations to molecular oxygen (O2). A selection of examples capable of sensing a variety of analytes 
is shown in this section. 
There are many examples of chemical sensors for metal cations based on luminescent complexes 
of Pt(II) and Ir(III). The detection of metal cations such as Na+, K+, Mg2+ and Ca2+ is of significant 
interest in biological and environmental sciences. The use of macrocyclic moieties such as crown-
ethers and aza-crown-ethers is common for binding metal cations and the incorporation of pendant 
macrocyclic receptor units on phosphorescent metal complexes have been widely reported. The 
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binding of the metal cation to the macrocyclic receptor perturbs the energy levels of the excited 
states on the Pt(II) or Ir(III) centre, leading to a change in the optical properties observed. For the 
platinum(II) complex shown in Figure 59, on binding of the aza-crown-ether to Mg2+, there is 
conversion of the lowest excited state from the non-emissive 3LLCT state to emissive 3MLCT 
state resulting in a turn-on in the emission. Similarly, for the iridium(III) complex shown, the 
addition of Ca2+ resulted in a change of the lowest excited state from ILCT to LLCT in accordance 
with the second mechanism of action described above.157, 159  
 
 
Figure 59: Structures of examples of platinum(II) and iridium(III) complexes bearing aza-crown-ether receptor units 
utilised in the detection of Mg2+ and Ca2+ cations respectively.157  
 
In addition to metal cations of alkali and alkaline earth metals, phosphorescent metal complexes 
have been used in the detection of alternative metal cations such as Hg2+. Mercury is highly toxic 
and therefore, its detection is of interest. It is well known that as a soft acid, Hg2+ cations interact 
preferentially with sulfur, a soft base. Consequently, incorporation of S atoms into the ligands of 
luminescent metal complexes has proved successful in the sensing of Hg2+ cations.  
 
 75 
 
 
Figure 60: Huang et. al. reported the use of Ir(btp)2(acac) (1.4.24) as a sensor for Hg2+ ions in CH3CN solutions.160  
 
Huang and co-workers reported that the complex Ir(btp)2(acac) (1.4.24) was successful in the 
selective detection of Hg2+ ions in CH3CN solutions using a multisignalling optical-
electrochemical response. Addition of Hg2+ ions to 1.4.24 results in a blue-shift in both the 
absorption and emission bands. As shown in Figure 60, these changes can be observed by eye. 
The solution changes colour from orange to yellow-green and the colour of emission becomes 
orange from deep-red. Additionally, the electrochemical properties of the complex are altered.157, 
160  
A second class of analytes detectable using luminescent metal complexes as chemosensors are 
anions, for example F-, Cl-, PO43- and CH3COO-. Two main approaches are used for sensing 
anions; the incorporation of acidic hydrogen-containing groups within the ligands or the 
exploitation of specific Lewis acid-base interactions such as that between boron and F-. Functional 
groups bearing acidic hydrogen atoms capable of acting as receptor units include hydroxyl and 
pyrrole. Huang et. al. reported the utilisation of an iridium(III) complex bearing an imidazolyl 
moiety (Figure 61) in the detection of F-, H2PO4- and CH3COO- anions. Upon addition of these 
anions to the complexes shown below, there is significant changes in both the absorption and 
emission properties. The solution colour changes from yellow-green to brown and the emission 
is quenched. It was suggested that following deprotonation, the PET process from the imidazolyl 
N lone pair quenches the emission from the complex as in the first mechanism of action.157, 161  
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Figure 61: A figure to show the structure of the bis-cyclometallated Ir(III) complexes reported by Huang and co-
workers (left). The changes in the solution colour and the emission upon binding to anions such as F-, H2PO4- and 
CH3COO- are also shown (right).157, 161  
 
In 2014, Gonzalez reported the cyclometallated Pt(II) complex (1.4.28) shown in Figure 62 as a 
highly selective chloride sensor. In buffered solutions containing the surfactant CTA+HSO4-, upon 
addition of NaCl, the green luminescence of the complex was turned on. This change in the 
photophysical properties of the complex allowed for detection of chloride anions in the 
micromolar (μM) concentration range.162  
 
 
Figure 62: A scheme to illustrate the action of the cyclometallated Pt(II) complex, reported by Gonzalez, for the 
detection of chloride in aqueous media.162  
 
Luminescent transition metal complexes, such as those discussed in this section, can also be used 
in the detection of alternative analytes including gases such as molecular oxygen (O2) and 
variations in pH. Examples of such chemosensors will not be discussed in this literature review.157  
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In this section, chemical sensors based on complexes of Pt(II) and Ir(III) have been discussed. As 
a result of the excellent photophysical properties including long luminescence lifetimes, 
complexes such as these are excellent candidates for application as chemosensors for a range of 
analytes and local environment changes. Research in this area is ongoing to ensure that the 
development of chemical sensors boasting increased sensitivity and selectivity as well as 
improved water solubility is achieved.  
 
1.5 Aims and Objectives 
As has continually been shown throughout this literature review, the structure of a transition metal 
complex, including the identity of the metal centre and selection of ligands, has a significant effect 
on the chemical and photophysical properties of the final complex.  
Cyclometallated mononuclear complexes of transition metals such as platinum(II) and 
iridium(III) have been widely studied and exhibit rich photophysical properties including colour 
tunability, high quantum yields and microsecond lifetimes. Consequently, these complexes have 
been successfully utilised in applications from OLEDs to bioimaging. 
There are relatively few examples of luminescent multimetallic complexes although interest in 
this area has been growing in recent years. A large proportion of the multinuclear complexes 
investigated are linked via flexible bridging ligands. Examples of such complexes in which the 
metals are rigidly linked are still relatively rare and those incorporating rigid, cyclometallating 
bridging ligands are even less common.  
The overall aim of this project is to synthesise and investigate novel bimetallic emitters in which 
the metal centres are rigidly-linked by cyclometallating bridging ligands and assess the suitability 
of such complexes for application in OLEDs and bioimaging. More specific aims of the project 
are listed below. 
 
(1) Di-Platinum(II) Complexes  
Based on previous research in the Kozhevnikov group, pyrimidine-based bis-bidentate bridging 
ligands incorporating bis-thiophene groups, such as those shown in Figure 63, are of interest for 
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the preparation of bimetallic platinum(II) complexes.85, 163 These ligands offer both increased 
conjugation length and electron-rich moieties, both of which are strategies often used in shifting 
absorption and emission to the red.  
 
 
Figure 63: Structures of the pyrimidine-based bis-bidentate bridging ligands bearing mono- and bis-thiophene groups 
that are of interest use in the synthesis of dinuclear platinum(II) complexes.  
 
Dinuclear platinum(II) complexes of the bis-bidentate ligands shown above, using 
acetylacetonate as an auxiliary ligand, will be prepared and their photophysical properties 
investigated. It is likely that such complexes will show emission in the near-infrared (NIR) region. 
Che et. al. have reported the synthesis of mononuclear platinum(II) complexes bearing rigid 
tetradentate N^C^N^O-coordinating ligands. These complexes proved to be excellent candidates 
for use in OLEDs. A multinuclear complex incorporating an equivalent ditopic bis-tetradentate 
ligand is an interesting target and to the best of our knowledge has never been reported before. 
Consequently, a di-platinum(II) complex in which the metal centres are linked via a rigid bis-
tetradentate ligand (Figure 64) will be prepared and the photophysical properties of the final 
complex will be investigated.164-167 
 
 
Figure 64: Proposed structure of the rigid bis-tetradentate ligand to be utilised in the synthesis of a dinuclear 
platinum(II) complex.  
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(2) Pyrimidine-Linked Dinuclear Iridium(III) Complexes 
Bis-bidentate bridging ligands based around a central pyrimidine heterocycle were previously 
used in the Kozhevnikov group for the preparation of bimetallic platinum(II) and heterotrimetallic 
Pt(II)/Ir(III) complexes as shown in Figure 39.84, 85 In this work, utilising similar pyrimidine-based 
bis-bidentate bridging ligands, a series of rigid dinuclear iridium(III) complexes of the general 
structure illustrated in Figure 65 will be prepared.  
 
 
Figure 65: The general structure of the dinuclear iridium(III) complexes to be prepared in this work. The metal centres 
in these complexes are rigidly-linked via a pyrimidine-based bis-bidentate bridging ligand.  
 
Terdentate N^C^N-coordinating auxiliary ligands will be incorporated in order to introduce 
additional rigidity to the multinuclear systems. Importantly, these terdentate ligands and the bis-
bidentate bridging ligands will be symmetrical, ensuring that the final dinuclear complexes 
prepared are achiral. This is crucial if laborious separation of mixtures of diastereoisomers is to 
be avoided.  
A range of different substituents, electron-withdrawing and –donating, will be incorporated into 
both the bridging and auxiliary ligands. The photophysical properties of the resulting series of 
dinuclear iridium(III) complexes will be measured and the effects of the structural variations on 
these properties will be investigated.  
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(3) Variation of the Central Heterocycle of the Bridging Ligands in Dinuclear Iridium(III) 
Complexes  
In the general structure of the dinuclear iridium(III) complex shown in Figure 65, each component 
from the terdentate auxiliary ligand to the monodentate ligand can be modified in order to tune 
the photophysical characteristics of the final complex. 
The central heterocycle of the bis-bidentate bridging ligand will be varied from pyrimidine to 
alternative heterocycles such as pyrazine and pyridazine as shown in Figure 66.  
 
 
Figure 66: A figure to illustrate the general structures of bis-bidentate bridging ligands in which the central heterocycles 
have been varied from pyrimidine to 2,5-substituted pyrazine (left), 2,3-substitued pyrazine (middle) and 3,6-
substituted pyridazine (right). 
 
Such modifications to the bis-bidentate bridging ligand are likely to have a large effect on the 
optical properties of the resulting dinuclear complexes, as has been previously shown in the 
Kozhevnikov group.85 The chemical and photophysical properties of the di-iridium(III) 
complexes prepared using these bis-bidentate bridging ligands will be investigated. 
 
(4) Variation of Monodentate Ligand in Dinuclear Iridium(III) Complexes 
Similarly, the monodentate chloride ligand in the general structure illustrated in Figure 65 can 
also be modified. Chloride ligands in luminescent metal complexes are highly labile and therefore, 
complexes bearing monodentate chloride ligands can have detrimental effects on the operation of 
OLED devices in which they are utilised.  
In this work, metathesis reactions will be carried out in order to introduce alternative monodentate 
ligands such as –CN, MeCN and OH2 to replace the labile chloride ligand. The resulting dinuclear 
iridium(III) complexes will be fully characterised and their optical properties measured. 
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Chapter 2 
Dinuclear Platinum(II) Complexes 
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2.0 Dinuclear Platinum(II) Complexes 
Platinum(II) complexes of cyclometallating ligands such as 2-phenylpyridine have been 
extensively investigated for use in an array of contemporary applications such as OLEDs, solar 
energy conversion and imaging.84, 85 The structure and electronic properties of the ligands used in 
the synthesis of a luminescent metal complex are exceptionally important in modulating the 
chemical and photophysical properties of the final compound.  
As discussed previously in section 1.2.3, systematic modification of the cyclometalling ligands 
used is a valuable tool in the facile tuning of the absorption and emission wavelengths of a 
luminescent complex. Strategies employed for tuning can involve the addition of electron-
donating or -withdrawing substituents, exclusively altering the HOMO or LUMO energy levels, 
or variation of ligand conjugation. These strategies enable tuning of the absorption and emission 
across the visible spectrum. In particular, there is a need for the development of materials that 
exhibit improved absorption and emission in the red region of the spectrum. This is due to the 
requirement of such materials for use in applications such as dye-sensitised solar cells (DSSCs) 
and bio-imaging. Specifically, in order to shift to the red region of the spectrum, classical 
approaches used are (i) incorporation of a more electron-deficient heterocycle to lower the energy 
of the LUMO, (ii) use of more electron-rich aromatic units to raise the HOMO energy, and (iii) 
extension of the conjugated system of the ligand decreasing the HOMO-LUMO gap.85 
 
Cyclometallated platinum(II) complexes incorporating auxiliary diketonate ligands, such as 
acetylacetonate, have been reported to be strongly luminescent at room temperature. [Pt(L)(acac)] 
complexes were reported by Kozhevnikov and co-workers in which the cyclometallating ligands 
(L) used were substituted with thienylpyridine cyclometallating ligands. The thiophene ring of a 
thienylpyridine ligand is more electron-rich than the corresponding aryl ring present in 2-
phenylpyridine ligands. Consequently, the use of thienylpyridine ligands should result in a red-
shift. A selection of the 2-(2-thienyl)pyridine ligands used, incorporating a range of substituents, 
are shown in Figure 67. These platinum(II) complexes 2.0.1-2.0.4 display red-shifted emission 
relative to the corresponding unsubstituted [Pt(thpy)(acac)] complex. This red-shift is attributed 
 83 
 
to stabilisation of the LUMO as a result of increased delocalisation across the 
aromatic/heterocyclic substituents incorporated. The largest red-shift is exhibited by 
[Pt(L4)(acac)] with emission observed at 622 nm compared with 558 nm for [Pt(thpy)(acac)].85, 
168  
 
 
Figure 67: A figure to show the general structure of the [Pt(L)(acac)] complex prepared by Kozhevnikov et. al. and a 
selection of the substituted 2-(2-thienyl)pyridine proligands utilised in the synthesis of this series of platinum(II) 
complexes.168 
 
Further research by Kozhevnikov et. al. into [Pt(L)(acac)] complexes of thienylpyridine ligands 
reported on the use of (oligo)thienylpyridines. In this work, two of the classical strategies used to 
red-shift emission were used; incorporation of electron-rich thiophene groups and increased 
conjugation length. The ligands and complexes reported are shown in Figure 68.163  
 
 
Figure 68: A figure to show the structures of the (oligo)thienylpyridine ligands used by Kozhevnikov and co-workers 
in the synthesis of a series of cyclometallated platinum(II) complexes. The conjugation length of HL5 is increased 
through the incorporation of an additional one or two thiophene units to give HL6 and HL7 respectively. A dodecyl 
chain was added to HL6 and HL7 in order to increase solubility of the ligands and corresponding complexes.163  
 
Measurement of the photophysical properties of the series of platinum(II) complexes 2.0.5-2.0.7 
showed that extension from one to two and to three thiophenes results in a shift of the absorption 
bands to progressively longer wavelengths. This is the expected effect of increasing the 
conjugation length through elongation of the thiophene chain.163 Investigation of the 
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luminescence properties of these complexes revealed some interesting results. [Pt(L5)(acac)] 
displayed strong phosphorescence with the emission observed at 554 nm with a quantum yield of 
ϕ = 0.36. The emission spectrum of [Pt(L6)(acac)] was also recorded, exhibiting a very different 
spectrum from that of [Pt(L5)(acac)]. Two sets of bands were observed, one at 495 nm and further 
bands at 706 and 775 nm, both with low intensities. The emission quantum yield of the complex 
was measured to be ϕ = 0.0058. Through studying the excitation spectra of both the lower and 
higher energy bands in addition to determining the lifetime of the lower energy emission (< 0.5 
ns), this band was assigned to spin-allowed fluorescence from the singlet excited state. Therefore, 
[Pt(L6)(acac)] was found to display dual emission, exhibiting both fluorescence and 
phosphorescence. The relative ratios of the fluorescence and phosphorescence bands was found 
to be independent of concentration and therefore, it was concluded that the appearance of the 
additional emission band is not a result of aggregate or excimer formation. Further extension of 
the conjugation length in [Pt(L7)(acac)] did give a red-shift in the emission, however, similar dual 
emission was observed with bands at 525 and 735 nm and the quantum yield measured to be ϕ = 
0.002, lower than [Pt(L6)(acac)]. 
The observation of dual emission from [Pt(L6)(acac)] and [Pt(L7)(acac)] suggests that as the 
conjugation length of the ligand increases there is a lower degree of participation of the metal d 
orbitals in the HOMO states. As a result, the influence of the SOC from the heavy metal atom is 
reduced. This leads to a decrease in the rate of ISC and radiative decay from T1 → S0. In addition, 
with increasing conjugation length, the S1–T1 energy gap increases, further decreasing the rate of 
intersystem crossing. This leads to a decrease in the yield of triplet formation, a decreased T1 → 
S0 radiative decay rate and as the energy of the excited state decreases there is increased non-
radiative decay. Consequently, fluorescence becomes observable whilst the intensity of 
phosphorescence decreases.163  
 
Previous studies, such as those discussed, in which classical methods for red-shifting the 
absorption and emission of luminescent transition metal complexes have been employed, have 
shown that such strategies are not always successful in achieving highly luminescent red emitters.  
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An alternative strategy for achieving the desired red-shift, reported in the literature, is the addition 
of a second metal centre. As mentioned previously in section 1.3.2, Kozhevnikov et. al. 
synthesised a series of dinuclear platinum(II) complexes in which the two metal centres were 
rigidly-linked and both bound to a common nitrogen-containing heterocycle, as shown in Figure 
69.85  
 
 
Figure 69: A figure to show the series of rigidly-linked dinuclear platinum(II) complexes reported by Kozhevnikov 
and co-workers. A range of heterocycles were used to link the two Pt(II) centres and their photophysical properties 
investigated.85  
 
The dinuclear platinum(II) complexes shown above are all intensely luminescent in degassed 
solution at room temperature, exhibiting deep red emission and displaying very different 
properties compared with their mononuclear analogues. On introduction of a second Pt(II) centre, 
a significant red-shift in the absorption and emission of the complexes was observed. This red-
shift in absorption was accompanied by an increase in the molar absorptivities by a factor of 2. In 
addition to the red-shift in the emission, an increase in the radiative decay constant (2-fold) is also 
observed. It is thought that the radiative T1 → S0 transition becomes more allowed in the 
bimetallic complex as a result of a higher degree of SOC coupling resulting from the presence of 
a second heavy metal ion. The dinuclear platinum(II) complexes show relatively high quantum 
yields in the red region of the spectrum, but quantum yields for emitters in the NIR region were 
below 3%. Lifetimes in the microsecond region were also recorded.85  
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This same strategy, achieving a red-shift through incoporation of two or more metal centres into 
the same complex, has been successfully employed previously by Kozhevnikov et. al. in the 
preparation of a mixed metal Pt(II)/Ir(III) trinuclear complex and di-iridium(III) complexes.83, 84  
 
2.1 Bis-Thiophene Di-Platinum(II) Complex 
In this work, in order to achieve highly-luminescent red-shifted emitters, we have combined the 
classical strategy of increasing the conjugation of the ligand and the new alternative strategy of 
rigidly-linking two metal centres. We synthesised two dinuclear platinum(II) complexes of bis-
bidentate cyclometallating ligands incorporating mono- and bis-thiophene groups as shown in 
Figure 70. 
 
 
Figure 70: A figure to show the structures of the target di-platinum(II) complexes in which the two metal centres are 
rigidly-linked by 4,6-bis(5-hexylthiophen-2-yl)pyrimidine and 4,6-bis[5-(5-hexylthiophen-2-yl)thiophen-2-
yl]pyrimidine bridging ligands and bear diketonate auxiliary ligands. 
 
The first step in the synthesis of these two dinuclear platinum(II) complexes is the preparation of 
the bis-bidentate ligands. The C^N-N^C–coordinating bridging ligands, 2.1.5 and 2.1.8, were 
prepared via Suzuki-Miyaura cross-coupling reactions using a synthetic procedure adapted from 
that reported by Kozhevnikov and co-workers for the preparation of similar pyrimidine-linked 
bridging ligands.84 The bis-bidentate bridging ligands could be isolated, following 
recrystallisation from ethyl acetate, in yields of 84% and 90% respectively.  
 
 87 
 
 
Figure 71: A reaction scheme to illustrate the synthetic route followed in the preparation of 2.1.5 and 2.1.8.  
 
The thiophene-containing bis-bidentate bridging ligands were then utilised in the synthesis of the 
corresponding dinuclear platinum(II) complexes as shown in Figure 72 and Figure 73 below.  
 
 
Figure 72: A reaction scheme to illustrate the synthesis of the dinuclear platinum(II) complex, 2.1.1. The desired 
complex could be isolated in a yield of 43% following purification by column chromatograpy.   
 
As is shown in Figure 72, the first step in the synthesis of 2.1.1 is reaction of the bridging ligand 
4,6-bis(5-hexylthiophen-2-yl)pyrimidine with the platinum salt PtCl2(NCPh)2 to form a dichloro-
bridged platinum dimer, 2.1.9. This platinum dimer was then converted to the corresponding 
DMSO complex through refluxing the dichloro-bridged dimer in DMSO for 5 minutes. The 
DMSO complex, 2.1.10, was the reacted with sodium acetylacetonate in acetone and the final 
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dinuclear platinum(II) complex, 2.1.1, was isolated as a red solid in a yield of 43% following 
purification by column chromatography. 
Using the same synthetic route, the equivalent bimetallic platinum(II) complex incorporating the 
bis-bidentate ligand 2.1.8 with extended, conjugated bis-thiophene moieties was prepared. This 
bis-N^C-coordinating ligand was reacted with K2PtCl4 to form the dichloro-bridged dimer 2.1.11. 
In the same way as described for 2.1.1, the platinum(II) dimer was first converted to the 
corresponding DMSO complex before reaction with sodium acetylacetonate to give the target 
dinuclear Pt(II) complex, 2.1.2, as shown in Figure 73. This complex was also purified via column 
chromatography. 
 
 
Figure 73: A reaction scheme to show the synthetic route used to isolate the dinuclear platinum(II) complex, 2.1.2.  
 
These complexes were characterised using 1H and 13C NMR spectroscopy and high-resolution 
mass spectrometry.  
The 1H NMR spectra of 2.1.1 and 2.1.2 show signals integrating to 44 and 60 protons respectively. 
The aromatic regions of these NMR spectra are shown below in Figure 74 and Figure 75. These 
figures illustrate the characteristic proton signals present in the NMR spectra that are used to 
identify the pure bimetallic platinum(II) complexes. 
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Figure 74: Aromatic region of the 1H NMR spectra of dinuclear platinum(II) complex 2.1.1.  
 
 
Figure 75: Aromatic region of the 1H NMR spectra of dinuclear platinum(II) complex 2.1.2.  
 
The characteristic proton signals at high chemical shift (≈ δ 9.3 ppm) in both NMR spectra, 
correspond to the proton at the 2-position of the central pyrimidine ring. In addition, the peak at 
approximately δ 5.4 ppm in each of the spectra corresponds to the central proton of the acac 
auxiliary ligands. The 1:2 ratio between these proton signals, for both complexes 2.1.1 and 2.1.2, 
confirms that we have isolated the dinuclear platinum(II) complexes.  
The photophysical properties of these two dinuclear platinum(II) complexes were measured by 
Marsel Shafikov in the group of Professor Hartmut Yersin at Regensburg University. The 
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absorption and emission spectra for both the mono- and bis-thiophene bis-bidentate bridging 
ligands and their corresponding bimetallic platinum(II) complexes are shown in Figure 76. 
Numerical absorption and emission data are summarised in Table 2. 
 
 
Figure 76: Absorption and emission spectra of the mono- and bis-thiophene bis-bidentate bridging ligands and their 
corresponding dinuclear platinum(II) complexes. The mono-thiophene analogues (2.1.5 and 2.1.1) are shown in the 
spectra on the left and the bis-thiophene compounds (2.1.8 and 2.1.2) are shown in the right. 
 
Table 2: Ambient temperature absorption and emission data of the platinum(II) complexes 2.1.1 and 2.1.2, and of 
proligands 2.1.5 and 2.1.8. 
 
Absorption 
CH2Cl2 solution 
λ max/ nm (ε / M1·cm-1) 
 
Emission 
CH2Cl2 solution (c ≈ 10-5 
M) 
300 K 
(degassed solution) 
λmax/ nm τ / µs ΦPL 
2.1.1 
235 (27873), 270 (19852), 347 
(37593), 400 (18740), 470 
(22443), 500 (53822) 
610, 660 11.9 0.85 
2.1.5 
271 (12108), 296 (16236), 344 
(30515), 355 (29884) 
390 - 0.65 
2.1.2 
232 (28824), 270 (24862), 320 
(20169), 380 (34900), 415 
(34048), 527 (41546), 560 (68450) 
730, 800 10.5 0.15 
2.1.8 
262 (12929), 332 (12987), 406 
(45460), 420 (44841) 
480 - 0.80 
 
Firstly, from the absorption of the bis-bidentate proligands, it can be observed that increasing the 
conjugation length through the extension of the thiophene chain, going from 2.1.5 to 2.1.8, leads 
to a red-shift in the energies of all absorption bands. This is the expected effect of increasing the 
conjugation length.  
 91 
 
We also see the effect of this conjugation increase in the emission spectra of the two proligands, 
with the emission maxima of 2.1.8 red-shifted by 90 nm compared with 2.1.5. Both of the bis-
bidentate proligands are luminescent in degassed CH2Cl2 solution at room temperature with 
quantum yields measured at ϕ = 0.65 and ϕ = 0.80 for 2.1.5 and 2.1.8 respectively. 
The absorption spectra of 2.1.1 shows higher energy bands between 235 and 347 nm that are 
comparable to peaks in the absorption spectra of the proligand 2.1.5, suggesting that these bands 
arise from ligand-centred transitions. Lower energy bands above 400 nm are also observed and 
likely arise due to charge transfer transitions.163 As we increase the length of the thiophene chain, 
in 2.1.2, we again see a shift in the absorption bands to longer wavelengths (≈ 60 nm) but still see 
bands corresponding to ligand-centred and charge transfer transitions.   
The dinuclear platinum(II) complexes both exhibit strong phosphorescence at room temperature 
in degassed dichloromethane solution with a substantial red-shift of 120 nm observed on 
increasing the thiophene chain. Quantum yields for the 2.1.1 and 2.1.2 were measured to be ϕ = 
0.85 and ϕ = 0.15 respectively. A large proportion of the emission of 2.1.2 is in the near-infrared 
region of the spectrum and therefore, could not be detected by the instrument used to perform 
luminescence measurements. As a result, the quantum yield measured is an underestimation of 
the true value. Luminescence lifetimes of 11.9 and 10.9 μs recorded for 2.1.1 and 2.1.2 
respectively. These lifetimes are relatively long for a cyclometallated platinum(II) complex and 
may be suggestive of emission from an excited state with a high degree of ligand character. 
Importantly, no dual emission was observed in the spectra recorded for 2.1.2, in which the 
bridging ligand features an extended thiophene chain. This contrasts with the report by 
Kozhevnikov et. al. previously mentioned. The absence of dual emission in this case suggests that 
introduction of a second metal centre leads to an increase in the contribution from the metal d 
orbitals in the emissive state, sufficiently promoting ISC and phosphorescence.  
 
In this section of work, two dinuclear platinum(II) complexes, in which the metal centres are 
rigidly-linked by bis-bidentate ligands incorporating mono- and bis-thiophene cyclometallating 
units, have been prepared and their photophysical properties investigated.  
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The results of this work show that through combining both classical and new alternative strategies, 
the absorption and emission of cyclometallated platinum(II) complexes can be further shifted to 
the red. The bimetallic complexes prepared show emission in the orange-red (610-660 nm) and 
near-infrared (730-800 nm) regions of the spectrum.  
 
 
Figure 77: A scheme to illustrate the two strategies utilised in shifting emission of 2.1.2 to the NIR region of the 
spectrum; introduction of a second metal centre and extension of the conjugated system of the ligand.  
 
In contrast to analogous monometallic platinum(II) complexes, no dual emission was observed 
on increasing the conjugation length of the cyclometallating ligand through the incorporation of 
additional thiophene groups. This suggests that there is sufficient metal-ligand orbital mixing for 
the high SOC of the Pt(II) centres to be effective in the promotion of ISC and phosphorescence 
from the T1 excited state.163  
The new emitters are now being evaluated as red and near-infrared emitters in applications such 
as OLEDs. The results will be published in due course.  
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2.2 Bis-Tetradentate Di-Platinum(II) Complex 
As is shown throughout the work reported here, the bridging ligand selected to link two metal 
centres can have a large effect on the structural, chemical and photophysical properties of the 
resulting luminescent multimetallic complex. The preparation of dinuclear platinum(II) 
complexes with emission maxima in the red region of the visible spectrum has been previously 
discussed in sections 2.0 and 2.1. In complexes 2.1.1 and 2.1.2 previously discussed, the 
incorporation of two metal centres and an extended conjugated system lead to highly luminescent 
bimetallic Pt(II) complexes. The rigidity introduced by the bis-bidentate bridging ligand is also 
an important factor in the efficient luminescence exhibited by these complexes.  
In this work, we have synthesised an unprecedented rigid, dinuclear platinum(II) complex through 
the use of a highly-conjugated bis-tetradentate bridging ligand. 
 
Che et. al. suggested that the use of dianionic tetradentate ligands in the synthesis of neutral square 
planar platinum(II) complexes would give robust, rigid complexes with high thermal stability. 
Che and co-workers reported a wide range of dianionic tetradentate ligands with a variety of 
coordination modes as shown in Figure 78. These modes include (O^N^N^O), (N^N^N^N), 
(C^N^N^C), (O^C^C^O) and (O^N^C^N). 
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Figure 78: A figure to show a selection of the tetradentate ligands utilised in the preparation of charge-neutral, 
luminescent Pt(II) complexes as reported by Che and co-workers.164, 167, 169-172 
 
Initially Che et. al. focussed on the synthesis of non-cyclometallating, dianionic, tetradentate 
ligand systems as shown in Figure 78 (top panel). These simple N-donor ligands are easily 
synthesised and structurally modified and from these ligands emissive Pt(II) complexes were 
prepared. The platinum(II) complex Pt(Pren), reported in 2005, exhibits yellow emission with the 
maxima at 566 nm and a lower energy shoulder at 613 nm in CH3CN solution. This complex 
shows concentration-dependent emission both in solution and thin films, with an increase in 
concentration resulting in a red-shift. This lower energy emission was assigned to excimer or 
oligomer formation. Pt(Pren) was subsequently used in the fabrication of a highly efficient red 
electroluminescent device showing high brightness.169, 170 Using these types of dianionic, 
tetradentate ligands in the preparation of Pt(II) complexes, emission in the red (630 nm) and 
yellow-green (550 nm) regions of the visible spectrum have been demonstrated.169, 170  
Che and co-workers also reported a series of tetradentate Pt(II) complexes, based on bis(N-
heterocyclic carbene) ligands, showing deep-blue emission (443-461 nm). The resulting 
complexes were used in the preparation of blue-emitting OLEDs with efficiencies in the range of 
24-29%.171, 172 
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A third class of tetradentate ligand, with O^N^C^N coordination, was investigated by Che et. al. 
(Figure 78). These structurally rigid tetradentate ligands afford robust Pt(II) complexes exhibiting 
high luminescence quantum yields (ϕ = 0.60–0.99) and high thermal stability (>400 °C).164-167  
 
 
Figure 79:  A figure to illustrate a selection of the tetradentate Pt(II) complexes reported by Che et. al., displaying 
varied ligand substitution patterns. The changes in ligand substitution pattern have been observed to have a marked 
effect on the photophysical properties of the resulting Pt(II) complexes.164, 165 
 
It has been observed that the substitution pattern of the tetradentate O^N^C^N ligand has a 
significant effect on the emission properties, for example, the ratio of monomer and excimer 
emission. Consequently, it is possible to exploit the ligand substitution pattern in order to utilise 
Pt(II) tetradentate complexes as emitters in monochromatic devices or as single emitters in white 
light-emitting devices. Figure 79 shows a selection of the tetradentate platinum(II) complexes 
reported.  
The polymer light-emitting devices (PLEDs) of these complexes (top panel) were fabricated. 2.2.8 
shows strong low-energy emission, in addition to monomer emission, assigned to the formation 
of excimers. Excimer emission is detrimental to the performance of monochromatic PLEDs as 
evidenced by the efficiency decrease of the 2.2.8 device from 9.53% to 7.25% and the lowering 
of colour purity. Excimer emission is not observed for 2.2.9, 2.2.10 or 2.2.11. This is due to the 
suppression of intermolecular interactions through the use of bulky substituents. As a result, 
complexes bearing tetradentate ligands with bulky substituents are ideal for utilisation in 
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monochromatic PLEDs. The device fabricated using 2.2.11 showed the best performance at 8wt% 
doping and an external quantum efficiency (EQE) of 15.55%.  
2.2.12 was previously reported by Che and co-workers as a single emitter in both white light-
emitting OLEDs and PLEDs showing EQEs of 16.5% and 9.7%. In order to investigate the effect 
of alkyl chain length on the extent of intermolecular reactions and attempt to control excimer 
emission, PLEDs of 2.2.13 and 2.2.14 were prepared. It was observed that the alkyl chains 
significantly affect the distance between two [Pt(O^N^C^N)] complexes and therefore, the 
intermolecular interactions. The EL spectra of 2.2.13 shows notable excimer emission at low 
concentrations of 4wt%. The intensity of this excimer emission increases quickly as the 
concentration is increased, equalling the intensity of monomer emission at 10wt%. Conversely, 
for 2.2.14 and 2.2.12, excimer emission is unobservable at low concentrations and grows more 
slowly with desired balanced white emission observed at doping concentrations of 16wt% and 
20wt% respectively. The longer ethyl chain of 2.2.14 leads to weaker interactions between 
[Pt(O^N^C^N)] molecules, resulting in the need for higher doping concentrations for balanced 
white emission. PLEDs of these complexes were fabricated with 2.2.14 giving the best 
performance. The optimised white light-emitting PLED, utilising 2.2.14 as a single emitter, was 
prepared using a doping concentration of 16wt% and showing an EQE of 12.73%.165  
 
Building on the success of tetradentate O^N^C^N platinum(II) complexes reported by Che and 
co-workers; in this work we were interested in the preparation of a bis-tetradentate ligand for use 
in the synthesis of a luminescent, rigid, bimetallic Pt(II) complex.164-167 
 
 97 
 
 
Figure 80: A reaction scheme to show the multi-step synthesis of the bis-tetradentate ligand 2.2.23.  
(i) BuLi, N-methoxy-N-methylacetamide, Et2O (anhydrous), 90%; (ii) 2.2.18, KOtBu, THF (anyhydrous), NH4OAc in 
AcOH, 83%; (iii) 1-Bromobutane, KOtBu, THF (anhydrous), 93%; (iv) Bis(pinacolato)diboron, KOAc, Pd(dppf)Cl2, 
1,4-dioxane (anhydrous), 87%; (v) 4,6-dichloropyrimidine, aq. K2CO3 (2M), Pd(PPh3)4, 1,4-dioxane (anhydrous), 14%; 
(vi) Pyridine hydrochloride, 70%. 
 
The bis-tetradentate O^N^C^N-N^C^N^O ligand, 2.2.23, was prepared as shown in Figure 80 
and was isolated in good yield.83, 84, 173 Compound 2.2.20 was prepared as described by Che et. al. 
using the synthetic route shown above. The desired compound was isolated in high yield (93%).174 
Compound 2.2.20 was then converted into the boronate derivative (2.2.21) via a Miyaura 
Borylation reaction through coupling with bis(pinacolato)diboron. The boronate derivative was 
also isolated in high yield (87%) and was further reacted with 4,6-dichloropyrimidine via a 
Suzuki-Miyaura cross-coupling reaction to give compound 2.2.22. This Suzuki-Miyaura reaction 
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proceeded in low yield (14%) and therefore, optimisation of the reaction conditions for this step 
is required in the future in order to isolate a higher yield of compound 2.2.22. The methoxy-
protected bis-tetradentate proligand was deprotected via reaction with pyridine hydrochloride at 
250 °C to give the desired bis-tetradentate proligand (2.2.23).  
The final bis-tetradentate ligand consists of two O^N^C^N binding sites linked by a 4,6-
disubstituted pyrimidine heterocycle. Pyrimidine was selected as the central heterocycle as a 
result of previous reports, by Kozhevnikov and co-workers, of highly luminescent dinuclear 
complexes of platinum(II) and iridium(III). Tert-butyl and n-butyl groups have been incorporated 
into the structure of the bis-tetradentate ligand in order to improve the solubility of the final 
dinuclear platinum(II) complex whilst decreasing the likelihood of excimer formation as 
discussed by Che and co-workers.165  
 
Following the successful synthesis of bis-tetradentate ligand 2.2.23, this ligand was utilised in the 
synthesis of a dinuclear platinum(II) complex as shown in Figure 81.164  
 
 
Figure 81: A scheme to show the synthesis of a rigidly-linked bis-tetradentate dinuclear platinum(II) complex (2.2.24) 
via the reaction of bis-tetradentate ligand 2.2.23 with K2PtCl4 in 9:1 mixture of acetic acid:chloroform. 
 
The synthesis of this bimetallic Pt(II) complex proceeded under the same reaction conditions as 
those reported in the literature by Che et. al. in the synthesis of analogous monometallic, 
tetradentate platinum(II) complexes.164 The bis-tetradenate ligand was heated to reflux with 
K2PtCl4 in a 9:1 mixture of acetic acid and chloroform. The desired dinuclear platinum(II) 
complex was isolated following purification by column chromatography and recrystallization 
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from methanol. The complex was isolated in very low yield (21%) and therefore, optimisation of 
the reaction procedures is required in the future.  
The di-platinum(II) complex was characterised by 1H and 13C NMR spectroscopy and high-
resolution mass spectrometry. The aromatic region of the 1H NMR spectrum of 2.2.24 is shown 
in Figure 82. The peak at δ 10.2 ppm corresponds to proton environment 1 on the central 
pyrimidine ring and shows evidence of the ligand binding to the platinum(II) centres through 
observation of platinum(II) satellites.  
 
 
Figure 82: Aromatic region of the 1H NMR spectrum of the di-platinum(II) complex 2.2.24, in which the metal centres 
are rigidly-linked by a highly conjugated bis-tetradentate ligand. 
 
The identity of the dinuclear platinum(II) complex was further confirmed by high-resolution mass 
spectrometry. The spectrum recorded is shown in Figure 83. The peak observed at m/z 1318.4860 
corresponds to the ion [M+H]+ and is a close match to the calculated value m/z 1318.4884. 
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Figure 83: High resolution mass spectrum obtained for 2.2.24, showing a peak for [M+H]+ at m/z 1318.4860 (calc’d 
m/z 1318.4884). 
 
In this section, we have successfully prepared a novel di-platinum(II) complex in which the metal 
centres are linked through a rigid, ditopic bis-tetradentate ligand. To the best of our knowledge, 
this is the first example of a bimetallic complex linked by a rigid, cyclometallating bis-tetradentate 
ligand of this type. The photophysical properties of this dinuclear platinum(II) complex, 2.2.24, 
in which the metal centres are linked through a rigid bis-tetradentate ligand, will now be fully 
investigated in the group of Dr Fernando Dias at Durham University. The incorporation of 2.2.24 
in an OLED device will also be investigated. The results of this study will be published in due 
course.   
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2.3 Experimental Section for Chapter 2 
2.3.1 Bis-Thiophene Di-Platinum(II) Complex 
Compound 2.1.5  – 4,6-di(5-hexylthiophenyl)pyrimidine173  
 
 
5-Hexyl-2-thiopheneboronic acid pinacol ester (1.96 g, 6.80 mmol), 4,6-dichloropyrimidine 
(0.392 g, 2.61 mmol), potassium carbonate (2.16 g, 15.6 mmol) and 1,4-dioxane (20 mL) were 
placed in a round bottomed flask and the reaction mixture degassed with argon for 10 min. 
Tetrakis(triphenylphosphine)palladium (0.183 g, 0.157 mmol) was added and the reaction 
mixture degassed for a further 10 minutes. The reaction mixture was then heated to reflux for 24 
h. Toluene (15 mL) was added and the solution washed with water (3 x 10 mL). The organic layer 
was dried over MgSO4 and the solvent evaporated under reduced pressure. The residue was 
recrystallised from ethyl acetate to give the product as a grey solid.  
Yield: 0.908 g, 2.20 mmol, 84%  
1H NMR (400 MHz, CDCl3): δ 8.98 (d, 1H, J = 1.4), 7.68 (d, 1H, J = 0.8), 7.65 (d, 2H, J = 3.7), 
6.86 (d, 2H, J = 3.7), 2.87 (t, 4H, J = 7.8), 1.72-1.69 (m, 4H), 1.43-1.29 (m, 12H), 0.89 (t, 6H, J 
= 7.1). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 159.06 (C), 158.97 (CH), 151.71 (C), 139.32 (C), 
127.37 (CH), 125.78 (CH), 107.85 (CH), 31.54 (CH2), 31.44 (CH2), 30.54 (CH2), 28.72 (CH2), 
22.56 (CH2), 14.09 (CH3).  
 
Compound 2.1.8 – 4,6-di(5′-hexyl-bithiophenyl)pyrimidine 
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5′-Hexyl-2,2′-bithiophene-5-boronic acid pinacol ester (0.875 g, 2.32 mmol), 4,6-
dichloropyrimidine (0.139 g, 0.923 mmol), potassium carbonate (0.771 g, 5.58 mmol) and 1,4-
dioxane (20 mL) were placed in a round bottomed flask and the reaction mixture degassed with 
argon for 10 min. Tetrakis(triphenylphosphine)palladium (0.0645 g, 0.0558 mmol) was added 
and the reaction mixture degassed for a further 10 minutes. The reaction mixture was then heated 
to reflux for 24 h. Toluene (20 mL) was added and the solution washed with water (3 x 10 mL). 
The organic layer was dried over MgSO4 and the solvent evaporated under reduced pressure. The 
residue was treated with methanol (20 mL) and the product collected as a dark green solid by 
filtration.  
Yield: 0.478 g, 0.829 mmol, 90%  
1H NMR (400 MHz, CDCl3): δ 9.00 (s, 1H, J = 0.9), 7.72-7.71 (m, 3H), 7.16 (d, 2H, J = 4.1), 
7.13 (d, 2H, J = 3.7), 6.73 (d, 2H, J = 3.7), 2.82 (t, 4H, J = 7.8), 1.73-1.66 (m, 4H), 1.43-1.30 (m, 
12H), 0.90 (t, 6H, J = 6.9). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 159.02 (CH), 158.67 (C), 147.03 (C), 142.76 (C), 
139.51 (C), 134.16 (C), 128.14 (CH), 125.17 (CH), 124.65 (CH), 123.89 (CH), 107.91 (CH), 
31.55 (CH2), 30.23 (CH2), 28.75 (CH2), 22.58 (CH2), 14.09 (CH3).  
 
Compound 2.1.1 (via 2.1.9 & 2.1.10) 
 
 
To a solution of 4,6-bis(5-hexylthiophen-2-yl)pyrimidine (0.134 g, 0.325 mmol) in acetic acid 
(80 mL), N-[dichloro(phenylformonitrile)platinio]benzonitrile (0.338 g, 0.714 mmol) was added. 
The reaction mixture was heated to reflux under argon for 17 h. The reaction mixture was cooled 
to room temperature and the solvent removed under reduced pressure. The dark red solid was 
filtered and washed with methanol (10 mL), water (15 mL) and methanol (10 mL).  
Yield: 0.283 g, 0.324 mmol, 99%. 
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To the di-chlorobridged dimer (0.283 g, 0.324 mmol), DMSO (5 mL) was added and the reaction 
mixture was heated to reflux for 5 min. The reaction mixture was cooled slightly before methanol 
(10 mL) was added. Further methanol (30 mL) was added to aid in precipitation of the product. 
The precipitated solid was filtered and washed with methanol to give a dark red solid.  
Yield: 0.201 g, 0.195 mmol, 60%.  
The DMSO complex (0.198 g, 0.192 mmol) and acetone (100 mL) were added to a round-
bottomed flask. To this, sodium acetylacetonate (0.235 g, 1.92 mmol) was added. The reaction 
mixture was heated to 100 °C under argon for 5 h 30 min. The reaction mixture was cooled to 
room temperature and water (100 mL) was added. The dark red solid formed was filtered and 
washed with water and acetone. The crude product was purified by column chromatography 
(silica gel) using DCM 100%.  
Yield: 0.0821 g, 0.0822 mmol, 43% 
1H NMR (400 MHz, CDCl3): δ 9.37 (s, 1H), 6.87 (s, 2H), 6.70 (s, 1H), 5.45 (s, 2H), 2.91 (t, 4H, 
J = 7.6), 1.75-1.67 (m, 4H), 1.42-1.29 (m, 12H), 0.88 (t, 6H, J = 6.8).  
13C DEPT135 NMR (100 MHz, CDCl3): δ 185.02 (C), 183.58 (C), 167.64 (C), 157.35 (C), 128.31 
(CH), 102.52 (CH), 100.59 (CH), 31.61 (CH2), 31.53 (CH2), 31.09 (CH2), 28.89 (CH2), 27.98 
(CH), 26.75 (CH), 22.60 (CH), 14.12 (CH2).  
HRMS (FTMS+): for [M]+ calc’d 998.2027, found 998.2031. 
 
Compound 2.1.2 (via 2.1.11 & 2.1.12) 
 
 
 104 
 
To a solution of 4,6-bis[5-(5-hexylthiophen-2-yl)thiophen-2-yl]pyrimidine (0.153 g, 0.265 mmol) 
in acetic acid (120 mL), potassium tetrachloroplatinate (0.242 g, 0.583 mmol) was added. The 
reaction mixture was heated to reflux under argon for 3 d. The reaction mixture was cooled to 
room temperature. The precipitated solid was filtered and washed with methanol (10 mL), water 
(15 mL) and methanol (10 mL).  
Yield: 0.242 g, 0.233 mmol, 88%. 
To the dichloro-bridged dimer (0.242 g, 0.233 mmol), DMSO (2 mL) was added. The reaction 
mixture was stirred at 110-120 °C for approximately 5 min and allowed to cool to room 
temperature. Methanol (10 mL) was added and the mixture was filtered. The solid collected was 
washed with methanol. This solid was re-dissolved in DMSO (2 mL) and stirred at 120-130 °C 
for 1 hour. The reaction mixture was cooled to room temperature and again methanol was added. 
The resulting solid was filtered. This product was purified by column chromatography (silica gel, 
DCM → DCM:MeOH). This product was further purified by column chromatography (fine silica 
gel, DCM → DCM:EtOAc 4:1 → DCM:MeOH 20:1) to give the DMSO intermediate, 2.1.12.  
Yield: 0.0950 g, 0.0797 mmol, 30%. 
The DMSO complex (0.0950 g, 0.0797 mmol) and acetone (40 mL) were added to a round-
bottomed flask. To this solution, sodium acetylacetonate (0.0973 g, 0.797 mmol) was added. The 
reaction mixture was heated to reflux under argon for 5 h. The reaction mixture was then cooled 
to room temperature and water (100 mL) was added. The precipitated dark red solid was filtered 
and washed with water (5 mL) and acetone (5 mL). The crude product was purified by column 
chromatography (silica gel, DCM:MeOH, 20:1) to give the desired product.  
Yield: 0.0446 g, 0.0383 mmol, 48% 
1H NMR (400 MHz, CDCl3): δ 9.27 (s, 1H), 7.11-7.09 (m, 4H), 6.70 (d, 2H, J = 3.7), 6.60 (s, 
1H), 5.41 (s, 2H), 2.81 (t, 4H, J = 7.6), 1.74-1.66 (m, 4H), 1.42-1.32 (m, 12H), 0.91 (t, 6H, J = 
6.7).  
HRMS (FTMS+): for [M]+ calc’d 1162.1782, found 1162.1794. 
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2.3.2 Bis-Tetradentate Platinum(II) Complex 
Compound 2.2.16 – 1-(3-bromo-5-tert-butylphenyl)ethan-1-one167  
 
 
To a stirring solution of 1,3-dibromo-5-tert-butylbenzene (5.01 g, 17.2 mmol) in anhydrous 
diethyl ether, BuLi (12.9 mL, 20.6 mmol, 1.6 M) was added dropwise under argon at -78 °C. The 
mixture was stirred at -78 °C for 30 min. N-methoxy-N-methylacetamide (2.74 mL, 25.8 mmol) 
was added dropwise. The reaction mixture was stirred for 12 h and allowed to warm to room 
temperature. The reaction mixture was quenched with saturated NH4Cl solution. Water was added 
and the mixture was extracted with diethyl ether (2 x 150 mL). The combined organic extracts 
were washed with water (2 x 200 mL), separated and dried with MgSO4. The solvent was 
evaporated to dryness under reduced pressure/ The crude product was purified by column 
chromatography (silica gel, hexane:ethyl acetate, 10:1) to give the desired product as a yellow oil. 
Yield: 3.95 g, 15.4 mmol, 90% 
1H NMR (400 MHz, CDCl3): δ 7.91 (t, 1H, J = 1.6), 7.88 (t, 1H, J = 1.6), 7.71 (t, 1H, J = 1.6), 
2.60 (s, 3H), 1.34 (s, 9H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 197.12 (C), 154.15 (C), 138.66 (C), 133.35 (CH), 
128.88 (CH), 123.87 (CH), 122.77 (C), 35.18 (C), 31.20 (CH3), 26.83 (CH3).  
 
Compound 2.2.18 – (2Z)-2-[(dimethylamino)methylidene]-7-methoxy-2,3-dihydro-1H-inden-1-
one166, 167 
 
 
7-Methoxy-1-indanone (2.40 g, 14.8 mmol) and N,N-dimethylformamide dimethyl acetal (9.90 
mL, 74.1 mmol) were added to a round-bottomed flask. The reaction mixture was heated to reflux 
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for 18 h. The reaction mixture was cooled to room temperature and the precipitated solid was 
filtered in vacuo and washed with petroleum ether 60-80°C. The product was isolated as a brown 
solid.  
Yield: 2.99 g, 13.8 mmol, 93% 
1H NMR (400 MHz, CDCl3): δ 7.42-7.38 (m, 2H), 7.00 (dd, 1H, J = 7.3, 0.9), 6.80 (d, 1H, J = 
8.2), 3.95 (s, 3H), 3.85 (s, 2H), 3.14 (s, 6H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 191.35 (C), 157.79 (C), 150.59 (C), 146.05 (CH), 
133.14 (CH), 127.97 (C), 117.49 (CH), 108.85 (CH), 104.06 (C), 55.87 (CH3), 31.32 (CH2).  
 
Compound 2.2.19 – 2-(3-bromo-5-tert-butylphenyl)-9-methoxy-5H-indeno[1,2-b]pyridine 
 
 
1-(3-bromo-5-tert-butylphenyl)ethan-1-one (3.65 g, 14.3 mmol), (2Z)-2-
[(dimethylamino)methylidene]-7-methoxy-2,3-dihydro-1H-inden-1-one (3.11 g, 4.3 mmol) and 
KOtBu (1.93 g, 17.2 mmol) were added to a dry, argon-flushed round-bottomed flask. Anhydrous 
THF (100 mL) was added and a red suspension was formed. A solution of NH4OAc in acetic acid 
(55.0 g, 73 mL) was added. The red solution was heated to reflux for 16 h. The reaction mixture 
was cooled to room temperature. Water was added and the mixture extracted with 
dichloromethane. The organic phase was separated, dried with MgSO4 and the solvent evaporated 
to dryness under reduced pressure. The crude residue was purified by column chromatography 
(silica gel, hexane:ethyl acetate, 10:1) and the desired product isolated  as a yellow solid.  
Yield: 4.80 g, 11.8 mmol, 83% 
1H NMR (400 MHz, CDCl3): δ 8.19 (t, 1H, J = 1.6), 8.06 (t, 1H, J = 1.6), 7.85 (d, 1H, J = 8.0), 
7.60 (d, 1H, J = 7.6), 7.55 (t, 1H, J = 1.8), 7.39 (t, 1H, J = 7.8), 7.20 (d, 1H, J = 7.6), 6.98 (d, 1H, 
J = 8.4), 4.11 (s, 3H), 3.92 (s, 2H), 1.40 (s, 9H). 
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13C DEPT135 NMR (100 MHz, CDCl3): δ 160.72 (C), 156.49 (C), 154.95 (C), 153.60 (C), 146.47 
(C), 141.66 (C), 135.23 (C), 132.33 (CH), 130.03 (CH), 128.78 (CH), 128.65 (C), 127.13 (CH), 
122.92 (CH), 122.77 (C), 117.63 (CH), 116.96 (CH), 109.80 (CH), 56.06 (CH3), 35.10 (C), 34.65 
(CH2), 31.25 (CH3).  
 
Compound 2.2.20 – 2-(3-bromo-5-tert-butylphenyl)-5,5-dibutyl-9-methoxy-5H-indeno[1,2-
b]pyridine 
 
 
2-(3-bromo-5-tert-butylphenyl)-9-methoxy-5H-indeno[1,2-b]pyridine (4.80 g, 11.8 mmol) was 
added to a dry round-bottomed flask flushed with argon. Anhydrous THF (150 mL) was added 
and the mixture stirred. 1-bromobutane (3.16 mL, 29.4 mmol) was added and the mixture was 
further stirred. KOtBu (3.30 g, 29.4 mmol) was added. The reaction mixture was heated to reflux 
for 15 h under argon. The reaction mixture was cooled to room temperature. Water was added 
and the reaction mixture was extracted with dichloromethane. The organic phase was separated, 
dried with MgSO4 and the solvent evaporated to dryness. The crude product was purified by 
column chromatography (silica gel, hexane:ethyl acetate 10:1) and the desired product was 
isolated as a brown solid.  
Yield: 8.62 g, 16.6 mmol, 93% 
1H NMR (400 MHz, CDCl3): δ 8.30 (t, 1H, J = 1.6), 8.07 (t, 1H, J = 1.6), 7.63 (q, 2H, J = 8.0, 
6.4), 7.54 (t, 1H, J = 1.8), 7.40 (t, 1H, J = 7.8), 7.01 (d, 1H, J = 7.3), 6.93 (d, 1H, J = 8.2), 4.11 
(s, 3H), 2.03-1.95 (m, 4H), 1.41 (s, 9H), 1.11-1.02 (m, 4H), 0.67-0.55 (m, 10H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 160.59 (C), 156.40 (C), 154.79 (C), 154.26 (C), 153.78 
(C), 142.96 (C), 141.55 (C), 130.68 (CH), 130.47 (CH), 128.91 (CH), 127.97 (C), 127.03 (CH), 
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122.85 (CH), 117. 09 (CH), 115.12 (CH), 109.62 (CH), 56.04 (CH3), 53.20 (C), 40.13 (CH2), 
35.28 (C), 31.40 (CH3), 26.20 (CH2), 23.19 (CH2), 13.98 (CH3).  
 
Compound 2.2.21 - 5,5-dibutyl-2-[3-tert-butyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)phenyl]-9-methoxy-5H-indeno[1,2-b]pyridine 
 
 
2-(3-bromo-5-tert-butylphenyl)-5,5-dibutyl-9-methoxy-5H-indeno[1,2-b]pyridine (1.26 g, 2.42 
mmol) was added to a dry round-bottomed flask flushed with argon. Anhydrous 1,4-dioxane (50 
mL) was added. The reaction mixture was stirred. Bis(pinacolato)diboron (0.920 g, 3.62 mmol) 
and potassium acetate (0.494 g, 5.03 mmol) were added and the reaction mixture was degassed 
under argon for 15 min. [1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (0.0986 g, 
0.121 mmol) was added and the reaction mixture was degassed for a further 10 min. The reaction 
mixture was heated to 90 °C for 18 h. The reaction mixture was cooled to room temperature. The 
reaction mixture was extracted with diethyl ether and washed with water. The organic phase was 
separated and dried with MgSO4. The solvent was evaporated to dryness under reduced pressure. 
The crude mixture was purified by column chromatography (silica gel, gradient elution with 
hexane:ethyl acetate 100:0 to 10:1) and the product was isolated as a brown oil. 
Yield: 1.20 g, 2.11 mmol, 87% 
1H NMR (400 MHz, CDCl3): δ 8.65 (t, 1H, J = 2.1), 8.30 (s, 1H), 7.87 (m, 1H), 7.78 (d, 1H, J = 
7.8), 7.62 (d, 1H, J = 7.8), 7.38 (t, 1H, J = 7.8), 7.00 (d, 1H, J = 6.9), 6.92 (d, 1H, J = 8.2), 4.11 
(s, 3H), 2.01-1.96 (m, 4H), 1.46 (s, 9H), 1.38 (s, 12H), 1.06 (sext, 4H, J = 22.0, 14.8, 7.3), 0.66-
0.55 (m, 10H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 171.17 (C), 160.26 (C), 156.22 (C), 156.03 (C), 154.06 
(C), 150.65 (C), 142.01 (C), 138.58 (C), 131.95 (CH), 130.27 (CH), 130.18 (CH), 130.11 (CH), 
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128.28 (C), 127.00 (CH), 116.98 (CH), 114.94 (CH), 109.48 (CH), 55.87 (CH3), 53.00 (C), 40.03 
(CH2), 34.94 (C), 31.45 ((CH3)3), 26.07 (CH2), 24.95 (CH3), 23.06 (CH2), 21.07 (C), 13.84 (CH3).  
 
Compound 2.2.22  
 
 
5,5-dibutyl-2-[3-tert-butyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9-methoxy-5H-
indeno[1,2-b]pyridine (4.38 g, 7.72 mmol) was added to a dry round-bottomed flask flushed with 
argon. Anhydrous 1,4-dioxane (100 mL) was added and the reaction mixture was stirred. 4,6-
Dichloropyrimidine (0.460 g, 3.09 mmol) and 2M K2CO3 solution (2.56 g, 18.5 mmol, 9.50 mL) 
were added and the reaction mixture was degassed under argon for 10 min. 
Tetrakis(triphenylphosphine)palladium(0) (0.214 g, 0.185 mmol) was added and the reaction 
mixture degassed for a further 10 min. The reaction mixture was heated at 95 °C for 24 h. The 
reaction mixture was cooled to room temperature and extracted with ethyl acetate. The organic 
phase was washed with water, separated and dried with MgSO4. The solvent was evaporated to 
dryness. The crude product was purified by column chromatography (silca gel, gradient elution 
with hexane:ethyl acetate) to give the product as a pale yellow oil  
Yield: 0.400 g, 0.417 mmol, 14% 
1H NMR (400 MHz, CDCl3): δ 9.43 (d, 1H, J = 0.9), 8.69 (s, 2H), 8.61 (t, 2H, J = 1.6), 8.38 (d, 
1H, J = 0.9), 8.32 (t, 2H, J = 1.6), 7.83 (d, 2H, J = 7.8), 7.69 (d, 2H, J = 7.8), 7.37 (t, 2H, J = 8.2, 
7.8), 7.01 (d, 2H, J = 7.8), 6.86 (d, 2H, J = 8.2), 4.03 (s, 6H), 2.04-1.98 (m, 8H), 1.54 (s, 18H), 
1.08 (sext, 8H, J = 22.2, 14.7, 7.3), 0.68-0.59 (m, 20H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 165.51 (C), 160.52 (C), 159.10 (CH), 156.24 (C), 
155.47 (C), 154.08 (C), 152.43 (C), 142.60 (C), 140.22 (C), 137.46 (C), 130.86 (C), 130.42 (CH), 
 110 
 
130.33 (CH), 128.98 (C), 127.93 (C), 127.24 (C), 126.70 (CH), 124.85 (CH), 124.57 (C), 122.85 
(C), 122.76 (CH), 117.09 (CH), 114.94 (CH), 113.72 (CH), 113.19 (C), 109.46 (CH), 55.94 (CH), 
53.03 (C), 39.99 (CH2), 35.23 (C), 31.46 (CH), 26.08 (CH2), 23.04 (CH2), 13.83 (CH).  
 
Compound 2.2.23 
 
 
2.2.22 (0.360 g, 0.375 mmol) was added to a round-bottomed flask. Pyridine hydrochloride (0.867 
g, 7.50 mmol) was added and the reaction mixture was heated to 250 °C under argon for 12 h. 
The reaction mixture was cooled to room temperature. Water was added and the resulting 
precipitate was filtered in vacuo and washed with water to give the desired product as a grey solid  
Yield: 0.243 g, 0.261 mmol, 70% 
1H NMR (400 MHz, CDCl3): δ 9.43 (s, 1H), 8.60 (s, 2H), 8.32-8.31 (m, 5H), 7.80-7.74 (m, 4H), 
7.34 (t, 2H, J = 7.8), 6.95 (d, 2H, J = 7.3), 6.90 (d, 2H, J = 7.8), 2.07-1.95 (m, 8H), 1.53 (s, 18H), 
1.13 (sext, 8H, J = 22.2, 14.7, 7.3), 0.78-0.69 (m, 16H).  
13C DEPT135 NMR (100 MHz, CDCl3): δ 165.14 (C), 161.28 (C), 159.26 (CH), 154.81 (C), 
154.47 (C), 152.79 (C), 152.46 (C), 142.25 (C), 139.43 (C), 137.47 (C), 131.15 (CH), 131.01 
(CH), 126.53 (CH), 124.93 (CH), 124.28 (C), 123.09 (CH), 117.98 (CH), 114.30 (CH), 113.43 
(CH), 54.32 (C), 39.46 (CH2), 35.24 (C), 31.46 (CH3), 26.25 (CH2), 23.03 (CH2), 13.83 (CH3).  
HRMS (FTMS+): for [M+H]+ calc’d 931.5885, found 931.5873. 
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Compound 2.2.24 
 
 
2.2.23 (0.103 g, 0.110 mmol) was added to a round-bottomed flask. Potassium 
tetrachloroplatinate (0.114 g, 0.275 mmol) was added. A 9:1 mixture of acetic acid and 
chloroform (50 mL) was added and the reaction was heated to reflux for 3 d. The mixture was 
cooled to room temperature and neutralised with a saturated solution of Na2CO3. The reaction 
mixture was then extracted with dichloromethane. The organic phase was separated and dried 
with MgSO4. The solvent was evaporated to dryness and the crude red residue purified by column 
chromatography (silica gel, DCM 100:0). The solid obtained was further purified by 
recrystallisation from methanol to give the desired product as a dark red solid. 
Yield: 0.0301 g, 0.0228 mmol, 21 % 
1H NMR (400 MHz, CDCl3): δ 10.25 (br s, 1H), 8.06 (br s, 1H), 7.95 (d, 2H, J = 7.3), 7.89 (br s, 
4H), 7.61-7.58 (m, 4H), 7.42 (d, 2H, J = 8.2), 6.73 (d, 2H, J = 7.3), 2.07-2.05 (m, 8H), 1.53 (s, 
18H), 1.14-1.11 (m, 8H), 0.72-0.68 (m, 16H). 
HRMS (FTMS+): for [M+H]+ calc’d 1318.4884, found 1318.4860. 
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Chapter 3 
Dinuclear Iridium(III) Complexes   
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3.0 Dinuclear Iridium(III) Complexes 
The aim of this research was to prepare multimetallic complexes, for example dinuclear 
iridium(III) complexes, in which the two metal centres are rigidly linked by cyclometallating 
bridging ligands. As previously discussed in section 1.3, multinuclear complexes have become 
widely investigated as a consequence of their advantageous photophysical and electrochemical 
properties. 
The bridging ligand used to link metal centres has an important role in the modulation of both the 
chemical and photophysical properties of the final multimetallic complex. In section 1.3, a large 
range of the bridging ligands previously reported in the preparation of polynuclear complexes 
were discussed.  
The majority of dinuclear iridium(III) complexes reported to date are those in which the two metal 
centres are linked via polypyridine bridging ligands incorporating partially insulating spacer 
groups. Therefore, the two metal-containing units are electronically isolated from one another and 
retain the characteristics of their analogous monometallic components.15, 71, 102-104, 106, 118, 120, 122, 123, 
175 Tsuboyama et. al. reported, in 2004, the preparation of a dinuclear iridium(III) complex linked 
by a cyclometallating bis-bidentate bridging ligand, 1,4-bis(pyridine-2-yl)benzene (dpb). This 
complex exhibits intense red phosphorescence that is not observed for the analogous mononuclear 
complexes. This is one of the first and only examples of a di-iridium(III) complex in which the 
metal centres are rigidly-linked via a cyclometallating bridging ligand.112  
Additionally, the preparation of multinuclear complexes as a single, pure isomer can be difficult. 
Despite showing red luminescence, the dinuclear iridium(III) complex synthesised by Tsuboyama 
and co-workers could only be isolated in a 3% yield following purification by column 
chromatography and recrystallisation from DMF.112 Tris-bidentate Ir(III) complexes of the type 
Ir(C^N)3 or Ir(C^N)2(L^X) have D3 or C2 symmetry meaning that they are chiral and are formed 
as a racemic mixture of enantiomers (Λ and Δ). In the case of monometallic complexes, this is 
not a problem as they have identical linear optical properties. However, when two chiral 
iridium(III) centres are brought together into one molecule, a mixture of diastereoisomers is 
formed. These diastereoisomers have different properties and must be separated. This separation 
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can be laborious, time consuming and result in low yields or difficulty in isolating any pure 
multinuclear complexes.107, 112  
 
The design of the highly luminescent dinuclear iridium(III) complexes described in this work is 
such that the issues described above have been alleviated.  
Previously, ligands based around the nitrogen-containing heterocycles pyrimidine, pyrazine and 
pyridazine that are capable of binding two transition metal centres were reported in the 1990s by 
Steel and co-workers and Rourke et. al.176, 177 Similar bridging ligands were also used in the 
preparation of luminescent dinuclear platinum(II) complexes published by Kozhevnikov et. al.85, 
176-178 In the bimetallic iridium(III) complexes prepared here, the two iridium(III) centres are 
rigidly-linked using cyclometallating, bis-bidentate bridging ligands, incorporating the same 
range of N-containing heterocycles as reported in the literature. Linking two Ir(III) centres in this 
way facilitates electronic communication between the two metal centres leading to formation of 
a dinuclear complex with distinctly different properties compared with the corresponding 
monometallic complexes.84 
Secondly, the formation of diastereoiomsers is avoided through the use of symmetrical, 
cyclometallating, terdentate N^C^N ligands as the use of these ligands leads to achirality in the 
final bimetallic Ir(III) complex. The use of such ligands in the preparation of achiral metal 
complexes has been previously reported in the literature. Bis-terpyridyl metal complexes have 
C2v symmetry and are achiral. This class of complexes has been widely studied whereas the 
corresponding cyclometallated Ir(III) complexes have had significantly less investigation. 
Williams et. al. reported the synthesis of achiral monometallic iridium(III) complexes of the 
general formula Ir(N^C^N)(N^C)X. These complexes are comprised of a derivative of 1,3-
dipyridylbenzene as a terdentate cyclometallating N^C^N ligand, a 2-phenylpyridine derivative 
as an N^C-coordinating bidentate ligand and an anionic monodentate ligand, for example a halide. 
These Ir(III) complexes showed strong luminescence with high quantum yields (ϕ = 0.20–0.71) 
and have been shown to perform well in OLED devices.30  
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Consequently, dinuclear iridium(III) complexes synthesised in this work comprise two 
iridium(III) centres linked by a bis-N^C-coordinating bridging ligand. The coordination of each 
Ir(III) centre is completed with a terdentate N^C^N-coordinating ligand and a monodentate 
chloride ligand. Combining both symmetrically-substituted bis-N^C-coordinating bridging 
ligands and terdentate N^C^N-coordinating auxiliary ligands is an attractive route to achiral 
dinuclear complexes that exhibit exciting photophysical properties.30, 173  
 
In the following sections, the synthesis of the auxiliary terdentate N^C^N ligands, bis-bidentate 
bridging ligands and their corresponding dinuclear iridium(III) complexes will be discussed. 
Variation of the monodentate ligands from chloride to alternatives ligands, both anionic and 
neutral, will also be considered.  
 
3.1 Auxiliary Terdentate N^C^N Ligands 
In 2003, Williams et. al. reported on the use of N^C^N-coordinating cyclometallating ligands in 
the preparation of highly luminescent platinum(II) complexes with quantum yields of ϕ = 0.58–
0.68.18 This was the first investigation of luminescence of this class of platinum(II) complexes 
following the synthesis of the first example of a platinum(II) dipyridylbenzene complex in 1999.65  
Williams and co-workers have also synthesised and studied the luminescence of iridium 
complexes incorporating terdentate ligands. A range of bis-terdentate iridium(III) complexes, 
containing the N^C^N ligand 1,3-di(2-pyridyl)-4,6-dimethylbenzene (dpyx) were reported in 
2006.5 Haga et. al. have also prepared bis-terdentate iridium(III) complexes incorporating 1,3-
bis(1-methyl-benzimidazol-2-yl)benzene ligands.69 Previously, despite their structural 
advantages, iridium(III) complexes of terdentate ligands had been largely overlooked.27, 30 
Terdentate ligands are known to have structural advantages over analogous bidentate ligands and 
complexes of such ligands often have outstanding performance. The higher degree of rigidity 
offered by terdentate ligands means that there is less molecular distortion on excitation from the 
ground state to the excited state and therefore, less excited stated energy is lost through non-
radiative decay. Additionally, terdentate N^C^N ligands are likely to afford a complex with 
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increased chemical stability and have beneficial effects on chirality with respect to eliminating 
the formation of diastereoisomers in multimetallic systems.5, 25, 27, 30, 179 
 
In this project, terdentate N^C^N-coordinating ligands were selected for use as auxiliary ligands 
based on the studies discussed above. Initially, only ligands based on 1,3-dipyridylbenzene were 
prepared. These ligands were synthesised in high yield via traditional cross-coupling methods 
such as Stille and Suzuki-Miyaura reactions as shown in Figure 84.  
 
 
Figure 84: A scheme to illustrate the cross-coupling reactions used to synthesise a selection of terdentate N^C^N 
ligands. 
 
Figure 85 shows the range of terdentate N^C^N-coordinating ligands prepared by cross-coupling 
methods. Ligands 3.1.1 to 3.1.3 were prepared via Suzuki-Miyaura reactions as described in the 
literature.68, 70, 180 The synthesis of compounds 3.1.4 and 3.1.5 was reported by Chou et. al. in 
2015, again utilising the Suzuki-Miyaura synthetic method. Alternatively, in this project, these 
ligands were prepared via the Stille cross-coupling route (Figure 84). 
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Figure 85: A figure to show the terdentate N^C^N-coordinating ligands prepared using traditional cross-coupling 
methods, Suzuki-Miyaura and Stille reactions. 
 
When reacting terdentate cyclometallating ligands such as 1,3-dipyridylbenzene with a metal 
centre, the metal centre can bind in two possible modes, terdentate or bidentate (Figure 86). In 
this project, terdentate binding is desired and has been previously observed with Ru(II), Os(II) 
and Pt(II). In the reaction of iridium(III) with 1,3-dipyridylbenzene, the Ir(III) primarily binds in 
a bidentate mode with cyclometallation occurring at the C4 position. Williams and co-workers 
reasoned that cyclometallation at the 4-position on the central phenyl ring must be kinetically 
favoured over the analogous reaction at the more sterically hindered 2-position.5, 17, 25, 27, 179  
 
 
Figure 86: A figure to show the possible binding modes of a metal centre with a terdentate NCN ligand.  
 
In order to direct cyclometallation to 2-position and ensure terdentate binding of the ligands with 
an iridium(III) metal centre, Williams et. al. showed that it is necessary to block the C4/C6 
positions through the addition of substituents such as methyl, fluoro and trifluoromethyl. As 
shown in Figure 85, ligands 3.1.1 to 3.1.4 have fluoro substituents at C4 and C6 to block the 
competitive metallation. Alternatively, in the case of compound 3.1.5, a single tert-butyl 
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substituent at the 5-position was used in an attempt to block bidentate chelation of the metal 
centre. We found this strategy to be successful in the synthesis of Ir(III) complexes of this ligand 
with binding going via a terdentate mode as will be discussed in section 3.2. This was also 
demonstrated by Chou et. al.70 
 
As a result of the success of the tert-butyl substituent in blocking competitive metallation, a wider 
variety of terdentate N^C^N ligands also bearing this substituent were prepared via alternative 
synthetic routes utilising heterocyclic chemistry.  
 
The first class of alternative terdentate N^C^N ligands we considered was those with the general 
structure 1,3-bis(benzimidazol-2-yl)benzene. Ligands of this type have been used in the 
preparation of luminescent complexes of transition metals such as Ir(III), Pt(II) and Au(III).28, 69, 
155, 162, 181-184 The five-membered imidazole rings present in these ligands are electron rich and 
push more electron density onto a metal centre when compared with ligands such as 1,3-
dipyridylbenzenes. The increased electron density on the metal centre leads to a destabilisation 
of the metal-centred d-d states and as previously mentioned, this is one way to reduce non-
radiative decay and increase the quantum yield. 
Yam and co-workers reported the first examples of a platinum(II) complex incorporating 1,3-
bis(N-alkylbenzimidazol-2’-yl)benzenes (bzimb) in 2011. This complex showed strong green 
luminescence (508-587 nm) with a quantum yield of ϕ = 0.19 at room temperature.185 Haga et. al. 
reported the first examples of the preparation of mononuclear iridium complexes incorporating 
these benzimidazole-type ligands as is shown in Figure 87.28, 69 These complexes show high 
quantum yields, ϕ = 0.10–0.95, with the mixed terdentate-bidentate complex [Ir(Phbib)(ppy)Cl] 
showing the highest quantum yield of 0.95.  
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Figure 87: A figure to illustrate the iridium(III) complexes 3.1.6-3.1.8 prepared by Haga et. al. incorporating terdentate 
NCN ligands containing benzimidazole moieties.  
 
Based on this literature precedent for highly luminescent complexes of N^C^N 1,3-
bis(benzimidazol-2-yl)benzene ligands, a small selection of this class of ligands bearing different 
N-substituents was prepared.   
The synthetic routes to the benzimidazole-type ligands prepared in this work are shown in Figure 
88. These compounds were prepared via the condensation reaction of either 5-tert-butyl 
isophthalic acid or the corresponding acid chloride with a diamine as shown below. 182, 184 162, 186 
Compounds 3.1.11 and 3.1.12 were isolated in good yields, 76% and 77% respectively, following 
purification by column chromatography.  
 
 
Figure 88: A figure to show the structures of the benzimidazole ligands 3.1.11 and 3.1.12 prepared through the 
condensation reactions.  
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The incorporation of these compounds as ligands in dinuclear iridium(III) complexes and the 
effects of the benzimidazole moieties on their photophysical properties will be discussed in 
sections 3.2 and 3.3. 
 
The second type of alternative N^C^N ligands considered in this work were those with the general 
structure 1,3-bis(pyrazolyl)benzene. Cyclometallating N^C^N ligands in which the heterocycle 
used is a pyrazole have been widely investigated for the preparation of blue-emitting iridium(III) 
complexes. When compared with pyridine, pyrazole is a poorer π-acceptor. Therefore, in a 
complex of a 1,3-bis(pyrazolyl)benzene ligand, the LUMO is raised relative to those in which 
dipyridylbenzenes are used as the terdentate ligand. This leads to emission that is blue-shifted in 
the pyrazole-containing complexes.126 
 
 
Figure 89: A figure to show the structures and binding modes both bidentate and terdentate pyrazole-containing 
ligands.  
 
The majority of reports of luminescent complexes incorporating pyrazole-containing ligands are 
those with bidentate ligands. There has been less investigation into terdentate pyrazole ligands. 
Figure 89 shows the structures of pyrazole-containing ligands, both bidentate and terdentate. C-
linked pyrazole ligands have been the most widely investigated for use in luminescent complexes. 
This type of structure has two tautomeric forms in which the proton can reside on N1 or N2. The 
N2-deprotonated form can bind a metal centre as an anionic ligand and so can be considered an 
analogue of 2-phenylpyridine. N-linked 1-aryl pyrazoles were incorporated as ligands into some 
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of the earliest examples of room-temperature-emissive platinum(II) complexes and in this work, 
terdentate N^C^N analogues of this type of ligand will be used.40 Terdentate ligands incorporating 
pyrazoles were first investigated for the preparation of luminescent Pt(II) complexes by Connick 
et. al., initially reporting complexes of 1,3-bis(1-pyrazolyl)pyridines and secondly, the analogous 
cyclometallating ligands 1,3-bis(1-pyrazolyl)benzenes. Williams and co-workers also reported 
luminescent cyclometallated Pt(II) complexes of such pyrazole-containing ligands.126, 187, 188 
Iridium(III) complexes of bis(pyrazolyl)benzene ligands (Figure 90) were reported by Haga et. 
al. in 2008. These complexes exhibit emission in the blue region (447-460 nm) at 77 K but only 
show weak room temperature emission with quantum yields ranging from ϕ = 0.4 x 10-3 to 8 x 
10-3. This weak emission under ambient conditions is thought to be due to a deactivation 
mechanism involving thermally accessible metal-centred d-d states.189  
 
 
Figure 90: Structures of iridium(III) complexes prepared by Haga and co-workers incorporating terdentate 
bis(pyrazolyl)benzene ligands. The quantum yields recorded for these complexes were (3.1.13) 5 x 10-3, (3.1.14) 0.4 x 
10-3 and (3.1.15) 0.5 x 10-3.189 
 
As previously mentioned, in this work ligands with the general structure 1,3-
bis(pyrazolyl)benzene will be investigated for use in the preparation of bimetallic iridium(III) 
complexes. The structures and suggested syntheses of the target pyrazole-containing N^C^N 
ligands are shown in Figure 91. The synthetic route shown below is a modified Ullmann reaction. 
This type of copper-mediated aromatic nucleophilic substitution reaction was first reported by 
Ullmann and Goldberg in the early 1900’s. Traditionally, these reactions required harsh reaction 
conditions and stoichiometric amounts of copper. More recently, the original reaction conditions 
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have been modified through the addition of organic additives capable of acting as a ligand for 
copper. This development has transformed these reactions into catalytic processes. 
Compound 3.1.17 was successfully isolated in high yield (70%) using these modified reaction 
conditions and was subsequently used in the formation of a dinuclear iridium(III) complex as will 
be discussed in sections 3.2 and 3.3.  
Compound 3.1.19 could not be isolated using this method. This is thought to be due to the low 
reactivity of the bromo- group. An alternative synthetic route is to go via the iodo-substituted 
compound following a bromo-iodo exchange reaction, however, due to time restraints this route 
was not attempted.126  
 
 
Figure 91: A scheme to show the structures and syntheses of two pyrazole-containing terdentate N^C^N ligands, 3.1.17 
and 3.1.19. 
 
The cyclometallating, terdentate N^C^N ligands discussed here incorporate a range of 
heterocycles and substituents in order to assess the effects of such factors on the photophysical 
properties of resulting dinuclear complexes. The incorporation of these N^C^N ligands into 
bimetallic iridium(III) complexes will be discussed in the following sections of this work.  
 
3.2 Di-Iridium(III) Complexes – Synthesis of Iridium Dichloro-bridged Dimers 
Following the successful synthesis of the range of symmetrically-substituted cyclometallating, 
terdentate N^C^N ligands shown in Figure 92, the first step in the preparation of our target 
dinuclear iridium(III) complex is the formation of a dichloro-bridged iridium dimer.  
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Figure 92: A figure to show the full range of terdentrate N^C^N-coordinating proligands synthesised for use in the 
preparation of dinuclear iridium(III) complexes.  
 
As is widely reported in the literature, the preparation of the a dichloro-bridged iridium(III) dimer 
of this type involves the reaction of a terdentate N^C^N ligand with IrCl3.H2O in a 3:1 solvent 
mixture of 2-ethoxyethanol and water as shown in the reaction scheme in Figure 93.25, 27, 30, 70, 122, 
123, 173  
 
 
Figure 93: Reaction scheme to show the synthesis of a dichloro-bridged iridium(III) dimer of terdentate N^C^N ligand 
3.1.2. The proligand is mixed with IrCl3.H2O in a 3:1 solvent mixture of 2-ethoxyethanol and water. This particular 
dichloro-bridged dimer, 3.2.1, was isolated in a yield of 82%. 
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Using the synthetic route shown above, the dichloro-bridged iridium(III) dimers were isolated in 
high yields of 67-91% and, as a result of the solubilising functional groups present, the dimers 
can be characterised by 1H, 19F and 13C NMR in CDCl3 solution.  
 
 
Figure 94: 1H NMR spectrum of iridium dichloro-bridged dimer 3.2.1. This spectrum shows 3 aromatic proton 
environments in the range of δ 8.4-6.9 ppm and 6 aliphatic peaks in the range of δ 4.2-0.9 ppm corresponding to the 7 
aliphatic proton environments. 
 
Figure 94 shows the 1H NMR spectrum of the iridium(III) dichloro-bridged dimer 3.2.1. The 
spectrum shows that there are 3 aromatic proton environments in the range of δ 8.4-6.9 ppm and 
6 peaks in the aliphatic region that correspond to 7 proton environments. This spectrum matches 
the structure of 3.2.1. 
 
The isolated iridium(III) dichloro-bridge dimers were used in the synthesis of target dinuclear 
Ir(III) complexes without any further purification. The synthesis and photophysical properties of 
the resulting luminescent complexes will be discussed in the following sections of this chapter.  
 
1 
3 2
4
5 6
7 + 8
10 
9 
 125 
 
3.3 4,6-Pyrimidine-Linked Dinuclear Iridium(III) Complexes 
The first bis-bidentate cyclometallating ligands investigated in this research were those containing 
a pyrimidine ring as the central heterocycle. This class of bridging ligands, based around a 4,6-
disubstituted pyrimidine ring, have been previously reported by Kozhevnikov et. al. in the 
preparation of both homo- and hetero- multimetallic complexes of Pt(II) and Ir(III). Using the 
same, Suzuki-Miyaura cross-coupling reactions as reported in these earlier works (Figure 95), 
these ligands were synthesised in moderate to good yields. 
 
 
Figure 95: A scheme to illustrate the Suzuki-Miyaura cross-coupling reaction used to synthesise the pyrimidine-based 
C^N^N^C bridging ligands. 
 
The range of pyrimidine-based bis-bidentate C^N^N^C ligands prepared using this method is 
shown in Figure 96. A range of electron-donating and –withdrawing substituents were 
incorporated in order to vary the electronic properties of the bridging ligands used. As discussed 
previously 1.2.3, addition of substituents can be used as a strategy for the tuning of photophysical 
properties of the final luminescent complex. In 2.1.5, the terminal phenyl rings were replaced 
with thiophene units.  Thiophene rings are more electron-rich than phenyl rings and therefore, 
complexes of ligands containing thiophene units have emission that is red-shifted relative to those 
containing phenyl rings. This is an alternative strategy available for tuning of emission colour as 
was described in chapter 2.0.163  
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Figure 96: A figure to show the pyrimidine-containing bis-bidentate C^N^N^C-coordinating proligands prepared using 
Suzuki-Miyaura reactions. 
 
Using the five bis-bidentate bridging ligands shown above, target dinuclear iridium(III) 
complexes were synthesised. In conjunction with these bridging ligands, a selection of three 
terdentate N^C^N-coordinating ligands based on 1,3-dipyrididylbenzene were incorporated; 
3.1.2, 3.1.1 and 3.1.3. The preparation of these proligands was previously discussed in section 
3.1. These N^C^N-coordinating ligands each comprise of lateral 4-tert-butylpyridine groups, 
however the substituents on the central ring were varied (Figure 85). In order to block competitive 
bidentate metalations, the 4- and 6- positions of the central phenyl rings are substituted with 
fluorine atoms. The synthetic route used to prepare the final dinuclear iridium(III) complexes 
allows the separate introduction of terdentate N^C^N auxiliary ligands and bis-bidentate bridging 
ligands.30 As a result, a series of eight dinuclear pyrimidine-linked iridium(III) complexes were 
prepared, as is shown in Figure 97, and the influence of the substitution pattern of both the bis-
N^C bridging and N^C^N auxiliary ligands was independently investigated. As part of this series 
of eight dinuclear complexes, monodentate ligand metathesis of the chloride ligand to a cyano- 
ligand and this will be discussed in a later section of this chapter (section 3.7). 
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Figure 97: Scheme to show the range of pyrimidine-linked di-iridium(III) complexes synthesised through variation of 
the substitution pattern on the bis-bidentate bridging ligand, the terdentate auxiliary ligand and the monodentate ligand. 
 
The synthetic route utilised for the isolation of the target dinuclear complexes is a two-step 
procedure and is similar to that previously developed for related mononuclear complexes.27, 30  
The first step is that described in section 3.2, the preparation of the dichloro-bridged iridium(III) 
dimer. Secondly, the dichloro-bridged dimers were reacted with the bis-N^C-coordinating 
proligands 3.3.3-3.3.6 and 2.1.5 under reflux in toluene, in the presence of silver triflate as a 
chloride scavenger. Following completion of the reaction, the mixture was treated with excess 
HCl (2M, aq.) in order to ensure that the monodentate ligands in the final products are exclusively 
chloride. The target complexes were isolated in good yields (50-80%) following treatment with 
methanol. 
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Figure 98: Synthetic route to the final dinuclear iridium(III) complex starting from terdentate N^C^N proligands. The 
reaction of the N^C^N-coordinating proligands with IrCl3.3H2O in leads to formation of the iridium(III) dichloro-
bridged dimer. Further reaction of this dimer with a bis-N^C bridging ligand in toluene and in the presence of AgOTf 
results in formation of the target dinuclear iridium(III) complexes.  
 
Characterisation of the resulting dinuclear iridium(III) complexes was carried out by 1H, 19F and 
13C NMR spectroscopy and high-resolution mass spectrometry.  
A critical point to note is that, due to the strong trans-influence of the formally anionic, metallated 
carbon atoms, the product that is formed is exclusively that in which the pyrimidine ring of the 
bridging ligand is trans to the central aryl ring of the N^C^N terdentate ligand. In each case, there 
is no evidence for the formation of isomers in which the cyclometallated aryl rings of the N^C 
and N^C^N units are trans to one another. This observation concurs with earlier studies of similar 
mononuclear systems.27, 28, 30, 179, 190 Therefore, in contrast to the majority of bimetallic complexes 
previously studied, only one stereoisomer is formed for these dinuclear iridium(III) complexes.83, 
84, 106, 107, 112, 118, 191-194 
Below is the 1H NMR spectrum of the target bimetallic complex 3.3.7. The 1H NMR spectra of 
these dinuclear complexes show characteristic features that can be used in conjunction with other 
data to confirm their identities. Firstly, a singlet at very high chemical shift between δ 11-12 ppm, 
assigned to the proton at the 2-position of the pyrimidine ring. Secondly, a low-frequency 
multiplet at chemical shifts between δ 5.6-6.8 ppm, assigned to the protons ortho to the 
cyclometallated carbon in the aryl ring of the bridging ligand. 
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Figure 99: 1H NMR spectrum of dinuclear iridium(III) complex 3.3.7 illustrating the presence of characteristic proton 
signals used to indicate the formation of the pure dinuclear iridium(III) complex. 
 
In addition to NMR spectroscopy and mass spectrometry, X-ray crystallography can also be used 
to characterise our dinuclear iridium(III) complexes. Crystals of 3.3.11 suitable for X-ray 
diffraction were obtained by slow evaporation of a solution of the bimetallic complex in 
CH2Cl2/MeOH (3:1 v/v). The molecular structure of 3.3.11 was solved using X-ray 
crystallography by Dr M. Probert and Prof. W. Clegg at Newcastle University. The crystal 
structure obtained is shown below in Figure 100 with important bond angles and lengths shown 
in  
Table 3. The complex has a crystallographic mirror plane passing through atoms C38 and C39. 
Two-fold disorder was modelled on atoms C28-C30 (and their H atoms) of the hexyl chain. 
Parameters determined using X-ray crystallography suggest further disorder of this hexyl chain 
and of the t-butyl groups, however this was not modelled.173 
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Figure 100: The molecular structure of 3.3.11 obtained using X-ray diffraction of a single crystal. The single crystal 
was grown by the slow evaporation of a solution of the dinuclear complex in CH2Cl2/MeOH (3:1 v/v). 
 
Table 3: Selected bond lengths (Å) and angles (°) for complex 3.3.11 as determined by X-ray diffraction and the 
corresponding values in the energy-minimised structure obtained by DFT calculations. (a) DFT-derived values in 
square parentheses are for the geometry with imposed mirror symmetry about the central ligand (see text). 
Bond Length (Å) or Angle (°) X-Ray Data DFT Data(a) 
Ir-N1 2.049(5) 2.090 [2.085] 
Ir-N2 2.048(5) 2.081 [ 2.085] 
Ir-N3 2.157(5) 2.208 [2.215] 
Ir-C11 1.926(7) 1.936 [1.936] 
Ir-C31 1.996(5) 2.024 [2.024] 
Ir-Cl 2.4406(15) 2.483 [2.479] 
   
N1-Ir-N2 160.4(2) 159.9 [159.9] 
N1-Ir-Cl11 80.3(2) 79.9 [80.0] 
N2-Ir-C11 80.1(2) 80.1 [80.0] 
N3-Ir-C11 173.4(2) 176.1 [176.5] 
N2-Ir-C31 78.9(2) 78.3 [78.5] 
N3-Ir-C1 93.66(12) 92.2 [92.7] 
C31-Ir-C1 172.6(2) 170.1 [171.1] 
C11-Ir-C31 95.3(3) 97.9 [98.0] 
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The crystal structure obtained for 3.3.11, when compared with structurally related mononuclear 
complexes bearing terpyridine terdentate ligands rather than cyclometallating N^C^N ligands, 
provides further evidence for the strong trans influence associated with the central metallated aryl 
ring of the N^C^N ligand. As shown in Figure 101, the Ir-N3 bond length of 2.157(5) Å is 
elongated when compared with the Ir-N bond of the N^C ligand of [Ir(tpy)(MeOmppy)Cl]+ (for 
which the value is 2.068(2) Å) and for the N^N ligand in [Ir(tpy)(bpy)Cl]2+ (for which the value 
is 2.081(1) Å).195 In the mononuclear iridium(III) complexes shown in Figure 101, these Ir-N 
bonds are trans to another Ir-N bond as opposed to Ir-C bonds. The strong trans influence of the 
metallated carbon atoms of the diarylpyrimidine ligand is also evidenced by the elongation of the 
Ir-Cl bonds. For example, in our dinuclear iridium(III) complex 3.3.11, the Ir-Cl bond length is 
2.4406(15) Å whereas the value is 2.334(5) Å in the complex [Ir(tpy)(bpy)Cl]2+, where the 
chloride is trans to a pyridine rather than a metallated aryl ring.  
 
 
Figure 101: A figure to illustrate the trans influence of the metallated carbon atoms in elongating trans-positioned 
bonds. The Ir-N and Ir-Cl bond lengths in both 3.3.11 and related mononuclear complexes highlight this point.  
 
Further investigation of the structures of these new dinuclear iridium(III) complexes was carried 
out using density functional theory (DFT) calculations, as performed by Dr M. Durrant at 
Northumbria University. In order to decrease the duration of the DFT calculations, the t-butyl and 
OC6H13 substituents of the terdenatate N^C^N ligands and the thienyl groups of the bis-N^C 
bridging ligand 2.1.5 in 3.3.13 were truncated to Me, OMe and Me respectively. The t-butyl 
groups of 3.3.6 were retained in full. The dinuclear complexes were subjected to full geometry 
optimisation although, due to the large size of these bimetallic iridium(III) complexes, frequency 
calculations proved difficult and therefore have been omitted.  
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The optimised geometries calculated for the full series of eight dinuclear iridium(III) complexes 
showed a twist about the central pyrimidine bridging ligand, giving dihedral angles between the 
two phenyl rings between 7.9° for 3.3.10 and 22.8° for 3.3.7. The dihedral angle between the 
thiophene rings in 3.3.13 was much smaller, at 1.0°. In all cases, the twisting results in rotational 
symmetry about the central pyrimidine ring of the bis-N^C ligand. This contrasts with the X-ray 
crystal structure obtained for 3.3.11, in which mirror symmetry about the pyrimidine ring is 
observed (Figure 100) such that the central bridging ligand remains planar rather than twisted. 
Consequently, there are different distances between the equivalent N atoms of the pyridine rings 
of the auxiliary N^C^N ligands in the experimental structure (6.293 and 7.433 Å), whereas in the 
calculated structures these distances are equal (7.104 Å). To investigate this further, a geometry 
optimisation starting from the X-ray crystal structure was carried out. This produced the same 
calculated structure and therefore, suggests that these two slightly different conformations are 
similar in energy. This conclusion was confirmed through re-optimising the geometry of 3.3.11 
with imposed mirror symmetry. This gave an optimised structure for the dinuclear complex that 
was closer to the experimental structure and only 0.3 kJ mol-1 higher in energy compared with the 
rotationally symmetric conformer. Therefore, it is possible to conclude that deformation about the 
central bis-N^C bridging ligand is a very low energy process within the margin of error of the 
calculations and the effects of molecular packing within the crystal structure. 
In all other respects, the calculated structures of our dinuclear iridium(III) complexes are as 
expected, giving good agreement between the calculated and experimental bond lengths and 
angles (Table 2). In each case, the metal centre has a distorted octahedral geometry. The Ir-
N(pyridine) bond lengths (2.079-2.096 Å) are shorter than the Ir-N(pyrimidine) bond lengths 
(2.208-2.263 Å). In addition, the Ir-C bond lengths (1.917-1.936 Å) for the terdentate auxiliary 
ligands are shorter than the equivalent Ir-C bond lengths (2.017-2.085 Å) for comparable 
bidentate cyclometallating ligands. These results are consistent with the expected trans influence 
of the various donor atoms involved and mirror the differences observed for related mononuclear 
complexes.30, 179 The Ir-Cl bond lengths range between 2.478-2.489 Å. 
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The next step in the study of this series of dinuclear iridium(III) complexes was to measure their 
absorption and emission properties. All of the photophyiscal measurements for these complexes 
were performed by Prof. J. A. Gareth Williams at Durham University. In order to discuss the 
photophysical properties of these complexes, we will divide them into two series with 3.3.7 
common to both series. In the first series, the bis-bidentate ligand remains constant in each 
complex and therefore, the changes in the photophysical properties can only be attributed to the 
variation of substituents on the terdentate N^C^N ligand. In the second series, the terdentate 
N^C^N ligand 3.1.2 is common to each complex and so only the influence of the variation of 
substituents on the bis-N^C bridging ligand account for the changes in optical properties. 
The UV-visible absorption spectra of the dinuclear iridium(III) complexes recorded in 
dichloromethane solution at room temperature are shown in Figure 102, with the absorption 
maxima and molar extinction coefficients tabulated in Table 4. All of the bimetallic complexes 
show a series of intense bands in the UV region of the spectrum (ε ≈ 30-80 x 103 M-1 cm-1) as well 
as intense bands in the visible region to around 500-530 nm (ε ≈ 5-30 x 103 M-1 cm-1). With 
increasing wavelengths, there is a trend to decreasing molar absorptivities. The absorption spectra 
recorded are typical of cyclometallated iridium(III) complexes, but with higher extinction 
coefficients than those of related mononuclear complexes, for example, those with the general 
structure Ir(N^C^N)(N^C)Cl as reported by Williams et. al.29-31, 88, 134, 136, 148, 158, 196-213 The 
observation of higher molar absorption coefficients for multimetallic complexes is consistent with 
previous examples investigated by Kozhevnikov and co-workers.83-85 
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Figure 102: UV-visible absorption spectra recorded for the pyrimidine-linked dinuclear iridium(III) complexes in 
CH2Cl2 at 298 K ± 3 K (left) the first series 3.3.7-3.3.9 in which the terdentate N^C^N ligand is varied (right) the 
second series 3.337 and 3.3.10-3.3.13 in which the bis-N^C bridging ligand is varied.  
 
Table 4: UV-visible absorption data for the pyrimidine-linked dinuclear Ir(III) complexes in CH2Cl2 at 298 K ± 3 K. 
Complex(a) λmax / nm (ε / M-1 cm-1) 
3.3.7 279 (63400), 312 (41500), 360 (32300), 408 (28600), 441 
(24400), 484 (11400), 520 (8080) 
3.3.8 270 (54700), 310sh (39500), 326sh (31100), 363 (30400), 
398 (25600), 438 (18500), 484 (10300), 514 (7300) 
3.3.9 260 (56500), 281 (51500), 327 (34900), 354 (36500), 385 
(22500), 430 (17500), 474 (13400), 500 (7800) 
3.3.10 281 (70400), 309 (49600), 376 (31500), 4040 (29800), 442 
(22600), 494 (9150), 526 (7120) 
3.3.11 279 (79300), 3030sh (55800), 358sh (32700), 372 (38600), 
397 (33200), 430 (24300), 477 (8970), 514 (6560)  
3.3.12 277 (53600), 335 (27600), 360 (34300), 409 (29700), 433sh 
(25200), 473 (13700), 498 (7070) 
3.3.13 281 (62300), 305sh (36200), 337sh (31800), 358 (42200), 
407 (30300), 446 (25300), 489 (36800), 514 (16100), 554 
(2100) 
 
(a) For comparison, data for the related mononuclear complex Ir(F2dpyb)(ppy)Cl are as follows: λmax / nm (ε = M-1 cm-1) = 260 
(44800), 280 (40300), 358 (9100), 381 (11300), 402 (14000), 438 (3640), 473 (1540).30 
 
From the UV-visible absorption spectra shown in Figure 102 and the corresponding data in Table 
4, it is possible to see that the spectra for the 3.3.7-3.3.9 series have very similar profiles, but with 
the bands at λ > 370 nm becoming increasingly blue-shifted on going from 3.3.7 to 3.3.8 to 3.3.9. 
In 3.3.9, the difluorophenyl ring of 3.3.8 is replaced with a difluoropyridyl ring. This leads to a 
more electron-withdrawing N^C^N ligand and shifts the absorption bands to higher energy by 
approximately 500 cm-1. Conversely, going from 3.3.8 to 3.3.7 the addition of the alkoxy 
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substituent leads to a terdentate auxiliary ligand with more electron-donating character and 
therefore the absorption bands of 3.3.7 are shifted to lower energy by around 200 cm-1. For the 
series 3.3.7 and 3.3.10-3.3.13, in which the bis-bidentate bridging ligand is varied, the absorption 
spectra of 3.3.7 and 3.3.10-3.3.12 are similar to one another in profile, with the lowest-energy 
absorption bands increasing in energy in the order 3.3.10 < 3.3.7 < 3.3.11 < 3.3.12. The spectra 
recorded for the bis-thienylpyrimidine complex, 3.3.13, is very different to those obtained for the 
rest of the series at wavelengths above 450 nm. The appearance of two bands in this region have 
much higher extinction coefficients than those of the other complexes. Additionally, there is a 
weakly-absorbing band at low energy (λmax = 554 nm, ε = 2100 M-1 cm-1) in the absorption spectra 
of 3.3.13. This band has no observable counterpart in the spectra of the other complexes in this 
series.  
The seven pyrimidine-linked dinuclear iridium(III) complexes being discussed in this chapter are 
highly luminescent in deoxygenated solutions at room temperature. The emission spectra 
recorded for these complexes are shown in Figure 103 (subdivided into the same series as in 
Figure 102) with the corresponding emission data shown in Table 5. The majority of the spectra 
show a well-defined emission maximum accompanied by a shoulder on the lower-energy side. 
Literature suggests that this type of emission profile is typical of rigid chromophores with a small 
Huang-Rhys factor, in which the emission is concentrated in the highest-energy 0,0 vibrational 
component band.20 At 77 K, the vibrational structure of the emission spectra becomes more 
pronounced with the emission spectra of all complexes exhibiting at least three components of a 
vibrational progression of 1400 cm-1. This is typical of aromatic C=C vibrational modes. The 
thienyl complex, 3.3.13, shows additional bands due to a second, lower-frequency vibrational 
progression. The emission spectra recorded for the two series of dinuclear iridium(III) complexes 
show two main trends. Firstly, for the series 3.3.7-3.3.9, the energy of the emission maxima 
increases in the order 3.3.7 < 3.3.8 < 3.3.9, equal to the trend observed for the absorption spectra. 
In addition, from the 0,0 maxima, the differences in emission energy on going from 3.3.7 to 3.3.8 
(≈ 200 cm-1) and from 3.3.8 to 3.3.9 (≈ 500 cm-1) are similar to the differences observed for the 
lowest-energy absorption band. Secondly, for the series 3.3.7 and 3.3.10-3.3.13, the trend in 
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emission energy at room temperature is 3.3.13 ≈ 3.3.11 ≈ 3.3.10 < 3.3.7 < 3.3.12. At 298 K, the 
vibrational shoulder in the emission spectra is only just detectable for 3.3.11 and is not observed 
at all for 3.3.10. When recorded at 77 K, all of the emission spectra for this series show clearly 
resolved 0,0 components although the order of emission energy varies to 3.3.13 < 3.3.11 < 3.3.10 
< 3.3.7 < 3.3.12. 
 
 
Figure 103: Luminescence spectra of the dinuclear iridium(III) complexes. (Top) Emission spectrum of series 3.3.7-
3.3.9 (a) in CH2Cl2 at 298 K ± 3 K and (b) in diethyl ether / isopentane / ethanol (2:2:1) at 77 K. (Bottom) Emission 
spectra of 3.3.7 and 3.3.10-3.3.13 (c) in CH2Cl2 at 298 K ± 3 K and (d) in diethyl ether / isopentane / ethanol (2:2:1) at 
77 K. 
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Table 5: Emission data for the pyrimidine-linked dinuclear iridium(III) complexes in degassed CH2Cl2 at 298 K and 
in EPA(a) at 77 K. 
Complex λmax / nm Φlum(b) τ / ns(c) kr(d) / 
106 s-1 
Σknr(d) / 
106 s-1 
kQO2 (e) / 
109 M-1 s-1 
Emission at 77K(f) 
λmax / nm τ / ns 
3.3.7 552, 582sh 0.94 440 [210] 2.14 0.14 1.13 513, 552, 594 6650 
3.3.8 544, 576sh 1.0 550 [160] 1.82 --(g) 2.01 512, 549, 593sh 7500 
3.3.9 526, 557sh 1.0 590 [230] 1.69 --(g) 1.21 501, 538, 578 7800 
3.3.10 568, 599sh 0.88 570 [230] 1.54 0.21 1.18 519, 559, 602 4200 
3.3.11 570 0.91 590 [220] 1.54 0.15 1.30 525, 563, 610sh 1300 
3.3.12 528, 557sh 1.0 360 [160] 2.78 --(g) 1.58 493, 530, 569 2400 
3.3.13 572, 611sh 0.94 4000 [380] 0.24 0.015 1.08 560, 582, 608, 
633, 663, 695, 728 
23000 
 
(a) EPA = diethyl ether / isopentane / ethanol (2:2:1 v/v). (b) Measured using Ir(ppy)3 in 2-MeTHF as the standard, for 
which the Φ = 0.97. (c) Values in air-equilibrated solution in parentheses. (d) kr and Σknr are the radiative and non-
radiative decay rate constants, estimated from the quantum yield and lifetime assuming that the emissive state is formed 
with unitary efficiency. (e) Bimolecular rate constant for quenching by O2, estimated from the luminescence lifetimes 
in degassed and air-equilibrated solutions, and taking [O2] = 2.2 mM in CH2Cl2 at p = 1 atm air and T = 298 K. (f) In 
EPA: see footnote a. (g) Since the measured quantum yield is unity within the error of measurement, it is not possible 
to make a meaningful estimate of knr. (h) For comparison, data for the related mononuclear complex Ir(F2dpyb)(ppy)Cl 
are as follows: At 298 K, λmax = 487, 516 nm; Φlum = 0.20; τ = 390 ns; kr = 0.5 x 106 s-1; Σknr = 2.1 x 106 s-1. At 77 K, 
λmax = 471, 508, 537, 548, 593 nm; τ = 2.5 μs.30  
 
The excitation spectra measured closely match the absorption spectra for all seven of the 
bimetallic Ir(III) complexes investigated in this section. This indicates that the same emissive 
state is formed with high efficiency, irrespective of the excitation wavelength. This is typical for 
cyclometallated complexes of third-row transition metals such as Ir(III). For such complexes, the 
processes of internal conversion and intersystem crossing to the lowest-lying triplet state are faster 
than the rate of fluorescence from the lowest-lying singlet state by several orders of magnitude.214-
216 The luminescence quantum yields in solution at room temperature are very high for all of the 
complexes, approaching unity, within the uncertainty of the measurement. The quantum yields 
measured are higher than those of related mononuclear Ir(III) complexes of the 
Ir(N^C^N)(N^C)Cl series previously studied by Williams et. al (see footnote to Table 5).30 The 
values obtained for the quantum yields are comparable to fac-Ir(ppy)3, despite the emission being 
significantly red-shifted in comparison.217 The luminescence lifetimes recorded for these 
dinuclear complexes are in the range of 360-590 ns at room temperature, except for 3.3.13 which 
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has a longer lifetime of 4000 ns under the same conditions. These lifetimes are much shorter than 
that of fac-Ir(ppy)3, for which a value of 1.6 μs has been reported under comparable conditions.217 
Given that the quantum yields are comparable to fac-Ir(ppy)3, the observation of much shorter 
luminescence lifetimes suggests a significantly higher rate of radiative decay in the dinuclear 
complexes. The radiative and non-radiative rate constants, kr and Σknr respectively, can be 
estimated using the equations below, assuming that the emissive state is formed with unitary 
efficiency upon excitation.  
𝑘𝑟 =
𝛷
𝜏
   and   ∑ 𝑘𝑛𝑟 =
1−𝛷
𝜏
 
 
The values for the radiative and non-radiative rate constants shown in Table 5 were estimated 
using this method. For fac-Ir(ppy)3, the value of kr has been estimated as 6 x 105 s-1.217 Therefore, 
it can be seen that, with the exception of 3.3.13, the values for kr for the dinuclear iridium(III) 
complexes are increased by a factor of 2-5. 
The luminescence observed for these complexes is quenched by oxygen with a bimolecular rate 
constant of the order of 109 M-1 s-1. This is typical for cyclometallated complexes of third-row 
transition metals such as Ir(III) and Pt(II). However, due to the high kr values and the very short 
luminescence lifetimes (except for 3.3.13), the effect of oxygen on the reduction of lifetimes and 
emission intensities is unusually small at atmospheric pressure. Only a reduction by around a 
factor of 2 is observed. As a consequence of the much longer lifetime of 3.3.13, both at 298 and 
77 K (4 and 23 μs respectively), the emission of this complex in solution is much more sensitive 
to quenching by O2.  
 
The photophysical properties observed for the seven pyrimidine-linked dinuclear iridium(III) 
complexes can be rationalised further with the aid of time-dependent DFT (TD-DFT) calculations. 
The optimised geometries of the dinuclear complexes, calculated as described previously, were 
utilised to obtain main excitation energies, oscillator strengths and the predominant molecular 
orbital contributions. UV-visible spectra were calculated in vacuum, and in dichloromethane 
solution. In all cases the general effect of the solvent is to blue-shift the frequency of the highest 
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energy singlet band by 15 to 38 nm and to increase its intensity. The simulated absorption spectra 
show less vibrational structure than the spectra obtained experimentally. Vibrational structure in 
the experimental absorption spectra likely arises as a result of excitation to vibrationally excited 
levels of the electronic excited states. This is not modelled theoretically and therefore does not 
appear in the simulated spectra.  
The data obtained from the calculation is extremely useful in providing further insight into the 
trends in absorption and emission energies. For all of the dinuclear complexes, both the 
experimental trends in the energy of the lowest-energy absorption band and the emission energy 
correlate well with the calculated HOMO-LUMO gap, as is shown in Figure 105. Plots of the 
calculated S1 and T1 energies both in vacuum and in solvent also show good correlation with the 
experimental data.  
Using the TD-DFT data, it is appropriate to attempt to understand the influence of the substituents 
on the cyclometalling ligands in terms of their effects on the energies of the HOMO and LUMO. 
Frontier orbital plots of the HOMO and LUMO of the dinuclear complex 3.3.7 are shown in 
Figure 104 with frontier orbital plots and related TD-DFT data of all the dinuclear iridium(III) 
complexes within this series shown in section 5.2. As discussed previously in section 1.2.3, it has 
been reported that for mononuclear complexes of Ir(III) and Pt(II) of cyclometallated ligands such 
as 2-phenylpyridine, the LUMO is based on the heterocycle with the HOMO localised on the 
metallated aryl ring and the metal atom.51 In the case of our dinuclear iridium(III) complexes, the 
calculations show that the LUMO is located predominantly on the pyrimidine ring of the bis-N^C 
ligand. This is as expected as the pyrimidine ring of the bridging ligand is more electron-deficient 
than the pyridine rings of the terdentate N^C^N ligand and therefore offers lower-energy π* 
orbitals. On the other hand, the calculations show that the HOMO for each complex is localised 
on the metal atom and the metallated aryl ring of either the N^C^N or the bis-N^C ligand 
depending on the identity of the two ligands.  
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Figure 104: Frontier orbital plots of dinuclear iridium(III) complex 3.3.7, with their energies in Hartree (energies in 
eV in parenthesis).  
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Figure 105: (a) Calculated HOMO and LUMO energies for the complexes in vacuo, in eV (filled and empty circles 
respectively). (b) The HOMO-LUMO gap (eV) calculated from the respective energies in (a). (c) Plot of experimental 
S1 energy (blue squares), estimated based on λmax of the lowest-energy absorption band (excluding the weak band at 
554 nm for 3.3.13, which is concluded to be a direct excitation to 3π-π* state); the T1 energy estimated from 
experimental λmax (0,0) values in the emission spectra at 298 K (open red circles) and at 77 K (filled red circles); and 
the calculated HOMO-LUMO gap (black diamonds). The lines between points are provided solely as a guide for the 
eye.  
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The plots above (Figure 105) show the calculated HOMO and LUMO energies of the dinuclear 
complexes as well as the magnitude of the resulting energy gap.  
For the first series of complexes, it can be seen that the blue-shift in absorption and emission on 
going from 3.3.7 to 3.3.8 and to 3.3.9 is due to a larger stabilisation of the HOMO than the LUMO. 
In 3.3.7, the HOMO is mainly localised on the aryl ring of the N^C^N ligand with a minor 
contribution from the metallated ring of the bis-N^C ligand. In 3.3.8, in which the electron-
donating alkoxy group is absent, the HOMO now involves primarily the bis-N^C aryl ring with 
only a minor contribution from the terdentate ligand. Replacement of the central aryl ring of the 
N^C^N ligand with a pyridine ring in 3.3.9 leads to a HOMO almost wholly localised on the aryl 
ring of the bridging ligand with the contribution of the terdentate ligand becoming negligible.  
For the second series of dinuclear iridium(III) complexes, the shifts in absorption and emission 
depend on the variation in both the HOMO and LUMO energies. Moving from 3.3.7 to 3.3.10, 
there is a small red-shift in the absorption and emission maxima arising primarily from 
stabilisation of the LUMO due to removal of the t-butyl substituents. In this case, the effect on 
the LUMO is larger than that on the HOMO. Figure 105 suggests that 3.3.11 should be fairly 
similar to 3.3.10 and this is indeed what is observed experimentally (only a small blue-shift is 
observed in the absorption spectra). At first, the similarity of these two complexes is surprising 
as, from the literature, it is known that fac-Ir(dfppy)3 is significantly blue-shifted relative fac-
Ir(ppy)3 as a result of stabilisation of the HOMO by the fluoro- groups.24 However, Figure 105 
shows that the electron-withdrawing fluoro- groups present in 3.3.11 stabilise both the HOMO 
and LUMO to similar extents and this is the reason for the lack of significant effect on the 
photophysical properties. In the methoxy-substituted complex, 3.3.12, a large blue-shift is 
observed in the absorption and emission spectra when compared with 3.3.7. It can be seen, using 
Figure 105, that this is exclusively due to destabilisation of the LUMO based on the bis-N^C 
bridging ligand. The electron-donating methoxy substituents on 3.3.12 are located para to the 
electron-deficient pyrimdine ring on which the LUMO is located and additionally are sufficiently 
electron-rich to shift the HOMO from the N^C^N ligand to the aryl ring of the bis-N^C ligand. 
Finally, for 3.3.13, this complex is predicted to have the lowest-energy emission of the bimetallic 
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iridium(III) complexes prepared as observed experimentally at 77 K. 3.3.13 has an anomalously 
long luminescence lifetime of 4 μs at 298 K and 23 μs at 77 K. Combining the observation of a 
long luminescence lifetime with the highly vibrationally-structured emission spectra of this 
complex at 77 K, it is appropriate to consider that the excited state of 3.3.13 may have more 
ligand-centred π-π* character.163 Based on the emission spectra of this complex both at 298 K and 
77 K, it seems likely that at room temperature the 3MLCT and 3π-π* states are close in energy 
whereas at 77 K, the former is displaced to higher energy leading to the 3π-π*-like emission 
spectrum at 77 K.  
 
Following this analysis of the photophysical properties of this series of seven dinuclear 
iridium(III) complexes, we can draw some conclusions about the influence of the second metal 
ion. From the emission data in Table 5, we can see that the radiative decay constants for these 
complexes is enhanced relative to related mononuclear complexes whilst the non-radiative decay 
is suppressed. The dinuclear complexes have significantly lower excited state energies than 
corresponding mononuclear complexes and therefore, considering the energy gap law, the 
observation of reduced non-radiative decay for our di-iridium(III) complexes is remarkable. The 
energy gap law says that for a given class of complex, non-radiative decay processes increase 
with decreasing excited state energy with possible decreases in kr to be anticipated also. The fact 
that kr is increased consistently for our multimetallic complexes supports the idea that a second 
heavy metal ion may enhance the spin-orbit coupling pathways. The same increase in kr has also 
been observed with multimetallic complexes previously investigated by Kozhevnikov et. al. The 
suppression of the non-radiative decay, is thought to be due to the greater conformational rigidity 
of the dinuclear systems.83-85  
 
Following on from this research into pyrimidine-linked dinuclear iridium(III) complexes bearing 
auxiliary terdentate N^C^N ligands derivatised from 1,3-dipyridylbenzene, we prepared a further 
series of pyrimidine-linked di-iridium(III) complexes incorporating the alternative N^C^N-
coordinating auxiliary ligands as discussed in section 3.1.  
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Firstly, the influence of the substituents attached to the N^C^N-coordinating ligand was 
investigated. The importance of blocking the competitive bidentate coordination of terdentate 
ligands through incorporation of substituents was discussed in section 3.1. Traditionally 
substituents have been added at positions 4- and 6- of the central phenyl ring of the N^C^N-
coordinating ligand, however, more recently the use of a single substituent at the 5-position has 
been reported.70 As a result, we prepared a terdentate ligand incorporating a single t-butyl 
substituent at the 5-position of central phenyl ring. In the synthesis of the dichloro-bridged 
iridium(III) dimer, this ligand 3.2.4 showed terdentate coordination to the metal centre. The 
corresponding dinuclear iridium(III) complex was prepared using the same two-step synthetic 
procedure as described previously in Figure 98, with the bis-N^C-coordinating bridging ligand 
3.3.6 selected. The desired pure bimetallic complex 3.3.15, as shown in Figure 106 was isolated 
in a relatively low yield of 15%, following purification by column chromatography.  
 
 
Figure 106: A reaction scheme to show the synthetic method used for the preparation of 3.3.15. The dinuclear complex 
was isolated as a red-orange solid in a yield of 15%.  
 
The identity of this dinuclear iridium(III) complex was confirmed using 1H and 13C NMR 
spectroscopy and using mass spectrometry. The aromatic region of the 1H NMR spectrum of 
3.3.15 is shown in Figure 107 and shows the characteristic features of the desired final dinuclear 
complex. The singlet at δ 11.8 ppm corresponds to the proton at the 2-position of the pyrimidine 
ring. This signal has a high chemical shift due to the proximity of this proton to the two 
monodentate chloro ligands. The doublet at δ 6.00 ppm corresponds to the two protons ortho to 
the metallated carbon atoms in the aryl rings of the bis-bidentate bridging ligand.  
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Figure 107: A figure to show the aromatic region of the 1H NMR spectrum of 3.3.15. The NMR shows characteristic 
features indicative of the final dinuclear iridium(III) complex. The singlet at δ 11.8 ppm corresponds to the proton at 
the 2-position of the pyridmidine ring and the doublet at δ 6.00 ppm corresponds to the two protons ortho to the 
metallated carbon atoms in the aryl rings of the bis-bidentate bridging ligand. Additionally, this NMR spectrum shows 
no evidence for the formation of diastereoisomers.  
 
Successful utilisation of terdentate auxiliary ligand 3.1.5 in a pyrimidine-linked dinuclear 
iridium(III) complex led to the preparation of further bimetallic iridium(III) complexes 
incorporating N^C^N ligands also bearing a single t-butyl substituent on the central aryl ring. In 
order to investigate the effect of the heterocycle of the terdentate ligand, the pyridine rings were 
replaced with alternative heterocycles; benzimidazole and pyrazole, as shown in Figure 88 and 
Figure 91 in section 3.1. This series of dinuclear complexes synthesised using these alternative 
N^C^N-coordinating auxiliary ligands are shown in Figure 108.  
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Figure 108: A figure to illustrate the structures of dinuclear iridium(III) complexes incorporating terdentate N^C^N-
coordinating ligands in which the N-coordinating moiety is a benzimidazole or a pyrazole. The complexes were isolated 
in moderate to good yields (33-83%). 
 
The target complexes in this case were isolated in moderate to good yield (33-83%) following 
purification by column chromatography.  
Again, each of the final complexes were characterised by 1H and 13C NMR spectroscopy and by 
mass spectrometry. In addition, a crystal suitable for X-ray diffraction was obtained for 3.3.16. 
The crystallographic analysis was performed by Marsel Shafikov in the group of Professor 
Hartmut Yersin at Regensburg University. The molecular structure is shown in Figure 109 and 
the corresponding crystallographic data is shown in Table 6. The crystal structure shows the two 
iridium(III) centres, each with distorted octahedral geometry, rigidly-linked via the bis-bidentate 
bridging ligand. Each iridium centre is bound to one auxiliary terdentate N^C^N ligand, 3.1.11, 
and the coordination sphere of each metal ion is completed by a monodentate chloride ligand. The 
crystal structure below shows that the unit cell contains three molecules of methanol originating 
from the crystallisation procedure. 
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Figure 109: The crystal structure of 3.3.16·3MeOH, obtained by X-ray crystallography.  
 
Table 6: Selected bond lengths (Å) for the complex 3.3.16·3MeOH as determined by X-ray crystallography.  
Bond Length (Å) X-Ray Data 
Ir-N(benzimidazole) 2.057(2) 
Ir-N(benzimidazole) 2.058(2) 
Ir-N(pyrimidine) 2.143(2) 
Ir-C(N^C^N) 1.946(3) 
Ir-C(bis-N^C) 2.018(3) 
Ir-Cl 2.477(7) 
 
The crystallographic data show in Table 6 illustrates that, like the series of pyrimidine-linked 
dinuclear iridium(III) complexes discussed previously in this section, there is a strong trans 
influence associated with the metallated carbon atoms of both the terdentate N^C^N and bis-N^C 
ligands. This is evidenced by the elongated bonds lengths of the Ir-N(pyrimidine) bond with a 
length of 2.143(2) Å and the Ir-Cl bond with a length of 2.477(7) Å. Similar elongated bond 
lengths were observed in the crystal structure of 3.3.11 (Table 3).  
Full investigation of the photophysical properties for this series of pyrimidine-linked complexes, 
3.3.15-3.3.18 is still required, however, luminescence measurements of 3.3.16 were carried out 
by Marsel Shafikov in the group of Professor Hartmut Yersin at Regensburg University. It was 
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observed that 3.3.16 exhibits a photoluminescence quantum yield of 100% and a luminescence 
lifetime of 450 ns, both measured in degassed CH2Cl2 solution at 300 K.  
 
In summary, in this section we have shown that 4,6-diarylpyrimdines can be used as bis-
cyclometallating bridging ligands, binding to two iridium centres via N^C-coordination to each 
metal. We have also shown that incorporation of a terdentate N^C^N ligand ensures that the 
resulting dinuclear complexes are achiral, contrasting with the mixtures of stereoisomers that form 
in the case of tris-bidentate metal complexes. In addition, the strong trans influence of the 
cyclometallated aryl rings of both the bis-bidentate and terdentate ligands lead to the formation 
of only one unique product, in which the pyrimidine ring is trans to the central aryl ring of the 
N^C^N ligand at both iridium centres. The final dinuclear iridium(III) complexes are intensely 
luminescent, with quantum yields close to unity and the emission energies tuneable through the 
variation of substituents on bis-N^C bridging ligand or the terdentate N^C^N ligand. In addition 
to the strong light absorption and intense emission in the visible region, these bimetallic 
complexes offer huge potential for structural diversity. This structural diversity is possible as a 
result of the versatility of the design strategy and the ease of synthesis of suitable of terdentate 
and bis-bidentate ligands. These numerous advantages to these pyrimidine-linked dinuclear 
iridium(III) complexes have led to further investigation into new compounds as will be discussed 
in the following sections of this chapter. These new complexes may be applied to a variety of 
applications in which multinuclear complexes are already recognised to offer unique 
opportunities, for example, as water splitting catalysts or for interaction with biomolecules.  
 
3.4 2,5-Pyrazine- vs. Thiazole-Linked Dinuclear Iridium(III) Complexes 
As has been stated previously, the bridging ligand linking the metal centres in a multinuclear 
complex is important in the modulation of both the chemical and photophysical properties of the 
final compound.84 Research into dinuclear iridium(III) complexes linked by cyclometallating bis-
N^C-coordinating 4,6-diphenylpyrimidine-based bridging ligands was described in section 3.3. 
The complexes studied were highly luminescent, displayed advantageous optical properties and 
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have enormous potential in terms of routes for structural variation. One fundamental way in which 
the structure of such bimetallic iridium(III) complexes can be altered is through variation of the 
bis-N^C-coordinating bridging ligand.  
Bridging ligands utilising pyrazine as a central heterocycle have been previously employed in the 
synthesis of multinuclear complexes. Zysman-Colman and co-workers reported the preparation 
of a cationic dinuclear iridium(III) complex in which the cyclometallated Ir(ppy)2 fragments are 
linked by 2,5-dipyridylpyrazine. This multinuclear complex shows no room temperature 
luminescence, unlike the related mononuclear complex and analogous dinuclear Ru(II) 
complexes.106, 218 In addition, previous work by Kozhevnikov et. al. used 2,5-diphenylpyrazine as 
a cyclometallating bridging ligand in the synthesis of a highly luminescent bimetallic platinum(II) 
complex.85 This complex showed room temperature phosphorescence with a quantum yield of ϕ 
= 0.41.85 In these cases, the pyrazine-based bis-bidentate bridging ligands offer a linear geometry 
with para-coordination of the two metal centres across the central pyrazine ring. Following on 
from previous reports and its favourable structural characteristics, we decided to investigate a 
derivative of 2,5-diphenylpyrazine as a bis-N^C-coordinating bridging ligand in our rigidly-
linked dinuclear iridium(III) complexes. This allowed the study of the influence of bridging ligand 
structure on the chemical and photophysical properties of the final multinuclear complex.  
Consequently, using the same synthetic method as previously described in section 3.3, a dinuclear 
iridium(III) complex was prepared incorporating the linear bridging ligand 2,5-bis(4-tert-
butylphenyl)pyrazine. The bimetallic complexes are composed of two iridium metal centres 
rigidly-linked via a bis-N^C-coordinating ligand, in this case 2,5-bis(4-tert-butylphenyl)pyrazine. 
Each iridium(III) centre is also bound to a terdentate N^C^N ligand and a monodentate chloro 
ligand. In the design of this dinuclear complex, the N^C^N-coordinating ligand 3.1.2 was 
selected. Therefore, the pyrazine-linked complex prepared here is analogous to the pyrimidine-
linked dinuclear iridium(III) complex 3.3.7, discussed in section 3.3. 
 
Firstly, the preparation of the bis-bidentate bridging ligand, 2,5-bis(4-tert-butylphenyl)pyrazine 
(3.4.1) was carried out via the Suzuki-Miyaura cross-coupling reaction of 2,5-dibromopyrazine 
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and 5-tert-butylphenylboronic acid, as shown in Figure 110. The tert-butyl substituents present 
on the final ligand increase the solubility of the final mulitmetallic complex. Using this method, 
the bis-N^C-coordinating ligand was prepared in high yield (85%).  
 
 
Figure 110: A reaction scheme to show the synthesis of compound 3.4.1 via a Suzuki-Miyaura cross-coupling reaction.  
 
The terdentate proligand 3.1.2 was synthesised as described previously in section 3.1. The fluoro- 
groups on the phenyl ring facilitate the synthesis of this ligand by ortho-directing the lithiation 
reactions involved in its preparation. Additionally, these fluoro- groups, at the 4- and 6- positions 
of the aryl ring, block the competitive bidentate binding of the iridium centre. Meanwhile, the 
hexyloxy- and tert-butyl substituents increase solubility of the proligands and the corresponding 
iridium complexes.173  
 
 
Figure 111: A figure to show the synthesis of dinuclear Ir(III) complex, 3.4.4. The target complex was isolated as a 
red solid in a good yield of 64%. 
 
The synthetic procedure used for the preparation of the target dinuclear complex, 3.4.4 is shown 
in Figure 111. The first step involves the reaction of the terdentate proligand with IrCl3.H2O at 
reflux in a mixture of 2-ethoxyethanol and water to yield the dichoro-bridged iridium(III) dimer 
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[Ir(N^C^N)Cl(μ-Cl]2 as a bright orange solid. The iridium dimer was isolated in high yield and 
fully characterised by 1H, 19F and 13C NMR spectroscopy. As stated previously, the tert-butyl and 
hexyloxy-substituents present on the terdentate ligand increase the solubility of the dichloro-
bridged iridium dimer, allowing characterisation in CDCl3.  
The iridium(III) dimer was then reacted with the bis-bidentate proligand, 3.4.1, in toluene in the 
presence of silver triflate as a chloride scavenger. At completion of the reaction, the mixture was 
treated with an excess of HCl (3M, aq.) in order to ensure that the only monodentate ligand present 
on the iridium centres was chloride. Purification was carried out via column chromatography to 
give the final dinuclear complex in a good yield of 64%.173  
As with the series of pyrimidine-linked complexes discussed in section 3.3, 3.4.4 was fully 
characterised by 1H, 19F and 13C NMR spectroscopy and mass spectrometry. The 1H NMR spectra 
of 3.4.4 (Figure 112) shows a characteristic signal at high chemical shift, δ 10.8 ppm, that 
corresponds to the two protons at the 2- and 5-positions of the pyrazine ring. This is, again, 
explained by the proximity of the electronegative chlorides to these protons. A second 
characteristic signal observed at δ 6.20 ppm can be assigned to the two protons ortho to the 
metallated carbon atoms of the bis-bidentate bridging ligand.  
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Figure 112: A figure to show the aromatic region of the 1H NMR spectrum of 3.4.4, recorded in CDCl3. Like the 
pyrimidine-linked complexes, the NMR spectrum shows characteristic features indicative of the final dinuclear 
iridium(III) complex. The singlet at δ 10.8 ppm corresponds to the two protons of the pyrazine ring and the doublet at 
δ 6.20 ppm corresponds to the two protons ortho to the metallated carbon atoms in the aryl rings of the bis-bidentate 
bridging ligand.   
 
The 1H NMR spectrum shown above was recorded in CDCl3. It was observed that the NMR 
sample of 3.4.4 degraded upon exposure to daylight, with the first signs of degradation noticeable 
after only a few minutes. This degradation of the CDCl3 sample of 3.4.4 was not observed when 
the sample was stored in the dark and additionally, no degradation of the dinuclear complex was 
observed when dissolved in d6-DMSO. Therefore, the degradation of 3.4.4 appears to occur only 
in chlorinated samples when exposed to light. In order to further study the degradation of this 
dinuclear iridium(III) complex, NMR spectra were recorded at time intervals of 0, 10, 60, 120, 
180 and 600 minutes, following exposure of the sample to sunlight. The NMR spectra obtained 
at each of these time intervals are shown in Figure 113. After just 10 minutes of exposure to 
sunlight, there is evidence in the 1H NMR spectrum for the formation of new species. Over time, 
the signals of several new species increase in intensity while the NMR signals corresponding to 
the dinuclear iridium(III) complex 3.4.4 decrease in intensity. After approximately 10-15 h, the 
sample is stable and no further degradation is observed. 
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Figure 113: A figure to illustrate the degradation of dinuclear iridium(III) complex, 3.4.4 in CDCl3 over a period of 
approximately 60 h. The NMR spectra were recorded at time intervals of 0 min, 10 min, 1 h, 2 h, 3 h, 10-15 h and 
approximately 60 h, following exposure of the NMR sample to sunlight.  
 
Following the degradation of the sample of 3.4.4 as shown in Figure 113, the final species was 
recovered and analysed by mass spectrometry. The mass spectrum obtained for the degraded 
material is shown in Figure 114. The spectrum shows intense peaks at m/z 1695.6596, 847.3734 
and 487.1942. The mass of fragment ions possible following ionisation of the initial pyrazine-
linked dinuclear iridium(III) complex were calculated, however, there were no close matches for 
the peaks observed on the mass spectrum of the degraded material.  
The fact that 3.4.4 was observed to degrade only in chlorinated solvents and only on exposure to 
light is suggestive of a photodegradation pathway, possibly involving radicals. Further 
investigation into the degradation of our pyrazine-linked dinuclear iridium(III) complex, 3.4.4, is 
required in order to fully understand the reasons for its instability. It appears that the para-
coordination of the two metal centres across the central pyrazine of the bis-bidentate bridging 
ligand incorporated has resulted in the final bimetallic complex being unstable.  
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Figure 114: The mass spectrum for the degraded material recovered from a sample of 3.4.4 that was degraded on 
exposure to light. 
 
In an attempt to increase the stability of the final dinuclear iridium(III) complex, an alternative 
bridging ligand, bis(4-tert-butylphenyl)-[1,3]thiazolo[5,4-d][1,3]thiazole, was prepared. The 
synthetic route used to prepare this bis-N^C-coordinating ligand, 3.4.5, is shown in Figure 115 as 
reported by Reginato et. al. A condensation reaction of dithiooxamide and 4-tert-
butylbenzaldehyde gave the desired compound in moderate yield of 36%.219 4-tert-
Butylbenzaldehyde was selected in order to incorporate tert-butyl substituents at the 4-positions 
of the phenyl groups of the final bis-bidentate ligand. This allows direct comparison between the 
bridging ligands 3.4.1 and 3.4.5 and an evaluation of the effects of the two central heterocyclic 
cores on the properties of the final dinuclear complexes can be carried out.  
 
 
Figure 115: A reaction scheme to show the synthesis of compound 3.4.5 via a condensation reaction of dithiooxamide 
and 4-tert-butylbenzaldehyde. The desired compound was isolated in a moderate yield (36%). 
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Thiazolo[5,4-d]thiazoles are an important class of bicyclic aromatic molecule containing two 
fused thiazole rings. The first compound containing this core structure was first discovered in 
1891 by Ephraim.220 Further research by Johnson et. al. in 1960 reported both the correct structure 
of the bicyclic core and a series of analogues.221 Many research groups have studied the synthesis 
of this class of compounds to optimise the reaction conditions and expand the range of substrates 
available.222 Reginato et. al. further investigated the synthesis, designing a microwave-assisted 
method for the preparation of symmetrically-substituted the thiazolo[5,4-d]thiazoles. Compounds 
containing the thiazolo[5,4-d]thiazoles core have been investigated as a result of their potential 
biological activity and possible inclusion in materials, for example, semiconducting polymer and 
optical devices. There have been few reports related to the coordination chemistry of these 
compounds.223, 224 Steel and co-workers investigated the utilisation of 2,5-di(2-
pyridyl)thiazolo[5,4-d]thiazole in the preparation of metal complexes of both copper and 
ruthenium.224 
Compound 3.4.5, containing a thiazolo[5,4-d]thiazole core, was selected as an appropriate 
alternative bis-bidentate bridging ligand to replace 3.4.1 as it is a coplanar molecule with a rigid, 
bicyclic core giving rise to an extended π-electron system capable of maintaining conjugation 
between the two binding sites.  
The preparation of the dinuclear iridium(III) complex 3.4.8 was carried out using the same 
synthetic route as previously described for 3.4.4 as shown in Figure 111.173 The final bimetallic 
complex was isolated in a moderate yield (55%) following purification by column 
chromatography. The identity of 3.4.8 was confirmed by 1H, 19F and 13C NMR spectroscopy and 
mass spectrometry. The aromatic region of the 1H NMR spectrum of 3.4.8 is shown in Figure 
116. The spectrum shows 6 aromatic proton environments; 3 signals corresponding to protons on 
the pyridyl rings of the terdentate N^C^N ligands and 3 signals corresponding to protons on the 
aryl rings of the bis-bidentate bridging ligand. Comparable with 3.4.4, the signal at δ 6.08 ppm 
can be assigned to the two protons ortho to the metallated carbon atoms of the aryl ring of the bis-
N^C-coordinating bridging ligand. This is a characteristic signal for our dinuclear iridium(III) 
complexes.  
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Figure 116: A figure to show the aromatic region of the 1H NMR spectrum of 3.4.8 recorded in CDCl3. The spectrum 
shows 6 aromatic proton signals; 3 signals corresponding to protons on the pyridyl rings of terdentate N^C^N ligands 
and 3 corresponding to protons on the aryl rings of the bis-bidentate bridging ligand, 3.4.5. The signal at δ 6.08 ppm is 
a characteristic signal for our dinuclear iridium(III) complexes, corresponding to the two protons ortho to the metallated 
carbon atoms of the aryl rings of the bridging ligands. 
 
The stability of the thiazolo[5,4-d]thiazole-linked bimetallic complex, 3.4.8, was investigated 
under conditions comparable to those employed in the case of 3.4.4. A solution of 3.4.8 in CDCl3 
was exposed to sunlight and 1H NMR spectra were obtained at time intervals of 0, 10, 60, 120, 
180 and 600 minutes. An additional NMR spectrum was recorded after the sample had been 
exposed to sunlight for 2 weeks. The eight 1H NMR spectra recorded to study the possible 
degradation of 3.4.8 are shown in Figure 117. This series of NMR spectra show that over the time 
period studied, there is no photodegradation of the initial sample of this dinuclear complex in 
chlorinated solvents. Therefore, varying the central heterocyclic core of the bis-N^C-coordinating 
bridging ligand from a 2,5-disubstituted pyrazine to thiazole[5,4-d]thiazole results in the 
formation of rigidly-linked dinuclear iridium(III) complex that is much more stable with respect 
to photodegradation in chlorinated solvents. Further investigation of the degradation mechanism 
of 3.4.4 may offer further insight into the reasons for the increased stability of 3.4.8. 
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Figure 117: A figure to illustrate the stability of dinuclear iridium(III) complex, 3.4.8 in CDCl3 over a period of 
approximately 60 h. The NMR spectra were recorded at time intervals of 0 min, 10 min, 1 h, 2 h, 3 h and approximately 
10 h, following exposure of the NMR sample to sunlight. An additional NMR spectrum was recorded after the sample 
had been exposed to sunlight for 2 weeks. The CDCl3 sample of 3.4.8 shows no degradation over this time period.  
 
The photophysical properties of both 3.4.4 and 3.4.8 were measured in order to further investigate 
the effects of the bridging heterocyclic system on the optical properties. 
The UV-visible absorption spectra of 3.4.4 and 3.4.8, measured in dichloromethane solution at 
room temperature are shown in Figure 118 with the absorption maxima and molar extinction 
coefficients being tabulated in Table 7. The UV-visible absorption data for the bis-bidentate 
bridging ligands are also included. The absorption spectra of both complexes display intense 
bands in the UV region of the spectrum (< 400 nm) (ε ≈ 30-55 x 103 M-1 cm-1) and relatively 
intense bands in the visible region (> 400 nm) (ε ≈ 6-30 x 103 M-1 cm-1). The pyrazine-linked 
complex, 3.4.4, has a similar absorption profile to that observed for the related pyrimidine-linked 
dinuclear iridium(III) complex, 3.3.7 (section 3.3). The molar extinction coefficients for 3.4.4 are 
also similar to those of the analogous pyrimidine-linked complex. For the thizolo[5,4-d]thiazole-
linked complex, 3.4.8, the spectral profile above ≈ 450 nm is very different to that of 3.4.4, with 
two peaks appearing exhibiting molar extinction coefficients much higher than for 3.4.4.  
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Figure 118: UV-visible absorption spectra recorded for the dinuclear iridium(III) complexes, 3.4.4 (red) and 3.4.8 
(blue), in CH2Cl2 at room temperature. 
 
Table 7: UV-visible absorption data for the dinuclear Ir(III) complexes, 3.4.4 and 3.4.8, in CH2Cl2 at room 
temperature. 
Complex(a) λmax / nm (ε / M-1 cm-1) 
3.4.1 278 (50000), 291 sh (45000), 335 (31000) 
3.4.5 276 (240000), 354 sh (40000), 366 (43000), 382 sh (27000) 
3.4.4 281 (53000), 316 sh (28000), 359 (33000), 376 (33000), 400 
(31000), 449 (14000), 475 sh (10000), 501 sh (7500), 530 (5900) 
3.4.8 279 (49000), 349 (31000), 372 sh (23000), 410 (32000), 448 sh 
(18000), 482 (22000) 
 
As is shown in the absorption spectra, the lowest energy absorption bands become more blue-
shifted on going from 3.4.4 to 3.4.8. Varying the central heterocycle of the bis-N^C bridging 
ligand from 2,5-substituted pyrazine to thiazole[5,4-d]thiazole results in a substantial shift of the 
lowest-energy absorption bands of 1900 cm-1. The higher energy part of the absorption spectrum 
is largely unaffected upon changing the bridging ligand.  
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Figure 119: Excitation and emission spectra recorded for 3.4.4 and 3.4.8 in deoxygenated CH2Cl2 at room temperature. 
Emission maxima are observed at 600 and 655 nm for 3.4.4 and at 628 and 686 nm for 3.4.8.  
 
The excitation and emission spectra of 3.4.4 and 3.4.8 were recorded in deoxygenated CH2Cl2 
solutions at room temperature and are shown in Figure 119. The excitation spectra recorded for 
the dinuclear iridium(III) complexes closely resemble the absorption spectra shown in Figure 118. 
The emission maximum for 3.4.4 is observed at 600 nm with a shoulder at lower energy (655 
nm). For 3.4.8, the emission is red-shifted relative to 3.4.4 with maxima observed at 628 and 686 
nm. The tail of the emission spectrum of 3.4.8 extends into the NIR region with the detection of 
this emission being limited by the instrument used. Further investigation of the photophysical 
properties of these dinuclear complexes is required in order to assess the luminescence quantum 
yields and lifetimes.  
 
In summary, we have shown that on variation of the central heterocycle of the bis-bidentate 
bridging ligand to a 2,5-substituted pyrazine ring, the final dinuclear iridium(III) complex is 
unstable in chlorinated solvents upon exposure to daylight. More investigation is required in order 
to understand the origin of the reduced stability and the mechanism of degradation. As a result of 
the observed degradation, an alternative dinuclear iridium(III) complex was prepared, 
incorporating a bis-bidentate bridging ligand with a thaizolo[5,4]thiazole core. Using this bis-
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bidentate bridging ligand, a more stable dinuclear complex was isolated. The photophysical 
properties of both the 2,5-substituted pyrazine and the thaizolo[5,4]thiazole based di-iridium(III) 
complexes were investigated with emission observed in the orange and red regions of the 
spectrum respectively.  
 
3.5 2,3-Pyrazine-Linked Dinuclear Iridium(III) Complexes 
The research into rigidly-linked iridium(III) complexes discussed so far in this work has provided 
further evidence for the importance of the bridging ligand and the extent of its influence on the 
chemical and photophysical properties on the final multinuclear complex. The rigid, bis-bidentate 
bridging ligands incorporated in the bimetallic iridium(III) complexes described so far have been 
based on 4,6-disubstituted pyrimidines and 2,5-disubstituted pyrazines. Variation of the central 
heterocycle to a 2,3-disubstituted pyrazine ring was also investigated in order to study the effect 
this would have on the properties of the corresponding dinuclear iridium(III) complex.  
Bridging ligands incorporating 2,3-disubstituted pyrazines, such as 2,3-dipyridylpyrazine (2,3-
dpp) have previously been utilised in the synthesis of rigid multinuclear complexes of transition 
metals such as Ru(II), Os(II) and Pt(II), amongst others.82, 191, 218, 225-227 The mono-, di-, tri- and 
tetranuclear ruthenium(II) complexes of the bridging ligand 2,3-dpp, reported by Denti et. al. all 
displayed luminescence, both in fluid solution at room temperature and in a rigid matrix at 77 K, 
with quantum yields in the range ϕ = 0.041 to ϕ = 0.001 and luminescence lifetimes ranging from 
60 to 620 μs in degassed solutions at room temperature.218 In 1990, the cyclometallating analogue 
of 2,3-dpp, 2,3-diphenylpyrazine, was utilised by Steel and co-workers in the synthesis of a di-
palladium complex. Structural analysis using the X-ray crystal structure was carried out but the 
photophysical properties of this complex were not investigated.178 In addition, previous work by 
Kozhevnikov et. al. used 2,3-diphenylpyrazine as a cyclometallating bridging ligand in the 
synthesis of a highly luminescent bimetallic platinum(II) complex. The optical properties of this 
di-platinum(II) complex were studied and the phosphorescence quantum yield was recorded to be 
ϕ = 0.37 in degassed solution at room temperature.85  
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In this section, the investigation of the bis-N^C-coordinating ligand, 2,3-diphenylpyrazine, as a 
bridging ligand in a rigid, dinuclear iridium(III) complex is described. The incorporation of 2,3-
diphenylpyrazine in our bimetallic iridium(III) complexes facilitated further study of the effects 
of the bridging ligand on the properties of the final multinuclear complex.  
Following on from the dinuclear iridium(III) complexes discussed in earlier sections of this work 
(3.3 and 3.4), a tert-butyl-substituted derivative of 2,3-diphenylpyrazine, 2,3-bis(4-tert-
butylphenyl)pyrazine, was selected to link the iridium(III) centres in our multinuclear complex. 
The use of this bis-bidentate bridging ligand, bearing identical substituents to those of 3.3.6 and 
3.4.1, allows direct comparison between the corresponding dinuclear complexes and evaluation 
of the effects of the central heterocycle of the bridging ligand.   
Firstly, the bis-bidentate ligand, 2,3-bis(4-tert-butylphenyl)pyrazine, was synthesised from the 
commercially available 4-tert-butylbenzaldehyde. As shown in Figure 120, this is converted into 
the diketone, bis(4-tert-butylphenyl)ethane-1,2-dione, before undergoing a condensation reaction 
with ethylene diamine. Using this method, the desired bis-N^C-coordinating ligand was isolated 
in moderate yield (35%).  
 
 
Figure 120: A reaction scheme to show the synthesis of the bis-N^C-coordinating ligand 2,3-bis(4-tert-
butylphenyl)pyrazine. 
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To prepare the dinuclear iridium(III) complex, the same synthetic procedure was used as that 
described previously in sections 3.3 and 3.4 and is as shown in Figure 121.173 For this complex, 
the N^C^N-coordinating compound, 3.1.5, was selected as the auxiliary ligand. This terdentate 
ligand bears a single tert-butyl substituent at the 5-position of the central phenyl ring. This 
substituent acts to block the competitive bidentate binding of the iridium(III) ion with the 
terdentate ligand whilst also increasing the solubility of the target dinuclear complex. Following 
the reaction of the terdentate ligand with IrCl3.H2O, the resulting iridium dichloro-bridged dimer, 
3.2.4 was reacted with the bis-N^C-coordinating ligand 3.5.4. This reaction was carried out in 
refluxing toluene and in the presence of silver triflate as a chloride scavenger. The final dinuclear 
complex, 3.5.5, was isolated in a low yield (11%) following purification by column 
chromatography.  
 
 
Figure 121: Reaction scheme to illustrate the synthesis of 3.5.5, in which the two iridium(III) centres are linked by the 
bis-N^C-coordinating bridging ligand 2,3-bis(4-tert-butylphenyl)pyrazine. 
 
The dinuclear iridium(III) complex linked by 2,3-bis(4-tert-butylphenyl)pyrazine was fully 
characterised by 1H and 13C NMR spectroscopy and mass spectrometry. Figure 122 shows the 
aromatic region of the 1H NMR spectrum of 3.5.5 recorded in d6-DMSO at room temperature.  
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Figure 122: The aromatic region of the 1H NMR spectrum of 3.5.5 recorded in d6-DMSO. This NMR spectrum shows 
the same characteristic signals as expected for our dinuclear iridium(III) complexes; the singlet at δ 9.92 ppm 
corresponding to the two protons on the 2,3-substituted pyrazine ring and the peak at δ 5.87 ppm corresponding to the 
two protons ortho to the metallated carbon atoms of the bridging ligand. The NMR spectrum of this dinuclear 
iridium(III) complex linked by 2,3-bis(4-tert-butylphenyl)pyrazine also shows evidence of twisting within structure of 
the bimetallic complex.  
 
This 1H NMR spectrum shows the same characteristic signals as discussed previously this type of 
di-iridium(III) complex. The singlet at δ 9.92 ppm corresponds to the two protons on the 2,3-
disubstituted pyrazine ring and the peak at δ 5.87 ppm corresponds to the two protons ortho to 
the metallated carbons of the bis-bidentate bridging ligand. The NMR spectrum of 3.5.5 also 
exhibits evidence of twisting in the structure of the dinuclear complex, about the bis-bidentate 
bridging ligand. This is shown by the presence of two sets of signals corresponding to the 
terdentate N^C^N auxiliary ligands. 
Twisting about the bridging ligand 2,3-diphenylpyrazine was also observed in the dipalladium(II) 
complex reported by Steel et. al. The X-ray crystal structure of this complex and a representation 
of the twist observed is shown in Figure 123. With two Pd(II) centres bound to the 2,3-
diphenylpyrazine bridging ligand, both metallated phenyl rings are constrained to be 
approximately coplanar with the pyrazine ring. This leads to a large steric interaction between the 
two protons on carbons C16A and C16B (Figure 123) and as a result the metallated phenyl rings 
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of the bis-N^C-coordinating bridging ligand twist in an attempt to relieve the steric strain. In the 
dinuclear palladium(II) complex shown in Figure 123, the twisting results in an angle of 19.6(5) 
° between the planes of the two metallated phenyl ring and a C11A-C1A-C1B-C11B torsion angle 
of 18.0(1) °.178  
 
 
Figure 123: A figure to show the X-ray crystal structure of the 2,3-diphenylpyrazine-linked dinuclear palladium(II) 
complex reported by Steel and co-workers. Also shown is the view of this complex with the two cyclometallated rings 
twisted. In this view, the acac ligands have been omitted for clarity.178 
 
The twist of the 2,3-bis(4-tert-butylphenyl)pyrazine bridging ligand results in the final dinuclear 
iridium(III) complex being a chiral molecule and therefore, leads to the formation of this complex 
in a racemic mixture of two enantiomers. In order to further investigate the properties of these 
enantiomers and attempt separation, a sample of 3.5.5 was sent to Durham University for analysis 
by chiral HPLC in the group of Professor J. A. Gareth Williams and the results will be described 
in due course.  
In addition, properties of the twist in our dinuclear iridium(III) complex 3.5.5 were studied by a 
variable temperature NMR experiment, as previously carried out for octahedral platinum(IV) 
complexes.228 The 1H NMR spectrum of 3.5.5 was recorded at intervals of 5 °C across a 
temperature range of 25-90 °C. As is shown in Figure 124, at 25 °C the 1H NMR of 3.5.5 shows 
two sets of signals corresponding to the terdentate N^C^N ligands as a result of the twist in the 
structure. As the temperature is increased, the NMR signals corresponding to the N^C^N-
coordinating ligands coalesce. Coalescence of these signals occurs at approximately 50 °C whilst 
the NMR signals assigned to the bis-N^C bridging ligand remain well-resolved. Increasing the 
temperature further, to 80 °C, leads to the formation of well-resolved proton signals which 
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correspond to the terdentate N^C^N ligands. The NMR spectrum of 3.5.5 was measured up to 
100 °C with the new signals remaining stable at this temperature.  
 
 
Figure 124: A figure show the change in the 1H NMR spectrum of 3.5.5 with varying temperature in the range of 25 
°C to 90 °C. The NMR spectrum was recorded at temperature intervals of 5 °C. 
 
To investigate the effect that the linking of the two metallated phenyl rings of the bis-N^C-
coordinating bridging ligand has on the twist observed within our 2,3-pyrazine-linked complex, 
we prepared a dinuclear iridium(III) complex in which the two metal centres are linked via the 
bis-bidentate bridging ligand, 3.5.6, shown in Figure 125. The use of this bridging ligand, 1,4-
diazatriphenylene, was previously used in the preparation of dipalladium(II) complexes by Steel 
and co-workers.178 
 
The preparation of the bis-N^C-coordinating bridging ligand 3.5.6 was carried out using a 
condensation reaction under the same conditions as that used in the synthesis of 3.5.4. The 
commercially available diketone, 9,10-phenanthrenequinone, was reacted with ethylene diamine 
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in refluxing ethanol. The desired compound was isolated in moderate yield (36%) without the 
need for oxidation using sulfur powder. The reaction scheme for this synthesis is shown in Figure 
125.  
 
 
Figure 125: A reaction scheme to show the preparation of compound via the condensation reaction of 9,10-
phenanthrenequione and ethylene diamine. The target compound was isolated as an off-white solid in a moderate yield 
of 36%. 
 
Of the 2,3-substituted pyrazine bridging ligands prepared in this work, compound 3.5.6 is the only 
one not to bear a tert-butyl substituent. The preparation of the analogous tert-butyl-substituted 
ligand was attempted via oxidative aryl-aryl coupling reactions of bis(4-tert-butylphenyl)ethane-
1,2-dione and 2,3-bis(4-tert-butylphenyl)pyrazine, using VOF3 in the presence of boron 
trifluororide diethyl ether, as shown in Figure 126. These reactions were unsuccessful and did not 
yield the desired product. 
 
 
Figure 126: Reaction schemes to show the synthetic routes attempted to prepare a 1,4-diazatriphenylene-based bis-
bidentate ligand bearing tert-butyl groups at the 4-positions of the phenyl rings. 
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The bis-N^C-coordinating bridging ligand, 3.5.6, was utilised in the preparation of a dinuclear 
iridium(III) complex as shown in Figure 127. Using the same synthetic procedure as used in the 
preparation of 3.5.5, the diiridium(III) complex 3.5.10 was synthesised. The target complex was 
isolated in a low yield (17%) following purification via column chromatography.  
 
 
Figure 127: Figure to show the synthetic route used in the synthesis of the dinuclear iridium(III) complex, 3.5.10. 
 
The final dinuclear iridium(III) complex, 3.5.10, was fully characterised by 1H and 13C NMR 
spectroscopy and mass spectrometry. Figure 128 shows the aromatic region of the 1H NMR 
spectrum of 3.5.10 recorded in CDCl3. This spectrum shows the same characteristic peaks as 
discussed for the 1H NMR spectra of dinuclear iridium(III) complexes previously shown in this 
work. The singlet at δ 10.5 ppm corresponds to the two protons on the 2,3-substituted pyrazine 
ring and the doublet at δ 6.25 ppm corresponds to the two protons ortho to the metallated carbon 
atoms of the bridging ligand. In comparison with the proton spectrum of 3.5.5, the 1H NMR 
spectrum of 3.5.10 shows only one set of signals for both the terdentate N^C^N-coordinating 
ligand and the bis-N^C-coordinating bridging ligand. Therefore, this proton NMR shows no 
evidence of twisting within the structure of 3.5.10.  
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Figure 128: The aromatic region of the 1H NMR spectrum of dinuclear iridium(III) complex, 3.5.10 recorded in CDCl3. 
This NMR spectrum shows characteristic signals of a dinuclear iridium(III) complexes. The singlet at δ 10.5 ppm 
corresponds to the two protons on the 2,3-substituted pyrazine ring and the doublet at δ 6.25 ppm corresponds to the 
two protons ortho to the metallated carbon atoms of the bridging ligand. The NMR spectrum of this dinuclear 
iridium(III) complex linked by 1,4-diazatriphenylene shows no evidence for twisting of the bridging ligand.  
 
In summary, dinuclear iridium(III) complexes linked via 2,3-pyrazine-based bis-bidentate 
bridging ligands have been successfully prepared and were observed to show better photostability 
than the related 2,5-isomers. The complex 3.5.5 has twisted geometry at room temperature and 
this has the potential for the preparation of an optically pure complex. However, the energy barrier 
for the twisted geometry can be overcome thermally. On linking the two phenyl rings of the 2,3-
substituted pyrazine ring, the bis-bidentate bridging ligand forces a planar geometry and the twist 
is no longer observed. Further study of these complexes is required in order to investigate the 
photophysical properties of these 2,3-pyrazine-linked dinuclear iridium(III) complexes.  
 
3.6 3,6-Pyridazine-Linked Dinuclear Iridium(III) Complexes 
The final class of rigid bis-N^C-coordinating ligand investigated for incorporation into our 
dinuclear iridium(III) complexes was those in which the central heterocycle was a pyridazine ring. 
Pyridazines have previously been incorporated into cyclometallating ligands utilised in the 
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preparation of both monometallic and bimetallic iridium(III) complexes.83, 130, 229-231 Rourke et. al. 
reported the preparation of dinuclear homometallic complexes of palladium(II) and platinum(II) 
in which the two metal centres were linked via a 3,6-bis[4-(alkoxy)phenyl]pyridazine bridging 
ligand. In the reaction between the pyridazine-based bridging ligand and potassium 
tetrachloroplatinate, the bimetallic complex was the only product formed. Analysis of the 
dimetallated species formed using 1H NMR data, mass spectrometry and elemental analysis 
showed that the complex was composed of two platinums, three chlorides and one potassium 
atom per pyridazine unit. Further reaction of this cycloplatinated species with triphenylphosphine 
gives the final diplatinum(II) complex, as shown in Figure 129. Both these dinuclear complexes 
contain a chloride bridge between the two platinum(II) centres. Rourke and co-workers suggested 
that the formation of this chloride bridge, in conjunction with the nitrogen coordination, is the 
driving force of the second cyclometallation.176, 177  
 
 
Figure 129: A reaction scheme to show the diplatinum(II) complex reported by Rourke et. al. in which the two metal 
centres are linked by both a bis-N^C-coordinating bridging ligand based on a 3,6-disubstituted pyridazine ring and a 
chloride bridge.  
 
It was observed, from preliminary work within our research group, that the use of a bis-N^C-
coordinating bridging ligand based on a 3,6-disubstituted pyridazine ring to link two iridium(III) 
centres resulted in the formation of a chloride bridge between the Ir(III) centres. This is consistent 
with that observed by Rourke et. al. as mentioned above. The sharing of a chloride by the two 
metal centres results in the final dinuclear complex being cationic. The ionic nature of the final 
complex leads to increased solubility in water which is advantageous for applications such as bio-
imaging.  
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In comparison with traditional bio-imaging and photodynamic therapy (PDT) agents, transition 
metal complexes combine longer emission lifetimes and higher photostabilities with the relative 
ease of chemical modification.232 During imaging, longer emission lifetimes permit the use of 
time-gating to reduce auto-fluorescence and can be utilised to detect biologically relevant 
analytes, for example, O2 in vitro and in vivo.232-234 For PDT applications, long emission lifetimes 
lead to high yields of 1O2 and other reactive oxygen species, and thus efficient photo-induced cell 
death. Increased photostability favours longer term tracking during bioimaging and increases 
photosensitising activity of an agent during PDT.146, 235 
In the field of transition metal complexes for use in bioimaging, ruthenium, rhenium and platinum 
complexes dominated the early literature. However, in the last decade iridium complexes with 
higher quantum yields and localisations to a wide variety of sub-cellular organelles have seen a 
surge in popularity.109, 145, 147, 151, 236, 237 In PDT, ruthenium(II) complexes have dominated the field 
of transition metal photosensitisers with one Ru(II) complex having entered clinical trials in 
Canada.238-244 In comparison, iridium complexes are yet to be fully explored with regard to PDT 
applications. Importantly, a few iridium(III) complexes have been recently shown to have 
phototoxicities with low light doses under both one- and two-photon excitation, suggesting that 
Ir(III) complexes hold future potential for PDT.245-256  
 
As has been shown in the previous sections of this work, bimetallic complexes of transition metals 
such as Pt(II) and Ir(III) offer several advantages over monometallic analogues. These beneficial 
properties include red-shifted absorption and emission which would minimise the observed 
background autoluminescence. In addition, the increased molar extinction coefficient of the low-
energy bands and high quantum yields leads to the high brightness of these complexes, making 
them good imaging agents. The red-shift is also advantageous for PDT as it allows a metal 
complex to be excited by and emit at wavelengths of light longer than those required for good 
tissue penetration (> 650 nm).  
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Dinuclear iridium(III) complexes formed from ditopic bis-N^C ligands in conjunction with 
symmetrically substituted terminal N^C^N ligands, as discussed in this chapter, show the highest 
quantum yields and are facile to synthesise with only one dinuclear product formed. The 
bimetallic Ir(III) complexes discussed so far in this work have all been designed for application 
in organic light-emitting diodes, however, there is huge potential for their utilisation in alternative 
applications such as bioimaging.  
 
Motivated by the potential for the utilisation of iridium(III) complexes in bioimaging and PDT 
applications, the advantages that our dinuclear iridium(III) complexes offer and drawing from 
reports of pyridazine-linked multinuclear complexes published by Rourke and co-workers, we 
designed a dinuclear iridium(III) complex in which the two metal centres were linked via a rigid 
bis-N^C-coordinating bridging ligand based on 3,6-diphenylpyridazine. 
 
In the preparation of our pyridazine-linked dinuclear iridium(III) complex, the first step was 
synthesis the bis-N^C-coordinating bridging ligand. Figure 130 shows the synthetic route utilised 
in the synthesis of the pyridazine-based bridging ligand, 3.6.5. Using Suzuki-Miyaura cross-
coupling methodology, 3,6-dichloropyridazine and 4-tert-butylphenylboronic acid were reacted 
together in 1,4-dioxane in the presence of 2M aqueous potassium carbonate and the palladium 
catalyst, Pd(PPh3)4. A similar synthetic route for the preparation of (3.6.5) was reported by Wang 
and co-workers.257 The desired bis-bidentate bridging ligand was isolated in good yield (62%) 
following recrystallisation from dimethylformamide (DMF). Again, tert-butyl substituents were 
incorporated at the 4-postion of the phenyl rings of 3.6.5 in order to increase the solubility of the 
corresponding dinuclear complex. Addition of these tert-butyl groups also allows direct 
comparison of the dinuclear iridium(III) complexes of bis-N^C-coordinating bridging ligands, 
3.3.6, 3.4.1 and 3.5.4.  
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Figure 130: A reaction scheme to show the synthesis of compound 3.6.5 via a Suzuki-Miyaura cross-coupling reaction.  
 
Preparation of the corresponding dinuclear iridium(III) complex of 3.6.5 was carried out using 
the synthetic procedure shown in Figure 131 and adapted from that previously shown in earlier 
sections of this chapter.  
 
 
Figure 131: Reaction scheme to show the synthesis of the cationic dinuclear iridium(III) complex, 3.6.8, in which the 
two Ir(III) centres are linked via the bis-bidentate bridging ligand 3,6-(bis(4-tert-butylphenyl)pyridazine. 
 
Firstly, the terdentate N^C^N- coordinating ligand, 3.1.5 was reacted with IrCl3·H2O at reflux in 
a mixture of 2-ethoxyethanol and water to give the dichloro-bridged iridium(III) dimer, 3.2.4. 
This dimer was then reacted with the bis-N^C-coordinating proligand, 3.6.5, in toluene, using 
silver triflate as a chloride scavenger. At completion of the reaction, the mixture was treated with 
excess HCl (3M, aq.) in order to ensure that chloride was the only monodentate ligand present. 
Following this, a PF6- exchange was carried out using a saturated solution of KPF6(aq). 
Purification was carried out using column chromatography to give the target dinuclear complex 
in 38% yield. 
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The dinuclear complex 3.6.8 was fully characterised by 1H and 13C NMR spectroscopy and high-
resolution mass spectrometry. The aromatic region of the 1H NMR spectrum is shown below in 
Figure 132. As with the dinuclear iridium(III) complexes previously discussed, this NMR 
spectrum shows characteristic signals of the target complex. The singlet at δ 8.72 ppm 
corresponds to the two protons on the pyridazine ring and the doublet at δ 6.00 ppm corresponds 
to the two protons ortho to the metallated carbon atoms of the bis-bidentate bridging ligand.  
 
 
Figure 132: The aromatic region of the 1H NMR spectrum of 3.6.8 recorded in CDCl3. This NMR spectrum shows the 
same characteristic signals as expected for our dinuclear iridium(III) complexes; the singlet at δ 8.72 ppm 
corresponding to the two protons on the 3,6-substituted pyridazine ring and the peak at δ 6.00 ppm corresponding to 
the two protons ortho to the metallated carbon atoms of the bridging ligand.  
 
As observed by Rourke et. al., we observe the presence of a chloride bridge between the two 
iridium(III) centres in 3.6.8. This is also consistent with preliminary work carried out within our 
research group. It is thought that the close proximity of the Ir atoms, following coordination to 
the pyridazine ring, causes the Cl atom to act as a bridging ligand. As a result, five-membered 
chelate rings form, providing the driving force for the reaction and leading to a rigid architecture. 
As a consequence of the chloride bridge, the final product is ionic in nature, bearing a PF6- 
4
1 
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counterion. To confirm the presence of the chloride bridge in 3.6.8, a 19F NMR spectrum was 
obtained. This NMR spectrum showed a peak at δ -71.8 ppm corresponding to the PF6- counterion 
to 3.6.8. High-resolution mass spectrometry was utilised to confirm the identity of the cation. The 
spectrum obtained is shown in Figure 133. The peak observed at m/z 1337.4144 corresponds to 
the molecular ion [M]+ (calc’d m/z 1337.4129) and the peak at m/z 823.3359 corresponds to [M-
(Ir(NCN))-Cl]+ (calc’d m/z 823.0780). The observed data experimentally matches closely with 
the theoretical data and confirms the identity of the 3.6.8 as shown in Figure 131. 
 
 
Figure 133: High resolution mass spectrum obtained for 3.6.8, showing a peak for the molecular ion [M]+ at m/z 
1337.4144 (calc’d m/z 1337.4129) and a peak for [M-(Ir(NCN))-Cl]+ at m/z 823.3359 (calc’d m/z 823.0780). 
 
The photophysical properties of the pyridazine-linked dinuclear iridium(III) complex, 3.6.8 were 
investigated and the UV-visible absorption and emission spectra recorded at the University of 
Sheffield. Figure 134 shows the absorption and emission spectra recorded with the related data 
tabulated in Table 8. In acetonitrile solution, 3.6.8 shows broad UV excitation with appreciable 
absorption up to ~500 nm. Upon excitation (λex = 400 nm) 3.6.8 shows broad emission (λem = 
~520 – 720 nm). A luminescence lifetime of 1.892 μs was measured in degassed acetonitrile. A 
quantum yield of ϕ = 0.5 ± 0.11 was measured for the complex in degassed acetonitrile solution. 
The quantum yield measured in aerated acetonitrile solution is far lower in comparison (ϕ = 0.05) 
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indicating significant quenching. The singlet oxygen yield, ΦΔ, was determined to be 45% when 
measured in direct detection with UV excitation (λex = 355 nm). The singlet oxygen yield clearly 
shows the potential for this class of compounds to be utilised as therapeutic agents as shown in 
Figure 135. 
 
 
Figure 134: Normalised UV-visible absorption and emission spectra of 3.6.8 measured in both acetonitrile and H2O 
solution at ambient temperature in air-equilibrated solvent. 
 
Table 8: Summary of the photophysical data recorded for 3.6.8. (a) Acetonitrile (b) λex = 400 nm (c) τ0 = degassed 
acetonitrile, τ1 = acetonitrile, τ2 = water from DMSO stock (d) Φ0 = degassed, Φ1 = aerated [Ru(Bipy)3]PF6 standard 
(e) λex = 355 nm, perinapthenone standard.  
Complex λmax abs. / nm (ε / dm3 
mol−1 cm−1)(a) 
λmax em. / nm (ε / 
dm3 mol−1 cm−1)(a, b) 
τ0, τ1, τ2 / 
ns(a, c) 
Φ0, Φ1 / 
%(a, b, d) 
ΦΔ / %(a, e) 
3.6.8 235 (79,900) 284 (54,700) 
397 (24,200) 
576 1890, 226, 
561/103 
52, 5 45 
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Figure 135: Multiphoton images of 3.6.8 in U2OS cells, 20 μM, 5 hours, emission (left), brightfield (right) and overlay 
(centre). Excitation at 800 nm and emission at 565-615 nm (green LUT chosen for clarity). Scale bars = 20 μm. 
 
The cellular uptake and toxicity of 3.6.8 was then investigated. The pyridazine-linked dinuclear 
complex is moderately soluble in water, however, DMSO was used to assist with solubility. Using 
multiphoton excitation microscopy (λex = 800 nm), 3.6.8 was observed to enter cells and localise 
in the cyctoplasm with distinct punctate staining. This is consistent with previously reported 
cationic metal complexes which are known to locate in mitochondrial and lysosomal or 
endosomal structures.252 Co-localisation of 3.6.8 with mitochondria was confirmed using 
organelle-specific stains and confocal microscopy (λex = 405 nm) as shown in Figure 136, giving 
a Pearson’s correlation coefficient of R = 0.76 (averaged over 15 cells) for Mitotracker red. Co-
localisation of 3.6.8 with Lysotracker red was not observed (Figure 136) indicating that the 
punctate staining may result from other endosomal structures (Pearson’s correlation coefficient 
of R = 0.53 with Lysotracker red (averaged over 15 cells).  
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Figure 136: Sub-cellular localisation of 3.6.8. HeLa cells following a 5 hour incubation with 3.6.8 (green), colocalised 
with (A) Mitotracker red (red) or (B) Lysotracker red (red). Zoomed sections (x9) are shown as insets. Scale bars = 20 
μm.  
 
Following a short incubation time of 5 hours, 3.6.8 induced a significant dose-dependent 
reduction in metabolic activity/cell viability in both U2OS and HeLa cancer cell lines as indicated 
by MTT assay. The toxicity of the associated ligands was also measured. The terdentate N^C^N-
coordinating ligand, 3.1.5, did not reduce cell viability whilst the bis-N^C-coordinating bridging 
ligand, 3.6.5, induced a similar reduction in metabolic activity as 3.6.8 (Figure 137).  
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Figure 137: 3.6.8 and 3.6.5 induce a significant reduction in cell viability. Cell viability as measured by MTT assay 
after a 5 hour incubation with A. 3.6.8 and B. Ligands as indicated. Mean and SEM of 4 independent repeats is shown. 
Significance calculated by Student’s T-test compared to respective untreated control is indicated, where * = p < 0.05 
and ** = p < 0.01.  
 
The MTT assay measures the metabolic activity of a cell, and therefore can be considered a read 
out of cell viability. Despite this it is not a measure of long term survival. A clonogenic survival 
assay was used in order to get a more accurate assessment of the cellular toxicity. In this assay, 
the cells were plated in a low density prior to a 5 hour incubation with 3.6.8 or the corresponding 
ligands. Subsequently the cells were left to recover and form colonies for 10 days. In this more 
reliable assay of cell toxicity, 3.6.8 showed significant toxicity (LD50 = 4.46 μM) while the 
associated ligand induced only a slight toxicity at the highest doses tested (LD50 > 20 μM) (Figure 
138).  
 
 
Figure 138: 3.6.8 reduces cell survival to a significantly greater degree than each ligand alone. Long term survival (10 
days) as measured by clonogenic survival assay after a 5 hour incubation with 3.6.8 as indicated. Mean and SD of 2 
independent repeats (each conducted in duplicate is shown). Significance calculated by Student’s T-test compared to 
respective untreated control is indicated, where * = p < 0.05, ** = p < 0.01 and *** = p < 0.001.  
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Taken together, the MTT and clonogenic survival data reveal that although both 3.6.8 and 3.6.5 
can reduce the metabolic activity of cells in the short term, 3.6.8 is significantly more toxic to 
cells than either of the ligands alone. This work also highlights the importance of assessing 
toxicity over a clinically-relevant period of time when considering the therapeutic use of any 
novel agent.  
 
In this study, 3.6.8 was also investigated for suitability for use as a contrast agent in transmission 
electron microscopy (TEM). Cells were both incubated in the presence or absence of a 20 μM 
solution of 3.6.8 for 4 h. Following this, cells were processed for TEM imaging with or without 
standard contrasting agents as shown in Figure 139. Enhanced contrast was observed using 3.6.8 
in comparison to unstained cells. Additionally, the dinuclear complex 3.6.8 did not interfere with 
the standard double contrast agents (uranyl acetate and lead citrate).   
 
 
Figure 139: A figure to show transmission electron microscopy (TEM) images using 3.6.8 as a contrast agent. Cells 
were incubated with or without at 20 μM solution of 3.6.8 for 4 h. (A) Example images of staining with only 3.6.8. (B) 
Example image of unstained cells, those stained with standard double contrast agents (uranyl acetate and lead citrate) 
and those stained with 3.6.8 in addition to standard agents. Scale bars = 1 μm. 
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In this section of this work, we have demonstrated that a novel pyridazine-bridged cationic 
dinuclear iridium(III) complex can enter cells, has favourable photophysics and shows 
appreciable singlet oxygen yield. However, due to the high cytotoxicity, this complex is likely 
unsuitable for PDT applications. Instead, the toxicity of the complex could be exploited in other 
applications where its intrinsic toxicity could be beneficial, such as in the development of new 
anticancer agents.  
The photophysical properties of the complex are of interest for luminescent bio-imaging and the 
presence of two heavy atoms allows its use as a contrast reagent. Potentially the structure of the 
complex can be varied through modification of both bridging and auxiliary ligands as well as 
incorporating alternative metals.  
Encouraged by these first results, more examples of such systems should be prepared in order to 
fine-tune the properties and reduce toxicity. 
 
3.7 Variation of Monodentate Ligand  
The work discussed in the previous sections of this chapter has showed that dinuclear iridium(III) 
complexes in which the metal centres are rigidly-linked via bis-N^C-coordinating bridging 
ligands are highly luminescent and exhibit advantageous structural and photophysical properties 
when compared with their monometallic counterparts.  
The structure of the dinuclear iridium(III) complexes studied as part of this work offers multiple 
routes for modulation of the photophysical and structural properties of the complexes. In the 
previous sections of this chapter, we have discussed the effect of varying both the terdentate 
N^C^N ligand and the ditopic bridging ligand. The results obtained show that variation in the 
nature of the substituents on the ligands or the core structure of the ligand (for example, the central 
heterocycle of the bridging ligand) have a large effect on the properties of the final multinuclear 
complex.  
In addition to the cyclometallating terdentate N^C^N ligand and the N^C-coordinating bridging 
ligand, each iridium(III) centre is also bound to a monodentate ligand. The synthetic procedure 
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followed in the preparation of the dinuclear iridium(III) complexes discussed so far in this chapter 
ensures, through addition of excess 2M HCl (aq.) during the work-up, that the monodentate 
ligands are exclusively chloride. The variation of this monodentate ligand may offer additional 
opportunities to tune the properties of our target bimetallic Ir(III) complexes.  
 
In the literature, alternative monodentate ligands are routinely used in cyclometallated complexes 
of Pt(II) and Ir(III). These ligands are incorporated through metathesis reactions of the analogous 
chloro complex.  
In 2009, Che et. al. utilised cyclometallated aryl acetylides bearing different R groups as shown 
in Figure 140. It was observed that the nature of the R group on the monodentate aryl acetylide 
ligand had a significant effect on the properties of the resulting complexes through altering the 
extent of Pt-Pt interactions between the mononuclear complexes.258  
 
 
Figure 140: A figure to show the series of cyclometallated Pt(II) complexes prepared by Che et. al. in which 
cyclometallating aryl acetylides, bearing different R groups, were utilised as the monodentate ligands.258  
 
In 2010, Li and co-workers demonstrated that the monodentate chloride ligand of Pt(N^C^N)X 
complexes could be displaced by an anionic phenoxide ligand. Through investigation of the 
photophysical properties of both the chloride and phenoxide complexes, it was concluded that the 
monodentate ligand has a large effect on the photophysical properties of the final Pt(N^C^N)X 
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complexes through Pt-X interactions. This occurs despite the excited state being localised on the 
Pt(N^C^N) fragment.21 
Further monodentate ligands such as MeCN, OH2 and halogens (Br- and I-) have also been 
reported by a number of research groups.259-261 
 
Previously, in section 3.3, the preparation of a series of eight dinuclear iridium(III) complexes 
with the metal centres linked by a 4,6-disubstituted pyrimidine-based bridging ligand was 
discussed. As part of this work, it was demonstrated that facile metathesis reaction of the 
monodentate chloride ligands could be carried out in order to alter the identity of the monodentate 
ligand.  
The first example of this type of reaction with our pyrimidine-linked dinuclear complexes is 
shown in Figure 141. 3.3.14, in which the monodentate chloride ligands were replaced with 
cyanide ligands, was prepared by the reaction of 3.3.7 with excess KCN at room temperature. The 
target cyano complex was isolated in high yield (75%) following treatment of the crude product 
with methanol.  
 
 
Figure 141: Reaction scheme to show the metathesis reaction of 3.3.7 to 3.3.14 in which the chloride ligands are 
replaced by cyanide ligands. The final cyano complex was isolated in high yield of 75%.  
 
The final dinuclear iridium(III) complex was fully characterised by 1H, 19F and 13C NMR 
spectroscopy and mass spectrometry. The aromatic region of the 1H NMR spectrum of 3.3.14 is 
shown in Figure 142. The proton NMR spectrum shows the characteristic signals expected for a 
pyrimidine-linked dinuclear iridium(III) complex. The singlet at δ 11.5 ppm corresponds to the 
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proton at the 2-position of the pyrimdine ring with the doublet at δ 6.30 ppm corresponding to the 
two protons ortho to the metallated carbon atoms of the aryl rings of the bis-N^C bridging ligand.  
In addition to the NMR spectra recorded, the high-resolution mass spectrum can also be used to 
confirm the identity of the product 3.3.14. The peak observed at m/z 1739.7240 matches well with 
the calculated value of m/z 1739.7252 for [M+H]+. 
 
 
 
Figure 142: Aromatic region of the 1H NMR spectrum of 3.3.14. The NMR spectrum shows the characteristic signals 
expected for our pyrimidine-linked dinuclear iridium(III) complexes. The singlet at δ 11.5 ppm corresponds to the 
proton at the 2-position of the pyrimidine ring whilst the doublet at δ 6.30 ppm corresponds to the two protons ortho to 
the two metallated carbon atoms of the aryl rings of the bis-bidentate bridging ligand.  
 
The photophysical properties of the dinuclear iridium(III) complex bearing cyanide monodentate 
ligands were measured and compared with the analogous di-iridium(III) complexes bearing 
monodentate chloride ligands.  
The absorption spectrum recorded for 3.3.14 is shown below in Figure 143 with the related 
absorption data tabulated in Table 9. In each case, the data obtained for the chloride analogue, 
3.3.7, is included for comparison. On changing the monodentate ligand from chloride to cyanide, 
there is a relatively large blue-shift of the lowest-energy absorption bands of approximately 29 
nm. The overall spectral profile remains largely the same with the higher-energy region (< 350 
nm) of the absorption spectrum little affected.  
4
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Figure 143: UV-visible absorption spectra for the dinuclear iridium(III) complex 3.3.14 in CH2Cl2 at 298 ± 3 K. The 
absorption spectra of 3.3.7, recorded under the same conditions, is also shown for comparison with 3.3.14.  
 
Table 9: UV-visible absorption data for 3.3.14 and 3.3.7 in CH2Cl2 at 298 ± 3 K. 
Complex(a) λmax / nm (ε / M-1 cm-1) 
3.3.7 279 (63400), 312 (41500), 360 (32300), 408 (28600), 441 
(24400), 484 (11400), 520 (8080) 
3.3.14 279 (56300), 315 (38800), 353 (33000), 409 (33500), 460 
(12300), 491 (5390) 
 
The luminescence properties of the cyano di-iridium(III) complex, 3.3.14, were also measured 
and the emission spectra and related emission data are shown in Figure 144 and Table 10 
respectively. The bimetallic Ir(III) complex bearing monodentate cyanide ligands is highly 
luminescent in degassed CH2Cl2 solution at room temperature as was observed with the 
pyrimidine-linked complexes discussed in section 3.3. At 298 K, the emission spectrum of 3.3.14 
shows a well-defined maximum with a shoulder to the low-energy side. When compared with 
room-temperature emission of 3.3.7, the vibrational structure is more pronounced at 77 K with 
three peaks observed having a vibrational progression of approximately 1400 cm-1. This is typical 
of aromatic C=C vibrational modes. From the emission spectra in Figure 144 it can be observed 
that replacement of the monodentate Cl ligands by CN, going from 3.3.7 to 3.3.14, the emission 
is blue-shifted by ~ 1000 cm-1. This shift is of a similar magnitude to that observed in the 
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absorption spectra of the two complexes. Using the HOMO and LUMO energies calculated by 
TD-DFT and discussed in section 3.3 (Figure 105), it can be seen that the replacement of the 
chloride ligands by cyanide has a much larger stabilising effect on the HOMO than the LUMO. 
Therefore, this accounts for the large blue-shift observed experimentally, in both the absorption 
and emission spectra. This is consistent with the observation that the metal centre makes a more 
significant contribution to the HOMO than the LUMO.  
 
 
Figure 144: Luminescence spectra of the dinuclear iridium(III) complexes 3.3.14 and 3.3.7 (a) in CH2Cl2 at 298 ± 3 K 
and (b) in diethyl ether / isopentane / ethanol (2:2:1) at 77 K.  
 
Table 10: Emission data for the dinuclear iridium(III) complexes 3.3.14 and 3.3.7 at 298 K and in EPA(a) at 77K. 
Complex λmax / nm Φlum(b) τ / ns(c) kr(d) / 
106 s-1 
Σknr(d) / 
106 s-1 
kQO2 (e) / 
109 M-1 s-1 
Emission at 77K(f) 
λmax / nm τ / ns 
3.3.7 552, 582sh 0.94 440 [210] 2.14 0.14 1.13 513, 552, 594 6650 
3.3.14 517, 547sh 0.88 590 [240] 1.49 0.20 1.12 488, 523, 560 5100 
 
(a) EPA = diethyl ether / isopentane / ethanol (2:2:1 v/v). (b) Measured using Ir(ppy)3 in 2-MeTHF as the standard, for 
which the Φ = 0.97. (c) Values in air-equilibrated solution in parentheses. (d) kr and Σknr are the radiative and non-
radiative decay rate constants, estimated from the quantum yield and lifetime assuming that the emissive state is formed 
with unitary efficiency. (e) Bimolecular rate constant for quenching by O2, estimated from the luminescence lifetimes 
in degassed and air-equilibrated solutions, and taking [O2] = 2.2 mM in CH2Cl2 at p = 1 atm air and T = 298 K. (f) In 
EPA: see footnote a. (g) Since the measured quantum yield is unity within the error of measurement, it is not possible 
to make a meaningful estimate of knr. (h) For comparison, data for the related mononuclear complex Ir(F2dpyb)(ppy)Cl 
are as follows: At 298 K, λmax = 487, 516 nm; Φlum = 0.20; τ = 390 ns; kr = 0.5 x 106 s-1; Σknr = 2.1 x 106 s-1. At 77 K, 
λmax = 471, 508, 537, 548, 593 nm; τ = 2.5 μs.30 
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In order to demonstrate further versatility of our dinuclear iridium(III) complexes with respect to 
metathesis reactions of the monodentate chloride ligands, additional reactions were carried out to 
replace the chloride ligands with alternative monodentate ligands, both anionic and neutral, as 
shown in Figure 145. The use of anionic and neutral monodentate ligands results in the formation 
of both neutral and cationic dinuclear complexes. These complexes, bearing different overall 
charges, will have different properties which could be advantageous in a range of applications. 
For example, cationic di-iridium(III) complexes may be more water soluble and more applicable 
to bioimaging and water oxidation catalysis (WOCs).  
  
 
Figure 145: A reaction scheme to show the methathesis reactions carried out, starting with 3.3.15, to replace the 
monodentate chloride ligands with alternative monodentate ligands such as CN, MeCN or H2O. 
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The first metathesis reaction carried out on 3.3.15 was the equivalent reaction to that carried out 
on 3.3.7, as previously discussed, in order to replace the chloride ligands with cyanide ligands. 
The product, 3.7.1, was isolated as a yellow solid following treatment with methanol. The di-
iridium(III) complex was characterised by 1H and 13C NMR spectroscopy and mass spectrometry.  
The aromatic region of the 1H NMR spectrum of 3.7.1 is shown in Figure 146. The NMR spectrum 
is consistent with the product obtained being 3.7.1. 
 
 
Figure 146: Aromatic region of the 1H NMR spectrum of 3.7.1. The spectrum shows the characteristic signals for a 
pyrimidine-linked di-iridium(III) complex; the singlet at δ 11.6 ppm corresponding to the proton at the 2-position of 
the pyrimidine ring and the peak at δ 6.00 ppm corresponding to the two protons ortho to the metallated carbons of the 
bridging ligand.  
 
Following on from this success, the second metathesis reaction attempted was that to replace the 
Cl ligands with neutral MeCN ligands. The dinuclear complex 3.3.15 was stirred in acetonitrile 
at room temperature in the dark and in the presence of silver triflate as a chloride scavenger. An 
acetonitrile solution of the crude product was treated with a saturated KPF6(aq) solution in order 
to exchange the chloride counterion for PF6-. The desired product, 3.7.2, was isolated in high yield 
and was characterised by 1H NMR spectroscopy. The aromatic region of the 1H NMR spectrum 
of 3.7.2, bearing monodentate acetonitrile ligands is shown in Figure 147. The NMR spectrum 
1 
5 
2 
8 
4 + 7  
9 + 10 
3  
6 
 
 188 
 
shows 8 aromatic peaks corresponding to 10 aromatic proton environments. Within the aromatic 
region of the proton spectrum, at δ 10.6 ppm and δ 5.90 ppm, the characteristic peaks expected 
for a pyrimidine-linked dinuclear iridium(III) complex can be observed. In addition, the spectrum 
shows 3 aliphatic peaks accounting for the 3 aliphatic proton environments. The peak 
corresponding to the methyl groups of the acetonitrile ligands can be observed at δ 2.12 ppm. This 
1H NMR spectrum is therefore consistent with the isolation of 3.7.2.  
 
 
Figure 147: 1H NMR spectrum of the dinuclear iridium(III) complex, 3.7.2, in which the Cl ligands have been replaced 
with monodentate, neutral acetonitrile ligands.  
 
The final metathesis reaction attempted was that to substitute the monodentate chloride ligands 
for water molecules. Water acts as a neutral monodentate ligand and therefore, would result in 
the formation of a dicationic bimetallic iridium(III) complex. The synthetic route utilised for the 
metathesis reaction is shown in Figure 145. Unfortunately, this reaction was unsuccessful and the 
product 3.7.3 could not be isolated. The crude mixture, isolated after counterion exchange with a 
saturated solution of KPF6(aq), was analysed by thin layer chromatography (TLC) and 1H NMR 
spectroscopy. The TLC plate showed an inseparable mixture in which the majority of material 
was insoluble and remained on the baseline. The proton NMR spectra also showed a mixture of 
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species in the crude material isolated. Therefore, it is possible that the reaction did not go to 
completion or there is the formation of undesired byproducts in the course of the reaction. 
In this section of the work we have demonstrated facile methods for replacement of the 
monodentate chloride ligands in our pyrimidine-linked dinuclear iridium(III) complexes. Through 
metathesis reactions with the anionic cyanide and neutral acetonitrile ligands, neutral and cationic 
dinuclear iridium(III) complexes respectively have been produced. Unfortunately, the metathesis 
reaction carried out in an attempt to replace the chloride ligands with a neutral OH2 ligand was 
unsuccessful. It was shown that incorporation of the anionic cyanide ligand resulted in a highly 
luminescent dinuclear complex with emission blue-shifted relative to the corresponding chloro 
complex. Investigation of the properties of the di-iridium(III) acetonitrile complex is now required 
in order to assess the effects of this monodentate ligand on both the photophysical properties and 
solubility. This is important for the evaluation of such a complex for use in applications such as 
bioimaging.  
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3.8 Experimental Section 
3.8.1 Terdentate NCN Ligands 
Compound 3.1.1 – 1,3-di(4-tertbutylpyridine-2-yl)-5-tert-butylbenzene70, 173 
 
 
1,3-difluoro-4,6-di(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzene (1.56 g, 4.26 mmol), 2-
chloro-4-(tert-butyl)pyridine (1.87 g, 11.1 mmol) and 2M potassium carbonate solution (10 mL) 
were added to a round-bottomed flask with a 9:1 toluene:ethanol solvent mixture (30 mL). The 
reaction mixture was degassed under a vigorous flow of argon for 10 min. 
Tetrakis(triphenylphosphine)palladium was added (0.296 g, 0.256 mmol) was added and the 
reaction mixture degassed for a further 10 min. The reaction mixture was then heated to reflux 
(100 °C) for 48 h. The reaction was cooled to room temperature and the solvent removed under 
reduced pressure. Petroleum ether was added and the solid collected by filtration in vacuo and 
washed with petroleum ether. The filtrate was dried with MgSO4 and the solvent removed under 
reduced pressure. The crude product was purified by column chromatography (silica gel, 
hexane:ethyl acetate 4:1) to give the product as a pale yellow oil. 
Yield: 0.221 g, 0.581 mmol, 14% 
1H NMR (400 MHz, CDCl3): δ 8.62 (d, 2H, J = 5.6), 8.47 (t, 1H, J = 8.8), 7.73 (br s, 2H), 7.26 
(dd, 2H, J = 5.6, 1.6), 7.04 (t, 1H, J = 10.5), 1.36 (s, 18H).  
 
Compound 3.1.2 – 4-tert-butyl-2-[5-(4-tert-butylpyridin-2-yl)-2,4-difluoro-3-
(hexyloxy)phenyl]pyridine173 
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A solution of 4-tert-butyl-2-bromopyridine (0.772 g, 3.61 mmol) in 1,4-dioxane was degassed for 
15 min. 5-(4-tert-butylpyridine-2-yl)-2,4-difluoro-3-n-hexyloxyphenyl boronic acid MIDA ester 
(1.81 g, 3.61 mmol) was added and the solution degassed for a further 5 min. 2-
Dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (0.112 g, 0.361 mmol) and palladium acetate 
(0.0470 g, 0.180 mmol) were added and the reaction mixture degassed for 5 min. A degassed 
aqueous 3M solution of potassium phosphate (3.82 g, 18.0 mmol, 6 mL) was added and the 
reaction mixture degassed for a further 10 min. The mixture was stirred at 95 °C for 17 h. The 
reaction mixture was cooled to room temperature and the solvent evaporated under reduced 
pressure. Brine (30 mL) was added and the mixture extracted with ethyl acetate (3 x 50 mL). The 
organic layer was dried with MgSO4 and the solvent evaporated to dryness. The crude product 
was purified by column chromatography (silica gel, petroleum ether:ethyl acetate 3:1) to give the 
final product. 
Yield: 0.272 g, 0.567 mmol, 16% 
1H NMR (400 MHz, CDCl3): δ 8.60 (d, 2H, J = 5.4), 8.09 (t, 1H, J = 8.5), 7.69 (br s, 2H), 
7.20 (dd, 2H, J = 5.4, 2.1), 4.21 (t, 2H, J = 7.0), 1.57 (q, 2H, J = 7.2), 1.34 (m, 6H), 0.90 (t, 3H, 
J = 7.2). 
19F NMR (400 MHz, CDCl3): δ -131.30 (d, J = 21.5). 
13C NMR (100 MHz, CDCl3) δ 160.53, 154.25 (dd, J = 249.3, 5.6), 152.88, 149.72, 136.35 (t, J 
= 15.8), 125.76 (br s), 125.35 (dd, J = 9.7, 5.7), 121.54 (t, J = 3.8), 75.39, 34.91, 31.65, 30.66, 
30.14, 25.47, 22.68, 14.13.  
 
Compound 3.1.4 - 1,3-di(2-pyridyl)-4,6-difluorobenzene30 
 
 
A mixture of 1,5-dibromo-2,4-difluorobenzene (2.65 g, 9.75 mmol), 2-(tributylstannyl)pyridine 
(8.76 g, 24.0 mmol) and tetrakis(triphenylphosphine)palladium (0.310 g, 0.268 mmol) were 
added to toluene (90 mL) and the reaction mixture degassed for 15 min under argon. The reaction 
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mixture was heated to reflux (140 °C) for 24 h. The solvent was removed under reduced pressure. 
Petroleum ether (8 mL) was added and the solid filtered off and washed with petroleum ether. 
The grey solid obtained was dissolved in dichloromethane and filtered through Celite. The filtrate 
was collected and the solvent removed under reduced pressure. The desired product was obtained 
as an off-white solid. 
Yield: 1.58 g, 5.89 mmol, 60% 
1H NMR (400 MHz, CDCl3): δ 8.73 (d, 2H, J = 5.0), 8.61 (t, 1H, J = 8.8, 9.2), 7.77-7.74 (m, 4H), 
7.29-7.25 (m, 2H), 7.04 (t, 1H, J = 10.8). 
19F NMR (400 MHz, CDCl3): δ  
13C DEPT135 NMR (100 MHz, CDCl3): δ 161.83 (d, J = 12.4, C), 159.28 (d, J = 12.4, C), 152.59, 
149.92 (CH), 136.53 (CH), 133.73 (CH), 124.29 (CH), 122.60 (CH), 105.07 (t, J = 27.2, CH). 
 
Compound 3.1.5 – 1,3-di(2-pyridyl)-5-tert-butylbenzene70 
 
 
A mixture of 1,3-dibromo-5-(tert-butyl)benzene (3.01 g, 10.3 mmol), 2-(tributylstannyl)pyridine 
(9.54 g, 25.7 mmol) and tetrakis(triphenylphosphine)palladium (0.358 g, 0.309 mmol) were 
added to toluene (100 mL) and the reaction mixture degassed for 15 min under argon. The reaction 
mixture was heated to reflux (140 °C) for 20 h. The reaction mixture was purified by column 
chromatography (silica gel, petroleum ether:ethyl acetate 100:0 to 4:1 to 6:1 to 3:1) and a white 
solid was obtained.  
Yield: 2.11 g, 7.31 mmol, 71% 
1H NMR (400 MHz, CDCl3): δ 8.72 (d, 2H, J = 1.6), 8.34 (d, 1H, J = 1.4), 8.12 (d, 2H, J = 1.4), 
7.82 (d, 2H, J = 7.8), 7.76 (t, 2H, J = 7.8), 7.23 (t, 2H, J = 6.0), 1.45 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 157.83 (C), 152.23 (C), 149.66 (CH), 139.71 (C), 136.67 (CH), 
124.75 (CH), 123.02 (CH), 122.08 (CH), 120.93 (CH), 35.12 (C), 31.48 (CH3).  
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Compound 3.1.11 – 2-[3-tert-butyl-5-(1-phenyl-1H-1,3-benzodiazol-2-yl)phenyl]-1-phenyl-1H-
1,3-benzodiazole186  
 
 
N-phenyl-o-phenylenediamine (2.28 g, 12.3 mmol) was placed in a round-bottomed flask with 1-
methyl-2-pyrrolidinone (31 mL). To this mixture 5-tert-butylbenzene-1,3-dicarbonyl dichloride 
(1.60 g, 6.17 mmol) was added and the reaction mixture was stirred at room temperature for 2 h. 
The temperature was then increased to 50 °C for a further 2 h. The reaction was cooled to room 
temperature and then poured into cool water (100 mL). The precipitate formed was filtered off, 
washed with distilled water and dried in vacuo to give the crude diamide (5.51 g, 9.93 mmol). 
Cyclodehydration of the diamide intermediate (2.30 g, 4.15 mmol) at 290 °C under vacuum was 
then carried out in a Kugelrohr. The black solid was then dissolved in dichloromethane and 
purified by column chromatography (silica gel, DCM:ethyl acetate 3:1 to 3:2 to 1:1) to give the 
final product as a white solid.  
Yield: 0.938 g, 1.81 mmol, 70% 
1H NMR (400 MHz, CDCl3): δ 7.99 (t, 1H, J = 1.6, 1.2), 7.87 (d, 2H, J = 7.6), 7.49-7.39 (m, 8H), 
7.36-7.30 (m, 4H), 7.26-7.25 (m, 6H), 0.94 (s, 9H). 
13C DEPT135 (100 MHz, CDCl3): δ 152.15 (C), 150.70 (C), 143.04 (C), 137.02 (C), 136.88 (C), 
129.99 (C), 129.79 (CH), 128.50 (CH), 128.09 (CH), 127.79 (CH), 127.44 (CH), 123.30 (CH), 
122.91 (CH), 119.98 (CH), 110.40 (CH), 34.44 (C), 30.66 (CH3).  
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Compound 3.1.12 - 2-[3-tert-butyl-5-(1-methyl-1H-1,3-benzodiazol-2-yl)phenyl]-1-methyl-1H-
1,3-benzodiazole 
 
 
Polyphosphoric acid (18.7 mL) was added to a round-bottomed flask. To this 5-tert-
butylisophthalic acid (1.01 g, 0.454 mmol) and N-methyl-1,2-phenylenediamine (1.39 g, 11.4 
mmol) were added. The reaction mixture was heated to 190 °C for 17 h. The reaction mixture was 
removed from the heat and poured into vigorously stirred water (60 mL). The mixture was 
neutralised with NaOH (5 mL) solution. The blue precipitate was filtered in vacuo and washed 
with water and dried. The crude solid was purified by column chromatography (silica gel, 
DCM:acetone 4:1) to give the final product as a white solid. 
Yield: 1.37 g, 3.48 mmol, 77% 
1H NMR (400 MHz, CDCl3): δ 7.96 (s, 2H), 7.87-7.85 (m, 3H), 7.44-7.42 (m, 2H), 7.38-7.32 (m, 
4H), 3.90 (s, 6H), 1.46 (s, 9H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 153.51 (C), 153.72 (C), 142.95 (C), 136.56 (C), 130.47 
(C), 128.23 (CH), 127.21 (CH), 122.98 (CH), 122.57 (CH), 119.92 (CH), 109.71 (CH), 35.19 (C), 
31.79 (CH), 31.29 (CH).  
 
Compound 3.1.17 – 1-[3-tert-butyl-5-(1H-pyrazol-1-yl)phenyl]-1H-pyrazole  
 
 
To a dry flask, 1,3-dibromo-5-(tert-butyl)benzene (1.00 g, 3.42 mmol), pyrazole (0.583 g, 8.56 
mmol), syn-pyridine-2-aldoxime (0.0836 g, 0.685 mmol), copper(I) oxide (0.0490 g, 0.342 mmol) 
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and cesium carbonate (5.58 g, 17.1 mmol) were added. Anhydrous acetonitrile (60 mL) was 
added. The reaction mixture was degassed under a flow of argon for 20 min and heated to reflux 
for 3 d. The reaction mixture was cooled to room temperature. DCM (20 mL) was added and the 
mixture was filtered through Celite. The Celite was washed with further DCM. The filtrate was 
evaporated to dryness under reduced pressure. The crude residue was purified by column 
chromatography (silica gel, gradient elution, DCM:ethyl acetate 100:0, 9:1, 4:2) to give the 
product as an off-white solid.  
Yield: 0.640 g, 2.18 mmol, 70% 
1H NMR (400 MHz, CDCl3): δ 8.01 (d, 2H, J = 2.0), 7.83-7.82 (m, 1H), 7.76 (s, 2H), 7.68 (d, 2H, 
J = 1.6), 6.51-6.49 (m, 2H), 1.42 (s, 9H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 154.55 (C), 141.24 (CH), 140.84 (C), 127.07 (CH), 
114.45 (CH), 107.82 (CH), 107.58 (CH), 35.33 (C), 31.22 (CH3).  
 
3.8.2 Dichloro-Bridged Iridium(III) Dimers 
Compound 3.2.1 
 
 
4-tert-butyl-2-[5-(4-tert-butylpyridin-2-yl)-2,4-difluoro-3-(hexyloxy)phenyl]pyridine (0.272 g, 
0.567 mmol) and iridium chloride (0.206 g, 0.567 mmol) were placed in a round-bottomed flask 
with a 3:1 mixture of 2-ethoxyethanol and water (11 mL). The reaction mixture was heated to 
reflux for 14 h. The reaction mixture was cooled to room temperature and filtered to give an 
orange solid that was washed with ethanol and dried.  
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Yield: 0.345 g, 0.467 mmol, 82% 
1H NMR (400 MHz, CDCl3): δ 8.42 (d, 2H, J = 6.4), 8.25 (s, 2H), 6.96 (dd, 2H, J = 6.0, 2.4), 4.18 
(t, 2H, J = 6.8), 1.89 (quin, 2H, J = 14.4, 7.6), 1.59-1.56 (m, 2H), 1.49 (s, 18H), 1.43-1.40 (m, 
4H), 0.96 (t, 3H, J = 7.2). 
 
Compound 3.2.2 
 
 
To a mixture of 2,6-difluoro-3,5-di(tert-butylpyridin-2-yl)pyridine (0.221 g, 0.581 mmol) and 
iridium chloride hydrate (0.211 g, 0.581 mmol), a 3:1 mixture of 2-ethoxyethanol and water (25 
mL) was added. The reaction mixture was heated to reflux (130 °C) for 24 h under argon. The 
solvent was removed in vacuo and the resulting orange solid was filtered and washed with ethanol 
and water to give the desired product.  
Yield: 0.308 g, 0.486 mmol, 84% 
1H NMR (400 MHz, d6-DMSO): δ 8.93 (d, 2H, J = 6.4), 8.07 (d, 2H, J = 14.4), 7.73 (dd, 2H, J = 
4.0, 1.8, 7.27 (t, 1H, J = 11.8), 1.40 (d, 18H, J = 3.2). 
19F NMR (400 MHz, d6-DMSO): δ -107.38 (d, J = 12.8). 
13C NMR DEPT135 (100 MHz, d6-DMSO): δ 169.27, 163.72 (d, J = 183.2), 160.66 (d, J = 49.6), 
158.02 (d, J = 46.0), 152.03 (CH), 124.51 (t, J = 23.0), 121.80 (CH), 119.86 (t, J = 25.3, CH), 
99.53 (t, J = 111.2, CH), 35.03 (C-tBu), 29.92 (tBu). 
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Compound 3.2.3 
 
 
A mixture of 2.6-difluoro-3,5-di(tert-butylpyridin-2-yl)pyridine (0.151 g, 0.396 mmol) and 
iridium chloride hydrate (0.14 g, 0.396 mmol) were added to a 3:1 mixture of 2-ethoxyethanol 
and water (60 mL). The reaction mixture was heated to reflux (130 °C) for 24 h under argon. The 
solvent was removed in vacuo and the resulting orange solid was filtered and washed with ethanol 
and water to give the desired product. 
Yield: 0.162 g, 0.267 mmol, 67% 
1H NMR (400 MHz, d6-DMSO): δ 8.93 (d, 2H, J = 6.4), 8.04 (d, 2H, J = 1.8), 7.81 (dd, 2H, J = 
6.0, 2.3).  
 
Compound 3.2.4 
 
 
A mixture of 1,3-di(2-pyridyl)-5-(tert-butyl)benzene (0.724 g, 2.51 mmol) and iridium chloride 
hydrate (1.09 g, 3.01 mmol) were added to a 3:1 mixture of 2-ethoxyethanol and water (100 mL). 
 198 
 
The reaction mixture was heated to reflux (130 °C) for 24 h under argon. The resulting orange 
solid was filtered in vacuo and washed with ethanol and water to give the desired product. 
Yield: 1.25 g, 2.28 mmol, 91% 
1H NMR (d6-DMSO, 400 MHz): δ 9.01 (d, 2H, J = 5.0), 8.40 (d, 2H, J = 8.2), 8.09 (t, 2H, J = 
7.6), 8.05 (s, 2H), 7.55 (t, 2H, J = 6.4), 1.46 (s, 9H).  
 
Compound 3.2.5 
 
 
2-[3-tert-butyl-5-(1-phenyl-1H-1,3-benzodiazol-2-yl)phenyl]-1-phenyl-1H-1,3-benzodiazole 
(0.449 g, 0.866 mmol) and iridium chloride (0.316 g, 0.866 mmol) were placed in a round-
bottomed flask with a 3:1 mixture of 2-ethoxyethanol and water (50 mL). The reaction mixture 
was heated to reflux for 18 h. The reaction mixture was cooled to room temperature and filtered 
to give an orange solid that was washed with ethanol and water and dried.  
Yield: 0.602 g, 0.771 mmol, 89% 
1H NMR (400 MHz, CDCl3): δ 7.96 (d, 2H, J = 7.6), 7.90-7.86 (m, 4H), 7.77-7.68 (m, 4H), 7.57 
(d, 2H, J = 7.6), 6.90-6.82 (m, 4H), 6.75 (s, 2H), 6.53 (m, 2H), 0.98 (s, 9H). 
13C NMR DEPT135 (100 MHz, CDCl3): δ 160.22 (C), 144.10 (C), 141.34 (C), 135.31 (C), 135.14 
(C), 132.74 (C), 130.18 (CH), 130.12 (CH), 128.56 (CH), 128.31 (CH), 123.44 (CH), 122.90 
(CH), 122.21 (CH), 117.44 (CH), 109.71 (CH), 34.42 (C), 31.31 (CH).  
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Compound 3.2.6 
 
 
1-[3-tert-butyl-5-(1H-pyrazol-1-yl)phenyl]-1H-pyrazole (0.640 g, 2.40 mmol) and iridium 
chloride (0.872 g, 2.40 mmol) were placed in a round-bottomed flask. A 3:1 mixture of 2-
ethoxyethanol and water (60 mL) was added and the mixture was heated to reflux for 18 h. The 
reaction mixture was cooled to room temperature and the precipitate collected by filtration in 
vacuo. The product was washed with ethanol and diethyl ether. 
Yield: 0.969 g, 1.83 mmol, 76% 
1H NMR (400 MHz, CDCl3): δ 8.58 (br s, 1H), 8.03-7.76 (m, 4H), 7.41-7.35 (m, 4H), 4.40-4.37 
(m, 6H), 1.42 (s, 9H).  
 
Compound 3.2.7 
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2-[3-tert-butyl-5-(1-methyl-1H-1,3-benzodiazol-2-yl)phenyl]-1-methyl-1H-1,3-benzodiazole 
(0.502 g, 1.27 mmol) and iridium chloride (0.462 g, 1.27 mmol) were placed in a round-bottomed 
flask. A 3:1 mixture of 2-ethoxyethanol and water (40 mL) was added and the mixture was heated 
to reflux for 18 h. The reaction mixture was cooled to room temperature and the precipitate 
collected by filtration in vacuo. The product was washed with ethanol and diethyl ether. 
Yield: 0.772 g, 1.10 mmol, 87% 
1H NMR (400 MHz, CDCl3,): δ 9.01 (d, 2H, J = 2.8), 7.89 (d, 2H, J = 2.3), 7.73 (s, 2H), 6.81 (t, 
2H, J = 2.8), 1.39 (s, 9H).  
 
3.8.3 Pyrimidine-Linked Dinuclear Iridium(III) Complexes 
Compound 3.3.5 - 4,6-bis(4-methoxyphenyl)pyrimidine173 
 
 
(4-methoxyphenyl)boronic acid (1.59 g, 10.5 mmol), 4,6-dichloropyrimidine (0.601 g, 4.03 
mmol) and a 2M aqueous potassium carbonate solution (3.34 g, 24.2 mmol, 12.1 mL) were added 
to a round-bottomed flask. 1,4-Dioxane (35 mL) was added and the reaction mixture was degassed 
under argon for 15 min. Tetrakis(triphenylphosphine)palladium (0.280 g, 0.242 mmol) was added 
and the reaction mixture degassed for a further 10 m8inutes. The reaction mixture was heated to 
reflux for 48 h under an argon atmosphere. The reaction mixture was cooled to room temperature 
and toluene (20 mL) was added. The organic phase was separated and washed with water (3 x 10 
mL). The organic phase was dried with MgSO4 and the solvent evaporated to dryness. The crude 
residue was recrystallised from ethyl acetate to give the product.  
Yield: 0.377 g, 1.29 mmol, 32% 
1H NMR (400 MHz, CDCl3): δ 9.21 (d, 1H, J = 1.4), 8.14-8.10 (m, 4H), 9.78 (d, 1H, J = 1.4), 
7.06-7.02 (m, 4H), 3.90 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ 163.97 (C), 162.01 (C), 159.10 (CH), 129.61 (CH), 128.75 (CH), 
114.42 (CH), 111.14 (CH), 55.55 (CH3).  
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Compound 3.3.6 – 4,6-bis(4-tert-butylphenyl)pyrimidine84  
 
 
(4-tert-butylphenyl)boronic acid (2.01 g, 11.2 mmol), 4,6-dichloropyimidine (0.645 g, 4.30 
mmol), potassium carbonate (3.59 g, 26.0 mmol) and 1,4-dioxane (30 mL) were placed in a round 
bottomed flask and the reaction mixture degassed with argon for 10 min. 
Tetrakis(triphenylphosphine)palladium (0.151 g, 0.129 mmol) was added and the reaction 
mixture degassed for a further 10 minutes. The reaction mixture was then heated to reflux for 48 
h under an argon atmosphere. The reaction mixture was cooled to room temperature. Toluene (20 
mL) was added and the solution washed with water. The organic layer was dried over MgSO4 and 
the solvent evaporated under reduced pressure. The residue was recrystallised from ethyl acetate 
to give the product as a colourless solid. 
Yield: 1.10 g, 3.20 mmol, 74%  
1H NMR (400 MHz, CDCl3): δ 9.28 (s, 1H), 8.08 (d, 5H, J = 8.8), 7.56 (d, 4H, J = 8.4), 1.38 (s, 
18H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 164.45 (C), 159.15 (CH), 154.37 (C), 134.29 (C), 
126.92 (CH), 126.00 (CH), 112.26 (CH), 34.92 (C), 31.23 (CH3).  
 
Compound 3.3.7 
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Compound 3.5.1 (0.161 g, 0.215 mmol), and 4,6-di-(4-tert-butylphenyl)pyrimidine (0.0373 g, 
0.108 mmol) were placed in a round-bottomed flask with toluene (26 mL). Silver triflate (0.0840 
g, 0.323 mmol) was added and the reaction mixture heated to reflux for 8 h. The heat was then 
removed and to a still warm reaction mixture a 3M HCl solution (5 mL) was added and the mixture 
stirred for 5 min. The organic phase was separated and the solvent removed under reduced 
pressure. Methanol (20 mL) was added to the red-orange residue and the solid filtered in vacuo 
and the solid washed with methanol. The resulting orange solid was dissolved in dichloromethane 
(10 mL) and filtered by gravity. Methanol (20 mL) was added to the filtrate and the volume of 
solvent reduced under reduced pressure to 10 mL. The orange solid was collected by filtration in 
vacuo and was shown to be the desired product. 
Yield: 0.0735 g, 0.0419 mmol, 39%  
1H NMR (400 MHz, CDCl3) δ 11.77 (s, 1H), 8.40 (s, 1H), 8.12 (s, 4H), 7.81 (d, 2H, J = 8.0 Hz), 
7.79 (d, 4H, J = 5.9), 6.95 (dd, 2H, J = 8.0, 1.6),  6.92 (dd, 4H, J = 5.9, 1.6), 6.28 (d, 2H, J = 1.6), 
4.20 (t, 4H, J = 6.5), 1.92 (m, 4H), 1.62 (m, 4H), 1.44 (m, 8H), 1.32 (s, 36H), 1.01 (s, 18H), 0.97 
(t, 6H, J = 6.9). 
19F NMR (400 MHz, CDCl3): δ -126.9. 
13C NMR DEPT135 (100 MHz, CDCl3): δ 161.57 (CH), 150.69 (CH), 133.20 (CH), 125.87 (CH), 
120.33 (CH), 120.07 (CH), 119.32 (CH), 105.93 (CH), 75.77 (CH2), 31.7 (CH2), 30.9 (CH3), 30.5 
(CH3), 30.2 (CH2), 25.6 (CH2), 22.7 (CH2), 14.1 (CH3). 
HRMS (FTMS+): for [M-Cl]+ calc’d 1721.6791, found 1721.6795; for [M+Na]+ calc’d 
1779.6362, found 1779.6771; for [M+NH4]+ calc’d 1770.6761, found 1770.6771. 
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Compound 3.3.8 
 
 
Compound 3.2.2 (0.150 g, 0.230 mmol) in xylene (30 mL), silver trifluoromethanesulfonate 
(0.0901 g, 0.351 mmol) was added. 4,6-di(4-tert-butylphenyl)pyrimidine (0.0403 mg, 0.117 
mmol) was then added and the reaction mixture heated to reflux for 8 h. To the cooled reaction 
mixture, dichloromethane (10 mL) was added and the mixture filtered in vacuo. The filtered solid 
was washed with dichloromethane. Concentrated hydrochloric acid (3 mL) was added to the 
filtrate and the resulting mixture stirred for 5 min. The resulting mixture was filtered through 
Celite and the Celite washed with further dichloromethane. The filtrate was evaporated to dryness 
under reduced pressure and the residue treated with methanol (20 mL). The orange solid was 
filtered off and washed with methanol. 
Yield: 0.125 g, 0.08 mmol, 69% 
1H NMR (400 MHz, CDCl3): δ 11.75 (s, 1H), 8.41 (s, 1H), 8.11 (s, 4H), 7.81 (d, 6H, J = 6.8), 
6.94 (d, 6H, J = 6.4), 6.82 (t, 2H, J = 11.8), 6.27 (s, 2H), 1.32 (s, 36H), 1.02 (s, 18H). 
19F NMR (400 MHz, CDCl3): δ -109.49 (d, 4F, J = 12). 
13C DEPT135 (100 MHz, CDCl3): δ 170.90, 165.28, 161.58, 160.30 (CH), 155.17, 152.23, 150.66 
(CH), 138.42, 133.07 (CH), 125.80 (CH), 124.18, 120.29 (CH), 119.93 (CH), 119.30 (CH), 
105.87 (CH), 96.77 (CH), 34.98 (C-tBu), 34.52 (C-tBu), 30.86 (CH3), 30.50 (CH3).  
HRMS (FTMS+): for [M-Cl]+ calc’d 1521.5015, found 1521.5026; for [M-(Ir(NCN)Cl)-Cl]+ 
calc’d 915.3789, found 915.3784; for [M-2Cl]2+ calc’d 743.2663, found 743.2655. 
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Compound 3.3.9 
 
 
Compound 3.2.3 (0.150 g, 0.247 mmol) in xylene (30 mL), silver trifluoromethanesulfonate 
(0.101 g, 0.370 mmol) was added. 4,6-di(4-tert-butylphenyl)pyrimidine (0.0425 g, 0.123 mmol) 
was then added and the reaction mixture heated to reflux for 8h. To the cooled reaction mixture, 
dichloromethane (15 mL) and concentrated hydrochloric acid (3 mL) were added the mixture 
stirred for 5 min. The resulting mixture was filtered through Celite and the Celite washed with 
further dichloromethane. The filtrate was evaporated to dryness under reduced pressure and the 
residue treated with methanol (20 mL). The orange-yellow solid was filtered off and washed with 
methanol.  
Yield: 0.114 g, 0.07 mmol, 59% 
1H NMR (400 MHz, CDCl3): δ 11.76 (s, 1H), 8.46 (s, 1H), 8.12 (d, 4H, J = 2.0), 7.85 (d, 2H, J = 
8.4), 7.82 (d, 4H, J = 6.0), 7.02 (dd, 4H, J = 6.4, 2.4), 6.99 (dd, 2H, J = 8.4, 1.6), 6.24 (s, 2H), 
1.35 (s, 36H), 1.02 (s, 18H). 
19F NMR (400 MHz, CDCl3): δ -69.43 (s, 4F). 
13C DEPT135 (100 MHz, CDCl3): δ 170.79, 162.53, 155.90, 151.08 (CH), 137.98, 132.64 (CH), 
126.20 (CH), 120.68 (CH), 119.96 (CH), 106.00 (CH), 50.92 (), 35.15 (C-tBu), 34.74 (C-tBu), 
30.86 (CH3), 30.47 (CH3). 
HRMS (FTMS+) for [M-Cl]+ calc’d 1523.7135, found 1523.4917. 
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Compound 3.3.10 
 
 
To a stirred solution of compound 3.5.1 (0.148 g, 0.200 mmol) and 4,6-diphenylpyrimidine (0.024 
g, 0.100 mmol) in toluene (30 mL), silver triflate (0.077 g, 0.300 mmol) was added and the 
mixture was heated under reflux for 15 h. The heating was removed. To a still warm solution, 5 
mL of 2M HCl was added and the mixture was stirred for 15 min (during this time orange 
luminescence developed). The volume of the mixture was reduced to approximately 3 mL. This 
caused formation of solid residue and transparent aqueous layer. The aqueous layer was decanted. 
The residue was triturated with methanol (25 mL), filtered and the solid on filter was washed with 
methanol. The solid was dissolved in dichloromethane and filtered through Celite. To the filtrate, 
methanol (5 mL) was added and the mixture was reduced to a volume of 2 mL, causing formation 
of solid. The solid was filtered off and washed with methanol to give the desired product as an 
orange solid.  
Yield: 0.143 g, 0.0869 mmol, 87%. 
1H NMR (400 MHz, CDCl3): δ 11.86 (s, 1H), 8.53 (s, 1H), 8.12 (br s, 4H), 7.91 (br d, 2H, J = 
7.8),  7.74 (d, 4H, J = 6.0),  6.92 (m, 6H), 6.78 (br t, 2H, J = 7.8), 5.78 (d, 2H, J = 7.7), 4.21 (t, 
4H, J = 6.4), 1.91 (m, 4H), 1.61 (m, 4H), 1.43 (m, 8H), 1.32 (s, 36H), 0.97 (t, 6H, J = 6.9). 
19F NMR (400 MHz, CDCl3): δ -126.4 (s). 
13C NMR DEPT135 (100 MHz, CDCl3): δ 171.51 (), 161.65 (), 150.49(CH), 141.09 (CH), 136.78 
(CH), 132.04 (CH), 126.40 (CH), 121.79 (CH), 120.59 (CH), 120.00 (CH), 75.6(CH2), 35.08 (C-
tBu), 31.78 (CH2), 30.60 (CH3), 30.26 (CH2), 25.65 (CH2), 22.77 (CH2), 14.20(CH3). 
HRMS (FTMS+): for [M-Cl]+ calc’d 1609.5539, found 1609.5524; for [M+Na]+ calc’d 
1667.5108, found 1667.5055. 
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Compound 3.3.11 
 
 
To a mixture of compound 3.5.1 (0.148 g, 0.200 mmol) and 4,6-bis(2,4-
difluorophenyl)pyrimidine (0.030 g, 0.100 mmol) and toluene (30 mL), silver triflate (0.077 g, 
0.300 mmol) was added and the mixture was heated under reflux for 15 h. The heating was 
removed. To a still warm solution, 5 mL of 2M HCl was added and the mixture was stirred for 15 
min (during this time orange luminescence developed). The volume of the mixture was reduced 
to approximately 5 mL. The residue was triturated with methanol (40 mL), filtered and the solid 
on filter was washed with methanol. The solid was dissolved in dichloromethane and filtered 
through Celite. To the filtrate, methanol (5 ml) was added and the mixture evaporated to a volume 
of 2 mL causing formation of solid. The solid was filtered off, washed on filter with methanol to 
give the desired product as an orange solid.  
Yield: 0.116 g, 0.0676 mmol, 68%. 
1H NMR (400 MHz, CDCl3): δ 11.93 (s, 1H), 9.30 (br t, 1H, J = 3.7), 8.15 (d, 4H, J = 1.8), 7.79 
(d, 4H, J = 6.0),  6.97 (dd, 4H, J = 6.0, 1.8), 6.38 (ddd, 2H, J = 11.2, 8.8, 2.4), 5.78 (dd, 2H, J = 
8.8, 2.4), 4.21 (t, 4H, J = 6.4), 1.92 (m, 4H), 1.61 (m, 4H), 1.43 (m, 8H), 1.34 (s, 36H), 0.97 (t, 
6H, J = 6.9). 
19F NMR (400 MHz): δ -103.3 (m), -105.6 (m), -126.9. 
13C NMR DEPT135 (100 MHz, CDCl3): δ 160.3(CH), 150.1(CH), 120.7(CH), 120.1(CH), 
118.4(d, J = 16.0, CH), 114.1(t, J = 20.7, CH), 98.1(t, J = 28.0, CH), 75.6(CH2), 31.7(CH2), 30.5 
(CH3), 30.2(CH2), 25.5(CH2), 22.7(CH2), 14.1(CH3). 
HRMS (FTMS+): for [M+Na]+ calc’d 1739.4731, found 1739.4670. 
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Compound 3.3.12 
 
 
To a mixture of compound 3.5.1 (0.150 g, 0.200 mmol) and 4,6-bis(4-methoxyphenyl)pyrimidine 
(0.066 g, 0.220 mmol) in toluene (6 mL), silver triflate (0.067 g, 0.260 mmol) in toluene (1mL) 
was added.  The reaction was heated to reflux for 8 h before the solution was allowed to cool to 
room temperature and the toluene removed under reduced pressure.  The crude mixture was 
purified by column chromatography (silica gel, gradient elution, DCM:EtOAc 100:0→80:20). 
The product obtained after evaporation of the eluent was treated with methanol and filtered. The 
solid was recrystallized from DMSO, washed with methanol and dried under vacuum at 140°C 
for 24 h.  
Yield: 0.057 g, 0.0334 mmol, 17%.   
1H NMR (400 MHz, CDCl3): δ 11.65 (s, 1H), 8.23 (s,1H), 8.12 (s, 4H), 7.81 (d, 2H, J = 8.7), 7.78 
(d, 4H, J = 6.0), 6.93 (dd, 2H, J = 6.0, 1.8),  5.75 (d, J = 2.8), 4.19 (t, 4H, J = 6.4), 3.55 (s, 6H) 
1.91 (m, 4H), 1.61 (m, 9H), 1.49 (s, 2H), 1.42 (m, 8H), 1.33 (s, 36H), 1.25 (s, 6H), 0.96 (t, J = 
6.9, 6H). 
19F NMR (400 MHz, CDCl3): δ -126.49.  
13C DEPT135 (100 MHz, CDCl3): δ 160.2, 150.4, 127.7, 120.5, 120.5, 119.9, 108.4, 104.8, 77.2, 
75.6 (CH2), 54.8, 31.7 (CH2), 30.51, 30.2 (CH2), 29.7 (CH2), 25.6 (CH2), 22.7 (CH2), 14.1 (CH3). 
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Compound 3.3.13 
 
 
To a stirred solution of compound 3.2.1 (0.148 g, 0.200 mmol) and 4,6-di(5-
hexylthiophenyl)pyrimidine (0.041 g, 0.100 mmol) in toluene (30 mL), silver triflate (0.077 g, 
0.300 mmol) was added and the mixture was heated under reflux for 15 hours. The heating was 
removed. To a still warm solution 5 mL of 2M HCl was added and the mixture was stirred for 15 
minutes (during this time orange luminescence developed). The mixture was evaporated to a 
volume of around 3 mL. This caused formation of solid residue and transparent aqueous layer. 
The aqueous layer was decanted. The residue was triturated with methanol (25 mL), filtered and 
the solid on filter was washed with methanol. The solid was then dissolved in DCM and filtered 
through Celite. To the filtrate, methanol (5 ml) was added and the mixture was evaporated to a 
volume of 2 ml causing formation of solid. The solid was filtered off, washed on filter with 
methanol to give the desired product as an orange solid.  
Yield: 0.139 g, 0.0762 mmol, 76%. 
1H NMR (400 MHz, CDCl3): δ 11.15 (s, 1H), 8.10 (s, 4H), 7.88 (d, 4H, J = 6.4), 7.39 (s, 1H), 
7.00 (dd, 4H, J = 6.0, 1.6), 5.60 (s, 2H),  4.19 (t, 4H, J = 6.8), 2.62 (t, 4H, J = 7.8), 1.95-1.88 (m, 
4H), 1.65-1.57 (m, 4H), 1.51-1.41 (m, 12H), 1.35 (s, 36H), 1.20-1.16 (m, 12H), 0.97 (t, J = 7.2, 
6H), 0.81 (t, 6H, J = 6.8). 
19F NMR (400 MHz, CDCl3): δ -126.76. 
13C DEPT135 (100 MHz, CDCl3): δ 165.75, 164.97, 161.42, 160.53 (CH), 155.39, 151.12 (CH), 
131.74, 131.41 (CH), 124.36, 119.96 (CH), 102.18 (CH), 100.11, 75.61 (CH2), 35.00, 31.69 
(CH2), 31.32 (CH2), 31.09 (CH2), 30.63 (CH2), 30.54 (CH3), 30.18 (CH2), 28.62 (CH2), 25.57 
(CH2), 22.67 (CH2), 22.50 (CH2), 14.11 (CH3), 13.99 (CH3). 
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HRMS (FTMS+): for [M-Cl]+ calc’d 1789.6545, found 1789.6530; for [M+Na]+ calc’d 
1847.6114, found 1847.6053; for [M+NH4]+ calc’d 1838.6525, found 1838.6506. 
 
Compound 3.3.15 
 
 
Compound 3.2.4 (0.162 g, 0.294 mmol) and 4,6-di-(4-tert-butylphenyl)pyrimidine (0.0515 g, 
0.147 mmol) were placed in a round-bottomed flask with toluene (26 mL). Silver triflate (0.113 
g, 0.441 mmol) was added and the reaction mixture heated to reflux for 8 h. The heat was then 
removed and to a still warm reaction mixture a 3M HCl solution (5 mL) was added and the mixture 
stirred for 5 min. The organic phase was separated and the solvent removed under reduced 
pressure. DCM (10 mL) was added and the solution filtered through Celite. Methanol (10 mL) 
was added in an attempt to crash out the product. The solvent was removed under reduced 
pressure. Diethyl ether (20 mL was added and the solid filtered in vacuo and the solid washed 
with diethyl ether. The NMR shows that the solid collected was the iridium dichloro-bridged 
dimer showing that the reaction had not gone to completion. The solvent was removed from the 
filtrate under reduced pressure and the residue was purified by column chromatography (silica 
gel, gradient elution, DCM:EtOAc 100:0→20:1→10:1 to DCM:MeOH 10:1). The product 
collected was further purified by column chromatography (silica gel, gradient elution, 
DCM:EtOAc 5:1 to DCM:MeOH 20:1 to 10:1) to give the desired bimetallic iridium complex. 
Yield: 0.0305 g, 0.0221 mmol, 15% 
1H NMR (400 MHz, CDCl3): δ 11.76 (s, 1H), 8.41 (s, 1H), 8.04 (d, 4H, J = 5.5), 7.91-7.89 (m, 
8H), 7.75 (d, 2H, J = 8.2), 7.62 (t, 4H, J = 7.8), 6.93 (t, 4H, J = 6.6), 6.84 (dd, 2H, J = 8.2, 1.8), 
6.00 (d, 2H, J = 1.8), 1.54 (s, 18H), 0.92 (s, 18H). 
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HRMS (FTMS+): for [M-2Cl]2+ calc’d 651.2225, found 651.2217. 
 
Compound 3.3.16 
 
 
To the compound 3.2.5 (0.150 g, 0.192 mmol) in xylene (30 mL), silver trifluoromethanesulfonate 
(0.0777 g, 0.289 mmol) was added. 4,6-di(4-tert-butylphenyl)pyrimidine (0.0339 g, 0.0962 
mmol) was then added and the reaction mixture heated to reflux for 8 h. To the cooled reaction 
mixture, dichloromethane (10 mL) was added and the mixture filtered in vacuo. The filtered solid 
was washed with dichloromethane. Concentrated hydrochloric acid (3 mL) was added to the 
filtrate and the resulting mixture stirred for 5 min. The resulting mixture was filtered through 
silica and the silica washed with excess dichloromethane. The filtrate was evaporated to dryness 
under reduced pressure and the residue treated with methanol (20 mL). The red solid was filtered 
off and washed with methanol. 
Yield: 0.161 g, 0.0879 mmol, 91%  
1H NMR (400 MHz, CDCl3): δ 8.51 (s, 1H), 7.75-7.68 (m, 20H), 7.46-7.44 (m, 3H), 7.39 (d, 4H, 
J = 8.2), 7.26-7.25 (m, 2H), 7.08-7.02 (m, 8H), 6.83-6.77 (m, 10H), 0.98 (s, 18H), 0.96 (s, 18H).  
13C DEPT135 (100 MHz, CDCl3): δ 178.45 (C), 172.66 (C), 161.87 (C), 153.91 (C), 142.78 (C), 
141.12 (C), 139.93 (C), 135.69 (C), 135.32 (C), 132.71 (CH), 131.66 (C), 130.31 (CH), 129.99 
(CH), 129.90 (CH), 128.90 (CH), 128.71 (CH), 127.93 (CH), 125.35 (CH), 124.85 (CH), 122.78 
(CH), 122.22 (CH), 118.04 (CH), 116.01 (CH), 110.33 (CH), 34.53 (C), 34.40 (C), 31.20 (tBu), 
30.85 (tBu). 
HRMS (FTMS+): for [M-Cl]+ calc’d 1797.5826, found 1797.5836; for [M+2Na]2+ calc’d 
881.3072, found 881.3067. 
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Compound 3.3.17 
 
 
To compound 3.2.6 (0.150 g, 0.230 mmol) in toluene (30 mL), silver trifluoromethanesulfonate 
(0.0886 g, 0.345 mmol) was added. 4,6-di(4-tert-butylphenyl)pyrimidine (0.0396 g, 0.115 mmol) 
was then added and the reaction mixture heated to reflux for 18 h. The reaction mixture was 
removed from the heat. To the still warm reaction mixture, dichloromethane (10 mL) and 3M HCl 
(8 mL) were added. The resulting mixture stirred for 15 min before being filtered through Celite. 
The Celite was washed with excess DCM. The filtrate was evaporated to dryness under reduced 
pressure and the residue was purified by column chromatography (silica gel, gradient elution, 
DCM:EtOAc 10:1→5:1 to DCM:MeOH 10:1) to give the desired bimetallic iridium complex.  
Yield: 0.060 g, 0.0380 mmol, 60%  
1H NMR (400 MHz, d6-DMSO): δ 12.37 (s, 1H), 8.97 (s, 1H), 8.18 (br s, 4H), 8.02 (d, 2H, J = 
7.3), 7.67 (d, 4H, J = 8.2), 7.19-7.16 (m, 4H), 7.02-7.00 (m, 4H), 6.75-6.72 (m, 2H), 6.59-6.56 
(m, 4H), 5.84 (m, 2H), 4.47 (br s, 12H), 1.65 (s, 18H), 0.90 (s, 18H).  
HRMS (FTMS+): for [M-2Cl]2+ calc’d 757.2757, found 757.2752. 
 
Compound 3.3.18 
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To compound 3.2.7 (0.150 g, 0.284 mmol) in toluene (40 mL), silver trifluoromethanesulfonate 
(0.109 g, 0.426 mmol) was added. 4,6-di(4-tert-butylphenyl)pyrimidine (0.0489 g, 0.142 mmol) 
was then added and the reaction mixture heated to reflux for 18 h. The reaction mixture was 
removed from the heat. To the still warm reaction mixture, 3M HCl (8 mL) was added and the 
reaction mixture stirred for 10 min. The resulting mixture was filtered through Celite and the 
Celite washed with excess dichloromethane. The bright orange filtrate was evaporated to dryness 
under reduced pressure. The orange residue was purified by column chromatography (silica gel, 
gradient elution, DCM:EtOAc 10:1→5:1→1:1 to DCM:MeOH 10:1) leading to isolation of the 
desired dinuclear complex.  
Yield: 0.110 g, 0.0828 mmol, 58% 
1H NMR (400 MHz, CDCl3): δ 11.47 (s, 1H), 8084 (s, 1H), 8.78 (d, 4H, J = 2.8), 8.08 (d, 2H, J 
= 8.2), 7.76 (s, 4H), 7.51 (d, 4H, J = 1.2), 6.80 (d, 2H, J = 8.2), 6.48 (t, 4H, J = 2.3), 5.87 (br s, 
2H), 1.60 (s, 18H), 0.90 (s, 18H).  
HRMS (FTMS+): for [M-2Cl]2+ calc’d 629.2150, found 629.2108. 
 
3.8.4 2,5-Pyrazine- vs. Thiazole-Linked Dinuclear Iridium(III) Complexes 
Compound 3.4.1 – 2,5-Bis(4-tert-butylphenyl)pyrazine262 
 
 
3,6-Bis(4-tert-butylphenyl)pyrazine (0.306 g, 1.29 mmol), (4-tert-butylphenyl)boronic acid 
(0.596 g, 3.35 mmol) and a 2M aqueous potassium carbonate solution (1.07 g, 7.72 mmol, 3.86 
mL) were added to a round-bottomed flask. 1,4-Dioxane (10 mL) was added. The mixture was 
degassed under argon for 15 min. Tetrakis(triphenylphosphine)palladium (0.0892 g, 0.0772 
mmol) was added and the reaction mixture degassed for a further 10 minutes. The reaction was 
heated to 95 °C for 65 h. The reaction was cooled to room temperature. Toluene (20 mL) was 
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added. The organic layer was separated and washed with water (2 x 10 mL). The organic phase 
was dried and evaporated to dryness. To the pale green residue, a small amount of methanol was 
added and a precipitate formed. The solid was filtered in vacuo and washed with further methanol. 
The product was obtained as a white solid. 
Yield: 0.378 g, 1.10 mmol, 85% 
1H NMR (400 MHz, CDCl3): δ 9.05 (s, 2H, J = 3.6), 8.00 (d, 4H, J = 8.8), 7.55 (d, 4H, J = 8.8), 
1.38 (s, 18H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 153.00 (C), 150.33 (C), 141.05 (C-H), 133.54 (C), 
126.44 (CH), 126.05 (CH), 34.81 (C), 31.25 (CH3).  
HRMS (FTMS+): for [M+H]+ calc’d 345.2325, found 345.2326. 
 
Compound 3.4.5 - 2,5-bis(4-tert-butylphenyl)-3aH,6aH-[1,3]thiazolo[5,4-d][1,3]thiazole 
 
 
4-tert-butylbenzaldehyde (1.01 g, 6.22 mmol) and dithiooxamide (0.374 g, 3.11 mmol) were 
added to a round-bottomed flask. DMF (30 mL) was added and the reaction mixture was heated 
to reflux for 24 h. The reaction mixture was cooled to room temperature and further cooled in an 
ice bath. The mixture was filtered in vacuo and the product was isolated as a green solid.  
Yield: 0.459 g, 1.13 mmol, 36 % 
1H NMR (400 MHz, CDCl3): δ 7.93 (d, 4H, J = 8.7), 7.51 (d, 4H, J = 8.2), 1.37 (s, 18H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 169.03 (C), 154.17 (C), 150.60 (C), 131.34 (C), 126.17 
(CH), 126.09 (C-H), 34.97 (C), 31.18 (CH3).  
HRMS (FTMS+): for [M+H]+ calc’d 407.1610, found 407.1606. 
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Compound 3.4.4 
 
 
Compound 3.2.1 (0.148 g, 0.200 mmol), 2,5-bis(4-tert-butylphenyl)pyrazine (0.0340 g, 0.100 
mmol) and toluene (25 mL) were added to a round-bottomed flask. Silver triflate (0.0770 g, 0.300 
mmol) was added and the reaction mixture was heated under reflux for 17 hours. The heating was 
removed and, to a still warm mixture, 2M HCl (5 mL) was added. Toluene was evaporated leaving 
a suspension of the product in aqueous medial. The solid was separated, triturated with methanol 
and filtered.  The solid was then dissolved in DCM (20 mL) and filtered through Celite. To the 
filtrate, methanol (40 mL) was added the volume of the mixture was reduced to approximately 10 
mL using rotary evaporator. The red solid was filtered off, washed with little amount of methanol. 
The product was isolated as a red solid. 
Yield: 0.112 g, 0.0637 mmol, 64%   
1H NMR (400 MHz, CDCl3): δ 10.77 (s, 2H), 8.40 (s,1H), 8.15 (s, 4H), 7.89 (d, J = 8.0 Hz, 2H), 
7.63 (d, J = 5.9 Hz, 4H), 6.90 (m,6H), 6.18 (d, J = 1.6 Hz, 2H), 4.23 (t, J = 6.5 Hz, 4H), 1.94 (m, 
4H), 1.62 (m, 4H), 1.44 (m, 8H), 1.33 (s, 36H), 1.00 (s, 18H), 0.97 (t, J = 6.9 Hz, 6H). 
19F NMR (400 MHz): δ -126.5. 
(MALDI MS): for [M]+ calc’d 1756.6, found 1756.6. 
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Compound 3.4.8 
 
 
Compound 3.2.1 (0.149 g, 0.201 mmol) was added to a round-bottomed flask. Toluene (30 mL) 
was added and the mixture was stirred. Silver triflate (0.0774 g, 0.301 mmol) was added. Bis(4-
tert-butylphenyl)-[1,3]thiazole[5,4-d][1,3]thiazole (0.0408 g, 0.100 mmol) was added and the 
reaction mixture heated to reflux for 17 h. The reaction mixture was removed from the heat and 
3M hydrochloric acid solution (7 mL) was added. The mixture was stirred for a 10 min. The 
organic layer was separated and the solvent evaporated to dryness. The crude product was purified 
by column chromatography (silica gel, gradient elution, DCM:EtOAc) giving the product as a 
yellow solid. 
Yield: 0.100 g, 0.0550 mmol, 55% 
1H NMR (400 MHz, CDCl3): δ 8.14 (s, 4H), 7.82-7.80 (m, 4H), 7.52-7.50 (m, 2H), 6.98 (dd, 4H, 
J = 6.2, 1.8), 6.79 (dd, 2H, J = 8.2, 1.8), 6.08 (d, 2H, J = 0.4), 4.23 (t, 4H, J = 6.8), 1.97-1.90 (m, 
4H), 1.66-1.59 (m, 4H), 1.48-1.42 (m, 8H), 1.34 (s, 36H), 0.97-0.96 (m, 24H). 
19F NMR (400 MHz): δ -126.67. 
13C NMR DEPT135 (100 MHz, CDCl3): δ 180.11 (C), 171.60 (C), 167.34 (C), 165.60 (C), 161.78 
(C), 156.50 (C), 153.86 (C), 153.57 (C), 151.36 (CH), 149.45 (C), 147.05 (C), 145.30 (C), 138.22 
(C), 132.49 (CH), 124.46 (CH), 124.14 (C), 120.42 (CH), 119.54 (CH), 35.14 (C), 34.62 (C), 
31.81 (CH2), 31.01 (tBu), 30.61 (tBu), 30.26 (CH2), 29.81 (CH2), 25.67 (CH2), 22.78 (CH2) 14.28 
(CH3).  
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(MALDI MS): for [M]+ calc’d 1818.6, found 1818.6. 
 
3.8.5 2,3-Pyrazine-Linked Dinuclear Iridium(III) Complexes  
Compound 3.5.1 - 1,2-Bis(4-tert-butylphenyl)-2-hydroxyethan-1-one263 
 
 
To a mixture of 4-(tert-butyl)benzaldehyde (5.00 g, 30.8 mmol) in ethanol:water (14:8.75 mL), 
was added potassium cyanide (0.435 g, 6.68 mmol) was added. The reaction mixture was refluxed 
under argon for 6 h. The reaction mixture was cooled to room temperature. The reaction mixture 
was filtered and the grey solid obtained washed with water. This crude product was recrystallised 
from methanol (≈65 mL). The product was isolated as an off-white solid. 
Yield: 2.13 g, 6.56 mmol, 98% 
1H NMR (400 MHz, CDCl3): δ 7.89 (d, 2H, J = 8.0), 7.42 (d, 2H, J = 8.8), 7.35 (d, 2H, J = 8.4), 
7.27 (d, 2H, J = 8.4), 5.91 (d, 1H, J = 6.4), 4.52 (d, 1H, J = 6.0), 1.29 (s, 9H), 1.27 (s. 9H). 
 
Compound 3.5.2 - Bis(4-tert-butylphenyl)ethane-1,2-dione263 
 
 
1,2-Bis(4-tert-butylphenyl)-2-hydroxyethan-1-one (1.01 g, 3.08 mmol), copper(II) acetate 
monohydrate (1.23 g, 6.16 mmol) and ammonium nitrate (0.111 g, 1.39 mmol) were added to a 
round-bottomed flask. Acetic acid (80%, 15 mL) was added. The reaction mixture was refluxed 
for 3 h. The reaction was cooled to room temperature and filtered in vacuo. The solid was washed 
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with water, methanol and ethyl acetate. The filtrate was separated and the organic layer was dried 
with sodium sulphate. The solvent was evaporated to dryness. To the residue, methanol was added 
and the flask placed in an ice bath. The resulting solid was filtered in vacuo and washed with cold 
methanol. The product was obtained as an off-white solid. 
Yield: 0.672 g, 2.08 mmol, 68% 
1H NMR (400 MHz, CDCl3): δ 7.91 (d, 4H, J = 8.7), 7.52 (d, 4H, J = 8.7), 1.34 (s, 18H). 
13C NMR (100 MHz, CDCl3): δ 194.68 (C), 159.00 (C), 130.63 (C), 130.00 (CH), 126.11 (CH), 
35.49 (C), 31.08 (CH3).  
 
Compound 3.5.3 – 5,6-bis(4-tert-butylphenyl)-2,3-dihydropyrazine 
 
 
Ethylene diamine (0.0676 g, 1.13 mmol) was added slowly to a solution of bis(4-tert-
butylphenyl)ethane-1,2-dione (0.302 g, 0.938 mmol) in ethanol at room temperature. The reaction 
mixture was refluxed for 3 h. The reaction was cooled to room temperature and the solvent was 
evaporated to dryness. The crude product was obtained as an off-white solid and was used in the 
next step without further purification. 
Yield: 0.310 g, 0.894 mmol, 95% 
1H NMR (400 MHz, CDCl3): δ 7.39-7.36 (m, 4H), 7.30-7.26 (m, 4H), 3.65 (s, 4H), 1.28 (s, 18H). 
 
Compound 3.5.4 – 2,3-bis(4-tert-butylphenyl)pyrazine 
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To 5,6-bis(4-tert-butylphenyl)-2,3-dihydropyrazine (0.310 g, 0.889 mmol), sulphur powder 
(0.0570 g, 1.78 mmol) was added and the mixture heated to 140 °C for 30 min. The reaction 
mixture was cooled to room temperature. The crude reaction mixture was purified by column 
chromatography (silica gel, hexane:ethyl acetate 10:1) to give the product as an off-white solid. 
Yield: 0.106 g, 0.309 mmol, 35% 
1H NMR (400 MHz, CDCl3): δ 8.55 (s, 2H), 7.42 (d, 4H, J = 8.2), 7.32 (d, 4H, J = 8.2), 1.31 (s, 
18H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 152.63 (C), 151.74 (C), 141.69 (CH), 135.82 (C), 
129.19 (CH), 125.21 (CH), 34.65 (C), 31.25 (CH3).  
 
Compound 3.5.6 - 1,4-diazatriphenylene 
 
 
Ethylenediamine (0.341 g, 5.67 mmol) was added to a solution of 9,10-phenanthrenequinone 
(0.984 g, 4.73 mmol) in ethanol (50 mL) at room temperature with stirring. The reaction mixture 
was heated to reflux for 48 h. The reaction mixture was cooled to room temperature. The yellow 
precipitate formed was filtered and washed with excess ethanol until the washing became 
colourless. The product was isolated as an off-white solid. 
Yield: 0.389 g, 1.69 mmol, 36% 
1H NMR (400 MHz, CDCl3): δ 9.16 (dd, 2H, J = 8.0, 1.6), 9.08 (s, 2H), 8.88 (d, 2H, J = 8.2), 
7.93-7.88 (m, 2H), 7.52-7.81 (m, 2H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 143.61 (CH), 141.55 (C), 131.51 (C), 129.97 (C), 
129.69 (CH), 127.80 (CH), 125.47 (CH), 122.85 (CH).  
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Compound 3.5.5 
 
 
Compound 3.2.4 (0.163 g, 0.295 mmol) and toluene (40 mL) were placed in a round-bottomed 
flask and silver triflate (0.114 g, 0.443 mmol) was added. The reaction mixture was stirred. 2,3-
Bis(4-tert-butylphenyl)pyrazine (0.0508 g, 0.148 mmol) was added and the reaction mixture was 
heated to reflux for 8 h. The heat was then removed from the reaction mixture and 2M HCl (7 
mL) was added. The reaction mixture was then stirred for a further 10 min. The organic layer was 
separated and the solvent evaporated to dryness. The orange-red residue was treated with 
methanol (10 mL) and filtered. The resulting solid was filtered in vacuo and the solid washed with 
a small amount of methanol. The solid collected was dissolved in dichloromethane and the 
solution gravity filtered. The filtrate was evaporated to dryness and the red-orange precipitate 
treated with a small amount of methanol and the solid filtered in vacuo. The crude product was 
purified by column chromatography (silica gel, gradient elution, DCM:EtOAc 10:1→10:3). The 
desired product was isolated as a red solid. 
Yield: 0.0233 g, 0.0170 mmol, 11% 
1H NMR (400 MHz, CDCl3): δ 9.92 (s, 1H), 8.39 (d, 2H, J = 8.7), 8.32-8.27 (m, 4H), 8.24 (s, 
2H), 8.12 (s, 2H), 7.93-7.82 (m, 6H), 7.71 (d, 2H, J = 8.2), 7.14 (q, 4H, J = 6.3), 6.46 (dd, 2H, J 
= 8.7, 1.8), 5.86 (d, 2H, J = 1.8), 1.56 (s, 18H), 0.76 (s, 18H). 
HRMS (FTMS+): for [M-2H]2+ calc’d 685.1823, found 685.1815. 
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Compound 3.5.10 
 
 
Compound 3.2.4 (0.152 g, 0.275 mmol) and toluene (40 mL) were placed in a round-bottomed 
flask and silver triflate (0.106 g, 0.413 mmol) was added. The reaction mixture was stirred. 1,4-
diazatriphenylene (0.0317 g, 0.138 mmol) was added and the reaction mixture was heated to 
reflux for 17 h. The heat was then removed from the reaction mixture and 3M HCl (8 mL) was 
added. The reaction mixture was then stirred for a further 10 min. The organic layer was separated 
and the solvent evaporated to dryness. The crude product was purified by column chromatography 
(silica gel, DCM 100:0). The desired product was isolated as a dark red solid. 
Yield: 0.0300 g, 0.0238 mmol, 17% 
 1H NMR (400 MHz, CDCl3): δ 10.49 (s, 2H), 7.98 (s, 4H), 7.93 (d, 4H, J = 7.8), 7.75 (d, 2H, J 
= 7.8), 7.70 (d, 4H, J = 5.5), 7.58 (t, 4H, J = 7.8), 6.99 (t, 2H, J = 7.6), 6.79 (t, 4H, J = 6.6), 6.25 
(d, 2H, J = 7.3), 1.58 (s, 18H). 
HRMS (FTMS+): for [M+H]+ calc’d 1257.2415, found 1257.2318. 
 
3.8.6 3,6-Pyridazine-Linked Dinuclear Iridium(III) Complexes 
Compound 3.6.5  – 3,6-Bis(4-tert-butylphenyl)pyridazine257 
 
 
3,6-Dichloropyridazine (0.497 g, 3.33 mmol), (4-tert-butylphenyl)boronic acid (1.54 g, 8.67 
mmol) and a 2M aqueous potassium carbonate solution (2.76 g, 20.0 mmol, 10.0 mL) were added 
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to a round-bottomed flask. 1,4-Dioxane (25 mL) was added. The mixture was degassed under 
argon for 20 min. Tetrakis(triphenylphosphine)palladium (0.231 g, 0.200 mmol) was added and 
the reaction mixture degassed for a further 10 minutes. The reaction was heated to 95 °C for 42 
h. The reaction was cooled to room temperature. A precipitate formed and this precipitate was 
filtered in vacuo. The solid was then recrystallised from dimethlformamide to give the product as 
a lustrous white solid. 
Yield: 0.659 g, 1.91 mmol, 57% 
1H NMR (400 MHz, CDCl3): δ 8.11 (d, 4H, J = 8.2), 7.90 (s, 2H), 7.57 (d, 4H, J = 8.2), 1.39 (s, 
18H). 
13C DEPT135 NMR (100 MHz, CDCl3): δ 157.24 (C), 153.28 (C), 133.33 (C), 126.58 (CH), 
126.02 (CH), 123.86 (CH), 34.83 (C-tBu), 31.26 (tBu).  
 
Compound 3.6.8 
 
 
Compound 3.2.4 (0.170 g, 0.308 mmol) was added to a round-bottomed flask. Toluene (30 mL) 
was added and the mixture stirred. Silver triflate (0.122 g, 0.463 mmol) was added. 3,6-Bis(4-
tert-butylphenyl)pyridazine (0.0531 g, 0.154 mmol) was added and the reaction mixture was 
heated to reflux for 15 h. The reaction mixture was removed from the heat and 3M hydrochloric 
acid solution (7 mL) was added. The mixture was stirred for a 5 min. The solvent was evaporated 
to dryness. A solution of 1:1 acetonitrile:water (4 mL) was added to the residue. To the solution 
formed, excess saturated aqueous ammonium hexafluorophosphate solution was added. An 
orange solid precipitated and was filtered in vacuo to give the crude product (0.233 g, 0.174 
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mmol). The crude solid was purified by column chromatography (silica gel, DCM:EtOAc 10:1). 
The product was isolated as a bright yellow solid.  
Yield: 0.0781 g, 0.0584 mmol, 38%  
1H NMR (400 MHz, CDCl3): δ 8.72 (s, 2H), 8.00 (d, 4H, J = 5.0), 7.71 (dd, 6H, J = 8.2, 3.2), 7.69 
(s, 4H), 7.50 (td, 4H, J = 7.3, 1.8), 6.94-6.92 (m, 6H), 6.00 (d, 2H, J = 1.8), 1.37 (s, 18H), 0.87 
(s, 18H). 
19F NMR (400 MHz, CDCl3): δ -71.8 
HRMS (FTMS+) for [M]+ calc’d 1337.4129, found 1337.4144; for [M-(Ir(NCN))-Cl]+ calc’d 
823.0780, found 823.3359. 
 
3.8.7 Variation of Monodentate Ligand 
Compound 3.3.14 
 
 
To a solution of compound 3.3.7 (0.088 g, 0.0500 mmol) in dichloromethane (15 mL), a solution 
of KCN (0.065 g, 1.00 mmol) in methanol (15 mL) was added and the mixture was stirred at RT 
for 4 h. The mixture was then reduced to a volume of 2-3 mL. Methanol (10 mL) was then added. 
The yellow solid was filtered off, washed with methanol and dried.  
Yield: 0.065 g, 0.0374 mmol, 75%.  
1H NMR (400 MHz, CDCl3): δ 11.47 (s, 1H), 8.47 (s,1H), 8.15 (br s, 4H), 7.87 (d, 2H, J = 8.0), 
7.83 (d, 4H, J = 5.9), 7.00 (dd, 2H, J = 8.0, 1.6),  6.93 (dd, 4H, J = 5.9, 1.6), 6.30 (d, 2H, J = 1.6), 
4.22 (t, 4H, J = 6.5), 1.94 (m, 4H), 1.64 (m, 4H), 1.44 (m, 8H), 1.34 (s, 36H), 1.02 (s, 18H), 0.97 
(t, 6H, J = 6.9).  
19F NMR (400 MHz, CDCl3): δ -126.5. 
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13C NMR DEPT135 (100 MHz, CDCl3): δ 164.5(CH), 150.4(CH), 132.5(CH), 125.9(CH), 
120.5(CH), 120.1(CH), 120.0(CH), 107.4(CH), 75.8(CH2), 31.7(CH2), 30.9 (CH3), 30.5(CH3), 
30.1(CH2), 25.6(CH2), 22.7(CH2), 14.1(CH3). 
HRMS (FTMS+) for [M+H]+ calc’d 1739.7252, found 1739.7240. 
 
Compound 3.7.1 
 
 
To compound 3.3.15 (0.0200 g, 0.0145 mmol) in dichloromethane (3 mL), potassium cyanide 
(0.0224 g, 0.291 mmol) in methanol (3 mL) was added. The reaction mixture was stirred at room 
temperature for 4 h. The solvent was evaporated to dryness and the residue treated with a small 
amount of methanol. The resulting solid was filtered to give the desired product.  
Yield: 0.0156 g, 0.0115 mmol, 79% 
1H NMR (400 MHz, CDCl3): δ 11.57 (s, 1H), 8.46 (s, 1H), 8.07 (d, 4H, J = 5.0), 7.94-7.93 (m, 
8H), 7.81 (d, 2H, J = 8.2), 7.66 (t, 4H, J = 7.8), 6.92 (t, 6H, J = 6.6), 6.00 (m, 2H), 1.55 (s, 18H), 
0.90 (s, 18H).  
 
Compound 3.7.2 
 
 
To compound 3.3.15 (0.118 g, 0.0861 mmol), silver triflate (0.0663 g, 0.258 mmol) was added. 
To this acetonitrile (2 mL) was added. The reaction mixture was stirred at room temperature under 
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argon for 15 h. To the reaction mixture, a small amount of acetonitrile was added and the mixture 
filtered through Celite. The filtrate was evaporated to dryness. To the residue, a small amount of 
acetonitrile was added. To the solution, excess saturated aqueous ammonium 
hexafluorophosphate solution was added. A solid precipitated and was filtered in vacuo and 
washed with water. The product was obtained as an orange-yellow solid. 
Yield: 0.115 g, 0.0830 mmol, 96% 
1H NMR (400 MHz, CDCl3): δ 10.63 (s, 1H), 8.49 (s, 1H), 8.19 (d, 4H, J = 5.0), 7.91 (t, 8H, J = 
3.9), 7.76 (td, 6H, J = 7.7, 1.4), 7.21 (ddd, 4H, J = 6.0, 1.8, 1.4), 6.88 (dd, 2H, J = 8.2, 1.8), 5.89 
(d, 2H, J = 1.8), 2.12 (s, 6H), 1.58 (s, 18H), 0.90 (s, 18H). 
19F NMR (400 MHz, CDCl3): δ -70.69, -72.59  
HRMS (FTMS+) for [M+H]+ calc’d 1739.7252, found 1739.7240. 
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4.0 Conclusions and Further Work 
The aim of this project was to synthesise and investigate novel bimetallic emitters in which the 
metal centres are rigidly-linked by cyclometallating bridging ligands and to assess the suitability 
of such complexes for application in OLEDs and bioimaging.  
The first section of this work was concerned with shifting the absorption and emission of dinuclear 
complexes to the red. Two strategies were used to achieve this, including the introduction of a 
second metal centre and extension of the conjugation length of the ligand. The di-platinum(II) 
complexes shown in Figure 148 were successfully prepared and shown to emit in the red and 
near-infrared regions of the spectrum. Work to evaluate these complexes as emitters in OLED 
devices is in progress and the results will be published in due course.  
 
 
Figure 148: A figure to show the structures of orange- and red-emitting dinuclear platinum(II) complexes, 2.1.1 and 
2.1.2, prepared using bis-bidentate ligands incorporating electron-rich thiophene moieties and extended conjugation 
lengths. 
 
Additionally, an unprecedented di-platinum(II) complex, in which the two Pt(II) centres were 
linked via a rigid, highly-conjugated bis-tetradentate ligand was synthesised. The identity of this 
complex, as shown in Figure 149, was confirmed. It is expected that the presence of two heavy 
metal centres, coupled with both the rigidity and highly-conjugated nature of the bis-tetradentate 
ligand, will give this dinuclear complex excellent photophysical properties being ideal for 
application as an emitter in OLEDs. Work is now ongoing to investigate the photophysical 
properties of this novel di-platinum(II) complex and its suitability for application in an OLED 
device. 
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Figure 149: The structure of the novel dinuclear platinum(II) complex 2.2.24, prepared in which the two metal centres 
are linked via a rigid bis-tetradentate ligand.   
 
The second part of this work was concerned with the synthesis and photophysical investigation 
of dinuclear iridium(III) complexes. More specifically, those in which the metal centres were 
rigidly-linked via cyclometallating bis-bidentate bridging ligands. Firstly, dinuclear complexes 
linked by pyrimidine-based bridging ligands, of the general structure shown in Figure 150, were 
studied. The design of these systems leads to the formation of only one dinuclear product, with 
the laborious separation of diastereoisomers previously reported for similar dinuclear iridium(III) 
complexes avoided. These complexes were found to have excellent photophysical properties, with 
quantum yields in the range ϕ = 0.88–1.0 and luminescence lifetimes between 0.4 and 0.6 μs. 
These properties are ideal for application in OLED devices. The facile colour tunability of the 
emission wavelengths for these dinuclear iridium(III) complexes was successfully demonstrated 
through variation of the terdentate N^C^N auxiliary ligand, the pyrimidine-based bis-bidentate 
bridging ligand and the monodentate ligand. 
 
 
Figure 150: The general structure of our pyrimidine-linked dinuclear iridium(III) complexes.  
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Through the variation of the central heterocycle of the bis-bidentate bridging ligand, from 4,6-
substituted pyrimidine to pyrazine and pyridazine, the effect of the bridging ligand structure on 
the properties of the resulting dinuclear iridium(III) complexes was evaluated. The alternative 
bridging ligands incorporated are shown in Figure 151 and were observed to have a significant 
effect on the properties of the dinuclear iridium(III) complexes obtained. The structural and 
photophysical properties of the resulting bimetallic Ir(III) complexes were studied, with the 3,6-
pyridazine-linked complex being successfully applied in bioimaging applications. These 
dinuclear iridium(III) complexes show enormous potential for application in OLED devices and 
in bioimaging. Further work is required to obtain a deeper insight into the effect of the bis-
bidentate bridging ligand structure on the photophysical properties of such complexes and also to 
thoroughly investigate the stability of these complexes in applications.  
 
 
Figure 151: A figure to show the alternative bis-bidentate bridging ligands investigated in our dinuclear iridium(III) 
complexes.  
 
The research completed in this project has highlighted the versatility and huge potential of 
dinuclear Pt(II) and Ir(III) complexes, rigidly-linked by cyclometallating bridging ligands, for 
utilisation in applications such as OLEDs and bioimaging.  
Further study of these families of multimetallic complexes, including advanced optimisation of 
both their chemical and photophysical properties, is required in order to increase their suitability 
for use in the applications described above.  
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Of particular interest with regards to the dinuclear iridium(III) complexes discussed in chapter 
3.0, is further work with variation of the monodentate ligands. The monodentate chloride ligands 
present in our dinuclear iridum(III) complexes are labile and therefore, the Ir-Cl bonds present a 
potential source of instability for these dinuclear iridium(III) complexes. Such instability is an 
issue with respect to application of such complexes in OLEDs as it may lead to device degradation 
and a reduction in device performance. Replacement of the chloride ligands with alternative 
monodentate ligands removes this source of instability and also offers additional opportunities 
for fine-tuning of the photophysiscal properties of our dinuclear iridium(III) complexes.  
Although initial exploration of alternative monodentate ligands was discussed in section 3.7, 
further work in this area is required. In particular, investigation into the incorporation of 
monodentate acetylide ligands would be of interest, as this class of ligands have been shown to 
have a strong influence on the properties of luminescent metal complexes. Consequently, through 
variation of the R groups on the acetylide ligand, we may be able to further control and fine tune 
the photophysical properties of our dinuclear iridium complexes.91, 258 
 
 
Figure 152: A figure to show the structure of acetylides that have the potential for use as monodentate ligands in our 
dinuclear iridium(III) complexes.91, 258  
 
Figure 152 shows a selection of monodentate acetylide ligands that could be incorporated into 
our dinuclear iridium(III) complexes. The R groups present have a large effect on the size of the 
monodentate acetylide ligands and therefore will strongly influence whether incorporation of such 
ligands will be successful. In the presence of larger R groups, there may be unfavourable steric 
hinderance between the acetylide ligands. Conversely, the presence of an R group such as phenyl 
may allow favourable π-π stacking interactions between the acetylide ligands.  
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Further work is requied in order to assess the viability of incorpating such monodentate acetylide 
ligands into this class of dinuclear iridium(III) complexes and to investigate their effects on the 
photophysical properties.   
 
Alternatively, rather than replacing the monodentate chloride with other monodentate ligands, it 
would be extremely interesting to investigate whether the addition of a bidentate ligand, capbable 
of linking the metal centres, would be possible. In addition, a study of the effects this has on both 
the structural and photophysical properties should be carried out.   
 
 
Figure 153: The structure of potential bidentate ligands that may be used in the replacement of the two monodentate 
chloride ligands to further bridge the two metal centres in our dinuclear iridium(III) complexes.  
 
Figure 153 shows the structure of one class of bidentate ligand that may be used in attempts to 
replace the two monodentate chloride ligands and bridge the iridium centres.  
Future work in this area should include the identification a wider range of potential bidentate 
ligands and also the further exploration of this concept in terms of viability, as well as the effects 
on the structural and photophysical properties of our dinuclear iridium(III) complexes.   
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5.0 Appendices 
5.1 Appendix 1 - Equipment and Chemicals 
Reagents were purchased from Sigma Aldrich, Alfa Aesar, Fluorochem and Apollo Scientific 
and were used without any further purification. 
Solvents were purchased from Fisher Scientific, Sigma Aldrich and Alfa Aesar at reagent, HPLC 
or spectroscopic grade. When required, solvents were dried over activated 4 Å molecular sieves. 
Column chromatography was performed using Fisher Scientific silica gel 60 Å (35-70 µL). 
NMR spectroscopy was performed on JEOL ELS400 Delta spectrometer at frequencies of 400 
MHz for 1H and 19F NMR and 101 MHz for 13C NMR. Chemical shifts (δ) are in ppm, using 
tetramethylsilane (TMS) as an internal standard and coupling constants are in Hertz. Deuterated 
chloroform (CDCl3) and deuterated dimethyl sulfoxide (d6-DMSO) were used as solvents. 
Chemical shifts were observed with splitting, integrals and J values. The splitting of the signals 
were recorded as singlet (s), doublet (d), triplet (t), quartet (q), quintet (quin), sextet (sext) and 
multiplet (m). Additionally, further splitting of signals were recorded as e.g. doublet of doublets 
(dd) and triplet of doublets (td). 
Mass spectra were obtained at the EPSRC National Mass Spectrometry Service Centre at 
Swansea University using spectrometers including a Thermo Scientific LTQ Orbitrap XL Mass 
spectrometer, a Waters Xevo G2-S ToF spectrometer, a Bruker ultrafleXtreme spectrometer and 
a Finnigan MAT 9S XP spectrometer. Ionisation techniques used included low resolution 
electrospray (ESI), high-resolution nano-electrospray (NSI) ionisation, atmospheric solids 
analysis probe (ASAP) and matrix-assisted laser desorption ionisation (MALDI).  
Absorption spectra recorded at Durham University were measured on a Biotek Instruments XA 
spectrometer, using quartz cuvettes of 1 cm path length. 
Absorption spectra recorded at Northumbria University were measured on a Varian Cary 50 
UV-vis spectrophotometer, using quartz cuvetters of 1 cm path length. 
Luminescence Spectra recorded at Durham University were measured using a Jobin Yvon 
Fluoromax®-2 spectrofluorimeter fitted with a red-sensitive Hamamatsu R928 photomultiplier 
tube; the spectra show in section 3.3 are corrected for the wavelength dependence of the detector, 
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and the quoted emission maxima refer to the values after correction. Samples for emission 
measurements were contained within quartz cuvettes of 1 cm path length modified with 
appropriate glassware to allow connection to a high-vacuum line. Degassing was achieved via a 
minimum of three freeze-pump-thaw cycles whilst connected to the vacuum manifold; final 
vapour pressure at 77 K was <5 x 10-2 mbar, as monitored using a Pirani gauge. Luminescence 
quantum yields were determined using fac-Ir(ppy)3 in degassed 2-methyltetrahydrofuran solution 
as the reference (ϕlum = 0.97217); estimated uncertainty in relative values of ϕlum is ±10% or better. 
The luminescence lifetimes of the complexes were measured by time-correlated single-photon 
counting, following excitation at 405 nm with a EPL-405 pulsed-diode laser. The emitted light 
was detected at 90° using a Peltier-cooled R928 PMT after passage through a monochromator. 
The lifetime of 3.3.13 at 77 K was measured using the same detector operating in multi-channel 
scaling mode, following excitation with a microsecond pulsed xenon flash-lamp. The estimated 
uncertainty in the quoted lifetimes is ±10% or better. Bimolecular rate constants for quenching 
by molecular oxygen, kQ, were determined from the lifetimes in degassed and air-equilibrated 
solution, taking the concentration of oxygen in CH2Cl2 at 0.21 atm O2 to be 2.2. mmol dm-3.  
Luminescence spectra recorded at Northumbria University were measured using a Horiba Jobin 
Yvon FluoroMax®-4 spectrofluorimeter. Samples for emission measurements were contained 
within quartz cuvettes of 1 cm path length. Deoxygenation was performed by bubbling of argon 
through the solution. 
Density functional theory calculations were carried out using Gaussian 09W. The B3LYP 
hybrid functional was used, together with the LanL2DZ basis set for iridium, and 6-31+G(d) for 
all other atom types. Geometries were fully optimised in vacuo. UV-visible absorption spectra 
were obtained by single point TD-DFT calculations at the optimised geometries, using the same 
functional and basis sets, either in vacuo or with a PCM solvent correction for dichloromethane. 
The molecular orbitals and spectra were visualised using GaussView 5.0 with Gaussian line 
shapes and an arbitrary half-width at half-height of 1000 cm-1 for the latter.  
Photophysical analysis carried out at the University of Sheffield involved UV-vis spectra 
recorded on a Varian Cary 5000 UV-Vis-NIR spectrophotometer in 1 cm quartz cuvettes. 
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Luminescence spectra were recorded on a Horiba Jobin Yvon FluoroMax®-4 spectrofluorimeter. 
Emission lifetimes were performed on the mini-τ spectrofluorometer (Edinburgh Instruments), 
with a 405 nm pulsed diode laser as an excitation source. The emission decays were detected in 
the spectral range 475-525 nm selected by a bandpass filter.  
Singlet oxygen yield of 3.6.8 measured at the University of Sheffield was measured by direct 
detection of the singlet oxygen emission (λem = 355 nm) in aerated acetonitrile according to the 
method previously described.  
Cell cultures carried out at the University of Sheffield used the cell lines HeLa (human cervical 
cancer) and U2OS (bone osteosarcoma), both purchased from American Type Culture Collection 
– LGC Partnership (Teddington, UK). The cells were cultured in Dulbecco’s modified Eagles 
Medium (DMEM) (Lonza, Cambridge, UK) with 10% fetal calf serum (FCS) (Lonza, Cambridge, 
UK) and incubated at 37 °C (5% CO2). Cells were routinely checked for mycoplasma 
contamination. 
Cell imaging was carried out at the University of Sheffield. Cells were platied at 150000 
cells/well onto sterile coverslips (22 x 22 mm) and left to incubate overnight. Staining solution at 
10 or 20 μM was diluted from compound stock (1 mM in DMSO) and added to the well. Control 
wells were incubated with equivalent DMSO concentration and the plates were incubated for 5 
hours. Following incubation, the cells were washed (3 x PBS) and fixed (4% paraformaldehyde 
in PBS, 20 mins) before being washed (3 x PBS) and mounted to microscope slides (immumount, 
20 mins). For mitotracker red staining (MitoTracker™ Red CMXRos, Molecular Probes® by Life 
Technologies Ltd, Paisley, UK) a final staining concentration of 100 nM was added to the cells 
in 30 mins before washing, fixing and mounting. For lysotracker red staining (LysoTracker™ 
Red DND-99, Molecular Probes® by Life Technologies Ltd, Paisley, UK) a final staining 
concentration of 75 nM was added for 1 hour before washing, fixing and mounting. For 
multiphoton imaging (Coherent Chameleon femto-second pulsed laser, Inverted Zeiss LSM 510 
NLO microscope) multiphoton light (800 nm) was used to excite 3.6.8; emission was registered 
in the region 565 – 615 nm. For the co-localisation imaging, a confocal microscope was used 
(Nikon A1) using a 60× lens (CFI Plan Apochromat VC 60× oil, NA 1.4). An argon laser (405 
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nm) was used to excite 3.6.8 and a sapphire laser (561 nm) was used to excite the costains. 
Pearson’s correlation coefficients were calculated using the open source imaging software Fiji 
(based on ImageJ) and the coloc 2 co-localisation tool. The threshold regression chosen was 
Bisection. 
Proliferation assay – MTT was also carried out at the University of Sheffield. 96-well plates 
were seeded with cells (HeLa or U2OS at 8000 cells/well) in culture medium (DMEM with 10% 
FCS) and incubated (37 °C, 5% CO2, overnight). Treatment solutions were made up in media 
(DMEM with 10% FCS) with the compound diluted from a DMSO stock (1 mM) to the desired 
staining concentrations (0, 5, 10 and 20 μM) with the final concentration of DMSO equal in all 
samples (2%).  
Toxicity assay – clonogenic survival was carried out at the University of Sheffield. 6-well plates 
were seeded at low density (HeLa, 200 and 400 cells/well) in culture medium (DMEM with 10% 
FCS) and incubated (37 °C, 5% CO2, overnight). Treatment solutions were prepared as above and 
added (1 mL/well, 5 hours). Following incubation, the treatment solution was removed and cells 
washed (1 X PBS) and fresh media was added (2 mL/well). The plates were left until visible cell 
colonies had formed. Media was replaced with staining solution (4% methylene blue, 70% 
methanol, minimum 30 mins). The staining solution was washed off and colonies counted with 
each colony representing a surviving cell. 
Transmission electron microscopy was also carried out at the University of Sheffield. Cells 
were cultured in T-25 flasks as above until ~90% confluency is achieved. Media was then 
removed, and the cells washed with sterile PBS (5 mL) before incubation with 20 μM complex-1 
for 4 h. 3.6.8 was the removed and the cells washed with sterile PBS (2 x 5 mL). Cells were 
detached using Trypsin EDTA, washed in media and glutaraldehyde (2.5% in cacodylate buffer) 
was added to fix the cells overnight at ~4 °C. Cells were then dehydrated, embedded in Araldite 
and sectioned in to 85 nm sections and mounted on copper grids before imaging under TEM, 
having either been unstained or stained with standard contrast agent (OsO4 2%, 1 h, UAc2 3%, 
25 mins, Reynold’s Lead Citrate, 5 mins). All TEM images were recorded using a FEI tecnai 
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120Kv G2 Biotwin TEM with an Orius SC100 bottom mounted camera using Gatan Digital 
Micrograph software. Image analysis was performed using ImageJ.  
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5.2 Appendix 2 - Pyrimidine-Linked Dinuclear Iridium(III) Complexes - TD-DFT 
HOMO-LUMO  
Selected calculated excitation energies (ΔE), oscillator strengths (f), and main orbital components 
for complex 3.3.7.a 
vacuum dichloromethane 
ΔE, nm f transition (coefficient) ΔE, nm f transition (coefficient) 
526 (triplet) HOMO-1  LUMO (0.59) 
HOMO  LUMO (0.32) 
499 (triplet) HOMO-1  LUMO (0.50) 
HOMO  LUMO (-0.43) 
516 (triplet) HOMO-3  LUMO (0.55) 
HOMO-2  LUMO (0.37) 
484 (triplet) HOMO-5  LUMO (0.16) 
HOMO-3  LUMO (0.60) 
499 (triplet) HOMO-1  LUMO (-0.32) 
HOMO  LUMO (0.60) 
462 (triplet) HOMO-2  LUMO+1 (0.31) 
HOMO-1  LUMO+2 (-0.32) 
494 0.033   HOMO  LUMO (0.70) 461 (triplet) HOMO-2  LUMO+2 (-0.28) 
HOMO-1  LUMO+1 (0.35) 
490 0.118   HOMO-1  LUMO (0.70) 459 (triplet) HOMO-3  LUMO+1 (0.26) 
HOMO  LUMO+2 (0.36) 
441 0.060   HOMO-2  LUMO+1 (0.42) 
HOMO  LUMO+2 (0.39) 
459 (triplet) HOMO-2  LUMO+2 (-0.30) 
HOMO  LUMO+1 (0.41) 
433 0.018   HOMO-3  LUMO+1 (0.42) 
HOMO-1  LUMO+2 (-0.38) 
456 0.308   HOMO-1  LUMO (-0.47) 
HOMO  LUMO (0.52) 
418 0.115   HOMO-3  LUMO+4 (-0.33) 
HOMO-1  LUMO+3 (0.38) 
408 0.157   HOMO-2  LUMO+1 (0.44) 
HOMO  LUMO+2 (-0.37) 
412 0.053   HOMO-2  LUMO+4 (0.40) 
HOMO  LUMO+3 (0.40) 
398 0.020   HOMO-3  LUMO+1 (0.42) 
HOMO-1  LUMO+2 (-0.37) 
379 0.371   HOMO-5  LUMO (-0.17) 
HOMO-4  LUMO (0.60) 
387 0.219   HOMO-3  LUMO+5 (-0.34) 
HOMO-1  LUMO+3 (0.37) 
369 0.040   HOMO-6  LUMO (0.49) 
HOMO  LUMO+4 (-0.28) 
381 0.114   HOMO-2  LUMO+5 (0.36) 
HOMO  LUMO+3 (-0.36) 
369 0.030 HOMO-6  LUMO (0.43) 
HOMO-2  LUMO+3 (-0.35) 
380 0.030   HOMO-2  LUMO+3 (0.41) 
HOMO-1  LUMO+5 (-0.31) 
   374 0.092   HOMO-4  LUMO (0.48) 
HOMO-3  LUMO+4 (-0.36) 
   373 0.018   HOMO  LUMO+4 (0.41) 
HOMO  LUMO+5 (0.40) 
   364 0.160   HOMO-3  LUMO+1 (0.39) 
HOMO-1  LUMO+2 (0.36) 
   362 0.054   HOMO-5  LUMO (0.54) 
HOMO-3  LUMO+2 (0.33) 
   362 0.024   HOMO-5  LUMO (-0.32) 
HOMO-3  LUMO+2 (0.38) 
   359 0.109   HOMO-2  LUMO+1 (0.32) 
HOMO-2  LUMO+4 (0.28 
   359 0.075   HOMO-3  LUMO+4 (0.32) 
HOMO  LUMO+2 (-0.30) 
aFor brevity, only transitions with f > 0.01 and/or ΔE > 350 nm are included, and only the two largest components of 
each transition are listed. 
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Frontier orbitals and their energies in Hartree (eV) for complex 3.3.7 
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Selected calculated excitation energies (ΔE), oscillator strengths (f), and main orbital components 
for complex 3.3.8.a 
vacuum dichloromethane 
ΔE, nm f transition (coefficient) ΔE, nm f transition (coefficient) 
527 (triplet) HOMO-1  LUMO (-0.20) 
HOMO  LUMO (0.64) 
498 (triplet) HOMO-4  LUMO (0.18) 
HOMO  LUMO (0.66) 
516 (triplet) HOMO-3  LUMO (-0.16) 
HOMO-2  LUMO (0.65) 
483 (triplet) HOMO-3  LUMO (-0.19) 
HOMO-2  LUMO (0.59) 
492 0.130   HOMO  LUMO (0.70) 453 0.305   HOMO  LUMO (0.70) 
486 0.012   HOMO-1  LUMO (0.70) 399 0.107   HOMO-3  LUMO+1 (-0.35) 
HOMO-1  LUMO+2 (0.44) 
433 0.026   HOMO-2  LUMO+1 (0.32) 
HOMO-1  LUMO+2 (0.44) 
393 0.011   HOMO-2  LUMO+2 (0.36) 
HOMO  LUMO+1 (0.52) 
428 0.026   HOMO-2  LUMO+1 (-0.34) 
HOMO  LUMO+2 (0.49) 
393 0.029   HOMO-2  LUMO+1 (0.37) 
HOMO  LUMO+2 (0.50) 
415 0.127   HOMO-2  LUMO+5 (-0.34) 
HOMO  LUMO+3 (0.43) 
383 0.268   HOMO-2  LUMO+4 (-0.32) 
HOMO  LUMO+3 (0.45) 
406 0.048   HOMO-2  LUMO+4 (-0.37) 
HOMO-1  LUMO+3 (0.42) 
374 0.240   HOMO-4  LUMO (0.37) 
HOMO-1  LUMO+3 (0.41) 
398 0.019   HOMO-2  LUMO+4 (0.43) 
HOMO-2  LUMO+5 (0.28) 
373 0.034   HOMO-3  LUMO+3 (0.32) 
HOMO-1  LUMO+4 (0.33) 
380 0.015   HOMO-3  LUMO+1 (0.44) 
HOMO-1  LUMO+2 (-0.39) 
371 0.048   HOMO-4  LUMO (0.43) 
HOMO-2  LUMO+5 (0.42) 
379 0.341   HOMO-4  LUMO (0.61) 
HOMO-2  LUMO+4 (-0.19) 
369 0.045   HOMO-5  LUMO (-0.36) 
HOMO  LUMO+5 (0.49) 
369 0.067   HOMO-5  LUMO (0.68) 360 0.128   HOMO-2  LUMO+1 (-0.33) 
HOMO  LUMO+2 (0.43) 
   360 0.046   HOMO-5  LUMO (0.54) 
HOMO-1  LUMO+4 (-0.25) 
   356 0.111   HOMO-3  LUMO+5 (-0.30) 
HOMO-2  LUMO+5 (0.34) 
aFor brevity, only transitions with f > 0.01 and/or ΔE > 350 nm are included, and only the two largest components of 
each transition are listed. 
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Frontier orbitals and their energies in Hartree (eV) for complex 3.3.8 
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Selected calculated excitation energies (ΔE), oscillator strengths (f), and main orbital components 
for complex 3.3.9.a 
vacuum dichloromethane 
ΔE, nm f transition (coefficient) ΔE, nm f transition (coefficient) 
520 (triplet) HOMO-4  LUMO (-0.17) 
HOMO  LUMO (0.67) 
492 (triplet) HOMO-4  LUMO (0.19) 
HOMO  LUMO (0.65) 
509 (triplet) HOMO-7  LUMO (-0.13) 
HOMO-1  LUMO (0.66) 
476 (triplet) HOMO-1  LUMO (0.61) 
HOMO  LUMO+5 (-0.18) 
484 0.144   HOMO  LUMO (0.70) 449 (triplet) HOMO-1  LUMO+1 (-0.36) 
HOMO  LUMO+2 (0.38) 
409 0.127   HOMO-3  LUMO+1 (-
0.35) 
HOMO-2  LUMO+2 (0.42) 
449 (triplet) HOMO-1  LUMO+2 (-0.36) 
HOMO  LUMO+1 (0.38) 
396 0.014   HOMO-1  LUMO+4 (-
0.30) 
HOMO-1  LUMO+5 (0.47) 
448 0.324   HOMO  LUMO (0.70) 
390 0.071   HOMO-3  LUMO+4 (-
0.31) 
HOMO-2  LUMO+3 (0.44) 
397 0.013   HOMO-1  LUMO+2 (-0.43) 
HOMO  LUMO+1 (0.54) 
376 0.142   HOMO-4  LUMO (0.40) 
HOMO-3  LUMO+5 (0.37) 
397 0.016   HOMO-1  LUMO+1 (-0.44) 
HOMO  LUMO+2 (0.52) 
375 0.204   HOMO-4  LUMO (0.45) 
HOMO-3  LUMO+5 (-
0.37) 
374 0.277   HOMO-3  LUMO+1 (-0.42) 
HOMO-2  LUMO+2 (0.47) 
365 0.070   HOMO-5  LUMO (0.68) 368 0.093   HOMO-4  LUMO (0.46) 
HOMO-1  LUMO+5 (0.42) 
   363 0.189   HOMO-1  LUMO+1 (0.43) 
HOMO  LUMO+2 (0.38) 
   360 0.246   HOMO-2  LUMO+3 (-0.29) 
HOMO-1  LUMO+5 (0.46) 
   360 0.120   HOMO-5  LUMO (0.63) 
HOMO-2  LUMO+4 (0.20) 
aFor brevity, only transitions with f > 0.01 and/or ΔE > 350 nm are included, and only the two largest components of 
each transition are listed. 
  
 242 
 
Frontier orbitals and their energies in Hartree (eV) for complex 3.3.9 
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Selected calculated excitation energies (ΔE), oscillator strengths (f), and main orbital components 
for complex 3.3.10.a 
vacuum dichloromethane 
ΔE, nm f transition (coefficient) ΔE, nm f transition (coefficient) 
535 (triplet) HOMO-1  LUMO (0.64) 
HOMO  LUMO (-0.21) 
504 (triplet) HOMO-1  LUMO (0.64) 
HOMO  LUMO (-0.21) 
525 (triplet) HOMO-3  LUMO (0.62) 
HOMO-2  LUMO (-0.26) 
490 (triplet) HOMO-3  LUMO (0.64) 
HOMO-1  LUMO+3 (-0.14) 
510 (triplet) HOMO-1  LUMO (0.22) 
HOMO  LUMO (0.66) 
466 (triplet) HOMO-1  LUMO (0.20) 
HOMO  LUMO (0.62) 
497 0.123   HOMO-1  LUMO (0.70) 461 0.202   HOMO-1  LUMO (-0.48) 
HOMO  LUMO (0.51) 
438 0.070   HOMO-2  LUMO+1 (-
0.42) 
HOMO  LUMO+2 (0.45) 
459 0.059   HOMO-1  LUMO (0.51) 
HOMO  LUMO (0.48) 
430 0.017   HOMO-3  LUMO+1 (0.45) 
HOMO-1  LUMO+2 (0.43) 
405 0.177   HOMO-2  LUMO+1 (-0.45) 
HOMO  LUMO+2 (0.46) 
415 0.116   HOMO-3  LUMO+5 (0.42) 
HOMO-1  LUMO+4 (-
0.42) 
394 0.011   HOMO-3  LUMO+2 (-0.40) 
HOMO-1  LUMO+1 (0.48) 
412 0.057   HOMO-2  LUMO+5 (0.35) 
HOMO  LUMO+4 (0.41) 
394 0.024   HOMO-3  LUMO+1 (-0.42) 
HOMO-1  LUMO+2 (0.45) 
382 0.171   HOMO-5  LUMO (-0.29) 
HOMO-4  LUMO (0.58) 
384 0.215   HOMO-3  LUMO+5 (0.42) 
HOMO-1  LUMO+4 (0.46) 
380 0.110   HOMO-5  LUMO (0.56) 
HOMO-4  LUMO (0.36) 
380 0.143   HOMO-2  LUMO+5 (0.37) 
HOMO  LUMO+4 (0.41) 
370 0.021   HOMO-7  LUMO (0.33) 
HOMO-6  LUMO (0.61) 
379 0.018   HOMO-2  LUMO+4 (0.36) 
HOMO  LUMO+5 (0.34) 
368 0.013   HOMO-2  LUMO+4 (0.38) 
HOMO  LUMO+5 (-0.37) 
376 0.058   HOMO-4  LUMO (0.48) 
HOMO-3  LUMO+3 (-0.45) 
368 0.025   HOMO-7  LUMO (0.48) 
HOMO-2  LUMO+4 (0.31) 
373 0.023   HOMO-5  LUMO (0.27) 
HOMO-1  LUMO+3 (0.56) 
   362 0.180   HOMO-4  LUMO (0.39) 
HOMO-1  LUMO+2 (0.33) 
   362 0.061   HOMO-5  LUMO (0.61) 
HOMO-1  LUMO+3 (-0.19) 
   358 0.026   HOMO-3  LUMO+1 (0.38) 
HOMO-3  LUMO+3 (-0.36) 
aFor brevity, only transitions with f > 0.01 and/or ΔE > 350 nm are included, and only the two largest components of 
each transition are listed. 
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Frontier orbitals and their energies in Hartree (eV) for complex 3.3.10 
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Selected calculated excitation energies (ΔE), oscillator strengths (f), and main orbital components 
for complex 3.3.11.a 
vacuum dichloromethane 
ΔE, nm f transition (coefficient) ΔE, nm f transition (coefficient) 
518 (triplet) HOMO-2  LUMO (0.59) 
HOMO  LUMO (0.33) 
492 (triplet) HOMO-2  LUMO (0.63) 
HOMO  LUMO (0.21) 
509 (triplet) HOMO-3  LUMO (0.57) 
HOMO-1  LUMO (-0.37) 
481 (triplet) HOMO-3  LUMO (0.58) 
HOMO-1  LUMO (-0.28) 
506 (triplet) HOMO-2  LUMO (-0.33) 
HOMO  LUMO (0.61) 
473 (triplet) HOMO-2  LUMO (-0.21) 
HOMO  LUMO (0.66) 
501 (triplet) HOMO  LUMO (0.70) 470 (triplet) HOMO-3  LUMO+2 (0.31) 
HOMO  LUMO+4 (-0.40) 
487 0.092   HOMO-2  LUMO (0.70) 468 0.016 HOMO  LUMO (0.70) 
426 0.082   HOMO-1  LUMO+1 (0.45) 
HOMO  LUMO+2 (0.46) 
456 0.195 HOMO-2  LUMO (0.70) 
413 0.029   HOMO-3  LUMO+1 (0.42) 
HOMO-2  LUMO+2 (0.41) 
397 0.016 HOMO-1  LUMO+2 (-0.46) 
HOMO  LUMO+1 (0.50) 
402 0.072   HOMO-3  LUMO+4 (0.39) 
HOMO  LUMO+3 (-0.36) 
396 0.214 HOMO-1  LUMO+1 (-0.46) 
HOMO  LUMO+2 (0.49) 
399 0.119   HOMO-2  LUMO+3 (0.31) 
HOMO-1  LUMO+4 (0.38) 
379 0.011 HOMO-1  LUMO+4 (-0.34) 
HOMO  LUMO+3 (0.37) 
397 0.021   HOMO-1  LUMO+3 (0.41) 
HOMO  LUMO+4 (-0.38) 
378 0.402 HOMO-5  LUMO (0.59) 
HOMO-2  LUMO+2 (-0.23) 
385 0.121  HOMO-5  LUMO (-0.30) 
HOMO-4  LUMO (0.48) 
373 0.095 HOMO-4  LUMO (0.55) 
HOMO  LUMO+4 (-0.24) 
380 0.022   HOMO-1  LUMO+1 (0.40) 
HOMO  LUMO+2 (-0.35) 
371 0.036 HOMO-3  LUMO+3 (-0.44) 
HOMO-2  LUMO+4 (0.47) 
374 0.015   HOMO-1  LUMO+1 (0.27) 
HOMO-1  LUMO+5 (0.56) 
371 0.145 HOMO-3  LUMO+4 (-0.45) 
HOMO-2  LUMO+3 (0.48) 
373 0.044  HOMO-3  LUMO+1 (-0.43) 
HOMO-2  LUMO+2 (0.46) 
   
373 0.018  HOMO-6  LUMO (0.47) 
HOMO-3  LUMO+2 (-0.34) 
   
368 0.084   HOMO-5  LUMO (-0.22) 
HOMO-3  LUMO+5 (0.60) 
   
368 0.043  HOMO-7  LUMO (0.55) 
HOMO-2  LUMO+5 (0.35) 
   
aFor brevity, only transitions with f > 0.01 and/or ΔE > 350 nm are included, and only the two largest components of 
each transition are listed. 
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Frontier orbitals and their energies in Hartree (eV) for complex 3.3.11 
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Selected calculated excitation energies (ΔE), oscillator strengths (f), and main orbital components 
for complex 3.3.12.a 
vacuum dichloromethane 
ΔE, nm f transition (coefficient) ΔE, nm f transition (coefficient) 
510 (triplet) HOMO-4  LUMO (0.21) 
HOMO  LUMO (0.60) 
497 (triplet) HOMO-4  LUMO (0.17) 
HOMO  LUMO (0.65) 
490 (triplet) HOMO-3  LUMO (-0.39) 
HOMO-2  LUMO (0.43) 
475 (triplet) HOMO-5  LUMO (-0.26) 
HOMO-3  LUMO (0.52) 
485 (triplet) HOMO-2  LUMO+1 (0.37) 
HOMO-1  LUMO+2 (0.41) 
459 (triplet) HOMO-3  LUMO+1 (-0.22) 
HOMO  LUMO+2 (0.24) 
485 (triplet) HOMO-2  LUMO+2 (0.34) 
HOMO-1  LUMO+1 (0.46) 
459 (triplet) HOMO-3  LUMO+2 (-0.23) 
HOMO  LUMO+1 (0.24) 
476 (triplet) HOMO-3  LUMO+1 (0.31) 
HOMO  LUMO+2 (0.39) 
456 (triplet) HOMO-2  LUMO+1 (0.40) 
HOMO-1  LUMO+2 (0.41) 
476 (triplet) HOMO-3  LUMO+2 (0.31) 
HOMO  LUMO+1 (0.40) 
456 (triplet) HOMO-2  LUMO+2 (0.38) 
HOMO-1  LUMO+1 (0.44) 
461 0.238   HOMO  LUMO (0.69) 438 0.529   HOMO  LUMO (0.69) 
457 0.024   HOMO-2  LUMO+1 (0.10) 
HOMO-1  LUMO (0.69) 
406 0.148   HOMO-2  LUMO+1 (0.43) 
HOMO-1  LUMO+2 (0.47) 
441 0.054   HOMO-2  LUMO+1 (0.36) 
HOMO-1  LUMO+2 (0.47) 
387 0.224   HOMO-3  LUMO+4 (-0.37) 
HOMO  LUMO+3 (0.50) 
419 0.121   HOMO-3  LUMO+4 (0.32) 
HOMO  LUMO+3 (0.46) 
379 0.030   HOMO-2  LUMO+4 (0.40) 
HOMO-1  LUMO+3 (0.47) 
410 0.021   HOMO-2  LUMO+4 (0.33) 
HOMO-1  LUMO+3 (0.48) 
378 0.016   HOMO-2  LUMO+3 (0.43) 
HOMO-1  LUMO+4 (0.44) 
384 0.062   HOMO-4  LUMO (0.41) 
HOMO-2  LUMO+5 (0.42) 
367 0.232   HOMO-4  LUMO (0.51) 
HOMO-3  LUMO+1 (0.28) 
370 0.366   HOMO-4  LUMO (0.48) 
HOMO-3  LUMO+5 (0.28) 
352 0.091   HOMO-4  LUMO (0.15) 
HOMO-2  LUMO+5 (0.65) 
368 0.073   HOMO-3  LUMO+4 (0.36) 
HOMO-2  LUMO+4 (0.37) 
352 0.137   HOMO-7  LUMO (-0.13) 
HOMO-5  LUMO (0.67) 
358 0.056   HOMO-8  LUMO+1 (0.17) 
HOMO-4  LUMO+2 (0.63) 
350 0.292   HOMO-4  LUMO (0.27) 
HOMO-3  LUMO+5 (0.61) 
354 0.103   HOMO-8  LUMO (-0.16) 
HOMO-5  LUMO (0.64) 
   
353 0.023   HOMO-7  LUMO+1 (-0.14) 
HOMO-6  LUMO (0.68) 
   
aFor brevity, only transitions with f > 0.01 and/or ΔE > 350 nm are included, and only the two largest components of 
each transition are listed. 
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Frontier orbitals and their energies in Hartree (eV) for complex 3.3.12 
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Selected calculated excitation energies (ΔE), oscillator strengths (f), and main orbital components 
for complex 3.3.13.a 
vacuum dichloromethane 
ΔE, nm f transition (coefficient) ΔE, nm f transition (coefficient) 
581 (triplet) HOMO-4  LUMO (-0.18) 
HOMO  LUMO (0.63) 
572 (triplet) HOMO-2  LUMO+5 (-0.13) 
HOMO  LUMO (0.65) 
546 (triplet) HOMO-2  LUMO (0.51) 
HOMO  LUMO+5 (-0.30) 
536 (triplet) HOMO-2  LUMO (0.51) 
HOMO  LUMO+5 (-0.35) 
485 (triplet) HOMO-3  LUMO+1 (0.43) 
HOMO-1  LUMO+2 (0.38) 
461 (triplet) HOMO-2  LUMO+2 (0.28) 
HOMO  LUMO+1 (0.34) 
484 (triplet) HOMO-3  LUMO+2 (0.39) 
HOMO-1  LUMO+1 (0.48) 
461 (triplet) HOMO-2  LUMO+1 (0.28) 
HOMO  LUMO+2 (0.33) 
479 (triplet) HOMO-2  LUMO+2 (0.35) 
HOMO  LUMO+1 (0.45) 
461 0.620   HOMO  LUMO (0.69) 
478 (triplet) HOMO-2  LUMO+1 (0.36) 
HOMO  LUMO+2 (0.43) 
408 0.049   HOMO-1  LUMO+2 (0.37) 
HOMO  LUMO+3 (0.41) 
477 0.362   HOMO-2  LUMO+1 (0.10) 
HOMO  LUMO (0.69) 
394 0.322   HOMO-1  LUMO+2 (-0.35) 
HOMO  LUMO+3 (0.45) 
455 0.012   HOMO-2  LUMO (0.64) 
HOMO  LUMO+1 (0.21) 
378 0.019   HOMO-2  LUMO+1 (0.52) 
HOMO-1  LUMO+3 (-0.22) 
440 0.034   HOMO-3  LUMO+1 (0.37) 
HOMO-1  LUMO+2 (0.43) 
373 0.013   HOMO-2  LUMO+2 (0.54) 
HOMO-1  LUMO+4 (-0.24) 
422 0.157   HOMO-2  LUMO+4 (-0.31) 
HOMO  LUMO+3 (0.47) 
368 0.106   HOMO-4  LUMO (0.56) 
HOMO-2  LUMO+5 (-0.29 
385 0.098   HOMO-4  LUMO (0.55) 
HOMO-2  LUMO+5 (0.38) 
362 0.012   HOMO-2  LUMO+4 (0.55) 
HOMO  LUMO+3 (-0.33) 
368 0.088   HOMO-3  LUMO+4 (0.43) 
HOMO-1  LUMO+3 (-0.41) 
   
366 0.203   HOMO-3  LUMO+4 (-0.34) 
HOMO-2  LUMO+5 (0.45) 
   
355 0.066   HOMO-4  LUMO+2 (0.61) 
HOMO-2  LUMO+5 (-0.19) 
   
354 0.017   HOMO-7  LUMO+1 (0.12) 
HOMO-5  LUMO (0.68) 
   
350 0.148   HOMO-8  LUMO (-0.26) 
HOMO-6  LUMO (0.61) 
   
aFor brevity, only transitions with f > 0.01 and/or ΔE > 350 nm are included, and only the two largest components of 
each transition are listed. 
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Selected calculated excitation energies (ΔE), oscillator strengths (f), and main orbital components 
for complex 3.3.14.a 
vacuum dichloromethane 
ΔE, nm f transition (coefficient) ΔE, nm f transition (coefficient) 
496 (triplet) HOMO-5  LUMO (0.21) 
HOMO-2  LUMO (0.65) 
482 (triplet) HOMO-5  LUMO (0.24) 
HOMO-2  LUMO (0.63) 
483 (triplet) HOMO-3  LUMO (0.47) 
HOMO-1  LUMO (0.36) 
466 (triplet) HOMO-4  LUMO (0.36) 
HOMO-3  LUMO (0.42) 
472 (triplet) HOMO-1  LUMO+1 (-0.34) 
HOMO  LUMO (0.50) 
451 (triplet) HOMO-1  LUMO+1 (0.37) 
HOMO  LUMO+2 (0.33) 
470 (triplet) HOMO-1  LUMO+2 (0.40) 
HOMO  LUMO+1 (0.42) 
451 (triplet) HOMO-1  LUMO+2 (0.37) 
HOMO  LUMO+1 (0.36) 
463 (triplet) HOMO  LUMO (0.47) 
HOMO  LUMO+2 (0.37) 
445 (triplet) HOMO-1  LUMO+1 (0.26) 
HOMO  LUMO+2 (0.31) 
450 0.237   HOMO-2  LUMO (0.69) 445 (triplet) HOMO-3  LUMO+2 (0.26) 
HOMO  LUMO+1 (-0.30) 
413 0.023   HOMO-1  LUMO+2 (0.48) 
HOMO  LUMO+1 (0.48) 
438 (triplet) HOMO  LUMO (0.64) 
HOMO  LUMO+2 (0.18) 
412 0.151   HOMO-1  LUMO+1 (0.48) 
HOMO  LUMO+2 (0.48) 
431 0.418   HOMO-2  LUMO (0.69) 
390 0.046   HOMO-3  LUMO+1 (-0.40) 
HOMO-2  LUMO+2 (0.50) 
393 0.041   HOMO-1  LUMO+2 (0.48) 
HOMO  LUMO+1 (0.49 
379 0.010   HOMO-1  LUMO+1 (-0.20) 
HOMO-1  LUMO+3 (0.60) 
392 0.286   HOMO-1  LUMO+1 (0.48) 
HOMO  LUMO+2 (0.49) 
375 0.177   HOMO-5  LUMO (0.43) 
HOMO  LUMO+4 (-0.35) 
371 0.017   HOMO-3  LUMO+2 (0.36) 
HOMO-2  LUMO+1 (0.54) 
374 0.048   HOMO-1  LUMO+4 (0.36) 
HOMO  LUMO+5 (0.40) 
371 0.041   HOMO-3  LUMO+1 (0.37) 
HOMO-2  LUMO+2 (0.54) 
370 0.032   HOMO-5  LUMO (0.33) 
HOMO-3  LUMO+3 (0.38) 
364 0.133   HOMO-4  LUMO (0.61) 
HOMO-1  LUMO+4 (0.21) 
368 0.109   HOMO-3  LUMO+5 (-0.40) 
HOMO-2  LUMO+4 (0.51) 
363 0.351   HOMO-8  LUMO (-0.17) 
HOMO-5  LUMO (0.62) 
367 0.057   HOMO-3  LUMO+4 (-0.38) 
HOMO-2  LUMO+5 (0.47) 
358 0.035   HOMO-1  LUMO+3 (0.51) 
HOMO  LUMO+4 (-0.29) 
360 0.123   HOMO-3  LUMO+1 (0.37) 
HOMO-2  LUMO+2 (0.37) 
354 0.014   HOMO-1  LUMO+3 (0.33) 
HOMO-1  LUMO+5 (-0.32 
356 0.050   HOMO-3  LUMO+1 (0.33) 
HOMO-3  LUMO+3 (0.47) 
351 0.096   HOMO-3  LUMO+5 (-
0.40) 
HOMO-2  LUMO+4 (0.53) 
   351 0.015   HOMO-2  LUMO+3 (0.29) 
HOMO-2  LUMO+5 (0.31) 
   351 0.011   HOMO-2  LUMO+3 (-
0.32) 
HOMO-2  LUMO+5 (0.41) 
aFor brevity, only transitions with f > 0.01 and/or ΔE > 350 nm are included, and only the two largest components of 
each transition are listed. 
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